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Abstract 
Background: It is now widely accepted that physical training therapy is more reliable and 
effective than medication in improving fatigue in patients with Multiple Sclerosis (MS). 
However, efforts are still being made to maximise the benefits of training and hence increase 
independence and optimise the levels of daily functioning in those patients. The present 
research is a step in that direction. Towards this end, a 12-week training programme with new 
design guidelines has been developed and tested on a group of fatigued Kuwaiti MS patients 
with no previous training experience. 
Method: This was a mainly quasi controlled study (ABA design) with an independent 
assessor studying the effects of 12-week period of exercise on fatigue measure using the 
Modified Fatigue Impact Scale (MFIS). In addition to fatigue, a range of both quantitative 
and qualitative data were collected and these were: Expanded Disability Status Scale 
(EDSS), , Hospital Anxiety and Depression Scale (HADS), Barthel index (BI),   Berg 
Balance Scale (BBS), Timed Up and Go (TUG), the 10-metre walk, the 6-minute walk, and 
the 9-Peg-hole test. Handgrip strength, knee, elbow and hip flexion and extension and 
shoulder adduction were also assessed.  Two short and semi-structured interviews were 
administered to obtain additional information on the impact of fatigue on the participants and 
their attitude towards training. 
The training programme consisted of 3x30-minute weekly sessions of resistance or combined 
training. Initially, combined training consisted of 15 minutes of treadmill walking, followed 
by 2 sets of 9 stretching and strengthening exercises, 15-20 repetitions. For resistance training, 
participants performed 3 sets of 15-20 reps of stretching and strengthening exercise. In week 
7 onward, treadmill walking time was increased by 5 minutes, and resistance training sets 
were increased by one. 
Results: We recruited 26 patients (mean age 37.54, 8 males and 18 females). Following the 
12-week training programme, tests  showed significant improvements in fatigue, fine
mobility and static and dynamic balance (TUG); short duration walking speed (10m test); 
exercise tolerance (6-minute walk); balance and fear of fall (BBS); left and right shoulder 
flexion and adduction, and left and right elbow, knee and hip flexion and extension (MMT). 
All these gains were still maintained four weeks after the training intervention had been 
terminated. However, there was no significant effect of training on anxiety and depression 
(HADS); mobility disability (EDSS); personal basic functional activities (B1); fine motor 
coordination and finger dexterity (9-HolePeg) and hand grip (JAMAR). Results of the study 
also show that support for Kuwaiti MS patients is lacking and that the rigid cultural norms 
place those patients under a great deal of unnecessary stress and pressure 
Conclusion: MS patients with mild to moderate disabilities can gain immensely from 
individualised and customised resistance and combined training programmes. There is good 
reason to suggest that their gains can be increased even further with improved attitude 
towards training. Societal stressors are a significant confounder and these need to be 
addressed before an randomised controlled trial is carried out. 
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Chapter 1: Introduction 
1.1. Statement of the problem 
Multiple Sclerosis (MS) is a chronic, progressive and degenerative disease that affects the 
central nervous system, CNS (Mumford et al., 1992). To this day, no curative treatment for 
MS has been found, and its sources and causes remain unknown (Compston and McDonald, 
2005). The disease is usually associated with a wide range of impairments including, muscle 
weakness (Ng et al., 2004), sensory dysfunction (Thoumie and Mevellec, 2002), movement 
incoordination (Cattaneo et al., 2002), spasticity (Paisley et al., 2002), anxiety, depression, 
and fatigue (Schwid et al., 2002). Of these, fatigue is often described as one of the most 
common and debilitating symptom (Chatterton et al., 2006). It is reported to have a negative 
impact on the patient’s ability to perform physical or mental activities (Flensner and 
Lindencrona, 2002), bring a lower quality of life (Amato et al., 2001), lead to unemployment 
(Jarandhan and Bakshi, 2002); cause distress and psychological disorders ( Colosimo et al., 
1995; Kroencke et al., 2000); generate low levels of motivation and self-esteem (Fisk et al., 
1994), and result in disability and neurological impairment (Schwartz et al., 1995). To 
combat fatigue, a variety of psychological, psychosocial and pharmacological interventions 
have been traditionally prescribed (Krupp, 2003), and patients were, until recently, advised to 
avoid unnecessary physical activities so that they preserve the little energy they have in order 
to perform essential every day activities, and/or for fear that unnecessary physical effort 
might provoke MS symptoms and relapses (Solari et al., 1999). However, as the exact causes 
of MS fatigue are not known, the effect of conventional therapies has been modest and even 
controversial (Bethoux, 2006; Krupp, 2003).  
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Contrary to the traditional view that physical training for MS patients might exacerbate 
fatigue and provoke other symptoms of the illness (Freeman et al., 1997; Ponichtera, 1993), it 
is now widely accepted that exercise has no deleterious effect on patients with mild to 
moderate disability (Taylor et al., 2006), and that many of those patients can actually benefit 
from exercise in terms of reduced fatigue, increased independence and levels of daily 
functioning (Rasova et al., 1006), and improved quality of life (Turner et al., 2009; Romberg 
et al., 2005). Nevertheless, findings of studies on the impact of exercise on MS fatigue are 
somewhat confusing (Dalgas et al., 2010).  For, whereas some researchers find little or no 
positive impact of exercise (Van den Berg et al., 2006; Klieff and Ashburn, 2005), others 
report positive results though with different levels of improvement (Rasova et al., 2006; Oken 
et al., 2004). Indeed, given the fact that no consensus has been reached on the definition of 
fatigue or on a core set of outcome measures to be implemented in experimental trials, it is 
not surprising that those confusing findings are obtained. Added to the question of lacking 
consensus, it is to be noted that in almost all studies on exercise for MS fatigue, the intensity 
of exercise is not clearly described in terms of customisation and duration (Dalgas et al., 
2008).  Furthermore, although patients’ abilities and needs as well as their perceptions of 
exercise and what they feel about it are important determinants of the outcomes (Dodd et al., 
2006), researchers hardly pay any attention to those perceptions, feelings and needs. There is 
also the possibility that some participants in some trials are not fatigued or are already 
engaged in supervised or unsupervised physical training activities. All these failings in 
experimental designs can, no doubt, result in biased and distorted outcomes. Hence, there 
remains the question as to whether or not it would be possible to maximise the benefits of 
physical training if concerns over those shortcomings were addressed. The present research is 
an attempt to answer this question. 
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1.2. Importance of the research 
In the literature on MS, the negative effects of the disease on the patients’ activities of daily 
living, and hence their mood and quality of life, are widely reported. Because physical 
activity is usually restricted in many of those patients, their social and recreational activities 
are compromised, the reduced sense of control they experience can lead to depression and 
exacerbations, cardiovascular diseases and other illnesses can develop as a result of 
immobility, and they become more and more dependent on others for help. Those patients 
may have more than one reason to avoid un-necessary physical effort. The most obvious of 
those reasons is that they may be trying to conserve energy for essential tasks and also 
minimise the potential risk of exertion. The irony is that contrary to the understanding of 
those patients, reducing physical activity can lead to harmful physiological and psychological 
consequences, and optimising it can be an effective strategy in coping with their condition. In 
fact, it is now widely accepted that exercise has no harmful effects and that it can increase 
independence in MS patients and improve their mood and quality of life. If we manage to 
persuade those patients to engage in physical activity and, at the same time, succeed at 
maximising the benefits of exercise, this will be one of greatest achievements. The present 
study is a step in that direction. 
1.3. Study aims and objectives  
The present study has two objectives, one is primary, and the other is secondary. The former 
is to assess the effects of a supervised training programme on fatigue in a sample of MS 
patients. The latter is to explore the attitude of those patients towards physical training and 
the impact of fatigue on their daily living activities. Closely related to the former objective is 
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to assess the impact of training on muscle strength, gait and functional performance in the 
participants. To achieve these objectives, a number of aims have to be identified and met. 
1. Developing an appropriate and informed exercise protocol.
2. Determining the set of outcome measures to be employed.
3. Implementing the training programme and evaluating its effects.
Information obtained through an exploratory pilot study together with that obtained from a 
wide range of secondary data sources, including specialised journals, articles and 
experimental studies,  enabled the present writer to make informed decisions as to:  the type, 
duration and intensity of  the training programme to be implemented, the study sample, and 
data collection tools and analysis. These issues are considered in some detail in Chapter 5, 
and the rationale behind the decagons made throughout the study is given in different parts of 
the paper. Meanwhile, it suffices to note that the present study wanted to identify participants 
ZKR were fatigued, had no prior training experience, were involved in the decision making 
process as to the type of exercise they wished to perform, and training activities customised 
to their abilities and needs. Also, for the purpose of the study, both quantitative and 
qualitative data were obtained through a range of self-report questionnaires, functional tests 
and semi-structured interviews. 
 1.4. Scope of the study 
This study investigates the relationship between exercise and MS fatigue from a 
biopsychosocial perspective. The primary aim was to develop an intervention for reducing 
fatigue. The secondary aims were to investigate the effect of exercise on other impairments, 
activities in daily activities and social participation.  Whilst there is a significant body of 
research on exercise in MS in a western population there is almost no research within a 
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Kuwaiti (or Arab) population. In this context the experimental studies planned to be 
conducted in Kuwait will draw on the lessons learnt from the studies carried out in the 
Caucasian populations. 
1.5. Thesis structure 
The present research project is reported in eight chapters. Following this introductory chapter, 
focus in Chapter 2 is on general issues pertaining to MS. In particular, emphasis is on the 
nature, possible causes, prevalence, types, symptoms, diagnosis and treatment of MS. A case 
for the potential benefits of physical training for MS patients is also presented. The chapter 
concludes with a discussion on barriers to physical activities in MS patients. Chapter 3 
entitled, “Literature Review” is focused on MS fatigue, the main theme of the present study. 
The chapter begins with a discussion on the definition and nature of MS fatigue. Different 
fatigue measurement scales are then considered and contrasted. The   position taken by the 
present study is that MS fatigue is a multi-faceted rather than a unidimensional symptom. 
Hence, argument is made in favour of the Modified Fatigue Impact Scale (MFIS) as a reliable 
measure. The argument is followed by a review of studies on different physical exercise 
modalities targeting the symptom. The main features of those experimental studies are 
described, their findings are presented, and lessons learned from them are highlighted.  Such 
lessons should inform the present study and enable the writer to propose a novel approach to 
physical training to address the MS fatigue problem, and also, put the proposed approach to 
the test. Perceptions of two samples of patients, a British and a Kuwaiti, about MS fatigue 
and their attitude towards exercise are explored in Chapter 4. The methodology employed for 
the purpose of the present research is described in Chapter 5. Results obtained through the 
utilised data collection instruments are presented in Chapters 6 and 7. The former chapter is 
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concerned with quantitative data obtained through questionnaires and functional measures, 
and the latter with qualitative information obtained through interviews. Conclusions of the 
study, critique of the work carried out and suggestions for future directions are presented in 
Chapter 8. 
1.6. Search strategy 
To enable the present writer to establish the theoretical framework for this study, a 
comprehensive literature review activity was performed. For the purpose, four databases 
(MEDLINE, CINHAL, PEDro, and Sport Discuss) were searched using the following key 
words on their own or combined with “AND” or “OR”: 
1. Multiple Sclerosis
2. MS
3. Demyelination Autoimmune Diseases
4. Autoimmune Diseases of the Nervous System
5. Fatigue
6. Fatigue*
7. Fatigability
8. Muscle Fatigue
9. Lethargy
10. Tiredness
11. exercise therapy
12. Physiotherapy
13. occupational therapy
14. functional therapy
15. physical therapy
16. $therapy
17. physical$
18. physio$
19. training$
9 
20. function$
21. activities of daily living
22. disability of function
23. disability
24. rehabilitation
1 or 2 or 3 or 4 
4 or 5 or 6 or 7 or 8 or 9 or 10 
11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 
In all, 518 articles have been retrieved, and they were all screened on title and abstract.  Many 
of those papers were discarded because they were duplicates and repetitive. The number of 
papers left for close inspection was 248. These papers were classified into two groups that 
serve two different purposes. The first group (n=135) provide general information on MS (i.e. 
aetiology and epidemiology of the disease, its nature, types, symptoms and treatment). Some 
papers in this group also present a case of the potential benefits of physical training for MS 
patients. Main findings of these research papers are presented in Chapter 2. The second group 
of papers (n=113) are focused only on issues related to MS fatigue and the physical training 
interventions that target this particular symptom. Reference to these papers is made in 
Chapter 3 where they are examined in some detail. 
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Chapter 2: Background 
2.1. What is MS? 
All our actions from thinking to moving, seeing and breathing are controlled by the central 
nervous system (CNS) which consists of the brain and the spinal cord (McReynolds et al., 
1999). The CNS is made up of billions of nerve cells with fibres, known as axons, extending 
from those cells to connect them together. Axons are surrounded by a sheath of fatty protein 
(called myelin) that protects them and makes it possible for messages to be communicated 
throughout the brain and the body quickly and without interruption (Tyldesley and Grieve, 
1996). However, it sometimes happens that the myelin sheaths are damaged or even 
destroyed in that hard patches or scars (scleroses) develop in multiple areas (Lindsay and 
Bone, 2004). This condition is called, “multiple sclerosis” (MS), and it results in slowing 
down or even blocking the nerve messages (Figure 2.1). As a result of this process, varied 
symptoms that may change over time and vary from one patient to another are triggered in 
different parts of the body (Lindsay and Bone, 2004). More than often, such symptoms 
interfere with a range of bodily functions (Heeson et al., 2006), restrict the patient’s ability to 
engage in physical activities, and result in important consequences for living a full life 
(Mitchell et al., 2005). 
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Figure 2.1: Healthy and damaged nerves 
Although we now know what causes the symptoms of MS, the causes of the illness, itself, 
remain a mystery. To complicate things even further, MS has a variable and unpredictable 
time course of progression (McReynolds et al., 1999). For example, although symptoms such 
as sensory and cognitive disturbances are somewhat common among MS patients, these can 
vary greatly across individuals and episodes, and they can make the MS experience a very 
unique one to each patient (Lindsay and Bone, 2004). Also, whereas it has been found that 
gradual repair of the damaged tissue and some recovery of functioning is possible in some 
cases, damage in other cases may occur more quickly than it can be repaired, and the 
condition may decline sharply over time as more and more damage accumulates (Robinson et 
al., 2000). It is, indeed, this progressive, variable, and unpredictable nature of the disease that 
makes MS difficult to manage and, at the same time, interesting with respect to illness 
representation and coping (Cameron et al., 20002). 
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2.2. The Aetiology of MS  
A number of explanations as to the possible causes of MS have been suggested over the years. 
In the main, such explanations are genetically and/or environmentally based. As to the 
genetic factors, evidence from genome analysis shows that genes on at least two 
chromosomes make a person more likely to develop MS (O’Connor, 1999). In particular, it 
has been found that a group of genes in chromosome 6, which is associated with the immune 
system, increase the probability of acquiring the disease (Compston and Coles, 2008). In fact, 
it is widely believed that MS is an autoimmune disease (Robinson et al., 2000). By that, it is 
meant that the immune system perceives myelin as an intruder and attacks it. Evidence also 
suggests that the risk of acquiring MS is higher among the close relatives of a person with the 
disease than the general population (O’Connor, 1999, Compston, 2002). However, although 
some studies indicate that MS is likely to occur in generations of families, other studies show 
that the disease is not hereditary (Ebers et al., 2000). 
As to the environmental factors, research shows that MS is prevalent in countries farther 
away from the Equator (Ebers et al., 1998, Burgess, 2002).For example, whereas it is 
uncommon in countries such as the Ecuador and Malaysia, it is more common in Britain and 
Scandinavia (Hauser, 1994). Research has also shown that people born in areas of low 
prevalence who migrate to areas of high prevalence develop an increased risk of acquiring 
MS in their new environment. However, such risks diminish if the person moves after the age 
of 15. This suggests that exposure to environmental factors early in life (e.g. sunlight, diet, 
sanitation) may predispose a person to develop MS in later years. In this respect, decreased 
exposure to sunlight has been linked with higher risks of developing MS (Marrie, 2004). 
There also appears to be a connection between one’s lifestyle and likelihood of him/ her 
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acquiring MS. For instance, it has been found that individuals from middle and upper socio-
economic classes are more affected by the disease than individuals from other social groups 
(O’Connor, 1999). A link between MS and viral infections or sexually transmitted diseases 
has also been suggested (De Sousa et al., 2002). 
2. 3. The Epidemiology of MS
Early studies put the numbers of those affected by MS in the world at 1.1 million individuals 
(Sadovnik and Ebers, 1993). But more recently, it has been reported that those numbers have 
more than doubled to reach the 2.5 million figure (MS Trust, 2007). It is also noted that the 
disease is more common in cool temperature climates (i.e. in countries with close proximity 
to the North Pole or the South Pole) and rare in tropical and semi-tropical countries (Ebers et 
al. 1998). With reference to the United Kingdom in particular, it is reported that the number 
of those with MS is somewhat between 85,000 (Robinson et al., 2000) and 100,000 
individuals (Thomas et al., 2009) and that approximately 2,500 cases are identified every year 
(Robinson et al., 2000). According to reports complied in the United Kingdom  at the turn of 
the millennium, prevalence rates varied between 125 per 100,000 people in England and 200 
per 100,000 people in Scotland, with Surrey in the south of England having the lowest 
prevalence and Orkneys in the north of Scotland the highest (MS ,2000) (115 and 224 per 
100,000 inhabitants consecutively). Regional variations in the United Kingdom are in line 
with early research findings in New Zealand where the highest incidents of the disease were 
found in the southern part of the country, which is cold and close to the south pole (Skegg et 
al., 1987). Although results similar to these are interpreted by some writers as an indication of 
a possible correlation with latitude from the equator (Erbes et al., 1998), others suggest that 
diagnostic miscalculations and methodological differences may be responsible for reported 
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variations between countries and geographic regions (Forbes et al., 1999). In this respect, a 
more recent study in New Zealand shows that MS levels in the relatively warm northern part 
of the country may be much higher than previously reported (Chancellor et al., 2003). 
Research has also shown that females are twice more likely to be diagnosed with MS than 
males (Mohr and Cox, 2001). Reasons for this phenomenon are unknown (Compston, 1998). 
Further, whereas women tend to be diagnosed young, men are usually diagnosed when they 
are over 40 (McReynolds et al., 1999).There is also evidence that unlike women,  men are 
likely to develop more severe MS forms (Burgess, 2002). On the whole, however, it has been 
found that people are usually diagnosed with MS in their productive years, i.e. between the 
ages of 20 and 40 (Schultz et al., 2004, McCole, 2005). But, in some cases, people have been 
diagnosed with MS at the age of infancy or when they are in their seventies (Burgess, 2002). 
As to whether or not there is a relationship between MS and life expectancy, it has been 
found that those with the disease generally have a normal life expectancy (Reynolds et al., 
1999). However, individuals in the advanced stages of MS may be more susceptible than 
others to general health dangers such as pneumonia and serious infections (Antonak and 
Livneh, 1995). This implies that those patients in particular should be encouraged to keep fit 
and remain physically active. On the question of MS and ethnicity, although the disease 
affects all racial groups, it is still most frequent in white people (O’Connor, 1999). However, 
it is argued that geography rather than the racial makeup that is related to higher incidence 
(Robinson et al., 2000). 
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2.4. Types of MS 
Progression of MS and its symptoms follow different patterns and are highly unpredictable. 
In fact, unpredictability of the disease is often described as the most anxiety provoking issue 
among patients (Silcox, 2003). This being so, it is not surprising that the clinical profile and 
the MS experience is different for everyone (McReynolds et al., 1999). For instance, whereas 
some patients may regularly experience a number of symptoms that get worse very quickly, 
others may experience only mild symptoms or no symptoms at all over a long period of time 
(De Sousa et al., 2002). Despite this problem, researchers still found it possible to distinguish 
between four broad types of the disease (Figure 2.2.). Generally speaking, the differences 
between the four recognised types would suggest that differences in illness perceptions may 
exist.  
  Figure 2.2: Types of MS. Source: Department of Work and Pension, 2008. 
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2.4.1 Benign MS 
This type of MS accounts for between 15 and 20 per cent of cases and is characterised by 
infrequent, very mild or relatively minor attacks separated by long periods with no symptoms. 
Also in this form, the disease progresses slowly, it is even hardly perceptible (Rumrill, 1996), 
and patients usually experience a full recovery (Reynolds et al., 1999). However, the term, 
“benign”, does not necessarily indicate how the MS will progress in the future. For example, 
it has been found that individuals who were initially diagnosed as having benign MS had 
developed significant disabilities later in the lives (Robinson et al., 2000). 
2.4.2 Relapsing- Remitting MS 
This is when patients show symptoms of MS (relapse) but then their condition improves and 
the symptoms between the attacks becomes stable (remission). It is the most common type of 
MS (Gross and Sinaki, 1987), particularly among young patients (Robinson et al., 2000). 
Exacerbations may include a number of symptoms, and they are often several months apart. 
During the attack of MS, symptoms may worsen and it might a few days before they 
gradually start to improve over a few weeks (Robinson et al., 2000, McReynolds et al., 1999). 
In the early stages of the disease in particular, some attacks may have a little lasting effect, 
with a complete or almost complete remission. However, in some cases, attacks may result in 
permanent loss or reduction in functioning. 
2.4.3 Secondary Progressive MS  
The majority of individuals with relapsing-remitting MS are likely to start having attacks that 
last for a longer period of time with remissions between those attacks becoming smaller 
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(Mohr and Goodkin, 1999). This is known as secondary progressive MS. Early in this stage, 
disability is hardly noticeable after the attacks, but any problems the patient might already 
have can gradually start getting worse. For example, mobility becomes more and more 
restricted and even damage to the cerebellum might occur (Lindsay and Bone, 2004, Silcox, 
2003). 
2.4.4. Primary progressive MS 
Primary progressive MS affects nearly 20% of MS patients, particularly those who get the 
disease after the age of forty (Robinson et al., 2000). In primary progressive MS, symptoms 
start getting worse after the first attack, remissions do not occur, patients become gradually 
and increasingly inactive and disabled, and within a few years or even a few months, loss of 
sensory performance and serious disability can occur. This type of Ms is also associated with 
feelings of despair and perceived loss of control (McReynolds et al., 1999).   
Apart from the four types of MS mentioned above, reference is sometimes made to an 
extremely rare form, called “fulminating” or “malignant”. This is an aggressive and persistent 
form of MS that can render the patient totally incapacitated, and it may even result in death 
within a few months (Gross and Sanaki, 1987, McReynolds et al., 1999, Robinson et al., 
2000). 
2.5. Symptoms of MS 
Knowing that the central nervous system is highly specialised and that different areas of that 
system control different functions, it is not surprising that MS has a wide range of symptoms 
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and signs (Reynolds et al, 1999). Depending on the MS form of their condition, it is not also 
surprising that different patients may experience different symptoms at different stages and 
times (Buljevac et al., 2003). On the whole, however, researchers have identified marked 
differences between MS patients and healthy subjects in terms of increased fatigue, 
depression, cardiovascular disease risks, and decreased function, muscle strength, muscle 
activation, health related quality of life, VO2max, bone density and daily activity levels 
(Dalgas et al., 2008; Kersten and McLellan,1996). 
Some MS symptoms are, nevertheless, more common than the others. Common symptoms 
include: fatigue, weakness, depression, anxiety, anger, cognitive impairment, incontinence, 
and walking and concentration problems (Feinstein, 2004). Less common symptoms include: 
disinclination, delirium, psychosis, apathy, dementia, emotional and behavioural disturbances 
(Feinstein, 2004), blurred/double vision, pain at the back of the eye, tingling, ringing in the 
ear, nerve pain in the face (Compston and Coles, 2002) and sexual problems (McReynolds et 
al., 1999 ). Evidently, patients’ response to the disease and the kind of help or care they need 
are determined by the nature of the symptom and its level of severity. For instance, unlike 
patients with a relapsing or remitting form of the disease who may need little help, those with 
more progressive forms may require constant attention, and they may become more 
dependent on others for help (Cheung and Hocking, 2004). It is, however, to be noted that 
because MS is an unpredictable disease, it becomes difficult to determine the exact pattern of 
any specific symptom or establish when it will occur and how it will develop (Petajan et al., 
1996). Nevertheless, an understanding of the MS symptoms will, no doubt, increase our 
awareness about their impact on patients and enable us to suggest a care plan (Hadjimichael 
et al., 2008). In particular, this study is concerned with fatigue as it is often viewed as the 
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most disabling symptom that affects MS patients (this is discussed in Chapter 3). Other 
factors related to this symptom, particularly muscle weakness, depression and anxiety are 
considered below. 
2.5.1. Weakness 
Weakness, or the reduced ability to generate maximal force (Taylor et al., 2006), is often 
described as another MS major impairment that can lead to disability in people with MS 
(Frankel, 2001; Ponichtera et al., 1992), depression, anxiety, and hopelessness (White and 
Dressendorfer, 2004). It also explains why many MS patients limit their daily activities, 
especially those that require physical effort (White et al., 2000). Weakness and fatigue are 
closely linked and the one often affects and worsens the other (Kent-Braun et al., 1997). 
Other MS symptoms can be also affected by weakness. For instance, weak legs can lead to 
problems with mobility and balance (McCullagh, 2006). 
According to some studies, the primary cause of weakness in MS is reduced or interrupted 
transmission of messages by the nerve damaged as a result of demyelination or axonal 
degeneration (Ng et al., 2004; White and Dressendorfer, 2004). Other studies show that when 
muscles are not used, secondary changes to muscles mass occur, and these changes contribute 
to the weakness of the muscles (Lambert et al., 2000; Ng et al., 2004). In effect, at least as far 
as MS patients are concerned; lack of physical activity would mean that their condition can 
get even worse. Put differently, when those patients do not use an already weakened muscle, 
that muscle will be weakened even further (Fargoso, 2008). 
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2.5.2. Depression 
It has been noted earlier that MS is an unpredictable disease that is characterised by periods 
of relapse and remissions. This being so, it is to be expected that patients need to make 
constant behavioural changes in response to their illness and as a means of coping with or 
adapting to the uncertainties that accompany it. Among other things, depression becomes a 
possible consequence of such adaptations and changes (MS, 2010). As a matter of fact, there 
is compelling evidence that every other MS patient will experience at least one episode of 
clinical depression after getting the disease (McGuigan and Hutchinson, 2005; La Rocca, 
2000; Sadovnick et al., 1991). Other studies have found that up to 57 %  of MS patients can 
be depressed at any one time (Shubert and Foliart, 1993) compared to only 6% of the general 
population(Roth and Fonagy, 1996). The rate could be even higher as it has been found that 
one in four patients with MS had unrecognised and untreated symptoms of depression 
(McGuigan and Hutchinson, 2005). There is also evidence that the rate of depression among 
MS patients is higher than that in other progressive diseases such as osteoarthritis and 
systemic lupus erythematosus (Creed, 1990). Although research is inconclusive as to when 
depression exactly occurs, high levels of it are often associated with progressive forms of the 
disease. It is also generally accepted that it equally affects both males and females (Beal et al, 
2007). 
Research shows that depression affects MS patients in different ways. In the main, it has been 
found that MS patients suffer from insomnia and loss of appetite and experience symptoms 
such as anger, anxiety, irritability, hopelessness (Minden and Schiffer, 1991). Depression in 
those patients also involves a persistent feeling of sadness accompanied by a sense of low self 
esteem and guilt (Strenager et al., 1992). It is also reported that some MS patients may even 
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contemplate suicide. According to Turner et al., (2006), as many as 30 % of MS patients have 
suicidal thoughts at one stage during the course of the illness. It has been also found that 
suicide rate in MS patients is approximately twice that of the general population (Bonnum et 
al., 2005). In itself, this suggests that it is rather important for service providers to identify 
MS patients who are affected by depression so that they can provide them with the support 
they need. 
Researchers fail to agree on the exact source or cause of depression in MS patients. One 
reason for the controversy is that depression affects patients in different ways (Minden and 
Schiffer, 1991). Another is that some of the symptoms used to assess it (e.g. insomnia and 
lack of concentration) are also characteristic of MS (Mohr and Goodkin, 1999). Nevertheless, 
there is evidence that a relationship exists between depression and disability. For some 
researchers, this is interpreted to mean that depression occurs in response to specific disease 
processes and neurological damage (Lynch et al., 2001; Packenham, 1999; Reynolds et al., 
1999). On the other hand, there is also evidence that depression can be significantly reduced 
through counselling and other psychological interventions (Mohr et al., 2001). For some 
researchers, this means that lack of social support and inability to cope with the illness are at 
least partially responsible for depression in MS patients (Packenham, 1999). However, there 
is also the view that depression in MS patients can be attributed to a multitude of factors 
rather than only to one factor. Proponents of this view suggest that it may be caused by a 
combination of psychological reactions to illness, disease processes and neurological damage 
(Mohr and Cox, 2001). But regardless of its cause, most researchers agree that depression 
results in low self-esteem and reduced energy (Mohr et al., 2001; Robinson et al., 2000; 
Vercoulin et al., 1996). 
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2.5.3. Anxiety 
Anxiety is yet another common MS symptom that is closely related to depression. In fact, as 
it is the case with depression, rates of anxiety in MS patients have been found to be higher 
than those in the general population (Rumrill, 1996) with a prevalence rate of between 19-
34% (Srenager et al, 1994). In a study by Feinstein et al., (1999), it was even found that 
anxiety in MS patients has a higher prevalence rate than depression. The researchers also 
found that although the disease profiles were similar in their male and female subjects, the 
rate of anxious women to anxious men was 8:1. They further note that patients who are both 
anxious and depressed are more somatically preoccupied, socially dysfunctional and may 
contemplate suicide more than other patients.  Research also shows that patients with 
increased levels of depression are more likely to experience anxiety and less likely to adhere 
to medication (Mohr and Cox, 2001). This may have a negative impact on their quality of life 
and daily living activities. It has been also found that anxiety can exacerbate other MS 
symptoms (Mohr et al., (2000). 
2.6. Diagnosis of MS 
Diagnosing MS is a complex process that may take a considerably long period of time.  
Lovelend (1999) quotes many MS patients as having to wait for years before a diagnosis was 
made. According to Burnfield and Burnfield (1982), this is because the initial symptoms are 
vague and confusing for both the patient and the neurologist. Traditionally, a neurologist may 
not confirm diagnosis before the occurrence of two attacks involving different areas of the 
central nervous system and separated by a period of at least one month. Diagnosis may also 
involve testing samples of cerebrospinal fluid for abnormalities or electrodes placed on the 
head to measure the time the brain takes to receive and process information. More recently, 
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magnetic resonance imaging has been utilised for diagnostic purposes (Rolak and Fleming, 
2007). 
2.7. Measuring MS disability 
Two measures of disability and disease progression in MS are widely used, the MS 
Functional Composite (MSFC), and the Expanded Disability Status Scale (EDSS), (Polman 
and Rudick, 2010). The MSFC consists of three components that measure upper limbs 
function, walking speed and cognitive performance, by using a 9-hole peg test, 25 foot timed 
walk and the Paced Auditory Serial Addition Test (Cutter et al., 1999). By contrast, the EDSS 
measures neurological impairment across eight functional systems based on a standard 
neurological examination, walking speed and the symptom history of the patient (Kurtzke, 
1983). It has a complex scoring system with scores ranging from 0 (normal neurological 
examination) to 10 (death). Scores 1 to 3 indicate minimal disability, 3 to 5 moderate 
disability, and 6 to 9.5 denote severe to more severe disability ( Appendix 1). According to 
Francis et al., (1991), one major limitation of the EDSS is that scores of 4 and above are 
mainly determined on basis mobility, which means that the scale is insensitive to cognitive 
and upper limb disabilities. Despite this limitation, the EDSS is widely used in research trials 
and clinical practice (Sharrack and Hughes, 1996), and it is even described as the gold-
standard measure (Kragt et al., 2006). 
2. 8. Treatment of MS
Despite ongoing research, no cure has been found for the MS condition, and the gradual 
progression of the disease and the decline in function in MS patients remain almost inevitable 
(Lindsay and Borne, 2004). This being so, existing treatments remain largely aimed at 
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slowing the progression of the disease and relieving the various symptoms which arise during 
the course of the condition. Traditionally, steroid therapy and immunomodulating drugs have 
been used to treat relapses and reduce their rate and severity (Blasier, 2008, Burgess, 2005). 
However, although it is true that some of these drugs have been used with some success in 
treating a number of symptoms, they do not reverse the disease progression or suit all patients. 
It is also to be noted that traditional therapies remain highly controversial because of the 
unacceptable side-effects they can cause (Hernandez-Reif et al., 1998). The adverse side-
effects include: increased spasticity, nausea, depression, myelgia, fever, headache (Huntley 
and Ernst, 2000), flu-like symptoms, fatigue, muscle ache, and fever (Lublin et al., 1996). It 
has been also reported that they can affect blood count levels, provoke stiffness and insomnia 
(Walther and Hohlfeld, 1999). To state the obvious, such side-effects can have a negative 
impact on physical and social functioning and decrease the patient’s quality of life (Huntley 
and Ernst, 2000). In recent years, shortcomings of pharmacological interventions have led 
many researchers and patients to turn to complementary or alternative therapies. In fact, it has 
been reported that two thirds of MS respondents use alternative therapies because they think 
that they have not gained much from drugs (Hayes and Cox, 2000). In particular, there has 
been a growing interest in physiotherapy as a tool to relieve MS symptoms and improve 
functionality, mobility and quality of life. 
2.9. Exercise and MS  
Given the progressive nature of MS and its debilitating and unpredictable symptoms, it is not 
surprising that MS patients usually feel weaker and more depressed than the general 
population (Romberg et al., 2004). It is not also surprising that those patients are less active 
than the others and are even often reluctant to engage in simple physical activities (Dalgas et 
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al., 2008). This is either because they feel they need to preserve the little energy they have in 
order to perform essential every day activities, and/or for fear that unnecessary physical effort 
might provoke MS symptoms and relapses (Rietberg et al, 2004). It does; however, appear 
that many of those fears are unfounded or over-exaggerated. In fact, as we shall see later in 
the discussion, there is evidence that MS patients can actually benefit from physical training. 
It has been suggested that physical activity on part of the MS patient would lead to increased 
body temperature (Petajan and White, 1999), which would, in turn, lead to the exacerbation 
of the MS symptoms (White et al., 2000). In a study by Guthrie and Nelson (1995), it was 
found that an increase of 0.5 degree centigrade in body temperature can block nerve impulse 
conduction in demyelinated fibres and trigger fatigue. However, the authors note that the 
effect is only temporary. Other researchers have also found that when sensory symptoms 
were provoked after a bout of exercise, they settled within a short period of time (Smith et al., 
2006). On the other hand, there is evidence that increased core and skin temperature did not 
actually provoke any MS symptoms (Mulcare et al., 2001). Nevertheless, at least as far as 
heat sensitive patients are concerned, it has been suggested that pre-exercise cooling 
techniques or training in a shoulder deep pool of water can enhance performance and reduce 
subjective feeling of fatigue (Petajan and white, 1999). 
Fears have also been expressed that exercise might increase spasticity and MS related fatigue. 
However, although rare cases of spasticity have been recorded in patients undertaking graded 
exercise tests (Mostert and Kesserling, 2002), there is no evidence that such cases were the 
result of training (Rietberg et al., 200$). Similarly,  at least as far as patients with mild to 
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moderate disability are concerned, there is no evidence to suggest that training has a negative 
impact on fatigue. 
Weakness and respiratory problems in MS patients have been another area of concern for 
researchers. Yet again, there is no evidence that training would influence the primary cause of 
weakness, i.e. the reduced central activation (Rasova et al., 2005). In fact, it has been found 
that inactivity would result in secondary changes to muscle mass (De Haan et al., 2000). As 
regards patients with respiratory problems, although it is acknowledged that they might 
encounter breathing difficulties during training, it has been found that their condition can 
improve if they are given respiratory muscle training prior to the exercise intervention (Fry, 
2000). 
In summary, contrary to the traditional view that physical training for MS patients might 
provoke the symptoms of the illness, exercise has been gaining recognition as a tool that has 
the potential to address major impairments. In fact, plethora of evidence exists in the 
literature on the benefits of exercise for MS patients with mild to moderate disability in terms 
of improved muscle activity (Gutierrez et al., 2005; Romberg et al., 2004), improved aerobic 
capacity (Rasova et al., 2006; Rampello et al., 2007); improved function (Klieff and Ashburn, 
2005; Van den Berg, 2006); and improved quality of life (Stuifbergen et al., 2006; Motl et al., 
2007). In Chapter 2, studies on the effects of exercise therapy on MS related fatigue will be 
reviewed in some detail. 
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2.10. Barriers to physical activity 
It has been noted above that MS patients are usually less active than healthy individuals. This 
is due to the functional limitations and reduced abilities caused by the disease. With the 
passage of time, these patients find it more and more difficult to adjust to uncertainties and 
bodily changes, the level of their physical activity and mobility diminishes even further, and 
their muscles get weaker as a result of disuse and deconditioning (Motl et al., 2009). Hence, it 
is not surprising that the quality of life in those patients and their mental and physical health 
are adversely affected (Putman et al., 2006). In fact, some parts of the world, especially in 
Western Europe and North America, physical activity has now become an important 
component of MS management and rehabilitation programmes and patients are usually 
advised to remain physically active at the onset of the disease in order to increase their 
functional reserve. To persuade and encourage those patients to engage in physical training, it 
is rather important that barriers to exercising are explored. By "barriers", it is meant "the 
subjectively perceived costs inherent in undertaking health behaviour" (Becker and 
Stuifbergen, 2004: 75). 
A review of literature on barriers to exercising clearly indicates that the impact of these 
barriers is more noticeable in MS patients than in healthy individuals. However, although it is 
true that the majority of MS patients often rate fatigue and impairment as the two main 
obstacles to exercising, research shows that barriers to health practices are also often related 
to factors that are not directly associated with the disease itself (Becker and Stuifbergen, 
2004). Based on the "Incapacity Status Scale" which provides a measure of functional 
disability due to MS (Kurtzke, 1981), those barriers can be classified into three groups: those 
related to the psychological make-up of the patient and his/her personal circumstances (i.e. 
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intrapersonal barriers), those associated with the patient’s relationship with other people 
(interpersonal barriers), and those to do with the environment. These and other barriers 
associated with the disease are shown in Table 2.1. 
Beginning with interpersonal factors, it is often argued that the experience, attitude and 
behaviour of health and care professionals play a pivotal role in shaping patients' perception 
of physical activities. For example, it is reported that patients are less likely to engage in 
health promoting activities if they feel that they do not receive the proper screening, 
treatment and attention they need (Putman et al., 2003). They are also less likely to be 
physically active when they are denied the necessary advice, counselling or information. For 
instance, it is to be expected that the respiratory and cardiovascular systems are compromised 
in patients who smoke or have weight control problems. Unless a counselling service is 
available and tailored to meet the specific needs of those patients (in this case advice on 
smoke cessation and nutrition), they may still find it difficult to engage in or appreciate 
physical training (Rimmer, 1999; Nosck, 2008). Lack of encouragement and support from 
family and friends, social stigmatisation, concerns over appraisal by others, and negative 
exercise experience are also reported as reasons for decreased physical activity among MS 
patients. On the other hand, it is reported that patients who used to exercise before diagnosis 
as well as those with a positive post-diagnosis training experience are more determined than 
others to remain physically active (Borkoles et al., 2007). 
Table 2.1. Barriers to exercising. Adapted from Becker and Stuifbergen, 2004. 
a) Disability related factors
1. Fatigue
2. Impairment
d) Intrapersonal factors
1. Lack of time
2. Safety concerns
29 
b) Interpersonal factors
1. Lack of information
2. Lack of support from family and friends
3. Lack of support from health professionals
4. Communication problems
5. No one to provide help
c) Environmental factors
1. Problems with facilities
2. Bad weather
3. Interference with duties and 
responsibilities 
4. Financial problems
5. Lack of interest
6. Embarrassment
7. Low self-esteem
8. No faith in training
9. Transportation
Other barriers to physical training can be directly related to the patient's personal 
circumstances and demographic characteristics. For example, some patients noted that they 
refrained from exercising because they do not have enough time or because it interferes with 
other duties and responsibilities. Others described high training costs and transportation as 
major obstacles to training. It is also reported that young and inexperienced patients as well 
as those with a modest level of education may find it difficult to obtain or understand 
information about training programmes and services (Rimmer, 1999; Stuifbergen and Becker, 
1994). Patients' attitude towards exercise and their expectations about the outcomes are also 
powerful predictors of engaging in training. For example, they are less likely to undertake 
exercise if they lack faith in their abilities or feel that the training programme is not 
rewarding or too much demanding (Becker and Stuifbergen, 2004). 
The final set of barriers to participation in exercise programmes is termed "environmental". 
One example of these barriers is adverse weather conditions (e.g. rain, strong wind and high 
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or low temperature) that make it difficult for patients with disabilities to venture out because 
of concerns for personal safety. Other examples pertain to training facilities, exercising 
equipment and accessibility. To say the least, patients may be denied a training opportunity 
when training venues and programmes are not available, in the first place. The same thing 
can be said when training facilities are too busy, inappropriate for the patients’ disability 
needs or lacking in specialised equipment. Even when training venues are available and 
properly equipped, this does not necessarily mean that they can be accessed with ease. For 
example, some may not have sufficient parking slots, the routes to others may be long or 
unsafe, and patients may find it difficult to access rest places (Rimmer, 1999; Becker et al., 
1989; Borkoles et al., 2008). 
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Chapter 3:  Literature review 
3.1. Introduction 
It was noted in the opening chapter that literature search revealed 113 MS fatigue related 
papers and articles. Of those, 65 had discussions on the nature of MS fatigue, its types, 
related symptoms and measurement tools. All were read, contrasted and summarised. The 
remaining 48 research papers had discussions on exercise targeting MS related fatigue. A 
number of these papers were excluded from analysis because they did not meet the 
operational definition of therapeutic exercise. By that, it is meant that exercise was not 
prescribed, it did not comprise voluntary muscle contraction or body movement, and the aim 
of training was not to improve function or reduce fatigue (Taylor et al., 2007). Papers were 
also excluded if they were not peer-reviewed or published in a language other than English or 
involved less than five participants in the exercise programme. This left 19 papers that were 
closely read and considered for analysis (Figure 3.1). Before describing those papers and 
presenting the findings of the review, it is important that we establish what fatigue is and how 
it can be measured. 
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Figure 3.1 Study selection flowchart 
113 MS fatigue related articles 
65 article on fatigue types, 
nature and measurement 
48 related to exercise on MS 
fatigue 
Excluded articles: 
- Self-management and
educational (n=11). 
- Relaxation and breathing
(n=8). 
- Home based and not
supervised (n=3) 
- Less than 5 participants (n=3).
- Not in English (n=2)
- Not peer reviewed
(n=2) 
29 irrelevant and excluded 
19 relevant papers 
10 Endurance training 4 Resistance training 5 Combined training 
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3.2 MS fatigue 
It is not unusual that some people experience periods of heightened tiredness and exhaustion 
at some point during the day. Yet, more than often, such an experience is not disabling; it 
may have little, if any, impact on our physical wellbeing; and we usually recover after a 
period of rest. However, when we talk about fatigue in MS, we have in mind a completely 
different type of experience and feeling. What makes MS fatigue different from other types 
of fatigue or exhaustion is that it is characterised by the sudden loss of energy, the inability to 
continue an activity, and the relatively long recovery time (Table 3.1). MS fatigue can also 
affect the patient’s disability and physical, social and occupational well being and bring a 
lower quality of life (Chwastiac et al., 2005; Jarandham and Bakshi, 2002); interfere with 
work and/or home life (O’Connor, 1999); lead to unemployment; cause distress and 
psychological disorders; and have a negative impact on the patient’s ability to perform 
physical or mental activities (Stuifbergen and Rogers, 1997). Fatigue is also associated with a 
sense of loss of control over one’s environment; low levels of motivation and self-esteem; 
and neurological impairments (Bethoux, 2006; Bakshi, 2003).  
Although fatigue is common in MS patients, researchers do not agree on a single and unified 
definition of the symptom. In fact, rather than define it, they tend to describe it in broad and 
vague terms (Bethoux 2006; Flechenecker, 2006). Examples of those descriptions include: “a 
piercing feeling of weakness, lack of strength and energy, or total exhaustion” (Kumork and 
Piezchala, 2006); “a state of exhaustion distinct from depressed mood or physical weakness” 
(Krupp, 2003); “difficulty initiating or sustaining voluntary effort” (Chaudhuri and Behan, 
2004); and “a subjective lack of physical and/or mental energy that is perceived by the 
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individual or the care-giver to interfere with usual or desired activity” (Multiple Sclerosis 
Council, 1998). 
Despite disagreement among researchers on a unified definition of fatigue, they still agree 
that it is the most debilitating and the most common symptom of the disease. However, 
research shows that the rates of MS patients who suffer from fatigue are somewhat varied. 
For, according to some studies, it was reported by 75 to 90 per cent of MS patients with at 
least 50% of them stating that it was their worst problem (Fisk et al., 1994). Schwartz et al., 
(1996) find that fatigue is reported by the majority (77%) of patients. Giovannoni (2006) puts 
the rate at roughly 80%, and in agreement with Forwell et al (2008), he notes that half of 
those patients describe fatigue as the ‘most annoying’ symptom. Bakshi, (2003), notes that 
40% of patients with MS describe fatigue as the most disabling symptom. Somewhat 
different estimates are given by Kumork and Piezchala (2006) who state that fatigue is 
experienced by 40 to 90% of people with MS and other neurological disorders. What is 
disturbing, however, is that fatigue in MS remains elusive and the exact causes of the 
symptom and the course it may take are still not well-defined. In the main, this is because of 
the complexity of factors that contribute to it as well as the lack of defined biological markers 
(Forwell et al., 2008). 
In their discussions on MS, researchers often make reference to different types or categories 
of the symptom. For example, there are the notions of “central” and “peripheral” fatigue (i.e. 
whether fatigue is generated in the CNS or in the peripheral tissues) (Chaudhuri and Behan, 
2000); “acute” and “chronic persistent” fatigue (i.e. fatigue appearing only recently or being 
present for more than six weeks for 50% of the time) (Multiple Sclerosis Council, 1998); 
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“localised” and “global” fatigue (Bakshi, 2003); fatigue as opposed to fatigability (Comi et 
al., 2001); and “mental” and “physical” fatigue (Flenser Lindencrona, 2002). Other writers 
talk about more than two types of fatigue. Linyzer (1998) mentions four: objective, subjective, 
systematic, and asthenic. Coulthard and Vollmer (1995) identify eight types: that caused by 
sleep disturbance, fatigue related to diet, normal fatigue, deconditioning fatigue, fatigue 
caused by depression, fatigue resulting from disability, fatigue due to neuromuscular 
problems, and fatigue unique to MS. However, two broad types of fatigue are encountered 
most frequently in the literature: primary fatigue (PF) and non-primary or secondary fatigue 
(NPF). The former refers to the type of fatigue that is related directly to the MS disease 
process (Forwell et al., 2008) particularly the hardening or scarring of the myelin sheath 
(McReynolds et al., 1999), inflammation, disturbances in the neuroendocrine system related 
to fatigue (Kos et al., 2008), or immune dysfunction (Robinson et al., 2000). By contrast, 
NPF is thought to be influenced by other MS symptoms such as reduced muscle strength and 
endurance, spasticity, pain, sleep disturbances, cardiac and/or respiratory problems, physical 
disability, cognitive impairment, and poor mobility (Forwell et al., 2008; Bakshi, 2003; 
Colombo et al., 2000; McReynolds, 1999; O’Connor, 1999; Clark et al., 1992). Other 
possible contributors to fatigue include ambient temperature, medication, infections and 
inadequate diet (MS, 2010). There is also evidence that increased perception of fatigue can be 
the result of anxiety and depression (Kos et al., 2008). In this connection, it is often noted that 
because MS symptoms are subjective, vague and hard to measure, fatigue is sometimes 
misinterpreted as laziness. In itself, this can be a factor in the depression experienced by MS 
patients (McReynolds et al., 1999; Vercoulin et al, 1996). 
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In one study conducted by Forwell et al., (2008), it was found that non-primary fatigue was 
present in 36 of the 50 participants who completed the study (72% of the sample). Of those 
36 patients, 34 had a multiple of factors that contributed to fatigue. The most common factors 
were: sleep problems (58%), mobility limitations (52%), and depression (40%). It was also 
found that patients isolated with primary fatigue had lower fatigue scores. These findings led 
Forwell et al., 2008 to the conclusion that in order for MS fatigue to be studied and managed 
properly, non-primary fatigue factors should be identified and ameliorated before focusing on 
primary fatigue. In another study, Giovannoni (2006) found that the levels of fatigue in 
patients with benign MS were the same as the in patients with the non-benign form. However, 
other studies show that fatigue is not an indicator of the severity of MS (Fisk et al., 1994). 
Furthermore, although some studies indicate that fatigue occurs during the early stages of the 
disease, others claim that it is more prominent during the advanced stages (Bergamachi, 1997; 
Krupp, 1988). 
3.3. Measuring MS fatigue 
In the early studies on MS, fatigue was rarely recognised as a symptom of the illness, its 
severity, prevalence or impact on patients were not an issue of concern (Schwid et al., 2000), 
and it was even thought to have a basically psychological origin (Kurtzkie, 1961). It was not 
until the 1980s when that thinking began to change. That was when the results of a cross-
sectional survey of 656 MS patients revealed that fatigue was present in 78% of those 
surveyed (Freal et al., 1984). Even more, 50% of the sample equated fatigue with an 
exacerbation and described it as the most worrying symptom that affected their daily living 
activities and quality of life. In another study by Murray (1985), 96% of surveyed MS 
patients listed fatigue as a symptom, over three quarters described it as an abnormal feeling of 
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tiredness, and 40% mentioned that it was a worrying and major problem. It is to be noted, 
however, that the studies by Freal and Murray did not include healthy controls. This 
limitation was recognised by Krupp et al., (1988) who interviewed 32 MS patients and 33 
healthy adults with the aim of trying to assess the characteristics of MS fatigue and establish 
the connection between this symptom, physical activity, neurological disability and 
depression. Results of the study showed that fatigue was more severe in MS patients than in 
healthy controls. For example, fatigue was reported to interfere with physical functioning by 
79% of the MS group and 28% of the healthy controls. It has been also found that MS fatigue 
can be triggered quite easily and is worsened by heat (Table 3.1). However, the researchers 
found no relationship between fatigue and neurological disability measured by the Expanded 
Disability Status Scale (EDSS). 
Table 3.1: Characteristics distinguishing fatigue in MS patients and healthy controls. Source: Krupp et al., 
(1988). 
The findings of Krupp et al., (1988) triggered more interest in MS fatigue and formed the 
basis for Fatigue Severity Scale (FSS), one of the earliest fatigue measurement tools. Over 
the years, large numbers of scales that purport to measure fatigue have been proposed. Dittner 
Characteristic MS 
% 
Control P 
Heat worsens it 92 17 <0.001 
Prevents sustained physical Functioning 89 0 <0.001 
Comes on easily 82 22 <0.001 
Interferes with physical functioning 79 28 <0.001 
Interferes with responsibilities 67 0 <0.001 
Causes frequent problems 63 17 <0.001 
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et al (2004) identify thirty such scales and classify them into two major groups, 
unidimensional scales, and multidimensional scales (Tables 3.2a and 3.2b). The former group 
are designed to arrive at a single score, are relatively brief, easy to administer and more 
suitable for relatively large studies. On the other hand, the latter group are usually longer and 
provide more detailed quantitative and qualitative information which makes them suitable for 
identifying specific aspects of fatigue” (op.cit).       
Regardless of their types, fatigue measurement scales have been designed to assess fatigue in 
different clinical settings. Hence, if a particular measure is proven suitable in a specific 
clinical condition, this does not necessarily mean that it would be suitable in other groups of 
patients with different illnesses or experiences. Moreover, not all scales provide evidence of 
sensitivity to change, some even fail to provide information on reliability, and others have not 
been validated. Even when some are validated, it is more likely that validation takes place 
between MS patients and healthy individuals, not between fatigued and non-fatigued patients 
(Flachenecker et al., 2002). Added to this, many scales do not even make an attempt to 
investigate the possible effect on fatigue of some important factors such as the age, gender, 
culture or socioeconomic condition of respondents (Dittner et al., 2004). Indeed, 
unidimensional or otherwise and validated or not, all fatigue measurement instruments are 
often suspected of failing to provide a proper and accurate assessment of the symptom (Ford 
et al., 1997). One reason for their failings is that they often ask respondents to rate fatigue 
even without defining it (Schwid et al., 2002). Another is that questions put to participants are 
influenced by the developers' conception of fatigue and answers given are, in turn, 
determined by the respondent's interpretation of the questions being asked. Furthermore, 
results obtained through questionnaires are likely to be biased because respondents are 
usually asked to make retrospective judgements over a long period of time (Schwid et al., 
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2002). Despite these limitations, self-report questionnaires remain the most appropriate 
method of measuring MS fatigue (Comi et al., 2001). The question is: which is the most 
appropriate fatigue assessment approach, the unidimensional or the multidimensional? 
In research on MS fatigue, the Fatigue Severity Scale (FSS) has, until recently, been the most 
popular and frequently used scale. This scale  is often branded as a typical unidimensional 
measure that does not distinguish between motor and cognitive fatigue (Comi et al., 2001, 
Ford et al., 1998),  and is more focused on the physical aspects of the symptom possibly 
because these are more likely to be stressed by MS patients (Schreurs, 2002, Braley et al., 
2010). The FSS consists of only 9 items scored on a seven-point Likert scale. In itself, this 
makes it easy to administer and analyse and, at the same time, may explain why it is 
frequently used in MS research and clinical trials (Comi et al., 2001). Other reasons for the 
popularity of the FSS include its sensitivity to change in clinical conditions over time (Krupp 
et al., 1989), good concurrent validity and high internal consistency (Pepper et al., 1997). 
Despite that, the FSS is not without critics. 
Contrary to claims made by the developers of the FSS, there is the view that it has limited 
face validity as a measure of the severity of fatigue (Schwid et al., 2002). Similar concerns 
are voiced by Petajan et al., (1996) who note that although the FSS was found to distinguish 
between fatigue experienced by individuals with a medical condition and fatigue experienced 
by healthy controls, it still failed to show sensitivity to change over time. They further note 
that the assumption made by statement 4 in the scale (i.e. "fatigue interferes with my physical 
functioning") would be accepted by patients regardless of what they would be feeling at the 
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time of assessment. In the main, however, critics of the FSS often stress its limitations as a 
unidimensional approach to measuring fatigue. 
Dittner et al., (2004) observe that although unidimensional scales (particularly the FSS) may 
be useful in screening tests, multidimensional scales are more useful when used as outcome 
measures in clinical trials. In agreement with this view, the majority of writers find no good 
reason to suggest that MS fatigue is a single entity. Rather, for those writers, in order for 
fatigue to be better understood, it has to be considered as a multidimensional symptom (Kos 
et al., 2008; Pener et al., 2007). In fact, it is not unusual that recent studies on MS fatigue 
have long discussions on different types, divisions or subdivisions of the symptom with the 
two main aspects, the mental (or cognitive) and the physical (or motor), being the most 
frequently visited. Distinction between different components of fatigue is rather important 
because a patient may feel physically exhausted but mentally alert or he/she may experience 
different levels of mental and physical fatigue. In itself, this would mean that different types 
of fatigue may require different intervention therapies (Ford et al., 1998). From this 
viewpoint, a multidimensional instrument to measuring fatigue becomes the ideal alternative. 
One such instrument that is now gaining popularity is the Modified Fatigue Impact Scale, 
MFIS, (Tellez et al., 2005).  
Until recently, not much was mentioned in the MS literature about the MFIS. Lately, 
however, the MFIS has become one of the most widely used fatigue measurement 
instruments and is currently described as the most reliable of those tools (Tellez et al., 2005; 
Flachenecker et al., 2002). This tool, which was originally proposed by the American MS 
Council for Clinical Practice (1998), is a modified version of the 40-item Fatigue Impact 
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Scale, also known as the Fisk Fatigue Severity Scale (Schwid et al., 2002). Compared to the 
short 9-item FSS which has a physical focus, the MFIS is more descriptive of fatigue and it 
consists of 21 items scored on a 0 (never) to 4 (almost always) Likert scale with the total 
score ranging between 0 and 84 (Appendix 2). 9 of those items are intended to analyse the 
physical status, 10 the cognitive status, and 2 the psychosocial function (Flachenecker et al., 
2002). Put differently, this scale recognises the widely accepted principle of fatigue being a 
multi-faceted symptom in which different aspects play different roles (Tellez et al., 2005). 
Added to this, the MFI is reported to have proven high internal consistency as well as validity 
and reliability in assessing the impact of fatigue on daily living activities and the physical, 
cognitive and psychosocial domains on MS. It is also easy to use and has good 
reproducibility (MS Council, 1998; Comi et al., 2001; Flachenecker et al., 2002; Tellez et al., 
2005). Indeed, the MFIS addresses a major weakness in quantitative investigation in that it 
addresses the psychosocial experience of the patient (Mohr et al., 1999). For these same 
reasons, it is utilised for the purpose of the present research. 
No matter how reliable the fatigue measurement scale is, there remains the view that, on their 
own, self-report questionnaires may not reflect or capture the real experience of the 
symptoms. For example, there is good reason to suggest that patients' beliefs can influence 
their perceptions of fatigue, and also, their attitude towards physical activity (e.g. exercise) 
and its outcomes (Mohr et al., 1999). There is also the argument that fatigue is shaped and 
influenced by a wide range of factors including, depression, stress, pain, motivation, self-
efficacy, social impact, psychological consequences, sleep disturbances, patient’s behaviour 
and level of activity (Braley et al., 2009; Dodd et al., 2006; Dittner et al., 2004; Comi et al., 
2001; Fisk et al., 1994; Schwartz et al., 1993). Because these factors are not fully explored by 
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self-report questionnaires, and also because information about them is better obtained through 
qualitative data collection techniques, e.g. interviews   (Bethoux, 2006; Mohr et al., 1999), it 
is suggested that our understanding of fatigue would be improved if we used quantitative 
methods in conjunction with qualitative analysis (Bethoux, 2006; Dodd et al., 2004; MS 
Council, 1998). In fact, because qualitative analysis has been proven successful in evaluating 
fatigue and in patients with other neurological conditions (McBurney, 2003), there is now 
growing interest in applying this form of analysis in conjunction with quantitative analysis in 
MS research, particularly the areas of physical training and fatigue (Dodd et al., 2006). In this 
respect, the MS Council (1998) suggests that researchers seek answers to important questions 
such as: whether fatigue is related to muscle weakness or is precipitated by stress or physical 
activity, how it progresses during the day, factors that contribute to it and its impact on daily 
living activities and relationship with other people. Dodd et al., (2006) add that qualitative 
information obtained on the effect of exercise on patients can provide researchers with 
insights for developing and implementing training programmes and enable them to identify 
factors that hinder or facilitate MS patients’ participation in health promoting activities. With 
this in mind, the present study employs both quantitative and qualitative data collection 
methods. 
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   Table 3.2a.  Unidimensional fatigue scales.  (Source: Dittner et al., 2004: 160-161) 
Scale Assessed area Scale 
items 
Scale type Factors 
number 
Target 
population 
Internal 
consistency 
Test 
reliability 
Cut off 
score 
Sensitivity to 
change 
The Brief Fatigue 
Inventory (BFI) 
Severity 9 11-point Likert 1 Cancer 0.96 ! ! ! 
Cancer-Related 
Fatigue Distress Scale 
(CREDS) 
Impact 20 11-point Likert 1 Cancer 0.97 ! ! ! 
Daily Fatigue Impact 
Scale (DFIS) 
Impact 8 5-point Likert 1 General 
medical 
0.91 ! ! ! 
Fatigue Severity Scale 
(FSS) 
Impact and 
functional outcomes 
9 7-point Likert 1 Chronic medic 0.88 0.84 3/4 Yes 
Functional Assessment 
of Cancer Therapy 
Fatigue (FACT-F) 
Severity and impact 13 5-point Likert 1 Cancer 0.93 0.90 ! ! 
Global Vigour and 
Affect (GVA) 
Severity 8 Visual analogue 2 Psychiatric ! ! ! Yes 
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May and Kline 
Adjective Checklist 
Phenomenology 
and severity 
16 9-point Likert 1 Non-clinical ! ! ! ! 
Pearson Byars Fatigue 
Feeling Checklist 
Severity 26 Checklist 1 Non-clinical ! ! ! ! 
Rhotten Fatigue Scale Severity 1 10-point Likert 1 General 
medical 
! ! ! ! 
Schedule of Fatigue 
and Anergia 
Phenomenology 
and severity 
10 5-point Likert 1 Primary care 
and CFS 
! ! 1/2 or 2/3 !
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            Table 3.2b.  Multidimensional Fatigue Scales.  (Source: Dittner et al., 2004:162-164). 
Scale Assessed area Scale 
items 
Scale 
type 
Factors 
number 
Target 
population 
Internal 
consistency 
Test 
reliability 
Cut off 
score 
Sensitivity 
to change 
Cancer Fatigue Scale Phenomenology and 
severity 
15 5-point Likert 3 Cancer 0.88 0.69 18/19 ! 
Checklist of Individual 
Strength (CIS) 
Phenomenology and 
severity 
20 7-point Likert 4 CFS 0.90 ! ! Yes 
Fatigue, Anergia, 
Consciousness, Energised 
and Sleepiness Adjectives 
(FACES) 
Phenomenology and 
severity 
50 4-point Likert 5 Energy-
deficient 
states 
0.72-0.97 ! ! ! 
Fatigue Assessment 
Instrument (FAI) 
Phenomenology, 
severity and impact 
29 7-point Likert 4 General 
medical 
0.70-0.91 0.29-0.69 ! ! 
Fatigue Descriptive Scale Phenomenology, 
severity and 
frequency 
12 Yes/no 5 MS ! ! ! 
Fatigue Impact Scale (FIS) Impact 40 5-point Likert 3 MS 0.93 ! ! !
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HR-Related Fatigue Scale 
(HRFS) 
Intensity and impact 56 5-point Likert 3 HIV 0.94 0.43 3/4 ! 
Fatigue Questionnaire (FQ) Severity 11 Yes/no or 4-
point Likert 
2 CFS 0.88-0.90 ! ! ! 
Fatigue Symptom Checklist 
(FSCL) 
Severity, impact and 
direction 
13 11-point
Likert 
3 Cancer 70.94 0.35-0.75 ! ! 
Multidimensional 
Assessment of Fatigue 
(MAF) 
Severity, impact and 
distress 
16 Visual 
analogue and 
10-point
Likert 
5 Rheumatoi
d arthritis 
0.93 ! ! ! 
Multidimensional Fatigue 
Inventory-20 (MFI-20) 
Phenomenology, 
severity and impact 
20 7-point Likert 5 General 
medical 
! ! 
Multidimensional Fatigue 
Symptom Inventory 
(MFSI) 
Phenomenology and 
severity 
30 5-point Likert 5 Cancer 0.85-0.96 >50 ! ! 
Piper Fatigue Scale (PFS) Phenomenology and 
severity 
76 Visual 
analogue 
7 Cancer 0.85 ! ! !
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Profile of Fatigue- Related 
Symptoms (PFRS) 
Phenomenology and 
severity 
54 7-point Likert 4 CFS 0.96 0.97 ! ! 
Revised Piper Fatigue 
Scale 
Phenomenology and 
severity 
22 10-point
Likert 
4 Cancer 0.97 Yes ! ! 
Revised Swedish 
Occupational Fatigue 
Inventory 
Phenomenological 
and severity 
20 7-point Likert 5 Non-
clinical 
0.92 ! ! ! 
Schwartz Cancer Fatigue 
Scale (SCFS) 
Phenomenology and 
severity 
28 5-point Likert 4 Cancer 0.97 ! ! ! 
Visual Analogue Rating of 
Physical and Mental 
Energy 
Severity 2 Visual 
analogue 
2 Non-
clinical 
! ! ! ! 
Visual Analogue Scale for 
Fatigue (VAS-F) 
Severity 18 Visual 
analogue 
2 General 
medical 
0.91-0.96 ! ! Yes 
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3.4. Exercise and MS fatigue   
In 3.1, it has been noted that literature search has revealed 19 relevant studies on the 
effect of exercise on fatigue. These can be classified into three groups:  endurance 
training (ET, n=10 studies), resistance training (RT, n=4 studies), and combined training 
(CT, n=5 studies).The first training modality, ET, is described as moderate intensity 
exercise that involves the use of skeletal muscle groups and mainly aims at improving 
mobility and cardiovascular fitness (Newman et al., 2007). Examples of this type of 
training include treadmill walking and stationary cycling.  On the other hand, resistance 
training is primarily aimed at improving muscular strength and functional capacity 
(Dalgas et al., 2008).  As regards CT, this refers to two or more exercise types, mainly ET 
and RT training activities). In recent years, attention has been paid to another form of 
exercise therapy known as aquatic training which involves carrying out training activities 
in a   water pool. The rationale behind this form of training is that water will prevent body 
temperature from increasing and, as such, enable trainees to complete or prolong or 
training activities (Broach and Dattilo, 2001). In the discussion below, all 19 papers on 
exercise in MS fatigue are described and assessed. Assessment includes judgement as to 
the characteristics of participants, trial design and length, outcome measures, and rate of 
reporting on the effect of the training intervention. By contrasting different trials, the 
present writer should be able to identify and explain areas of strength or weakness   in 
research on exercise for MS fatigue. 
 
3.4.1. Endurance training  
The effects of an eight-week bicycling, walking and stretching training programme on 
balance, fatigue, depression and QoL in MS patients, were investigated by Cakit et al., 
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(2010). Patients were included in the study if they had a definite relapsing remitting or 
secondary progressive MS, an EDSS score of 6 or below, and the ability to stand upright 
unaided for a minimum of three seconds. Individuals were excluded if they had an acute 
exacerbation immediately before or during the training programme, were actively 
involved in physical therapy treatment or had participated in regular training activities 
four weeks before the trial, were unable to cycle a static bike, or had persistent fatigue or 
depression. The 45 patients who took part in the study were divided equally into three 
groups; a supervised exercise training group an unsupervised home-based training group  
and a control group. Only 33 of the 45 participants completed the trial: 14 in the 
supervised exercise training group, 10 in the home-based training group, and 9 in the 
control group. In the exercise training and home-based training groups, three patients 
dropped out because of acute exacerbations, and another three for undisclosed or work 
related reasons. Of the control group, three dropped out for unknown reasons, and three 
were discharged because of acute exacerbation. The training group had two training 
sessions a week. Each session began with static bicycle ergometer training, 15 sets of 
repetitions, followed by 5 minutes walking and 20-25 minutes of balance exercise. The 
home-based group received the same training as the exercise training group but without 
cycling, and they were contacted twice a month by phone to monitor their performances 
and adherence level. Tests were carried out at baseline and immediately at the end of the 
training programmes, and they included the Becks Depression Index (BDI) to measure 
depression, the Timed Up and Go (TUG) test to assess dynamic balance, the 10m walk to 
assess walking speed, the Falls Efficacy Scale (FES) to assess fear of falling, the short 
form – 36 (SF-36) to assess QoL, and the FSS to measure fatigue.   Results of the study 
showed no improvement in the control group but moderate to good improvement in the 
training group in gait, depression, balance, and fatigue. 
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A randomised controlled study by Oken et al., (2004) sought to determine the effects of a 
structured yoga intervention and an aerobic exercise on the cognitive function, fatigue, 
mood and QoL in MS patients. For the purpose of this study, they recruited 96 MS 
patients with an EDSS score of 6 or less. Patients were excluded if they had 
cardiovascular problems or any other illness that might prevent them from training. 
However, the researchers note that although they initially planned to exclude subjects 
‘taking any medication known to affect CNS function or subjects with significant 
psychiatric diseases’, they were forced to abandon their plan because they were ‘unable to 
recruit subjects with such exclusions’ (p.2059). To say the least, concomitant medication 
can be a confounding factor. After screening patients for medical problems, a series of 
tests were performed including Profile of Mood States, State-Trait anxiety Inventory to 
test the intensity of feelings of anxiety, short form-36 (SF-36) Health- related QoL, and 
Multidimensional Fatigue Inventory (MFI). The authors note that they have deliberately 
chosen to employ the MFI scale. In their view, this is because unlike the popular FSS, the 
MFI accounts for both physical and mental fatigue. Following the baseline tests, 
participants were randomly assigned to one of three groups; the yoga training group (YT, 
n=26), the aerobic exercise training group (ET, N = 21), and a waiting list control group 
(C, n=22). Yoga classes were held once a week and each class lasted for 90 minutes.  
Aerobic training consisted of bicycling on recumbent or dual-action stationary bicycle. It 
was held once a week and participants were instructed to exercise at the 2 to 3 or very 
light to moderate intensity on the modified Borg Rate of Perceived Exertion scale. They 
were also instructed to continue cycling until they were ready to stop because of fatigue. 
Both the YT and the ET groups were also encouraged to exercise at home. Outcome 
assessments were performed at the end of the six-month long trial period. Results of the 
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study showed no significant effect on either of the primary outcome measures of 
cognitive function or alertness. However, the researchers report that the exercise 
intervention and the yoga intervention produced significant improvements in measures of 
fatigue (in the ET, physical fatigue 13.2 ± 4.6 at baseline, 10.8 ± 4.0 at the end of the 
study, mental fatigue 8.3 ± 4.8 at baseline, 7.8 ± 4.4 at the end of the study, and in the YT 
group, physical fatigue 13.9 ± 3.5 and 12.1 ± 4.4 at baseline and at the end of the study 
consecutively and for mental fatigue, 11.4 ± 4.7 baseline, and 10.7 ± 4.0 at the end of the 
study).However, the authors note that the “yoga and exercise classes were significantly 
modified from the usual community classes “ to account for some of the limitations MS 
patients may have (p.2063). For this reason, they suggest that the results of their study 
may not be generlisable to typical community yoga or exercise classes. They further note 
that although subjects in their study were almost all women, the results can be generalised 
to men. However, they do not provide any justification for their claim.  
 
Impact of an 8-week aerobic training programme on immune-endocrine factors, 
coordinate functions and QoL in MS patients was assessed by Schultz et al., (2004). To 
be included in the study, patients had to pass a 30 minute stepwise incremental cycle 
ergometry test, provided they had a definitive MS condition and scored below 5 on the 
EDSS. Patients on immune-modulatory treatment were also included unless they had 
received medication (e.g. interferon) the day before the endurance test. Individuals were 
excluded if they were suffering from an acute relapse or had severe cognitive deficits or 
signs of any psychiatric disease. Patients who were eligible to take part in the study (n=39) 
were randomly assigned either to a bicycling training group (ET, N=23) or a control 
group (C, n=16). At the baseline and also at the end of the study, a number of measures 
were employed. These were; the SF-36 and the Hamburg Quality of life Questionnaire in 
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Multiple Sclerosis (HAQUMAS) to assess QoL, the Profile of Mood States (POMS) to 
assess affect and mood, HADS to assess depression, the MS Self-Efficacy Scale to assess 
self-efficacy, and the MFIS to measure fatigue. Members of the ET group had two 
sessions of bicycle ergometry training a week, thirty minutes a session. Training activities 
were tailored to their individual abilities. Results of the study showed improvement in the 
training group in both muscle coordination and disease specific quality of life, but no 
significant differences were found on the SF-36, POMS, HADS or the Self-Efficacy Scale. 
The authors conclude  Moreover, the training programme had no significant impact on 
fatigue (MFIS total 23.0 ± 15.4 pre-trial and 21.1 ± 15.0 post trial, p = 0.33). 
 
A non-controlled experiment was conducted by Klieff and Ashburn (2005) to investigate 
the effect of aerobic exercise on the mobility and function in a small group of MS patients. 
Participants in the trial were eight females aged between 33 and 61 with moderate 
disability and an EDSS score between 4 and 6. Patients with mild or severe disability or 
those who had a recent exacerbation or a major medical problem were excluded from the 
study. Individuals who were unable to cycle a static bike were also excluded. Six of the 
participants used walking aids. A number of outcome measures were used to assess 
participants at baseline and at the end of the three month trial. The 10m walk and the 6 
Minute Walk (6-MWT) were used to assess walking velocity and endurance respectively, 
the Gulick Scale was used to establish patients’ perception of their disability, as well as 
the kind of help they needed with their basic daily activities, the FSS to measure fatigue, 
and the Guys Neurological Disability Scale (GNDS) to measure various aspects of 
disability, including mood, vision, speech, swallowing, and upper and lower    limb 
function. The training intervention was aimed at enabling subjects to reach their “aerobic 
training zone “which involved working out 60-80% of their working heart rate. The 
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authors note that because they were concerned that training three times a week might 
worsen MS related fatigue, they decided to provide training only twice a week.  Initially, 
the first few sessions lasted for 15 minutes each, but they were gradually increased to 
reach 30 minutes over the first two weeks. Two participants dropped out of the trial, one 
due to a leg injury and the other because of a relapse. Results of the study showed 
significant improvement on the GNDS with the mean score reducing from 13 to 9 
(p=0.026), and the 6-MWT with the mean distance increasing from 200m to 261m. With 
reference to fatigue, the FSS failed to reach significance (p=0.058). 
 
Newman et al., (2007) investigated the effects of a four-week treadmill training 
programme on aerobic fitness and fatigue in MS patients with mild to moderate disability 
(  EDSS  scores of the  participants are not reported). Patients were included in the study 
if they were able to walk 10m in less than 60 seconds (with or without walking aids) and 
use a treadmill safely without support from a physiotherapist or partial body weight 
support harness. Those who had an exacerbation within eight week before the study or 
comorbidities that would make it unsafe for them to train were excluded. At baseline and 
at the end of the study, walking effort was measured by oxygen consumption during 
treadmill walking at comfortable speed, the Guy’s Neurological Disability Scale (GNDS) 
and the Rivermead Mobility Index (RMI) were used to assess functional mobility, and the 
FSS was used to measure fatigue. Three of the 19 participants who were originally 
recruited for the trial dropped out for reasons unrelated to their illness or training, and 
only 16 patients completed the training programme.  Participants were given three 
training sessions a week. Each session was up to 30 minutes of treadmill training at 55-
85% of age predicted maximum heart rate.  The researchers report that their short training 
programme resulted in significant improvements in walking speed and endurance (with 
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the mean 10m time reduced 15.6 seconds to 13.9 seconds, and the  6 -minute walk 
increased from 88.2m to 94.3m. Changes in reported fatigue levels at baseline and at the 
end of the trial were not significant (p= 0.178). 
 
 In a randomised crossover controlled study, Van Den Berg et al., (2006) investigated the 
effects of a four week treadmill training programme on mobility and fatigue in MS 
patients. Patients were included in the study if they had a confirmed diagnosis of MS, 
were able to walk 10m in less than sixty seconds with or without hands on support, and 
had the ability to walk on the treadmill with or without assistance. Individuals were 
excluded if they had a relapse during the two month before the study or suffered from a 
medical condition that might have a negative impact on their ability to exercise. Sixteen 
patients took part in the study, and they were allocated either to an immediate training 
group (n = 8) or a delayed training group (n = 8). Following assessment at baseline, the 
immediate group received training for four weeks, whereas members of the delayed group 
acted as controls. After the four weeks period, participants were reassessed, the delayed 
group underwent training and the final assessment took place after the intervention. Tests 
used to assess participants included a 10m timed walk, a 2 minute walk, the Rivermead 
Mobility Index and the FSS. The supervised treadmill walking intervention consisted of 
three training sessions per week. Walking duration was   increased as tolerated   up to a 
maximum of 30m and participants were encouraged to perform at an intensity of 55-85% 
of age predicted maximum heart rate. Results of the study showed a significant increase 
in the walking speed in both the immediate and the delayed training groups, a non-
significant increase in endurance and no changes in fatigue scores. However, follow up 
tests showed that training effects went back towards baseline scores. The authors note that 
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the small sample size, short duration of the intervention and rise in environmental 
temperature during the trial period might have affected their results. 
 
Rasova et al., (2006) examined the effects of different training techniques on muscle 
performance; fatigue, depression and cardio-respiratory fitness in patients with MS. 
Patients were excluded from the study if they had an exacerbation during the last four 
weeks before the study or an acute manifestation of other disease or injury. Individuals 
included in the study were those who showed no sign of progression of their illness for 
three months before the experiment, were able to walk independently with or without 
crutches up to 20m, and had an EDSS score of 6.5 or below. Participants (n = 95) were 
allocated to one of four groups on the basis of ‘next patient, next group’. Over the period 
of 8 weeks, the first group (n = 24) received neurophysiologically based therapy 
(operating on the principles of sensory-motor adaption and learning). They were given 
two training sessions a week, each lasting up to one hour. The second group (n = 26) were 
given training on a bicycle ergometer, twice a week. In this group, patients with lower 
levels of disability (EDSS ≤ 3) started training for a period of 5-10 minutes and increased 
the time gradually up to 20-30 minutes. Patient with a higher level of impairment 
(EDSS > 3 and ≥ 6.5) started training for a period of 2 minutes and increased to 10-15 
minutes. Training speed was approximately 60 RPM, and activities were interrupted in 
case of an increase in muscle weakness, spasticity or pain. The third group (n = 19) also 
trained twice a week, and they were given a mixed training programme consisting of 
aerobic exercise (received by the first group) and neurophysiologically based therapy 
(given to the second group). Members of the fourth group (n = 16) were asked to keep 
their normal daily habits unchanged. The following tests were used to assess patients at 
baseline and at the end of the study; the Multiple Sclerosis Quality of Life (to assess QoL), 
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the Modified Fatigue Impact Scale (MFIS to measure fatigue), and the Beck Depression 
Inventory Scale (to assess depression). Respiratory function and physical fitness were 
also assessed using spirometric parameters on a bicycle ergometer. According to the 
researchers, results of the study showed improvements in the neurological impairment 
only in the physiotherapy group and the physiotherapy and exercise group. However, all 
three training programmes had a positive impact on both depression and fatigue. In light 
of their study, the researchers suggest that rather than considering subjective fatigue as a 
limit of load within rehabilitation, it should be the principal point of therapeutic interest. 
The authors conclude by suggesting that it is rather important for MS patients to undergo 
a physiotherapeutic programme. In their view, such a programme should be specific to 
the patient’s symptoms and disease progression and applied during the early stages of the 
disease. 
 
A randomised crossover controlled study was conducted by Rampello et al., (2007) to 
compare the effects of aerobic training (AT) and neurological rehabilitation (NR) on 
walking capacity, health related quality of life and fatigue in patients with MS. 
Participants in the study were 19 patients aged between 20 and 51 and had a mild to 
moderate disability with an EDSS score of 6 or below. Patients were excluded if they had 
a relapse within the four weeks before the study, were receiving or had recently received 
steroid therapy, had a medical condition that would preclude them from participation, or 
had engaged in a regular exercise programme within two months before the study. 
Participants in the study were assigned either to an AT exercise group or to a parallel 8 
week NR group. Tests were carried out immediately before and after intervention. The 
disease specific Multiple Sclerosis Quality of Life-54 questionnaire was used to assess 
health related QoL, the MFIS was used to measure fatigue, a flow pyrometer was used to 
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assess pulmonary function, and the 6MWT was used to assess walking capacity. Over the 
period of 8 weeks, participants in the AT group received three weekly sessions of training 
on a leg cycle ergometer. Each session lasted for 30 minutes. On the other hand, the NR 
programme consisted of three weekly sessions of respiratory exercises and stretching 
exercise. Each session lasted for 60 minutes.  Of the 19 patients who initially took part in 
the study, only 11 were able to complete the overall crossover controlled parallel study. 
Four of those who dropped out complained of exercise induced fatigue and breathlessness, 
and the other four had a relapse. Results of the study showed no change over time in the 
neurological status of the participants as measured by the EDSS. There were also no 
changes in lung function and respiratory muscle strength in participants in the two 
training groups. However, within group analysis showed significant improvements in 
walking distance (p= .02)and walking speed (p=.02)after the AT programme but not after 
the NR programme.   AT was also found to have a positive effect on health related quality 
of life, and patients who were most disabled tended to benefit more from AT than from 
NR. No differences were found between AT and NR in effects on fatigue. The authors 
admit that their study had a major limitation in that a large number of participants failed 
to complete the study, which suggests that a type II error might have occurred. 
  
Petajan et al., 1996, carried out an RCT aimed at determining the impact of aerobic 
training on the quality of life, mood and fatigue in MS patients.  Forty six MS patients (15 
males and 31 females)   took part in the trial.  All participants had EDSS score of 6 or less, 
no medical condition that would preclude their participation in the trial, and none   had 
been involved in a physical activity programme for at least six months prior to the trial.  
Participants were randomly assigned to an exercise   group (EX) or a non- exercise 
‘control’ group (NE). Members of the EX group (n=21) took part in a supervised 
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programme of aerobic training (arm and leg ergometry) for 15 weeks, three sessions a 
week. Each session lasted for 40 minutes of aerobic training followed by 10 minutes 
stretching.  The 25 patients of the NE group agreed to keep their physical activity at its 
normal level throughout the entire period of the trial. A graded exercise test and 
psychological instruments were administered to all participants at baseline,   weeks 5 and 
10 and the end of the trial.  Fatigue was assessed using the Fatigue Severity Scale (FSS). 
Compared with the NE group, the EX group showed significant improvements in terms of 
overall fitness, ambulation, mobility and body care. Members of the EX group also 
demonstrated a non-significant trend toward decreased bad moods. As regards fatigue, 
although the results   showed no significant effect on the FSS, the researchers note that 
there had been a trend toward improvement. They further note that the training group 
received more attention than the control group. This is, according to them, a factor that 
might have affected the study outcomes. Nevertheless, they remain convinced that MS 
patients can benefit from aerobic exercise, and they   suggest encouraging those   patients   
to engage in this type of training. 
 
A four week training programme was designed by Mostert and Kesselring (2002) to 
investigate the effects of aerobic training on aerobic fitness, fatigue and health perception 
and activity level in MS patients. Individuals fulfilling the inclusion criteria (n = 26) were 
randomly assigned either to an exercise group (EX, n = 13) or a control group (C, n = 13). 
Patients were included if they had a confirmed diagnosis of clinical definite MS with an 
EDSS score of 1-6.5, had no acute exacerbations during the two months before the study, 
no disease history or medical conditions that would prevent them from taking part in the 
experiment and were able to pedal a free standing bicycle ergometer. A battery of tests 
was administered on participants at baseline and at the end of the study. Spasticity of 
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lower extremities was measured using the modified Ashworth Spasticity Scale, maximum 
aerobic capacity was determined by using an incremental graded exercise test, heart rate 
was measured by Polar system, BAECKE Activity Questionnaire was used to measure 
three dimensions of physical activity (work related activity, sport related activity and 
leisure time related activity), SF-36 to determine self perception of health status, and the 
FSS to measure fatigue. The training programme consisted of 5 x 30 minute sessions a 
week of bicycle exercise with individualised intensity. At the end of the study, the 
training group showed an increase in the activity level and remarkable improvements of 
the aerobic threshold and social functioning indexes of the SF-36. The researchers also 
note that there was a tendency for reductions in fatigue (-14%) in the training group.   
They also note that compliance to the training programme was quite low (65%).
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Table 3.3. Endurance training 
 
Study Design Sample Disability 
(EDSS) 
MS 
course 
Duration
/weeks 
Frequency 
(Day/Week
) 
Training programme Fatigue 
Scale 
Dependent 
variables 
Main  findings 
Cakt et al., 
2010 
(1) 
RCT 
 
EX(1): 
14  
EX(2):
10 
C: 9 
 
6.0 RR 
SP 
8 2 EX1: Ergometer 
bicycling 15 sets of 
2min of pedalling. 
Walking and 
stretching. 
EX2: As EX1 but  
home-based and 
without bicycling 
 
FSS/4-
5 
Progressive 
resistance 
training, 
depression, QOL, 
fatigue. 
Improvements in fatigue, gait 
and depression particularly in 
the supervised training group. 
 
Oken et 
al., 2004 
(2) 
RCT EX: 21 
Yoga 
EX: 26 
C: 22 
 
< 6 NR 26 1 Ergometer bicycling 
and yoga. Until fatigue 
or personal goals are 
reached. Exercise at 
home encouraged. 
MFI Fatigue, mood, 
QOL, cognitive 
function. 
No significant impact on 
depression. Significant impact 
on vitality and fatigue 
Schulz et 
al., 2004 
(3) 
RCT EX: 23 
C: 16 
 
<5.0 RR 
SP 
PP 
8 2 Aerobic bicycle 
training. 30 min 
training with max 
intensity. 
 
MFIS/3
8 
QOL, fatigue, 
coordinative and 
psychological 
function. 
Improvement in diseases-
specific quality of life. No 
effect on fatigue. 
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Kileff & 
Ashburn, 
2005 
(4) 
NC EX:8 4-6 NR 12 2 Ergometer bicycling. 
Cycling steadily 
increased from 15 min 
to 30 min over the first 
four sessions. 
 
FSS/4-
5 
Mobility, 
function, 
disability, fatigue 
Significant improvements in 
disability and mobility. A trend 
toward an effect on fatigue. 
Newman 
et al., 2000 
(5) 
NC EX:19 NR NR 4 3 Treadmill training: 
max 30min with up to 
3 rest periods 
FSS/4-
5 
Endurance , 
fatigue 
Significant improvement in 
endurance and walking speed. 
Reported fatigue levels 
remained unchanged.. 
 
Van Den 
Berg  et 
al., 2006 
(6) 
RCCT 
 
 
EX:8 
C: 8 
NR NR 4 3 Treadmill walking: 
max 30min with up to 
3 rest intervals. 
Intensity increased by 
increasing walking 
speed. 
 
FSS/4-
5 
Mobility, fatigue Significant improvement in 
walking speed and endurance. 
A return to baseline scores at 
week 12 after training had 
ceased .No significant changes 
in fatigue scores. 
Rasova et 
al., 2006 
(7) 
 
QE 
 
 
 
EX 36 
PT: 24 
EX+PT
: 19 
C: 16 
<6.0 NR 8 2 Ergometer bicycling.2-
10 min increased 
progressively to reach 
30min 
MFIS?
38 
Disability, 
depression, QOL, 
physical fitness, 
fatigue. 
Improvement in neurological 
impairment in the PT and PT 
and ET groups. Significant 
reduction in  depression and 
fatigue in those two groups in 
addition to the ET group 
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Rampello 
et al., 2007 
(8) 
RCCT 
 
EX: 19 
(11  
complet
ed the  
cross-
over 
study) 
 
<6 NR 8 (AT) 
8(NR) 
3 (AT) 
3(NR) 
30min Ergometer 
bicycling. 
60min of respiratory 
and stretching 
exercises 
MFIS/3
8 
Walking capacity, 
fatigue, QOOL. 
Significant impact of aerobic 
exercise on walking distance 
and speed. Most disabled 
patients tend to benefit from 
training. Insignificant effect on 
health related QOL. No effect 
on fatigue. 
 
C, Control group; CP, Chronic Progressive; EDSS, Expanded Disability Status Scale;  EX, Exercise Group; FSS, Fatigue Severity Scale; MFI, Multidimensional Fatigue 
Inventory; MFIS, Modified Fatigue Impact Scale; NC, Non-controlled; NR, Not Reported; PP, Primary Progressive; PT, Physiotherapy;  QE, Quasi Experiment;  QOL, 
Quality of Life; RCCT, Randomised  Controlled Crossover Trial; RCT, Randomised Controlled Trial; RR, Relapsing Remitting. 
 
 
 
 
Patajan et 
al., 1996 
(9) 
RCT  
EX:21 
C: 25 
<6.0 NR 15 3 - Arm & leg ergometry. 
40min (including 10m 
warm up & cool down 
period). 
FSS/4-
5 
Daily function. 
fatigue, mood, 
disability. 
No significant   improvement 
or change in depression anger 
or psychosocial factors. 
No effect of the intervention on 
FSS 
Mostert & 
Kesserling.
, 2002 
(10) 
RCT  
EX: 13 
C: 13 
1-6.5 RR 
CP 
RP 
4 5 Ergometer bicycling. 
30 min 
FSS/4-
5 
QOL, health 
perceptions, social 
interaction, 
fatigue. 
Significant improvement in 
aerobic threshold, vitality and 
social functioning. No 
significant impact on fatigue 
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3.4.2. Resistance training 
MS patients’ perceptions about Progressive Resistant Training (PRT) and the factors that 
might hinder or facilitate participation have been investigated in a qualitative study by 
Dodd et al., (2006). Participants in the study were seven females and two males aged 
between below 65. All participants had to demonstrate an ability to walk 200m without 
assistance, and also, produce a signed consent form from their doctor stating that it was 
safe for them to engage in PRT. Patients were excluded if they had recently participated 
in a PRT program or engaged in a physical therapy treatment. They were also excluded if 
they had an exacerbation immediately before or during the ten-week long training 
programme. 
 
Training sessions were held twice a week, and they targeted lower and upper extremities, 
three for the legs and another three for the arms, with patients completing two sets of 10-
12 repetitions of each exercise. Each exercise session lasted for nearly one hour followed 
by 30 minutes to give participants time to cool down and socialise over light refreshments. 
Soon after the programme, semi-structured interviews were conducted to explore 
participants’ perceptions of PRT and of participating in the study. Participants were also 
asked to evaluate the benefits of PRT on a 10cm visual analogue scale. On the whole, 
feedback from participants showed that physical, social and psychological benefits were 
gained as a result of the training. With reference to fatigue in particular, most participants 
noted that they felt less fatigued after the programme. However, a few negative but minor 
outcomes such as aches and pains that had no effect on the training programme were 
reported. Encouragement, enjoyment, socialisation, knowledge of exercise, positive 
attitude, determination and seeing signs of progress were all given as reasons behind 
completing the programme. 
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Dodd et al., 2011, investigated the effect of a ten-week PRT programme on the walking 
function and muscle performance in MS patients. Participants in the study were randomly 
assigned either to a training group (n=36) or a control group (n=35). Patients were 
included in the trial if they were 18 years or over old, had  a confirmed diagnosis of 
relapsing remitting MS, received medical clearance to take part in the trial, and had mild 
to moderate walking disabilities (an Ambulation Index score of 2,3 or 4). Patients were 
excluded from the research if they had benign or progressive relapsing MS, an 
exacerbation during the two months before the trial, a serious unstable medical condition, 
or participated in a PRT programme during the six months that preceded the training 
programme. Twice a week, the training   group performed a number of exercises targeting 
the lower limb muscle (namely, leg press, knee extension, calf raise, leg curl and reverse 
leg press). Training intensity consisted of two sets of 10-12 repetitions of each exercise. 
The weight lifted was increased when two sets of 12 repetitions of an exercise could be 
completed. The two exercise sets were separated by a 2-minute rest period. To control for 
the social aspects involved in the PRT programme, the control group participated in a 
purely social programme   for one hour each week. After completing the 10-week 
intervention programme, participants were asked not to continue with training until after 
the follow-up assessment session (after 12 weeks).  Outcome measures were recorded at 
baseline and at weeks 10 and 22. Changes in walking endurance were measured using the 
two-minute walk test (2MWT), and changes in muscle strength were determined by the 
amount of weight lifted in a single seated leg press. Changes in health-related quality of 
life were assessed using the WHOQoL-Bref, which is a 26-point scale that measures the 
domains of physical and psychological health as well as social relationships. The MS 
Spasticity Scale-28 was used to measure changes in muscle stiffness, and the MFIS was 
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used to assess fatigue.   As to the results, although PRT did not lead to improved walking 
performance, it still improved muscle endurance. Further, it did have a significant short-
term effect on physical fatigue (-3.9 units, 95% CI -6.6-1.3) and total fatigue (-5.9 units, 
95% CI-11.3-0.5) compared with the control group. The authors reported a high 
compliance rate (92%) to the training programme. The study’s major limitation is that 
only patients with relapsing remitting MS were included. 
White et al., 2004, evaluated the effects of an eight-week   progressive resistance training 
programme on lower extremity muscle strength, gait kinematics and self-reported fatigue 
and disability in MS patients. Participants in the trial (n=8: one male and seven females) 
were engaged in light physical activity for three months prior to the training programme. 
EDSS scores of participants ranged between 2.5 and 5.5.   Patients using   MS disease 
modifying drugs were included, but those who had   cardiovascular, thyroid or gout 
disorders were excluded. The training programme consisted of two weekly training 
sessions. Each session was up to 30min.At the beginning of each session, participants 
performed a warm-up set (5 reps at 40% of maximal voluntary contraction , MVC on 
each machine)Subjects performed one set of 6-10 repetitions at 5% of MVC during the 
first two weeks and one set of 10-15 repetitions at 70% MVC  in subsequent sessions . 
Before and immediately after the training programme, an isokinetic dynamometer was 
used to assess the isometric strength of the quadriceps, hamstring, plantaflexor and 
dorsiflexor muscle groups. A 25-ft walking test and a three minute step test were used to 
measure ambulatory function, and the MFIS was used to assess fatigue. Following the 
training programme, significant improvements were observed in muscle strength as well 
as in gait kinematics. Following the training programme, significant improvements were 
recorded in knee extension, plantar flexion and stepping performance. As regards self-
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reported fatigue, the average   score was 32 at baseline but it went down to 26 after 
training (p=0.05).   
 
Dalgas et al., 2010, used an RCT design to examine the effects of progressive resistance 
training (PRT) on fatigue, mood and quality of life in MS patients. Participants in the trial 
were 38 adults who were randomly assigned either to the exercise group (n=19) or the 
control group (n=19). Of those participants, seven dropped out of the intervention group, 
one because of back pain as a result of training, and the other six for reasons that were not 
related to the intervention.  Criteria for inclusion in the trial were: definite relapsing-
remitting MS; EDSS score between 3.0 and 5.5; ability to walk up to 100 meters; age 18 
years or over; and acceptance of diagnosis and treatment. Patients were excluded if they: 
suffered from dementia or alcoholism, had a pacemaker implanted or a serious medical 
condition, were pregnant, had an MS exacerbation during the last eight weeks prior to the 
trial, or had taken systematic resistance training within the last three months that preceded 
the intervention. The PRT intervention was performed twice a week over a twelve-week 
period, and it targeted the lower extremities. Each session began with a 5-minute warm up 
on a stationary bicycle. Participants were then asked to perform five different exercises: 
leg press, knee extension, hip flexion, hamstring curl and hip extension. During the first 
two weeks, participants performed three sets of 10 repetitions at a load of 15RM, weeks 3 
and 4  three sets of 12 repetitions at a load of 12 RM, weeks 5 and 6 four sets of 12 
repetitions at a load of 12 RM, weeks 7 and 8 four sets of 10 repetitions at a load of 10 
RM, weeks 9 and 10 four sets of 8 repetitions at a load of 8 RM, and weeks 11 and 12 
three sets of 8 repetitions at a load of 8RM.  During the intervention, one participant 
dropped out because training worsened his back pain condition, and six more patients quit 
due to circumstances not related to the intervention. Data obtained from the remaining 31 
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patients (training group, n=15, control group, n=16) were used for analysis. The two 
groups of participants were compared at the start and the end of the intervention, and also, 
at a twelve-week follow up point. Mood was assessed using the Major Depression 
Inventory, quality of life was assessed using the SF36, and fatigue was measured using 
the FSS and the MFI scales. AS regards the results, significant improvements were 
recorded in the training group (p= <0.05). Significant improvements were also reported in 
the physical component of the SF-36 in the exercise group (p= <0.05), but no significant 
differences were recorded in the mental component between the two groups(p=0.09).With 
reference to the effect of resistance training on fatigue,  significant improvements  were 
recorded in the FSS score (p= <0.05), and also, in the general fatigue score of the MFI 
scale((p= <0.05). However, the authors note that they have chosen a design in which 
social interaction might have influenced the results. Moreover, it is to be noted that 
participants in this study were a group of relapsing-remitting MS patients with low EDSS 
scores. This being so, it would be reasonable to suggest that such patients would tolerate 
and benefit from resistance training. 
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Table 3.4. Resistance training 
Study Design Sample Disability 
(EDSS) 
MS 
course 
Duration/
weeks 
Frequency 
(Day/Week) 
Training programme Fatigue 
Scale 
Dependent 
variables 
Main  findings 
Dodd et 
al., 2006 
(11) 
NC 
 
EX:9 NR NR 10 2 Three exercises for the 
legs and three for the 
arms. Two sets of 10-12 
repetitions of each 
exercise 
Semi-
structured 
in-depth 
interviews 
Perceptions about 
PRE, fatigue. 
Physical, 
psychological and 
social benefits 
reported. Reduced 
fatigue reported by 
7/8 of the sample. 
 
Dodd et 
al., 2011 
(12) 
RCT 
 
EX: 36 
C: 35 
 RR 10 2 Exercise targeting 
lower limb muscles. 
Intensity consisted of 
two sets of 10-12 
repetitions of each 
exercise 
 
MFIS Walking  
function, muscle 
performance, 
fatigue 
Increased muscle 
endurance and small 
improvements in 
QOL. Significant 
short term effect on 
fatigue. 
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White et 
al., 2004 
(13) 
NC EX:8 2.5-5.5 RR 8 2 Progressive resistance 
training (lower 
extremities). First two 
weeks: one set of 6-10 
repetitions. Last six 
weeks: one set of 10-15 
repetitions 
MFIS/38 Lower extremity 
strength, 
ambulatory 
function , fatigue, 
disability 
Significant 
improvements in 
muscle strength, gait 
kinematics and 
fatigue. 
Dalgas et 
al., 2010 
(14) 
RCT EX: 15 
C: 16 
3-5.5 RR 12 2 5-machine
exercise( lower 
extremities) 
FSS/4-5 
MFI-20 
QOL, depression, 
fatigue. 
Significant effect on 
fatigue. Long-term 
effect also recorded 
on depression and 
QOL. 
C, Control group; CP, Chronic Progressive; EDSS, Expanded Disability Status Scale;  EX, Exercise Group; FSS, Fatigue Severity Scale; MFI, Multidimensional Fatigue 
Inventory; MFIS, Modified Fatigue Impact Scale; NC, Non-controlled; NR, Not Reported; PP, Primary Progressive; PT, Physiotherapy;  QE, Quasi Experiment;  QOL, 
Quality of Life; RCCT, Randomised  Controlled Crossover Trial; RCT, Randomised Controlled Trial; RR, Relapsing Remitting ;SP, Secondary Progressive. 
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3.4.3. Combined training 
Surraka et al., (2004) conducted a RCT study to investigate the effects of a twenty six 
week combined endurance and resistance training program, on motor fatigue of knee 
flexor and extensor muscles in Multiple Sclerosis (MS) patients. Participants in the study 
were 95 male and female patients with a mild to moderate disability and an EDSS score 
between 1 and 5.5. Patients were excluded from the trial if they had taken part in any 
regular or intensive training activity during the last three months before the trial. Patients 
were also excluded if they had a relapse within four weeks before the baseline tests or a 
muscoskeletal disorder that would not allow them to complete the programme. At 
baseline, subjective fatigue was assessed using the FSS, ambulatory ability was assessed 
by means of a 500m walking test, and motor fatigue of knee flexor and extensor muscles 
was assessed during a static 30-s  maximal sustained muscle contraction. Measures were 
taken again at week three and week 26 at the end of the programme. Participants were 
assigned either to an exercise group (n=47) or a control group (n=48). The first three 
weeks of the training programme consisted of ten supervised exercise sessions, five 
resistance and five aerobic. Each resistance training session consisted of 10 minutes 
warming up followed by ten exercises of circuit type with 10-15 repetitions.  The aerobic 
training sessions covered different forms of gymnastic exercises in shoulder-deep water, 
and each session lasted for 45 minutes, including 10-15 minutes warming up and cooling 
down period. After the three week supervised training period, participants were asked to 
continue training at home for another 23 weeks, and they were instructed to keep a diary 
in which they recorded the duration and intensity of exercise, as well as general 
information about their condition. Patients’ progress and adherence were monitored by 
regular phone contact. 88 patients (44 in each group) completed the programme, with 
women scoring a 25% adherence rate higher than men. The results showed that whereas 
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associations were observed with changes in extension fatigue index and EDSS score and 
mean extension torque, no changes were detected in fatigue index or aerobic or strength 
exercise activity, mean Ambulatory Fatigue Index, mean FSS or in mean flexion torque. 
Motor fatigue was reduced in knee flexion (p=0.0014) and extension (ns) only in female, 
not male exercisers. The authors are of the view that lack of exercise effect in men is not 
necessarily related to the amount of training. Rather, in their view, reasons related to MS 
or to individual physiology may explain the difference in exercise effect between males 
and females. As noted above, this trial lasted for a relatively long period of time and no 
measures were taken between week three and week 26 when the programme was 
terminated. This means that some positive effects of exercise might have been hidden 
because of the progression of the disease. Nevertheless, the authors do agree that they 
should have applied their test measures more frequently.   
    
Another randomised controlled pilot study was carried out by McCullagh et al., (2008). 
The aim of the study was to explore the effects of a three-month combined aerobic and 
arm-strengthening training programme on the Quality of Life (QoL) and fatigue in MS 
patients. For the purpose of the research, 30 MS patients with mild disability were 
recruited and randomly allocated either to an exercise training (ET) group or a control (C) 
group. Of those individuals, only 24 completed the study, ET group, n=12 and C group, 
n=12. Subjects eligible for participation were those with no history of cardiac, cognitive 
or psychological conditions and those who had a definite diagnosis of MS and were 
independently mobile without the use of aids. Exercise training classes were held twice a 
week, and participants exercised independently once a week. Each session consisted of 2 
x 5 minutes warm up and cool down period and 40 minute of training. Training activities 
included treadmill walking/running, cycling, stair master training, arm strengthening and 
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outdoor walking. Rather than using specific heart rate as a target in training, patients were 
encouraged to maintain their level of exertion between ‘fairly low’ and ‘somewhat hard’. 
Members of the control group were visited by a psychotherapist once a month and they 
were asked to maintain their normal daily life activities. Fatigue was measured using the 
MFIS, a graded exercise test was used to measure exercise capacity, and QoL was 
assessed using the Functional Assessment of Multiple Sclerosis scale (FAMS) as well as 
the Multiple Sclerosis Impact Scale – 29 (MSIS-29). Measures were taken at baseline, at 
the end of the three month exercise period, and three months after training had been 
terminated. Based on the measures taken at three months the exercise group showed 
significant improvements in exercise capacity, QoL (FAMS but not the MSIS-29), and 
fatigue (MFIS: -13 (-20, -3) versus 1 (-4, 4.5)). At six months, the significant differences 
in the change scores for both the FAMS and the MFIS were still observed (p=0.002 and 
p=0.02 respectively). 
 
Smith et al., (2009) investigated the effects of an eight week long endurance and 
resistance training programme on perceived control over fatigue in MS patients. 
Participants in the trial were 10 patients (8 females and 2 males) who had a confirmed 
diagnosis of MS and were able to walk short distances without assistance. To gauge 
participants’ attitude towards exercise and   find out whether their perceptions of fatigue 
change over time, semi-structured interviews were performed at baseline, mid-way during 
the programme, and at the end of it. Training sessions were held three times a week. Each 
session lasted for one hour. The individually tailored programme consisted of a wide 
range of activities, including cycling, treadmill walking/running, jumping, balance, stair 
climbing, foam standing and strengthening. Findings of the study show that exercise 
outcomes are often determined by the individual’s level of perceived control over fatigue. 
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There are also indications that fluctuations in the patient’s perceived level of control are 
influenced by emotional and environmental changes.  
 
Effects of a12-week aquatic exercise programme on the QoL and fatigue in patients with 
primary progressive (PP) or secondary progressive (SP) MS were investigated by Roehrs 
and Karst (2004). For the purpose of their non-controlled study, the researchers recruited 
31 patients. Six of those recruits withdrew before the exercise intervention and another 
six dropped out during training, two due to exacerbations, one due to an infection and 
three because they lacked motivation. Patients below the age of 19 and those with severe 
cognitive impairments were excluded from the study. Inclusion criteria in the study 
required the availability of a care-giver to provide assistance when needed, clearance for 
exercise participation from a neurologist and a clinical course consistent with PP and SP. 
The EDSS scores of the participants ranged between 1.5 and 8. Outcome measures 
performed at baseline and at the end of the trial period were the Medical Outcome Study 
Short Form-36 (SF-36) and the Multiple Sclerosis Quality of Life Inventory to assess 
QoL, and the MFIS to measure fatigue. Participants were given two sessions a week, one 
hour a session. Training activities were individualised based on the ability of participants 
and water temperature was maintained between 83˚F and 85˚F, and they consisted of 
balance, endurance, strengthening and stretching activities. Of the 19 participants who 
completed the study, five attended between 25% and 49% of the training classes and 
another six scored between 50% and 74% rate of attendance. Results of the study showed 
significant improvements in the QoL domains of social functioning and on fatigue (Pre-
test 48.7 ± 12.1, Post-test 43.5 ± 15.0, p = 0.035). 
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Fargoso et al., 2008, evaluated the effect of a 20-week, three days a week training 
exercise programme on nine female and one male fatigued MS patients aged between 20 
and 49 years.   None of the participants enrolled for the trial had serious cardiac or 
respiratory problems, none was undergoing treatment for fatigue, and they were all 
allowed to continue with any treatment (including physiotherapy and immunomodulators) 
they were receiving. Patients with moderate to severe weakness of respiratory muscles 
were excluded. At entry and at the end of the training programme, fatigue was assessed 
using the Chadler Fatigue scale. The training programme was as follows: 4 weeks x 60 
minutes a session of stretching, 10 weeks of stretching for 15min followed by exercise 
with light weight for 30min then another 10min of stretching, and 6 weeks x 90min a 
session divided equally between stretching, resistance, and conditioning exercises that 
included walking and short running periods. All exercises were adapted to each 
participant’s special limitations. One female participant dropped out of the programme 
because she lacked motivation. Results of the study showed significant improvements in 
cardio circulatory parameters as well as a significant decrease in fatigue scores (46+- 6.3 
at baseline, 39.4+-3.4 at the end of the programme, p=0.01). The authors conclude by 
suggesting that reduction in fatigue may be caused by improvement in cardio-circulatory 
parameters and that, at least in part, physical inactivity may cause fatigue.
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        Table 3.5. Combined training 
Study Design Sample Disability 
(EDSS) 
MS 
course 
Duration/
weeks 
Frequency 
(Day/Week) 
Training programme Fatigue 
Scale 
Dependent 
variables 
Main  findings 
Surakka 
et al., 
2004 
 
(15) 
RCT 
 
 
 
EX: 47 
C: 48 
1-5.5 All 26 First   3 
wks:  5 
aerobic and 
5 resistance. 
Last 23 wks 
1 :aerobic 
and 3-4 
resistance 
First 3 weeks: 30min aerobic 
training and 10 exercises for 
whole body and 10-15 
repetitions   resistance 
training. Last 23 weeks: One 
30min  aerobics  exercise  and 
eight    resistance exercises 
 
FSS/4-5 Fatigue, 
muscle 
strength 
Endurance and resistance 
training reduced motor 
fatigue in female 
participants, but not in 
males. 
McCullag
h et al., 
2008 
 
(16) 
RCT EX: 12 
C: 12 
 
NR RR 
SP 
12 2 Combined training (treadmill 
walking/running, cycling, 
stair-master training, arm-
strengthening, outdoor 
walking). 
40 min training and 10 min 
warm up and cool down. 
MFIS/38 Fatigue, 
QOL 
At months three and six, a 
significant effect of 
combined training on 
fatigue and QOL was still 
observed. 
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Smith et 
al., 2009 
 
(17) 
NC 
 
 
 
EX: 10 NR NR 8 3 One hour long individually 
tailored exercise which 
included aerobic, 
strengthening and stretching 
activities. 
 
Qualitati
ve study 
(interpret
ive 
descriptio
n) 
Exercise, 
fatigue 
perception 
Patients’  level of 
perceived control over 
fatigue plays a pivotal 
role in determining 
exercise outcomes 
Roehrs & 
Karst., 
2004 
 
(18) 
 
NC 
 
EX: 19 1.5-8 PP 
SP 
12 2 Individualised aquatic 
training: balance activities, 
stretching, endurance training, 
strengthening. One hour 
 
MFIS/38 Health-
related 
QOL, 
fatigue 
Significant improvements 
in QOL and in fatigue 
Fragoso 
et al., 
2008 
 
(19) 
NC 
 
 
EX:10 6.0 RR 
SP 
20 3 Gradual exercise adapted to 
the specific abilities of each 
patient. 4weeks x60min 
stretching. 10 weeks   x 15min 
stretching followed by 30min 
exercise   with light weight 
and other 10min stretching. 
Chalder’s 
Fatigue 
Scale 
Fatigue Fatigue can be 
significantly improved 
with gradual and 
indivilduaised endurance 
and resistance training 
exercises 
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6 weeks x 90min   divided 
equally between stretching, 
resistances, and walking and 
running. 
C, Control group; CP, Chronic Progressive; EDSS, Expanded Disability Status Scale;  EX, Exercise Group; FSS, Fatigue Severity Scale; MFI, Multidimensional Fatigue 
Inventory; MFIS, Modified Fatigue Impact Scale; NC, Non-controlled; NR, Not Reported; PP, Primary Progressive; PT, Physiotherapy;  QE, Quasi Experiment;  QOL, 
Quality of Life; RCCT, Randomised  Controlled Crossover Trial; RCT, Randomised Controlled Trial; RR, Relapsing Remitting ;SP, Secondary Progressive
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3.5. Discussion 
To facilitate our discussion, the findings of the three training modalities considered above 
are summarised below in terms of participants in those studies, type of training, 
programme duration and intensity, and the measures employed. 
 
3.5.1. Study participants 
Although all participants in the 19 studies of the review fulfilled a clinical diagnosis in 
order to be eligible to take part in the training programmes, a huge diversity among 
studies exists with regard to the numbers of participants and their characteristics. To 
begin with, some studies recruited large numbers of participants (for example, between 46 
and 95 patients in Oken et al., 2004, Rasova et al., 2006; Petajan et al., 1996; Dodd et al., 
2011; Surakka et al., 2004. Other studies comprised a small or a relatively small sample 
size between 8 and 10 participants in  Klieff and Ashburn, 2005; Dodd et al., 2006; White 
et al. 2004; Smith et al., 2009; Fargoso et al., 2008 and not more than 19 in Newman et al., 
2000; Rampello et al., 2007; Fargoso et al., 2008. In itself, this can limit the statistical 
power to detect any differential effects of the intervention. Moreover, although it is 
widely accepted that the rate of MS female patients to male patients is 2 to 1, (see section 
2.4), gender bias can be observed in some studies.  For example, 7 females and 1 male 
took part in the study by White et al., 2004; 8 females and 2 males Smith et al., 2009 , and 
only one male compared to 9 females in Roehrs and Karst, 2004. In other words, it would 
be difficult to claim that findings of biased studies can be generalised. Also in the 
reviewed studies, three include all or three MS course types (Schultz et al., 2004; Mostert 
and Keeserling, 2002; Surakka et al., 2004), three include two types (McCullagh et al., 
2008; Roehrs and Karst, 2004; Fargoso et al., 2009), another three include only the 
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relapsing remitting type   (Dodd et al, 2011; White et al., 2004; Dalgas et al., 2010), and 
the rest make no reference to the MS course. Indeed, it would be unrealistic to assume 
that patients with more progressive forms of the illness or those with restricted mobility 
would tolerate exercise or benefit from it the same way as the others. Added to this, 
EDSS scores are generally within the range between 1 and 6.5. Only one study (Roehrs 
and Karst, 2004) included severely disabled patients (EDSS up to 8.5). This indicates 
diverse disabilities and severities of the disease among participants. However, three 
studies had fixed EDSS scores: 2.5-5.5 in White et al., 2004, 3- 5. 5 in Dalgas et al., 2010, 
and 4-6 in Klieff and Ashburn, 2005.  Added to this, a close look at   demographic 
information in the studies described above shows that only very few older patients are 
included in the trials.  This might give the impression that old age is a barrier to exercise. 
Nevertheless, at least one study that included relatively old participants (Newman et al., 
2007) shows that those individuals can actually benefit from exercise and tolerate it.  
These variations may explain why different results were obtained by different researchers. 
3.5.2. Exercise modality 
From the review above, it is clear that endurance training has received more attention 
than resistance training. Beginning with the first type of training modality, three out of the 
ten endurance training studies in the review showed significant improvements in fatigue 
as a result of training (Oken et al., 2010; Rasova et al., 2006; Mostert and Keeserling, 
2002), two showed a trend toward improvement (Cakit et al., 2010; Klieff et al., 2005), 
and the remaining five showed no improvement Schultz et al., 2004; Newman et al., 2000; 
Rasova et al., 2006; Rampello et al., 2007; Petajan et al., 1996). On the other hand, more 
positive results have been obtained from resistance training, with three studies revealing 
significant improvements (Dodd et al., 2011; White et al., 2004; Dalgas et al., 2010) and 
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study (Dodd et al., 2006) showing reduced fatigue levels. Similarly, positive results 
appear to be obtained when both endurance  and resistance training activities are 
combined in that significant improvements have been reported in three combined training 
studies (McCullagh et al., 2008; Roehrs and Karst, 2004; Fargoso et al., 2008 ) and 
reduced fatigue levels in two studies ( Surakka et al., 2004; Smith et al., 2009). It is to be 
noted that the study by Smith et al., 2009, is a qualitative study and that reductions in the 
level of fatigue were, according to the authors, dependent on the patient’s perception of 
exercise and the illness, with positive attitudes generating more favourable results. 
However, results obtained from combined training studies do not clearly show whether 
one training modality (i.e. endurance or resistance) is superior to the other. Nevertheless, 
it seems that both training modalities are well-tolerated and that patients benefit from 
both types of training because they complement each other. 
3.5.3. Duration and intensity 
Studies in the present review vary considerably in terms of duration, frequency and 
intensity. For example, in studies evaluating ET, intervention periods range between 4 
and 26 weeks, 2-3 weekly training sessions are applied within the range of 30-40 minutes. 
But, although some short-term interventions show positive effect on fatigue ( Cakit et al., 
2010; Rasova et al., 2008; Mostert and Keeserling 2002), others have no effect on the 
symptom(Shultz et al., 2004; Newman et al., 2000; Van den Berg et al., 2006; Rampello 
et al., 2007). The same applies to long or relatively long term intervention: significant 
improvement in fatigue in a 26-week long intervention (Oken et al., 2004), no effect in a 
15 week-long intervention (Petajan et al., 1996), and a trend toward improvement in a 12-
week long intervention (Cakit et al., 2010).  Intervention periods in RT and CT also vary 
between 8 weeks and 26 weeks and training sessions are held 2-5 times a week. However, 
81 
although all these studies have reported improvement in fatigue, the levels of those 
improvements remain unclear. On the whole, it can be said that it would be difficult to 
draw clear-cut conclusions on optimal exercise duration frequency and intensity. At the 
same time, it would be possible to arrive at general conclusions and recommendations 
based on the findings of the reviewed studies. 
As regards ET, there is evidence that well-functioning patients can benefit from arm-
ergometry, arm-leg ergometry and treadmill walking. During the early stages of training, 
it is suggested that intensity of 50%-70% of VO2-max corresponding to 60%-80% of 
maximum heart rate appears to be suitable. Exercise sessions lasting for 30 minutes each 
also appear to be effective. As to exercise intensity, it would be appropriate if it is 
customised against the RPE scale (on the patient’s level of disability) and training volume   
increased progressively either by increasing the session time or by adding an extra 
training day.  A rest period of one day   between exercise sessions and a maximum of four 
sessions a week are recommended. With reference to RT, it would more appropriate in 
the initial stages of training to use training machines (closed kinetic chains) instead of 
free weights (open kinetic chains) as the former method is easier to control rather than the 
latter. Intensity of 15 repetitions maximum (RM) would be also appropriate. This should 
be progressively increased to between 8-10RM. Also in the beginning of training, one to 
three sets would be sufficient, but they may be increased to three or four sets of every 
exercise if the patient can manage. It is necessary that patients have a rest period of 
between two and four minutes between sets and exercises to allow time for the muscle to 
recover between exercises. In order for treatment to be more effective, training activities 
must be designed in a way to activate working muscles but avoid overload that can result 
in conduction block. It is also recommended that exercise is planned in a way so that 
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large muscle groups are targeted before small muscle groups. All major muscle groups, 
including the trunk muscles, should be exercised. What has been said about ET and RT 
also applies to CT. However, it would be appropriate if the training programme included 
equal proportions of resistance   and endurance training activities. 
3.5.4. Fatigue measures 
In eight of the 19 studies under investigation, fatigue was assessed using the MFIS. Seven 
of those studies showed improvement in fatigue after training( (Shultz et al., 2004; 
Rasova et al., 2006; White et al., 2004; Dodd et al. 2011; McCullagh et al., 2008; Roehrs 
and Karst, 2004; Oken et al., 2004), and only one showed no change in fatigue levels 
(Rampello et al., 2007). The FSS was used in seven studies. Three of those showed 
positive effect of training on fatigue, (Cakit et al., 2010; Klieff and Ashburn, 2005; 
Surakka et al., 2004), and in the other four (Van den Berg et al., 2006; Mostert and 
Keeserling, 2002; Newman et al., 2000; Petajan et al., 1996) , no changes in fatigue levels 
were recorded. The Chadler Fatigue Scale was employed in one study (Fargoso et al., 
2008), two studies utilised semi-structured interviews for the purpose of assessment 
(Dodd et al., 2006; Smith et al., 2009), and both the MFIS and the FSS were used in one 
study (Dalgas et al., 2010). All last four studies showed improvements in fatigue after 
training. However, as noted in 3.4, FSS is often described as an effective tool to measure 
the social consequences of fatigue but not its intensity. 
Although no adverse effects of training on fatigue have been reported in any of the 
studies under investigation, not much is mentioned about drop-outs in the training groups. 
For example, there were six drop-outs in  Klieff and Ashburn., 2005; Petajan et al., 1996; 
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Mostert and Keeserling, 2002 (two dropouts each), and only small numbers of 
participants completed trials (Rampello et al., 2007; Roehrs and Karst, 2004). In some 
other studies, there were also losses to follow-up assessment. Hence, an adverse effect of 
fatigue in one or more than one of those studies is not to be discounted. It is also to be 
noted that in studies with control groups, individuals in those groups are usually given 
less attention than those in the training groups. In itself, this might have affected the 
results. 
 
3.6. Summary and conclusions 
In this chapter, a range of issues related to MS fatigue and physical training has been 
investigated and a number of oft-cited empirical studies have been examined. On the 
whole, there is a general agreement among writers that MS patients are at risk of 
developing physiological and psychological problems as a result of inactivity. Writers 
also agree that MS patients can benefit from training, provided that it is performed under 
the supervision of a professional physiotherapist. However, in almost all the clinical 
experiments reviewed above, emphasis is on patients with mild to moderate impairment 
with EDSS score ranging between 1 and 6.5. Moreover, there appears to be a tendency to 
exclude relatively old patients from participating in the trials. This can imply that old MS 
patients with severe disabilities may not benefit from exercise.  Given the fact that there is 
no concrete evidence to support this claim, it can be still argued that training can be 
tailored to meet the abilities of those patients. After all, we need to remember that they 
are more susceptible than others to health and inactivity related problems. 
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 The studies reviewed above also appear to have other failings.  One is that in some of 
those studies, the results are not fully explained and exercise intensity is not clear. More 
important is that researchers tend to treat participants as a homogeneous group and pay 
little, if any attention, to their mixed abilities and individual differences. Furthermore, 
although it is widely accepted that fatigue is a multidimensional symptom, the majority of 
the reviewed studies still regard it as a unidimensional symptom and measure it 
accordingly. In fact, there is no consensus among writers on a core set of outcome 
measures to be employed in physical training interventions. Added to this, in almost all 
the studies above (with the exception of only one study on attitude towards exercise), 
researchers rely on self-report questionnaires and quantitative analysis and pay no heed to 
qualitative data which can be a source of rich information. It is also possible that some 
recruits to some trials may not be fatigued, in the first place. Obviously, this would lead 
to biased results.  Furthermore, rather than taking into account the patients’ preferences,  
perceptions of exercise and what they feel about it, researchers often tend to impose the 
type of exercise and training activities on those patients. There is the possibility that 
patients recruited to some clinical trials in previous studies already participate in exercise 
in one way or the other. Hence, it is possible that any additional benefit gained through 
exercise in those research studies is likely to be minimal. In fact, it would be difficult to 
attribute any gains or adverse effects to the training programme, itself. 
Despite the failings of some previous studies on exercise, they can still provide us with 
general guidelines we need to consider when designing our training programme. 
Beginning with training modality, although endurance exercises are popular among 
researchers, no type of training appears to be superior to the other, and participants can 
benefit from resistance, endurance or combined training activities. However, regardless of 
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its type, the literature in our hands shows that participants can tolerate it, provided it is 
initially performed at low to moderate intensity. For resistance training, 2 to 3 sets of 8-15 
RM given in 3 or 4 weekly sessions each lasting between 30 and 45 minutes are initially 
recommended. This can be increased by 1 set and up to 10 reps but only after a few 
weeks.  The same applies to endurance training in terms of training frequency and session 
duration, and initial training using 50-70% of VO2 is recommended. After a few weeks, 
training sessions can be increased by one. In regards to combined training, it advisable 
that endurance and resistance exercises is provided on alternate days. It is also suggested 
that the training intervention should last for a minimum of 9 weeks. Lessons learned from 
the experimental studies outlined above should enable the present researcher to design his 
training programme. More about this point is mentioned in Chapters 5 and 6. 
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Chapter 4: Perceptions of MS patients towards exercise: a pilot study 
4.1. Background 
At an early stage of the present study, it was seen necessary to obtain the baseline 
information required to design individualised exercise interventions and investigate their 
effect on fatigue in MS patients. To say the least, it was rather important that the present 
researcher establishes whether or not fatigue was a problem in the local MS population in 
the first place. Also important were the questions of MS patients’ perception of fatigue, 
attitude towards exercise, willingness to participate in an exercise trial and the type of 
exercise they preferred. To answer these questions, a questionnaire survey was drafted 
and ethical approval, Ref. 12/NW/0107, (Appendix 3), dated, 13th March 2012) was 
obtained to administer the survey on a sample of MS patients. Evidently, because the 
intention had been to draw recruits for the subsequent exercise trial from eligible 
respondents in the Staffordshire area, the survey was initially administered on a sample of 
patients drawn from the MS patient database at the Department of Neurology, University 
Hospital of North Staffordshire. 
Soon after the data collection process was completed in September 2012, news of 
unexpected research findings on MS in the present writer’s home country, Kuwait, was 
brought to his attention. Until then, MS research in the small Persian Gulf state was 
almost an uncharted territory, and the country was classified as located in a low risk zone 
for the disease. However, contrary to that understanding, Roughani et al., (2011 and 2013) 
found an MS prevalence rate of 85 per 100,000 Kuwaiti nationals. They also reported a 
three-fold increase in the MS incidence in the country during the past decade. Added to 
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this, they found that the majority of patients were diagnosed with the illness at a young 
age and that approximately 70% of those patients have been diagnosed with the illness for 
only a few years. Nevertheless, when these findings were reported by the researcher to his 
supervisory team, they were of the view that more information about Kuwaiti MS patients 
and their perceptions of the illness and exercise would probably add to our knowledge 
about the illness. Consequently, contact was established with Kuwaiti authorities to 
discuss the possibility and feasibility of carrying out a questionnaire survey on a sample 
of MS patients in Kuwait. The outcome of the discussion was positive and arrangements 
were immediately made to obtain approval from Kuwaiti authorities to carry out the 
survey. Approval was granted in late 2012, and the same questionnaire survey that was 
carried out in the United Kingdom was translated and administered on a sample of 100 
Kuwaiti MS patients registered at the Dasman Hospital.   
 
In light of the questionnaire survey findings, it was seen more feasible to implement the 
training programme in Kuwait rather than in the United Kingdom, and it was 
implemented in that country later in 2013 (see 4.8 below). Although this would mean that 
findings of the British survey do not serve the real purpose of the present research, it is to 
be noted that the British and Kuwaiti samples exhibited different characteristics and 
perceptions as to MS fatigue and exercise. In fact, there is good reason to suggest that 
some perceptions towards the MS disease and physical activity are culturally determined 
and based. This being so, it may still be useful to allude to the distinct perceptions 
exhibited by the two samples. It is hoped that the findings trigger more interest in 
comparative studies on the role culture plays in determining MS patients’ attitude towards 
the disease and exercise as a health promoting activity, and even the course of the disease, 
itself. Nevertheless, it should be emphasised that the survey questionnaire was not 
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initially designed for or intended to serve any comparative purposes. Rather, it was 
mainly aimed at finding out the proportion of MS patients who were willing to take part 
in an exercise trial, their clinical characteristics, the type of help and support they receive 
and also, their individual preferences with respect to exercise type.  
 
4.2. Participants and Method 
The questionnaire survey was administered on a British sample and a Kuwaiti sample of 
MS patients. Each sample consisted of 100 adults (34 males and 66 females). The male-
female ratio is in line with research findings about women being twice more likely to 
develop the disease than men (Mohr and Cox, 2001). Patients were included in the survey 
if they were able to complete the questionnaire by themselves or with the help of others, 
were aged between 18 and 65 years, and had a confirmed diagnosis of MS as diagnosed 
by McDonald’s diagnostic criteria 2010 (Polman et al., 2011). Patients included in the 
survey were from both early and late stages of the disease, and some from different 
treatment groups as some were on disease modification treatment and others only on 
symptomatic treatment. Their level of disability was also variable. This was done to make 
sure that the patients included were representative of the group attending routine MS 
clinics and minimise any selection bias. Those who were incapable of giving informed 
consent (i.e. those who were known to have cognitive impairment) as well as those who 
were experiencing an exacerbation were not approached. Although completing the 
questionnaire can be considered as implicit consent, it is to be noted that many 
participants were contacted at a later date. Hence, consent was formally recorded by 
asking patients to provide a complete signature at the end of the covering letter (Appendix 
4). A copy of that letter was given to the participants. 
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For the UK sample, participants were identified from the MS patient database at the 
Department of Neurology, University Hospital of North Staffordshire. Similarly, Kuwaiti 
participants were identified from MS patients registered at the Neurological Department, 
Dasman Hospital. Eligible participants in both groups were approached in one of two 
ways. For a start, only those arriving in the outpatient clinic for their routine appointment 
were presented with copies of the questionnaire (Appendix 5) and the information sheet 
(Appendix 6). It was explained to them beforehand that participation was voluntary. 
Those who were willing to take part in the survey were given two choices: either fill in 
the questionnaire while they wait to be seen by their doctor then hand it back to the 
receptionist, or fill it in when they go back home. In the former case, they could use a 
room in the clinic equipped with the necessary facilities for the purpose. In the latter case, 
they were asked to return completed questionnaires by post. No matter what their choice 
was, a stamped and addressed envelope was included with the questionnaire. Through this 
method, it was possible to approach the entire Kuwaiti sample and 40 patients from the 
British sample over a four-week period. After the fourth week, postal questionnaires were 
sent to the remaining (n=60) British candidates. It is worth mentioning that in Arab 
culture, a disabling disease can be humiliating in that it usually generates pity, sorrow and 
even pain, particularly in members of the patients’ family. This explains why the majority 
of Kuwaiti respondents insisted on filling out the questionnaire in the clinic, as this would 
enable them to keep the secret of their illness to themselves. 
4.3. The questionnaire 
The questionnaire consists of four parts. In part 1, general information is sought about the 
participant, including age, gender and date of diagnosis. Part 2 is concerned with the 
participants’ MS condition, their disease severity levels, relapse frequency and perceived 
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causes, the kind of support they receive, and the symptoms they experience as a result of 
the disease. Part 3 seeks to establish whether respondents’ attitudes towards physical 
exercise have changed since diagnosis with the disease, and also, whether or not they 
currently engage in regular physical activities and the kind of help and support they 
receive. In part 4, respondents are asked whether or not they are willing to take part in an 
exercise trial and the type of exercise they wish to take. 
4.4. Data analysis 
Table 4.1 shows that of the 100 questionnaires distributed to the British sample, 65 were 
completed and returned. By contrast, of the same number of questionnaires distributed to 
the Kuwaiti sample, only 55 were completed and returned. Eight returned questionnaires 
(3 from the British sample and 5 from the Kuwaiti sample) were invalid, hence were 
excluded from analysis. This brings valid response rates to 62% (British sample) and 50% 
(Kuwaiti sample). Valid questionnaires were coded then analysed using the Statistical 
Package for Social Sciences (SPSS Version 15) which is often described as an ideal 
choice for analysing quantitative data. Descriptive statistics, including frequencies and 
percentages were utilised to summarise data and compare and describe the distribution of 
responses. 
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Table 4.1: Distributed questionnaires and valid responses (M= male, F= female). 
It is to be assumed that patients who chose not to take part in the survey were either 
unwilling or unable to participate in the intended exercise trial. Those individuals 
represent 35% and 45% of approached British and Kuwaiti patients respectively. 
4.5. Results 
Findings of the two surveys are presented below. The demographic and clinical 
characteristics of the participants are considered first. The participants’ levels of 
engagement in physical activities before and after diagnosis with the MS disease are 
considered next. The survey concludes with answers to the question as to whether 
individual participants are willing to take part in the planned exercise intervention and, if 
so, the type of exercise they wish to take. Throughout the presentation, results obtained 
from the male group and the female group in each sample are contrasted (i.e. British 
males are contrasted with British females, and Kuwaiti males are contrasted with Kuwaiti 
females). Where appropriate, results obtained from the same gender group in the two 
samples (i.e. British and Kuwaiti males, and British and Kuwaiti females) are also 
compared. Accordingly, focus throughout the presentation is on the percentage values 
pertaining to the gender of the participant.  Percentage values for the entire British as well 
Sample Distributed Tota
l 
Returned Total Valid Total 
Valid 
Valid % 
M F M F M F 
United 
Kingdom 
34 66 100 21 44 65 20 42 62 62% 
Kuwait 34 66 100 24 31 55 22 28 50 50% 
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as the entire Kuwaiti samples also appear in the tables. However, reference to these is 
only made where necessary. 
4.5.1. Demographic and clinical characteristics of the participants 
 4.5.1.1. Age and gender 
As seen in Table 4.2, the British sample (n=62) consisted of 20 males and 42 females 
(32.3% and 67.7% of the sample respectively). The overwhelming majority of those 
participants (85% of the male group and 83.3% of the female group) were 41 years old or 
over. Next came participants who fell within the age group 26-40 (15% and 14.3% of the 
male and female groups respectively). None of the participating British males was aged 
between 18 and 25, and only one female participant (2.4% of the female sample) fell 
within that age group. In general, the proportion of participating British males and 
females was almost in similar in each of the three age groups. On the other hand, Kuwaiti 
participants (n=50) were 22 males and 28 females (44% and 56% of the sample 
respectively). Whereas 50% of males in this sample (n=11) were aged between 18 and 25, 
only 17.9% of their female counterparts (n=5) fell within this age group. In sharp contrast, 
the proportion of male participants aged between26 and 40 was much lower than that of 
the females in this same age group (27.3% and 64.2% respectively). Those who were   41 
years or over represented 27.3% and 17.9% of the Kuwaiti male and female groups 
respectively. 
On the whole, unlike British participants who were relatively old (84% being 41 years or 
over), Kuwaiti participants were relatively younger in that a total of 80% were below 40 
years of age. In this latter group, males were also relatively younger than females. 
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Table 4.2: Participant age and gender (M= male, F= female, N= number). 
4.5.1.2. Duration of the disease 
Table 4.3 shows that the proportion of participating British males who had been 
diagnosed with MS over the ten year period before the survey was lower than that of their 
female counterparts (30% and 50% respectively). Conversely, the proportion of British 
participants who had been with the disease for 10 to 20 years was higher for males than 
females (40% and 23.8% respectively). The same thing goes for those who had been with 
the disease for 20 to 30 years (20% of males and 9.5% for females). In this same sample, 
similar proportions of males and females (10% and 9.5%) reported being diagnosed with 
MS for 30 to 40 years. None of the British male participants reported being with MS for 
over 40 years but 7.2% of the female group said they had been with the disease for that 
considerably long period of time. 
As regards the Kuwaiti sample, almost similar proportions of males and females (77.3% 
and 78.6% respectively) reported they had been diagnosed with MS during the past ten 
United Kingdom 
N= 62 (M=20, F= 42) 
Kuwait 
N= 50 (M= 22, F= 28) 
Age 
(Years) 
M % F % All % M % F % All % 
18-25 0 0% 1 2.4% 1 1.5% 11 50% 5 17.9% 16 32% 
26-40 3 15% 6 14.3% 9 14.5% 6 27.3% 18 64.2% 24 48% 
41+ 17 85% 35 83.3% 52 84% 5 22.7% 5 17.9% 10 20% 
Total 20 100% 42 100% 62 100% 22 100% 28 100% 50 100% 
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years of their lives. Similar proportions of the two sexes (18.2% of males and 17.9% of 
females) also reported being diagnosed with MS for 10 to 20 years. Only two participants, 
a male (4.5% of the male group) and a female (3.5% of the female group) stated they had 
been with the disease for 20 to 30 years. None of the Kuwaiti male or female respondents 
reported being with MS for over 30 years. 
 Table 4.3: Duration of the disease (M= male, F= female, N= number). 
Overall, the majority of respondents in both the British and the Kuwaiti samples have had 
the MS disease for 1-10 years. However, the proportion of Kuwaiti patients who have had 
the disease for this relatively short period of time is considerably higher than that of their 
British counterparts (78% of the former sample and 43.4% of the latter).  Also, compared 
to 29.1% of the British sample who had been with the disease for 10 to 20 years, only 
18% of the Kuwaiti sample reported being with the MS condition for that length of time. 
Moreover, 13% of the British sample and only 4% of the Kuwaiti sample stated they have 
been with the disease for 20-30 years. Also, whereas no Kuwaiti participant reported 
United Kingdom 
N= 62 (M=20, F= 42) 
Kuwait 
N= 50 (M= 22, F= 28) 
Duration 
(Years) 
M % F % All % M % F % All % 
1-10 6 30% 21 50% 27 43.4% 17 77.3% 22 78.6% 39 78% 
10-20 8 40% 10 23.8% 18 29.1% 4 18.2% 5 17.9% 9 18% 
20-30 4 20% 4 9.5% 8 13% 1 4.5% 1 3.5% 2 4% 
30-40 2 10% 4 9.5% 6 9.7% 0 0% 0 0% 0 0% 
40+ 0 0% 3 7.2% 3 4.8% 0 0% 0 0% 0 0% 
Total 20 100% 42 100% 62 100% 22 100% 28 100% 50 100% 
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being with MS for over 30 years, 14.5% of British participants said they had been with 
the disease for 30 years or more. 
4.5.1.3. Severity of the disease 
Just over 40% of the British sample (55% of the male group and 33.3% of the female 
group) described their MS condition as mild (Table 4.4). A further 56.5% of this sample 
mentioned a moderate condition. However, it is to be noted that the proportion of women 
with this level of severity is nearly twice than that of men (66.7% of the former group and 
35% of the latter). Only two British males (10% of the male group) but no British females 
described their condition as severe. By contrast, 68% of Kuwaiti participants (59% of the 
men group and 75% of the women group) thought that their condition was of the mild 
type. Although the rate of this level of severity is somewhat similar in both the British 
and Kuwaiti male groups, it was reported by three fourths of Kuwaiti female respondents 
and by only one third of the corresponding British group. On the other hand, moderate 
MS appears to be more prevalent in the British female sample than in the Kuwaiti female 
sample (affecting two thirds of respondents in the former sample and only just over one 
fifth of respondents in the latter). As is the case with mild MS, almost similar proportions 
of British and Kuwaiti males reported having the moderate type of the disease. The rate of 
severe MS is also similar in both male and female groups. 
96 
Table 4.4: Severity of the disease (M= male, F= female, N= number). 
4.5.1.4. Relapse frequency 
Nearly two thirds of the British sample (representing 40% of women and 76.2% of men in 
the sample) reported having a relapse once per year. Also in this sample, 50% of males 
and 21.4% of females reported having two relapses per year. The remaining 10% of the 
male group and 2.4% of the female group stated they had three relapses a year. Put 
differently, relapses appear to be more frequent in British males than in their female 
counterparts. 
With reference to the Kuwaiti sample, the overwhelming majority of respondents (81.8% 
and 82.1% of the male and female groups respectively) stated they had a relapse once per 
year. The rest of the sample (18.2% of males and 17.9% of females) reported having two 
attacks per annum. None of the Kuwaiti respondents reported having more than two 
relapses per year. 
On the whole, 64.5% and 82% of participants in the British and Kuwaiti samples 
respectively reported having a relapse once per year. However, relapses at this rate appear 
United Kingdom 
N= 62 (M=20, F= 42) 
Kuwait 
N= 50 (M= 22, F= 28) 
Severity M % F % All % M % F % All % 
Mild 11 55% 14 33.3% 25 40.3% 13 59% 21 75% 34 68% 
Moderate 7 35% 28 66.7% 35 56.5% 7 31.9% 6 21.5% 13 26% 
Severe 2 10% 0 0% 2 3.2% 2 9.1% 1 3.5% 3 6% 
Total 20 100% 42 100% 62 100% 22 100% 28 100% 50 100% 
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to be more common in Kuwaiti males than in their British counterparts (reported by 
81.1% of participants in the former group and 40% of participants in the latter). On the 
other hand, the overwhelming majority, and at the same time, nearly similar proportions 
of participants in the two female groups reported having a relapse once a year (76.4% of 
British females and 82.1% of Kuwaiti females).  Two relapses per year were reported by 
30.6% and 18% of the British and the Kuwaiti samples respectively.  Relapses at this rate 
appear to be more common in the British male group than all other groups.  
Table 4.5: Relapse frequency (M= male, F= female, N= number). 
4.5.1.5. Relapse causes 
When asked what in their opinion caused relapses, almost similar proportions of British 
and Kuwaiti respondents (40.3% and 40% of the two samples respectively) gave “do not 
know” as an answer (Table 4.6). In the British sample, the proportion of men who failed 
to identify the possible causes of relapses was higher than that of women (50% and 35.7% 
respectively). In the Kuwaiti sample, this pattern is reversed (36.4% of males and 42.9% 
of males). Back to the British sample, 30% of male respondents thought that fatigue was 
the first major cause of relapses, and the other three factors (infection, depression and 
United Kingdom 
N= 62 (M=20, F= 42) 
Kuwait 
N= 50 (M= 22, F= 28) 
Per year M % F % All % M % F % All % 
Once 8 40% 32 76.2% 40 64.5% 18 81.8% 23 82.1% 41 82% 
Twice 10 50% 9 21.4% 19 30.6% 4 18.2% 5 17.9% 9 18% 
Thrice 
Total 
2 
20 
10% 
100% 
1 
42 
2.4% 
100% 
3 
62 
4.8% 
100% 
0 
22 
0% 
100% 
0 
28 
0% 
100% 
 0 
50 
 0% 
100% 
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heat) came second in ranking (each factor being cited by 25% of those respondents). On 
the other hand, fatigue was seen as the first major cause of relapses in British females 
(reported by 40.5% of those respondents). Next came infection and heat (each being 
reported by 35.7% of the group). Depression as a cause of relapses in this group came 
third in ranking (cited by 21.4% of those women). In other words, three elements appear 
to have a more negative effect on British females than on British males: fatigue, infection, 
and heat. On the other hand, depression appears to have a more negative impact on males 
than on females. 
As regards the Kuwaiti sample, 54% of male participants thought that heat was the main 
cause of relapses, 40.1% reported depression as the second major cause, third and fourth 
in ranking were fatigue and infection, reported by 36.4% and 27.3% of that group of 
participants. By contrast, heat was reported as the first major cause of relapses by 46.2% 
of   Kuwaiti female participants, depression and fatigue were identified as the second 
major cause (each being reported by 42.9% of those females), and infection was 
described as the third major cause (reported by 35.7% of the group). Put differently, 
whereas Kuwaiti females more than Kuwaiti males appear to be affected by fatigue, 
depression and infection, heat appears to have a more negative impact on Kuwaiti males 
than on their female counterparts. 
Table 4.6 shows that identical proportions of the two female groups reported infection as 
one of the major causes of relapses (35.7% of respondents in each group).The same can 
be said about the two male groups where infection was reported by almost equal 
proportions of respondents ( 25% and 27.3% of British and Kuwaiti males respectively). 
Nevertheless, this does not necessarily suggest that one universal pattern is peculiar to 
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males and another to females. In fact, as noted in the discussion above, not only those 
differences exist between the two sexes of the same sample, but also, they can be seen in 
different groups of the same sex. At least, this appears to be the case when those groups 
of MS patients belong to distinct ethnicities or cultures and are geographically dispersed. 
For example, whereas fatigue was rated as the first major cause of relapses by British 
males, it was rated third by their Kuwaiti counterparts. At the same time, it was reported 
by 30% of the former group and 36.4% of the latter. Also, the proportion of Kuwaiti 
males who perceived fatigue as the first major cause of relapses is more than double that 
of the British males. Similarly, whereas depression was considered as an area for concern 
by only one in four males in the British group, it was viewed as such by two in five 
Kuwaiti males. In this respect, it is worth noting that unlike the British sample where 
females appear to be less troubled by depression than males, the pattern in the Kuwaiti 
sample is reversed. The proportion of Kuwaiti females who described depressions as a 
causal factor of relapses is also double than that of British females (42.9% compared to 
21.4%).  With reference to fatigue, although this appears to affect higher proportions of 
females than males, it was associated with relapses by almost equal proportions of the 
two female groups (40.5% and 42.9% of British and Kuwaiti females respectively). On 
the other hand, whereas heat is perceived as a cause of relapses by a higher proportion of 
Kuwaiti females than British females, this same factor is reported to result in a higher rate 
of relapses in British females than British males but a lower rate in Kuwaiti females than 
their male counterparts.  
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Table 4.6: Relapse causes (M= male, F= female, N= number).       
 
4.5.1.6. MS symptoms 
MS affects different patients in different ways. At the same time, some symptoms of the 
disease are often described by most patients as more common and/or more worrying than 
others. Participants in this survey were presented with a list of symptoms which are often 
associated with MS and asked to identify the symptoms they experience. They were also 
requested to report whether or not they were worried or troubled by each of the symptoms 
they identified (Table 4.7a). 
 
Beginning with the British sample, the most common symptoms reported by the male 
group were balance (95%), fatigue (75%), and loss of sensation (70%). Slurred speech, 
spasticity, spasms, tremor and weakness were also reported by nearly two thirds (60% - 
65%) of the group. Less common symptoms were: poor concentration ability and 
depression (50% each), swallowing (45%), and stress and pain (40% each). The least 
reported symptoms were: blurred vision, lethargy, dizziness and bladder and bowels 
disorders. Each of these symptoms appears to affect nearly one third (30%-35%) of the 
 United Kingdom 
N= 62 (M=20, F= 42) 
 
Kuwait  
N= 50 (M= 22, F= 28) 
Cause M  % F  % All % M  % F  % All % 
Don’t know 10 50% 15 35.7% 25 40.3% 8 36.4% 12 42.9% 20 40% 
Fatigue 6 30% 17 40.5% 23   37% 8 36.4% 12 42.9% 20 40% 
Infection  5 25% 15 35.7% 20 32.2% 6 27.3% 10 35.7% 16 32% 
Depression 5 25% 9 21.4% 14  22.6% 9 40.1% 12 42.9% 21 42% 
Heat 5 25% 15 37.5% 20 32.2% 12 54.5% 13 46.2% 25 50% 
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group. In terms of the impact of reported symptoms on the patients’ quality of life and 
behaviour, the overwhelming majority of British males rated balance and fatigue as the 
two most annoying symptoms (reported by 95% and 75% of the group respectively). Two 
other symptoms, tremor and loss of sensation, were also described as worrying by 50% of 
the group, and between 35% and 45% reported that they were troubled by problems 
related to concentration, stress, swallowing, vision, weakness, speech, spasms, spasticity 
and pain. Less worrying symptoms were dizziness, lethargy and bladder and bowels 
disorders (reported by 10% to 30% of the group).  
 
The most common symptoms reported by the British female group were weakness 
(76.1%), fatigue (73.8%), balance (66.6%), pain (61.9%), and loss of sensation (54.7%). 
Depression, stress and bladder problems were reported by every other member of the 
group, followed by poor concentration (45.2%), bowels disorders (42.8%), speech 
difficulties (38%), lethargy (35.7%), and dizziness (30.9%). Swallowing difficulties, 
blurred vision, spasticity, spasms and tremor were reported by 11.9% to 28.5% of those 
females. Two thirds of the group described fatigue and balance as the two most worrying 
symptoms. These were followed by stress (47.6%), weakness (40.4%), poor concentration, 
loss of speech and pain (35.7% each), and depression (30.9%). All other symptoms were 
described as worrying by 7.1% to 26.1% of the females. These were: slurred speech, 
bowels and bladder disorders, lethargy, swallowing difficulties, spasticity, tremor, and 
blurred vision.  
 
In regards to the Kuwaiti sample, the most common symptoms reported by the male 
group were: fatigue (90.9%), depression (81.8%), pain and stress (68.1% each), and 
balance and weakness (63.6% each). Another seven symptoms were reported by much 
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lower proportions of those males: lethargy (45%), poor concentration (36.3%), blurred 
vision and dizziness (31.8% each), bladder problems (27.2%) and tremor and bowel 
disorders (13.6% each). Five symptoms (reported by all British participants) were not 
reported by any Kuwaiti male respondent. These were: spasticity, spasms, speech 
difficulties, swallowing problems, and loss of sensation. Worrying symptoms reported by 
that group of participants were as follows in terms of ranking: fatigue (86.3%), stress 
(68.1%), depression (59%), pain (45.4%), poor concentration (36.3%), weakness (31.8%), 
balance and lethargy (22.7% each), tremor (13.6%), dizziness and bladder problems (9% 
each), and bowels disorders (4.5%). Although blurred vision was rated as a common 
symptom by nearly one third of those respondents, none of them described it as annoying.  
 
The most common symptoms reported by the last group of participants, the Kuwaiti 
female group, were: balance (85.7%), fatigue (82.1%), weakness, stress and depression 
(67.8% each), pain (60.7%), and lethargy (57.1%). Less reported symptoms were: 
swallowing and bowels problems (42.8% each), bladder disorders (39.5%), poor 
concentration ability (35.7%), dizziness (32.1%), and blurred vision (25%). Spasms, 
slurred vision and tremor were respectively reported by only 17.8%, 14.2% and 3.5% of 
the group. Two symptoms spasticity and loss of sensation were not reported. Most 
worrying symptoms reported by the group were: fatigue (75%), stress (64.3%),   
depression (57.1%), and weakness (42.8%). Nearly one third of the group described 
swallowing as a worrying problem, and one in four females said they were troubled by 
problems related to balance, lethargy, concentration and bladder and bowels function. 
Four females (14.1% of the group) said they were annoyed by dizziness, two (7.1%) by 
blurred vision, and only one (3.5%) by tremor. Although 60.7% of the group noted that 
pain was a common symptom, they all stated that it was not worrying. Similarly, all 
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females who said that they experienced problems with speech stated that they were not alarmed by such problems. 
Table 4.7a: This table identifies problems of patients and also shows proportion of patients who were worried about these problems with MS. 
United Kingdom 
M= 20  F=42 
Kuwait 
M= 22  F=28 
Symptoms M %M L95% 
CI 
U95% 
CI 
F %F L95% 
CI 
U95% 
CI 
M %M L95% 
CI 
U95% 
CI 
F %F L95% 
CI 
U95% 
CI 
Tremor 12 60 38.53 81.47 5 11.9 2.11 21.7 3 13.64 -0.7 27.98 1 3.57 -3.3 10.45 
worrying 10 83.33 5 100 3 100 1 100 
Concentration 10 50 28.09 71.91 19 45.24 30.19 60.29 8 36.36 16.26 56.47 10 35.71 17.97 53.46 
worrying 7 70 15 78.95 8 100 7 70 
Depression 10 50 28.09 71.91 21 50 34.88 65.12 18 81.82 65.7 97.94 19 67.86 50.56 85.16 
worrying 5 50 13 61.9 13 72.22 16 84.21 
Stress 8 40 18.53 61.47 21 50 34.88 65.12 15 68.18 48.72 87.65 19 67.86 50.56 85.16 
worrying 7 87.5 20 95.24 15 100 18 94.74 
Fatigue 15 75 56.02 93.98 31 73.81 60.51 87.11 20 90.91 78.9 102.92 23 82.14 67.96 96.33 
worrying 15 100 28 90.32 19 95 21 91.3 
Speech 13 65 44.1 85.9 16 38.1 23.41 52.78 0 0 0 0 4 14.29 1.32 27.25 
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worrying 8 61.54     11 68.75     0 0     0 0     
Swallowing 9 45 23.2 66.8 9 21.43 9.02 33.84 0 0 0 0 12 42.86 24.53 61.19 
worrying 7 77.78     6 66.67     0 0     9 75     
Vision 7 35 14.1 55.9 8 19.05 7.17 30.92 7 31.82 12.35 51.28 7 25 8.96 41.04 
worrying 7 100     3 37.5     0 0     2 28.57     
Dizziness 6 30 9.92 50.08 13 30.95 16.97 44.93 7 31.82 12.35 51.28 9 32.14 14.84 49.44 
worrying 5 83.33     6 46.15     2 28.57     4 44.44     
Sensation 14 70 49.92 90.08 23 54.76 39.71 69.81 0 0 0 0 0 0 0 0 
worrying 10 71.43     15 65.22     0 0     0 0     
Pain 8 40 18.53 61.47 26 61.9 47.22 76.59 15 68.18 48.72 87.65 17 60.71 42.62 78.8 
worrying 8 100     15 57.69     10 66.67     0 0     
Balance 19 95 85.45 104.55 28 66.67 52.41 80.92 14 63.64 43.53 83.74 24 85.71 72.75 98.68 
worrying 19 100     28 100     5 35.71     7 29.17     
Spasticity 13 65 44.1 85.9 11 26.19 12.89 39.49 0 0 0 0 0 0 0 0 
worrying 8 61.54     6 54.55     0 0     0 0     
Spasms 13 65 44.1 85.9 12 28.57 14.91 42.23 0 0 0 0 5 17.86 3.67 32.04 
worrying 9 69.23     7 58.33     0 0     2 40     
Bladder 7 35 14.1 55.9 21 50 34.88 65.12 6 27.27 8.66 45.88 11 39.29 21.2 57.38 
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worrying 3 42.86     10 47.62     2 33.33     7 63.64     
Bowels 6 30 9.92 50.08 18 42.86 27.89 57.82 3 13.64 -0.7 27.98 12 42.86 24.53 61.19 
worrying 2 33.33     11 61.11     1 33.33     7 58.33     
Weakness 12 60 38.53 81.47 32 76.19 63.31 89.07 14 63.64 43.53 83.74 19 67.86 50.56 85.16 
worrying 7 58.33     17 53.13     7 50     12 63.16     
Lethargy 7 35 14.1 55.9 15 35.71 21.22 50.21 10 45.45 24.65 66.26 16 57.14 38.81 75.47 
worrying 6 85.71     10 66.67     5 50     7 43.75     
 
 
In the table above, it can be seen that certain MS symptoms affect equal proportions of males and females within the same sample of respondents 
(e.g. depression and fatigue in the British sample and concentration and dizziness in their Kuwaiti counterparts). Other symptoms are also 
present in equal or almost equal proportions of the same sex groups (e.g. dizziness and weakness in the male groups and pain and bowels 
disorders in the female groups). However, the majority of MS symptoms appear to affect the four participating groups in completely different 
ways. For example, in the British sample, tremor and balance problems are more common in males than females, but pain and bladder and 
bowels disorders are more common in the female group. The same can be said about other symptoms in the Kuwaiti sample. Moreover, whereas 
certain symptoms are common in one particular group, they are less common, rare or even absent in others (e.g. compare symptoms related to 
speech, swallowing and spasticity in the four groups). Added to this, regardless of how common the symptoms are, they also appear to have a
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 different impact on the quality of life in different groups of respondents. For example, 
not all tremor cases reported by nearly two thirds of British males are described as 
worrying. On the other hand, although only a few tremor cases were reported by the other 
three groups, all such cases were described as annoying. Also, whereas balance was 
reported by a sizeable majority of Kuwaiti respondents, only a small minority of those 
individuals appear to be troubled by this symptom. By contrast, all balance cases reported 
by British respondents are found to be annoying.   In fact, this applies to almost every 
symptom in the list in Table 4.7a. However, for the sake of brevity and also as a point of 
reference, the four groups (British males versus British females, Kuwaiti males versus 
Kuwaiti females, British males versus Kuwaiti males, and British females versus Kuwaiti 
females) are separately compared in Table 4.7b in terms of the level of concern over MS 
symptoms. For example, in the first two columns, British males (BM) find tremor more 
worrying than do British females (BF), and equal or almost equal proportions of BM and 
BF describe concentration as a worrying symptom. In the last two columns, Kuwaiti 
females (KF) are less troubled by tremor than are BF, and whereas the former group is 
troubled by pain, the latter is not. The marks (+), (-), (=) and (0) indicate the level of 
concern over the symptom between the two parties in each of the four groups.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 107 
Table 4.7b: Worrying symptoms: levels of concern (BM/F= British males/females, KM/F= Kuwaiti 
 males/females). 
 BM BF KM KF BM KM BF KF 
Tremor + - + - + - + - 
Concentration = = + - = = + - 
Depression - + + - - + - + 
Stress - + + - - + - + 
Fatigue + - + - - + - + 
Speech + - 0 0 + 0 + 0 
Swallowing + - 0 + + 0 - + 
Vision + - 0 + + 0 = = 
Dizziness + - - + + - = = 
Sensation + - 0 0 + 0 + 0 
Pain + - + 0 - + + 0 
Balance + - - + + - + - 
Spasticity + - 0 0 + 0 + 0 
Spasms + - 0 + + 0 + - 
Bladder - + - + + - = = 
Bowels - + - + + - = = 
Weakness - + - + + - - + 
Lethargy + - - + + - = = 
 
4.5.1.7. Help and support with MS 
Participants in the survey were asked whether or not they sought or received help and 
support from different groups of professionals as a result of their health condition (Table 
4.8). In answer to this question, Kuwaiti respondents reported an extremely limited 
number of sources. For example, none of those respondents reported seeking or receiving 
help from a counsellor, optician, psychologist occupational therapist or social worker. 
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Assistance from a physiotherapist was reported by only two females (7% of the female 
group), one female cited her GP, and another mentioned her dietician. No male mentioned 
receiving help from a GP, physiotherapist or dietician. Even the two females who 
reported help from a physiotherapist mentioned that that form of treatment was received 
in the United Kingdom. However, all members of the sample (males and females) 
mentioned they were dependent on their neurologist for assistance. 
 
Compared to their Kuwaiti counterparts, British respondents, particularly females, 
reported they received help and support from a wide range of professional groups with a 
wealth of knowledge, experience and skills. Beginning with the male group in this sample, 
neurologists were identified as the first major source of assistance (reported by 55% of 
the group), followed by GPs (40%), and occupational therapists (30%). Practice nurses 
and physiotherapists were mentioned by one in four respondents, social workers by one in 
five, and counsellors by nearly one in seven. Only one member of the group (representing 
5% of the group) mentioned his optician, and no reference was made to dieticians or 
psychologists. On the other hand, 52% of the British female group said they sought help 
from their neurologists, 31% from GPs, and nearly 24% from physiotherapists. Smaller 
proportions of those females reported other sources: practice nurses (19%), counsellors 
(16.7%), social workers (12%), occupational (9.5%), opticians and dieticians (7% each), 
and psychologists (Table 4.8).   
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 Table 4.8: Help and support (M= male, F= female, N= number).       
 
4.5.2. Physical activity before and after diagnosis 
To gauge patients’ attitude towards exercise as a health promoting activity, participants  
were asked whether or not they used to exercise before diagnosis, whether they still 
exercise, and if so, the kind of activities they perform and the support they receive. 
Reasons for not exercising after diagnosis were also investigated. 
 
4.5.2.1. Physical activity before diagnosis 
The first question on physical activity put to participants was whether or not they were 
regularly engaged in physical training activities before they had been diagnosed with the 
MS disease. In answer to this question, 70% of British male respondents and 78.5% of 
 United Kingdom 
N= 62 (M=20, F= 42) 
 
                     Kuwait 
               N= 50 (M= 22, F= 28) 
 Who helps M  % F  % All % M  %  F  % All % 
 Neurologist 11 55% 22 52% 33 53% 22 100% 28 100% 50 100% 
 GP 8 40% 13  31% 21 34% 0 0.0% 1 3.5% 1 2% 
 Dietician  0 0.0% 3  7% 3 5% 0 0.0% 1 3.5% 1 2% 
 Psychologist  0 0.0% 2 4.8% 2 3% 0 0.0% 0 0.0% 0 0% 
 Occupational   
    therapist       
6 30% 4 9.5% 10 16% 0 0.0% 0 0.0% 0 0% 
 Optician 1 5% 3  7% 4 6.5% 0 0.0% 0 0.0% 0 0% 
 Counsellor  3 15% 7 16.7% 10 16% 0 0.0% 0 0.0% 0 0% 
Practice nurse 5 25% 8  19% 13 21% 0 0.0% 0 0.0% 0 0% 
Physiotherapist 5 25% 10 23.8% 15 24% 0 0.0% 2 7% 2 4% 
 Social worker 4 20% 5 12% 9 14.5 % 0 0.0% 0 0.0% 0 0% 
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their female counterparts stated they were involved in such activities. On the other hand, 
only 31.8% and 17.8% of Kuwaiti male and female respondents respectively gave a 
positive answer.  Put differently, this would mean that in healthy British and Kuwaiti 
populations, three in four and one in four adults respectively appear to be appreciative of 
exercise as a health promoting activity (Table 4.9).  
  
Table 4.9: Physical activity before diagnosis (M= male, F= female, N= number). 
 
Next question put to participants pertains to the type of physical activity they used to 
perform before they had been diagnosed with the MS. In the British male group, 60% 
noted they had been involved in aerobic exercises, 35% strengthening, 30% stretching, 
and 25% aquatics as well as racket sports. Three other types of activities were mentioned 
by lower proportions of those male respondents: martial arts 15%, dancing 10% and yoga 
5%. By contrast, British female respondents indicated that aerobics were the most popular 
type of activity in the health female population (reported by nearly 55% of the group), 
followed by stretching (28.5%), racket sports (nearly 24%), and dancing921.4%). 
Strengthening exercises were also reported by 16.6% of those females, aquatic exercises 
by 14.3%, yoga by nearly 12%, and martial arts, the least popular type of training, by 
only one respondent (2.4% of the group).   
   
 United Kingdom 
N= 62 (M=20, F= 42) 
 
Kuwait 
N= 50 (M= 22, F= 28) 
 M % F % All % M % F % All % 
Yes 14 70% 33 78.5% 47 75.8% 7 31.8 % 5 17.8% 12 24% 
No 6 30% 9 21.5% 15 24.2% 15 68.2% 23 82.2% 38 76% 
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In the Kuwaiti male group, 22.7% said they had been involved in aquatic exercises, and 
the same proportion of 13.6% mentioned aerobic, stretching and strengthening exercises. 
Racket sports and martial arts were (each) cited by 9% of the group, but no reference was 
made to yoga or dancing. In the corresponding female group, three participants (10.7% of 
the group) mentioned stretching, and equal proportions of 7.1% said they used to have 
aerobic and aquatic training. All other types of exercise activities (namely strengthening, 
martial arts, dancing, yoga and racket sports) were not reported by that group. 
In all, whereas the majority of British respondents of the two sexes appear to have been 
involved in a wide range of pre-diagnosis training activities, only a small minority of 
Kuwaiti respondents, particularly females, appear to have been left with a limited number 
of choices (Table 4.10). 
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Table 4.10: Type of physical activity before diagnosis (M= male, F= female, N= number). 
Moreover, even when the same type of activity is reported to have been undertaken by all 
participants, it is often the case that males and females (particularly those in the Kuwaiti 
sample) show different levels of interest in that activity. For example, although racket 
sports and stretching were reported by almost equal proportions of the British male and 
female groups, males more than females appear to prefer aerobics, aquatics, strengthening 
and martial arts. On the other hand, dancing and yoga appear to be more appealing to 
United Kingdom 
N=62 (M= 20, F= 42) 
Kuwait 
N= 50 (M= 22, F= 28) 
Activity M % F % All % M % F % All % 
Aerobics/Walking 12 60% 23 54.8
% 
35 56.4
% 
3 13.6
% 
2 7.1% 5 10% 
Stretching 6 30% 12 28.5
% 
18 29% 3 13.6
% 
3 10.7
% 
6 12% 
Strengthening 7 35% 7 16.6
% 
14 22.4
% 
3 13.6
% 
0 0% 3 6% 
Aquatic exercise 5 25% 6 14.3
% 
11 17.7
% 
5 22.7
% 
2 7.1% 7 14% 
Martial arts 3 15% 1 2.4% 4 6.4% 2 9% 0 0% 2 4% 
Dancing 2 10% 9 21.4
% 
11 17.7
% 
0 0% 0 0% 0 0% 
Yoga 1 5% 5 11.9
% 
6 9.6% 0 0% 0 0% 0 0% 
Racket sports 5 25% 10 23.8
% 
15 24% 2 9% 0 0% 2 4% 
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females than males. Also, compared to their male counterparts, Kuwaiti females showed 
much lower levels of interest and involvement in aerobic, stretching and aquatic exercises. 
4.5.2.2. Physical activity after diagnosis 
In 4.5.2.1, it was noted that participants' responses to the question on involvement in pre-
diagnosis physical training activities are reflective of the healthy population's attitude 
towards and/or perceptions of exercising. The conclusion drawn from those responses 
was that unlike the British healthy population where a sizeable majority (70% males and 
78% females) appear to be involved in exercising, only a small minority of the Kuwaiti 
healthy population (31.8% males and 17.8% females - Table 4.9) appear to have a pro-
training culture. 
Given the negative impact of MS and its symptoms, it is not surprising that MS patients 
become less physically active than healthy individuals. Even then, the patients' rate of 
involvement in physical activity appears to be determined by a number of variables, most 
notably levels of disability, age, gender, geographic location and culture. For, when 
patients were asked whether or not they were engaged in physical activity after diagnosis, 
60% and 71.5% in the British male and female groups (a decline of 10% and 7%) gave a 
positive answer. On the other hand, the rate went down from 31.8% to 18.2% (i.e. by 
13.5%) in the Kuwaiti male group of patients, and from 17.8% to 10.7% (a drop of 7%) in 
the female group (Table 4.11). However, as will be seen in the discussion below, more 
important than the rate of involvement in training are the extent and level of that 
involvement. 
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Table 4.11: Physical Activity (exercising) after diagnosis (M= male, F= female, N= number). 
Participants who remained physically active after diagnosis were asked to identify the 
type of activities, in which they were involved, and also, the frequency and duration of 
their training sessions. In the British male group (n=12), seven participants (58.3%) 
mentioned strengthening exercises at the rate of 2 - 5 sessions per week. Five (41.6%) 
said they performed aerobic exercises, also at the rate of 2 - 5 sessions a week. Four 
(33.3%) mentioned 3 - 6 weekly training sessions of stretching exercises. Another four 
reported up to four weekly sessions of aquatic training, and two respondents said they had 
2 - 5 weekly sessions of posture exercises. 
In terms of session duration, each session of aerobic and strengthening exercises was 
reported to take up to 30 minutes, a stretching or posture session between 10 - 15 minutes, 
and aquatic training sessions were reported to last for a longer period of time between 30 
- 60 minutes.
In the female group of the British sample (n=30), aerobic exercises were reported by 
53.3% of the group, strengthening 50%, stretching 33.3%, and posture and aquatic 
United Kingdom 
N= 62 (M= 20, F= 42) 
Kuwait 
N= 50 (M= 22, F= 28) 
M % F % All % M % F % All % 
Yes 12 60% 30 71.5% 42 67.7% 4 18.2% 3 10.7% 7 14% 
No 8 40% 12 28.5% 20 32.3% 18 81.8% 25 89.3% 43 86% 
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exercises 23.3% each. Compared to their male counterparts, British females reported 
shorter but more weekly sessions of aerobic and stretching exercises (3 - 7 sessions x 10 – 
15 minutes, and 4 - 7 sessions x 5 - 10 minutes consecutively). They also reported less 
frequent and shorter sessions of strengthening and aquatic exercises (1 - 3 sessions of 
either type, each lasting 5 - 10 minutes in the former and between 30 - 45 minutes in the 
latter). The number of weekly posture training sessions reported by those females was 
equal to that of the males but each lasted for a relatively short period of time (5 - 10 
minutes). One or more than one type of exercise was reported by both British male and 
female active exercisers. 
In the active Kuwaiti male group (n=4), up to three weekly sessions of aerobic exercises 
were reported by all four members of the group. Two of those respondents also 
mentioned 2 - 4 weekly sessions of stretching exercises, and only one reported up to 4 
sessions of strengthening exercises. Each aerobic and stretching session lasted for 10 - 15 
minutes, and each strengthening session was of short duration of between 5 - 10 minutes. 
In the active Kuwaiti female group (n=3), two females reported 1 - 4 weekly sessions of 
aerobics and 2 - 5 sessions of stretching, and only one female mentioned a maximum of 2 
weekly strengthening sessions. Each session of the two former types of training took 
between 5 and 10 minutes, and sessions of the latter type lasted for only 3 to 5 minutes. 
Overall, compared to their Kuwaiti counterparts, all active British males trained more 
frequently and performed different types of activities for longer periods of time. Similarly, 
compared to the Kuwaiti female group, British females reported larger numbers of 
weekly training sessions of longer periods of time. Unlike Kuwaiti females, they also 
reported engaging in a large number of exercise types. In short, compared to British 
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respondents of the two sexes , we can hardly claim that Kuwaiti respondents are active 
exercisers. 
Table 4.12: Type of exercise after diagnosis 
Percentage based on the numbers of those who remained physically active after they had been diagnosed 
with MS (British sample: M=12, F=30, Kuwaiti sample: M= 4, F= 3). 
Exercise type United Kingdom Kuwait 
Male Female Male Female 
Aerobics Number 
% 
5 
41.6% 
16 
53.3% 
4 
100% 
2 
66.6% 
Session/w  min. 2 
max. 5 
 min. 3 
max. 7 
 min. 1 
max 3 
 min. 1 
max.4 
Duration/m min. 15 
max. 30 
min. 10 
max. 15 
min. 10 
max. 15 
min. 5 
max. 10 
Stretching Number 
% 
4 
33.3% 
10 
33.3% 
2 
50% 
2 
66.6% 
Session/w min. 3 
max. 6 
min. 4 
max. 7 
min. 2 
max. 4 
min. 2 
max. 3 
Duration/m min. 10 
max. 15 
min. 5 
max. 10 
min. 10 
max. 15 
min. 5 
max. 10 
Strengthening Number 
% 
7 
58.3% 
15 
50% 
1 
25% 
1 
33.3% 
Session/w min. 2 
max. 5 
min. 1 
max. 3 
min. 1 
max. 4 
min.1 
max. 2 
Duration/m min. 15 
max. 30 
min. 5 
max. 10 
min. 5 
max. 10 
min.3 
max. 5 
Posture Number 
% 
2 
16.6% 
7 
23.3% 
0 
0% 
0 
0% 
Session/w min. 2 
max. 5 
min.2 
max. 5 
min. 0 
max. 0 
min. 0 
max. 0 
Duration/m min. 10 
max. 15 
min. 5 
max. 10 
min. 0 
max. 0 
min. 0 
max. 0 
Aquatic Number 
% 
4 
33.3% 
7 
23.3% 
0 
0% 
0 
0% 
Session/w min. 1 
max. 4 
min. 1 
max. 3 
min. 0 
max. 0 
min. 0 
max. 0 
Duration/m min. 30 
max. 60 
min. 30 
max. 45 
min. 0 
max. 0 
min. 0 
max. 0 
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4.5.2.3. Current advice and guidance 
Table 4.13 shows that different professional groups provide British patients with 
assistance and guidance on physical training. In the male group of this sample, 35% 
reported receiving help from neurologists and gym instructors, 30% from GPs and 
physiotherapists, and 10% from practice nurses and counsellors. On the other hand, 38% 
of the British female group reported relying on their neurologists, 33.3% on 
physiotherapists, 28.5% gym instructors, 26.2% GPs, and 4.7% on practice nurses and 
counsellors.  By contrast, Kuwaiti respondents, particularly females appear to have an 
extremely limited number of choices. In the male group, two respondents (9%) said they 
sought or received help from neurologists, and only one respondent (4.5% of the group) 
mentioned a gym instructor. In the female group, three respondents (10.7%) said they 
received help from their neurologist and another two mentioned receiving advice from 
(British) physiotherapists.   
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Table 4.13: Current advice or help with physical activity (M= male, F= female, N= number). 
4.6. Barriers to exercise 
It was noted above that 20 British (8 males and 12 females) and 43 Kuwaiti (18 males and 
23 females) participants have stated that they have chosen not to engage in physical 
training after they had been diagnosed with MS (see Table 4.11). Those participants gave 
different explanations as to why they remain physically inactive (Table 4.14). In the 
British sample, 50% of the male group cited fatigue as the main reason, next came 
transport and family or work commitments (each being reported by 25% of the group), 
and in third place were problems related to facilities or lack of faith in physical training 
(each reported by 12.5%  of those males). In the British female group, fatigue was 
perceived as an inhibiting factor by 41% of physically inactive women, family or work 
United Kingdom 
N= 62 (M= 20, F= 42) 
Kuwait 
N= 50 (M= 22, F= 28) 
Who helps M % F % All % M % F % All % 
Neurologist 7 35
% 
16 38% 23 37% 2 9% 3 10.7
% 
5 10
% 
GP 6 30
% 
11 26.2
% 
17 27.5
% 
0 0% 0 0% 0 0% 
Gym instructor 7 35
% 
12 28.5
% 
19 30.6
% 
1 4.5% 0 0% 1 2% 
Physiotherapis
t 
6 30
% 
14 33.3
% 
20 32.2
% 
0 0% 2 7.1% 2 4% 
Practice nurse 2 10
% 
2 4.7% 4 6.5% 0 0% 0 0% 0 0% 
Counsellor 2 10
% 
2 4.7% 4 6.5% 0 0% 0 0% 0 0% 
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commitments 33.3%, lack of encouragement 25%,  transport 20%, facilities and transport 
16.6% each, and only one female (5% of the group) thought that exercise was not useful. 
On the opposite side, 77.7% of inactive Kuwaiti males thought that lack of 
encouragement was the main obstacle, 61% were of the view that training was not 
rewarding, 55.5% mentioned fatigue, 44.4% problems related to training facilities, and 
27.7% family and work responsibilities. On the other hand, almost all inactive Kuwaiti 
females (96% of the group) gave lack of encouragement as the main reason for not 
exercising, 92% mentioned problems related to training facilities, 62.7% failed to see the 
benefits of training, 52% cited fatigue, and 32.2% reported commitments towards family 
and work as another cause.  Unlike some of their British counterparts, all physically 
inactive Kuwaiti respondents do not find a link between transport and lack of training. 
Table 4.14: Reasons for not exercising (M= male, F= female, N= number). 
United Kingdom 
N= 20 (M=8, F= 12) 
Kuwait 
N= 43 (M= 18, F= 25) 
M % F % All % M % F % All % 
Fatigue 4 50% 5 41% 7 45% 10 55.5% 13 52% 23 53.5% 
Family/Work 2 25% 4 33.3
% 
6 30% 5 27.7% 8 32% 13 30.2% 
Not useful 1 12.5
% 
0 0% 1 5% 11 61% 16 64% 27 62.7% 
Facilities 1 12.5
% 
2 16.6
% 
3 15% 8 44.4% 23 92% 31 72% 
Transport 2 25% 2 16.6
% 
4 20% 0 0% 0 0% 0 0% 
Encouragement 0 0.0% 3 25% 3 15% 14 77.7% 24 96% 38 88.4% 
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Percentages based on the numbers of those who have not been physically active after they had been 
diagnosed with MS (See Table 4.11). 
4.7. Willingness to participate in the trial 
In answer to the question whether or not participants were willing to take part in a 
supervised physical training programme, 87% of the British sample with almost equal 
proportions of the two sexes (85% and 88% of the male and female groups respectively) 
said they were willing to participate (Table 4.15). This is despite the fact that the majority 
of those respondents were already involved in physical training activities (see Table 4.11). 
By contrast, 70% of the Kuwait sample (50% of the male group and 85.7% of the female 
group) agreed to take part in the proposed trial.  In all, whereas the overwhelming 
majority of British male and British and Kuwaiti female respondents appeared to be keen 
on taking part in the training programme, only one in two in the Kuwaiti male group 
appeared to be interested (Table 4.15). 
Table 4.15: Willingness to participate in the exercise trial (M= male, F= female, N= number). 
Table 4.16 shows respondents’ perceptions of different types of training activities. In the 
British male group, the majority (75%) said they would opt for aerobic exercises if they 
United Kingdom 
N= 62 (M=20, F= 42) 
Kuwait 
N= 50 (M= 22, F= 28) 
M % F % All % M % F % All % 
Yes 17 85% 37  88% 54 87 % 11 50% 24 85.7% 35 70% 
No 3 15% 5 11.9% 8 13% 11 50% 4 14.3% 15 30% 
Total 20 100% 42 100% 62 100% 22 100% 28 100% 50 100% 
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were given a choice, 60% preferred stretching exercises, 50% agreed on strengthening 
activities, and 45% chose aquatic exercises. Yoga and posture exercises were the least 
preferred types of activity in this group. Aerobics were also the first preferred type of 
training in the British female group (chosen by 81% of those respondents), strengthening 
exercises came second (66.6%), stretching exercises third (54.7%), and aquatics fourth 
(40.5%). Smaller proportions of the group said they would engage in yoga and posture 
training (19% and 14.3% respectively).  By contrast, none of the Kuwaiti male or female 
respondents showed interest in three types of training: aquatic, yoga and posture. On the 
other hand, the overwhelming majority of the female group stated they would choose 
aerobic exercises (89.2%), strengthening (78.5%), and stretching (71.4%). In the male 
group, aerobic training was the most preferred type of activity, though it was selected by 
only 45.5% of respondents, a slightly smaller proportion of 41% mentioned strengthening 
activities, and 27.2% opted for stretching exercises. 
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Table 4.16: Preferred type of exercise (M= male, F= female, N= number). 
4.8. Summary and conclusions  
In the opening section of this chapter, it was noted that although the present survey was 
administered on two samples of British and Kuwaiti MS patients, it was never intended to 
serve any comparative purposes. Rather, the survey was carried out on British subjects 
only because the original plan was to implement the exercise intervention in the United 
Kingdom, and the decision of implementing it in Kuwait was taken soon after the survey 
had been conducted in that country (see 4.1 and also below). In other words, it is only the 
findings of the Kuwaiti, not the British, survey that have a direct bearing on the present 
research and the training intervention. Those findings, their implications and the lessons 
learnt from them are considered at a later stage in this paper.  Nevertheless, because the 
United Kingdom 
N= 62 (M= 20, F= 42) 
Kuwait 
N= 50 (M= 22, F= 28) 
Activity M % F % All % M % F % All % 
Aerobic 
exercises 
15 75% 34 81% 49 79% 10 45.5% 25 89.2% 35 70% 
Stretching 
exercise 
12 60% 23 54.7% 35 56.5% 6 27.2% 21 71.4% 27 54% 
Strengthening 
exercise 
10 50% 28 66.6% 38 61.3% 9 41% 22 78.5% 31 62% 
Aquatic 
exercise 
9 45% 17 40.5% 26 42% 0 0% 0 0% 0 0% 
Yoga 2 10% 8 19% 10 16.1% 0 0% 0 0% 0 0% 
Posture 
exercise 
2 10% 6 14.3% 8 13% 0 0% 0 0% 0 0% 
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two surveys unveiled marked group differences within and across the two samples, it is 
felt that their results need to be highlighted and the questions they raised to be brought to 
the attention of interested researchers. 
In general, compared to their British counterparts, Kuwaiti respondents are younger, have 
been diagnosed with the disease for a shorter period of time, their disability is less severe, 
and they are less likely to have more than one relapse per year. In relation to relapse 
causes, whereas depression is the least reported cause by British respondents, it is the 
most reported causal factor by Kuwaitis. Some MS symptoms also appear to be more 
common in one sample than the other. For example, higher proportions of British 
respondents reported balance, tremor, loss of sensation, blurred vision, concentration, 
slurred speech, spasticity, spasms, dizziness, swallowing and bladder and bowls problems. 
On the other hand, higher proportions of Kuwaiti respondents reported depression, stress, 
fatigue, pain, weakness and lethargy. In this respect, it is worth noting that Kuwaiti 
participants find depression, stress and fatigue more worrying than do British respondents. 
However, unlike their British counterparts, they appear to be less worried or not worried 
at all about symptoms such as balance, tremor, slurred speech, loss of sensation and 
spasticity. Other major differences exist between the two samples in terms of the support 
they receive and perception of and attitude towards exercise. For, whereas British 
respondents reported receiving advice and guidance from a wide range of sources, 
Kuwaiti respondents appear to rely entirely on their neurologist. Also, whereas the 
majority of British respondents reported active involvement in physical activity before 
and after diagnosis, only a small minority of Kuwaiti respondents mentioned they used to 
engage in physical activity when they were healthy, and even a smaller minority said they 
continued to exercise after they had been diagnosed with the disease. Nearly two thirds of 
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Kuwaiti respondents were also of the view that not much would be gained from training. 
This compares to only 5% of British respondents. 
The study also revealed marked difference between the two sex groups within each 
sample as well as differences between the same sex groups across the two samples.  What 
is mentioned below is only a simple illustration (for more details, the reader is referred to 
the tables in the study: 
Age: Nearly no difference in terms of age groups between British males and females, but 
Kuwaiti males appear to be relatively younger than their female counterparts. 
Disease duration: Length of time respondents have been with the disease varies between 
British males and females, but is almost constant in the Kuwaiti sample. 
Disease severity: In the British sample, mild MS is more common in males than in 
females, and moderate MS is more common in females than in males. In the Kuwaiti 
sample, the case is the opposite. Moreover, the proportion of British females with 
moderate MS is much higher than that of the   Kuwaiti females. 
Relapse causes: In both samples, females appear to be affected by fatigue and infection 
more than are males. In the British sample, females are more sensitive to heat than males, 
but in the Kuwaiti sample, the picture is reversed. The proportion of Kuwaiti females who 
reported depression as a possible cause of relapses is double than that of the British 
females. 
MS symptoms: Tremor is reported by a high proportion of British males but by only 
small numbers of participants in all other groups. In booth samples, fatigue is reported by 
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higher proportions of males than females. Two symptoms are absent in the Kuwaiti 
females but absent in their male counterparts (slurred speech and swallowing. Some 
symptoms are present in both British males and females, but are absent or almost absent 
in the Kuwaiti sample (e.g. spasms, spasticity, loss of sensation). 
Attitude towards training: In the British sample, higher proportions of females than males 
remain physically active after diagnosis. Compared to their Kuwait counterparts, British 
females are   more active and engage in a much wider range of activities. 
When results obtained from the Kuwaiti sample and the UK sample were contrasted, it 
was decided that it would be more feasible to implement the intended exercise 
intervention on a group of recruits to be drawn from Kuwaiti respondents who stated that 
they were willing to participate in supervised training activities. The rationale behind 
implementing the trial in that country is simple. For, as we have seen from the 
questionnaire above, unlike British respondents who appear to be actively involved in the 
management of their condition and also in supervised or unsupervised physical training 
activities, Kuwaiti respondents haven’t been engaged in physical exercise since they were 
diagnosed with the illness. In fact, the notion of exercise as a health promoting activity 
appears to be somewhat alien to Arab culture. Put differently, had the trial been 
conducted on British subjects, any gains obtained during the experiment would have been 
minimal. It would also been difficult to establish whether such gains (or adverse effects) 
were the results of the supervised programme or other training activities. On the other 
hand, because Kuwaiti MS patients had not been involved in exercising before the trial, 
the benefits they may gain would, in the main, be attributed to the training programme, 
itself.  
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Chapter 5:  Methodology 
5.1. Introduction 
The objectives of the present study were stated in the opening sections of this paper. To 
recapitulate, the primary objective is to investigate the effect of customised, 
individualised, self-selected and different exercise modalities on fatigue in MS patients. 
The secondary objectives are to assess the impact of exercise on the strength, walking 
ability, and activities of daily living in MS patients, and also, the psychosocial impact of 
MS and fatigue on patients and their attitude towards physical training.  To achieve these 
objectives, quantitative and qualitative data were obtained through the application of self-
report questionnaires, functional tests and interviews. In this chapter, methodological 
issues pertaining to the exercise trial are discussed. 
5.2. Primary arrangements 
In Chapter 4, it was noted that recruits for the exercise intervention were drawn from the 
Kuwaiti group of patients who took part in the pilot study on patients’ perceptions 
towards physical exercise. Initially, 35 patients from that group stated that they were 
willing to take part in the exercise trial (Table 3.15). They, all, were registered at the 
Dasman Institute (DI) in the state of Kuwait. Late in 2012, the researcher’s supervisory 
team at Keele University formally approached Kuwaiti authorities with a request to 
implement the exercise intervention in that country. Positive response was received from 
the Kuwaitis and, in accordance with their regulations a "Statement of Compliance", 
(Appendix 7), was signed by the researcher and his supervisory team in April 2013. In 
May 2013, ethical approval to conduct the trial (RA/069/2013, Appendix 8) was granted 
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by the Kuwaiti Ethical Review Committee. Soon afterwards, arrangements were made to 
hire a training venue and appoint a Kuwaiti team of professionals to assist the researcher. 
The team consisted of a consultant physiatrist, a consultant neurologist and a professional 
exercise therapist. A gym at the Fawzia Sultan Rehabilitation Institute (FSRI) was chosen 
as the training venue. This institute is one of the leading healthcare organisations in the 
Gulf region and is renowned for its modern facilities and quality of service. At that early 
stage of the experiment, the researcher’s chief supervisor paid his first visit to Kuwait to 
inspect the training facilities, meet the Kuwaiti team of assistants, consider the action plan 
and give permission for the experiment to be kick-started. 
5.3. Participants  
As noted above, potential participants (n=35) in the exercise experiment were already 
identified long before the researcher arrived in Kuwait to conduct the trial. However, 
because the majority of those patients were not willing to disclose the secret of their 
illness to others (sometimes not even to their friends and family members), it was not 
possible to contact them by post or pay them home visits. Hence, they were approached 
only when they arrived for their routine visits at the outpatient clinic at the Dasman 
Institute.  Of the 35 patients who initially stated that they were willing to participate in the 
trial, 9 stated that they were unable or unwilling to attend. Even without asking them for 
an explanation, 2 mentioned work commitment as a reason; 3 said they would be outside 
the country at the time of the trial, and 4 hinted that they were not in need of exercising. 
The remaining 26 patients (8 males and 18 females) agreed to participate in the trial. They, 
all, met the selection criteria and were presented with an information sheet. They also, 
gave written informed consent to take part in the training programme (Appendix 9), and 
letters of their eligibility to participate in the trial were also obtained from their doctors. 
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All those participants were drawn from the register of the Dasman Institute (DI), a 
government sponsored healthcare and research establishment that provides services 
exclusively to Kuwaiti citizens. With the exception of only one Arab expatriate (who was 
registered at DI due to special circumstances), all participants were Kuwaiti nationals 
who shared a common culture. (As will be seen in the course of our discussion, the 
culture factor is rather important as it appears to shape patients' attitude towards MS and 
health promoting activities). Demographic information (age, gender, marital status, 
number of children, employment, year of diagnosis, MS type and the EDSS score) were 
obtained from the participants and/or their medical records. 
After baseline 1 and baseline 2 tests had been performed (see below), and just before the 
trial was started early October, 2014, four recruits (two males and two females)   decided 
to withdraw from the trial. One of those had renal failure, one had a relapse, and the other 
two gave work and family commitment as a reason for withdrawal. Five of the remaining 
22 participants withdrew during the training programme for personal reasons, and another 
participant dropped out because she developed hernia and shoulder problems. This brings 
down the number of those who completed the trial to 16 (Figure 5.1). 
5.4. Inclusion criteria 
Patients were accepted in the study if they were between 18 and 65 years old, had a 
confirmed diagnosis of clinical MS. They were also accepted if they are able to stand 
upright, walk a 100 metres distance, and pedal on a freestanding ergometer bicycle with 
or without aid. In order to be included, patients also needed a clearance letter from their 
doctor stating that it is safe for them to take part in the training programme. 
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5.5. Exclusion Criteria 
Patients were excluded from the study if they had a relapse within 30 days of the 
inclusion date, were engaged in a physical training programme and/or had any medical 
condition that would preclude them from training, including liver or kidney failure, 
uncontrolled hypertension, insulin dependent diabetes and heart diseases. Patients were 
also excluded if they were reliant on motorised or personal assistance to ambulate, were 
receiving or had recently received steroid therapy or were unable to understand or follow 
instructions (more about participants and dropouts will be said in Chapter). End of trial 
measures were performed and Interview 2 (see below) was administered when the 12-
week training programme was terminated in late December, 2014, and follow-up 
measures were taken four weeks later (Figure 4.1). 
5.6. Measures and instruments 
For the purpose of the present study, a battery of tests were utilised to collect both 
quantitative and qualitative data on subjective fatigue, functional performance and the 
impact of psychosocial factors on fatigue. These are considered below. Before that, it is to 
be noted that participants were assessed twice before the training experiment. These are 
henceforth referred to as baseline 1 (B1) and baseline 2 (B2). B1 tests were performed 
nearly six weeks before the actual exercise trial, and B2 measures were taken over a two 
week period before that trial. At B1, only four measures were employed, EDSS, MFIS, 
Barthel Index (BI), and Hospital Anxiety and Depression Scale (HADS). In B2, these 
four tests were repeated in addition to the full range of tests considered below (i.e. 
balance tests, upper and lower extremities tests, and muscle tests). The full range of tests 
was also applied at weak 12 at the end of the trial, and at weak 16, four weeks after the 
trial had been terminated (Table 5.1). 
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Table 5.1. Assessment Tools 
Tool Properties B1 B2 W12 W16 
Expanded Disability 
Status Scale 
(EDSS) 
Assesses aspects of 
functional system 
deficits 
x x x x 
Modified Fatigue 
Impact Scale 
(MFIS) 
Assesses physical, 
cognitive and 
psychosocial aspects 
of fatigue 
x x x x 
Hospital Anxiety 
and Depression 
Scale 
(HADS) 
Assesses anxiety and 
depression 
x x x x 
The Barthel Index 
(BI) 
Assesses the basic 
personal and 
instrumental activities 
of daily living 
x x x x 
The Berg Balance 
Scale 
(BBS) 
To measure static and 
dynamic balance 
impairments and 
assess fear of falls 
- x x x 
Timed Up and Go 
(TUG) 
- x x x 
10-metre walk test To measure walking 
velocity and 
endurance 
- x x x 
6-Minjute Walk
(6MW) 
- x x x 
9-Peg-hole Assesses dexterity of 
upper extremity 
+ x x x 
JAMAR To assess handgrip 
strength 
- x x x 
Nicholas MMT 
hand-held 
dynamometer 
To assess knee, elbow 
and hip flexion and 
extension and 
shoulder flexion and 
adduction 
- x x x 
Interview 1 To evaluate impact 
and nature of fatigue 
Before the training programme 
Interview 2 To rate the training 
programme 
  At the end of the training programme 
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The idea behind applying B1 tests is simple: there was good reason to presume that 
radical changes might take place in participants' behaviour and daily routine activities 
over the one month period that preceded the training programme. In turn, those changes 
might have an impact on those patients' mobility disability, fatigue levels, mood and basic 
bodily functions. The changes in question pertain to the holy month of Ramadan. During 
this month, Muslims (and all participants were) are supposed to abstain from eating, 
drinking, smoking and sexual relations from early dawn hours to sunset and engage 
heavily in prayer and meditation throughout meditation throughout the night. Indeed, 
dietary change aside, Islamic prayer (alone) involves considerate physical effort (e.g. 
ablution and repeated bowing and prostration). Unless we establish whether or not 
behavioural changes precipitated by Ramadan had an impact on the study participants, it 
can be argued that any possible changes in post-training measurements might have been 
influenced by un-investigated behaviours rather than by the training alone. 
5.6.1. Modified Fatigue Impact Scale (MFIS) 
For the purpose of this study, the Modified Fatigue Impact Scale (MFIS) was used to 
assess fatigue. Rationale for employing this instrument was provided in 3.3. On the whole, 
the MFIS is described as one of the most reliable tools to assess MS fatigue and is now 
widely used in MS research. One of the main advantages of this tool is that it not only 
measures physical and cognitive fatigue, but also, addresses the psychosocial experience 
of the symptom (Tellez et al., 2005; Flachenecker et al., 2002). 
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5.6.2. Balance 
To asses balance and fear of falls, the present study employed two instruments: the 
‘Timed Up and Go’ test, TUG, (Appendix 10) and the Berg Balance Scale, BBS, 
(Appendix 11). In the TUG test, the subject is requested to stand up from a chair, walk a 
distance of three meters, turn around, walk back to the chair and be seated again. Time is 
recorded from the moment the subject makes the first move until he/she sits back on the 
chair. Scores over 13.5 seconds indicate a risk for falls (Cattaneo et al., 2006). TUG is 
widely used with MS patients and it has shown acceptable concurrent validity (Cattaneo 
et al., 2006, McConvey and Bennett, 2005). The other instrument, BBS, is also widely 
used in clinical research, easy to administer, and safe to use with elderly patients. It is 
designed to assess the person’s ability to maintain balance as he/she performs a range of 
dynamic and static activities. Tasks include sitting unsupported, to rising from seated 
position, to standing on one leg. The scale consists of 14 items, and each item is scored on 
a 5-poit (0-4) scale, with 0 indicating inability to attempt or perform the activity, and 4 
indicating perfect execution. The BBS is reported to have high levels of internal 
consistency (Cronbach Alpha, 0.83-0.98) (Berg and Norman, 1996). 
5.6.3. Function of upper and lower extremities 
Upper and lower extremity function is usually affected in MS patients. Hence, tests of 
motor function are now increasingly applied in MS research and clinical trials (Motl et al., 
2012; Bethoux and Bennett, 2011). For the purpose of this study, the 10 metre walk has 
been employed to test walking velocity, the 6-minute walk to assess ambulation 
endurance performance, and the 9 peg-hole to assess speed and dexterity of upper 
extremity. 
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For the 25-foot walk, participants are directed to a clearly marked 25-foot flat tiled 
surface and instructed to walk the distance as fast as they can. Time is calculated from the 
initiation of the instruction until the participant reaches the end of the 25-foot mark. The 
task is then administered again by asking the participant to walk back to the starting point. 
In performing the task, patients are allowed to use assistive devices. 
The 6-minute walk is administered on a 150-foot straight course marked in 10-foot 
intervals. Patients are instructed to walk at their own pace with or without assistive 
devices. The distance they cover in the allotted time of six minutes is recorded to the 
nearest foot. Compared to other tests, the 6-minute walk provides more sensitive and 
reliable information about walking performance in MS patients (Motl et al., 2012). T also 
correlates strongly with overall disability measures, including the EDSS ((r = 
0.73, P < .0001) (Goodman et al., 20007. 
The 9 peg-hole test ((Mathiowetz et al., 1985) is increasingly used in MS research and 
clinical trials (Fischer et al., 2001). It consists of 9 small wooden or plastic pegs, a square 
board with 9 holes arranged in a three by three design and spaced 3.2 cm apart, a 
container and a stopwatch. The patient is instructed to use his dominant hand to place the 
pegs in the holes and remove them immediately as fast as he/she can. Time to execute the 
task is recorded to the nearest one-hundredth of a second. The participant then uses the 
other hand to repeat the process. 
5.6.4. Muscle function 
In the present study, ability to generate maximal strength during exercise was assessed in 
different muscle groups. Maximal grip strength was assessed using JAMAR, a standard 
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hand-held dynamometer, and Nicholas MMT was carried out using the dynamometer 
provided isometrically against a static load in the following manner: seated:  shoulder 
flexion/abduction, elbow flexion/extension, knee flexion/extension (all mid range), supine 
lying:  hip  flexion (mid range), prone lying:  hip extension (end muscle range). Each 
muscle was tested three times with 30 seconds rest provided between each test. Data was 
immediately recorded from the dynamometer screen by the tester during the 30 second 
breaks between each muscle test. 
5.6.5. Daily living activities 
In MS patients with moderate to severe disability, the ability to perform personal and 
instrumental daily living activities is often adversely affected (Mansson and Lexell, 2004).  
To assess limitations to daily living activities in those patients, a number of scales have 
been developed. One such scale, which has been utilised for the purpose of the present 
study, is the Barthel Index, BI, (Appendix 12) of activities of daily living. The BI was 
originally developed by Mahoney and Barthel (1965), but it was later modified by 
Granger et al., (1979) to assess the ability of patients with neuromuscular disorders to 
care for themselves. Hobart et al., (2001) observe that the BI has an edge over other 
newer and more extensive rating scales in that it is more practical and economical, has 
excellent reliability and validity, and is sensitive to change and easy to use. The BI 
quantifies patients’ performance in ten daily life activities: feeding, grooming, bathing, 
dressing, bowel and bladder care, toilet use, ambulation, transfers, and stair climbing. 
Each   activity on the scale is rated with a number of given points   assigned to different 
levels of performance or needs. The lowest score, 0, indicates a totally dependent 
individual, and the highest score, 100, indicates a fully independent person. Too complete 
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the form, information can be obtained from the patient, through observation, or from 
those who are familiar with the patient’s abilities. 
5.6.6. Anxiety and depression 
To assess anxiety and depression in participants, the ‘Hospital Anxiety and Depression 
Scale (HADS) has been utilised. This tool seeks to achieve “the maximum possible 
separation between the concept of anxiety and depression” (Zigmond and Snaith, 1983) 
and is also short an easy to administer. HADS contains 14 items which are divided evenly 
between the two constructs, and each item is rated on a four-point (ranging from 0 to 3) 
on the Likert scale representing level of distress experienced during the past week 
(0=none, 1=a little, 2= a lot, and 3= unbearable) . Total scores range from 0-21, with 
higher scores indicating higher levels of anxiety or depression To be more precise, scores 
of 7 or below are considered normal or no case, 8-11 indicate mild anxiety/depression, 
11-14 reflect a moderate case and 15-21 point to a severe condition (Cresswell and
Chalder, 2002). Unlike other scales used to measure anxiety and depression, HADS does 
not include somatic symptoms of depression, which means that it cannot be confounded 
by symptoms of physical illness (Moss-Morris & Petrie, 2003) and, as such, it is 
recommended for use with clinical patient groups rather than physically well individuals 
(Zigmond and Snaith, 1983).This scale is described as a valid tool for use with MS 
patients and is also known to be sensitive enough to detect significant changes following 
intervention Feinstein et al., 1999). HADS is also reported to have good internal 
consistency with Cronbach alpha ranging from 0.80-0.90 for both anxiety and depression 
subscales (Moorey et al., 1991). A copy of the scale is provided in (Appendix 13). 
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5.6.7. Interviews 
In 3.3, it was argued that  self report questionnaires may not fully capture a wide range of 
factors that can shape or influence MS fatigue including, depression, stress, pain, 
motivation, self-efficacy, sleep disturbances, patient’s behaviour and the psychosocial 
consequences of the symptom. Because information about these factors is better obtained 
through qualitative data collection methods, it was suggested that our understanding of 
fatigue would be improved if we supplemented quantitative data obtained through self-
report questionnaires with qualitative information (Braley et al., 2009; Dodd et al., 2006; 
Dittner et al., 2004; Comi et al., 2001; Mohr et al., 1999). With this in mind, two sets of 
short and semi-structured interviews serving different purposes were employed in the 
present study. The former was employed just before the actual raining programme was 
started and it aimed at establishing whether fatigue was chronic or transient, how it 
progresses during the day, what makes better or worse, and  its impact on the patients’ 
mood, behaviour and daily living activities. The second interview was employed after the 
training programme, and it was meant to identify the positive and negative outcomes of 
the trial and the factors that hinder or facilitate participation in physical training.  
5.6.7.1. Interview sample 
All patients who were originally recruited for the purpose of the study (n=26) were 
invited to take part in both interviews. 8 participants (3 males and 5 females) agreed to 
take part in the first interview and 6 participants (2 males and 4 females) in the second. 
Although the interview samples are relatively small, they are still reflective of the entire 
study sample. 
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5.6.7.2. Interview arrangements 
Participants in the pre-training interview were approached during their routine visits to 
their neurologist at Dasman Institute (DI), and those who took part in the pos-training 
interview were approached at the training gymnasium when post-training measures were 
taken. The purpose of the interview was explained to participants and they, all, were 
assured of anonymity and confidentiality. Questions raised during the semi-structured 
interviews were informed by suggestions made by the MS Council (1998) and Dodd et al., 
(2006).  More about interview participants and schedule is mentioned in Chapter 7. 
The time and venue of the interview were also negotiated with every participant. The 
researcher made sure that no participant was under the pressure of time and that all 
interviews were conducted in a quiet secluded room, safe environment and without 
interruption. All interviews were performed either at Dasman Hospital or the training 
gymnasium. Each interview took 30-45minutes, and at the time of interviewing, only the 
researcher and the interviewee were present. With the permission of participants all 
interviews were tape-recorded. 
5.6.7.3. Qualitative data analysis 
Following the interviews, recorded conversations were transcribed verbatim by the 
researcher. To ensure validity and reliability, transcripts were verified against recordings 
and/or with the interviewee (Patton, 2002). Transcripts were then thoroughly read and 
coded. In an ideal situation, better results would be achieved if more than one researcher 
were involved in the process of coding, interpreting and analysing information. For 
example, Dodd et al., (2006) employed three researchers who first worked independently 
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using different coding methods (manual and computer assisted) and then met to refine the 
coding and agree on the main themes. In this study, this process was not possible due to 
limitations of time and resources. Hence, the present researcher worked on his own and 
employed a simple manual method that required him to code every passage in the 
interview transcript with a descriptive word. Response codes were related to the main 
issues and questions raised during the interview. These were then arranged into key 
concepts and themes based on the interview objectives as well as themes brought up by 
the interviewees (Rubin and Rubin, 1995). During this process, attention was paid to 
points of agreement and disagreement, as well as repetitive information which were 
common among the interviewees.  
5.7. Statistical Methods 
The SPSS was used to analyse the data from this quasi-controlled study. Because this is a 
repeated measure study design the Wilcoxon’s matched pair rank test was used.  The data 
were anaysed by the principal investigator under the supervision of his supervisor. 
5.8. Data Management 
All the data were collected and stored securely. The data from the forms were transferred, 
in an anonymous form, to an excel spread sheet which was then used to inform the 
analysis. Data collected were also randomly cross checked by the researcher’s supervisors 
to assess the validity of the data transferred from the form to the spread sheet 
independently. 
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Figure 5.1: Study procedure 
Initially recruited 35 
patients 
26 recruits remaining 
9 withdrawals 
n=2 work commitment 
n=3 travelling abroad 
n=4 not convinced 
Consent taken 
Awareness raising session 
B1 and B2 measures taken 
Interview 1 conducted 
4 withdrawals before trial 
n=1 relapse 
n=1 renal failure 
n=2 family commitment/problems 
22 participants 
Exercise type specified 
Trial begins 
6 dropouts 
n=2 family problems/commitment 
n=2 no explanation given 
n=1 hernia and shoulder problems 
n=1 study abroad 
16 participants completed trial 
End of trial measures and interview 2, week 12 
Follow-up measures, week 16 
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Chapter 6: Study findings 
6.1. Introduction 
In this chapter, results of the functional tests and other measures employed for the 
purpose of the study are presented. Before that, demographic and clinical characteristics 
of the participants are described. Reference is also made to the training intervention. 
6.2. Subjects and measures 
In Chapter 5, reference was made to study participants and methods. To recapitulate in 
our discussion, 26 patients (8 males and 18 females) were originally recruited for the 
purpose of the trial. Table 6.1 shows the demographic characteristics of those participants. 
Table 6.1. Summary of demographic characteristics of participants (n=26) 
Age (in years) Mean: 37.54 S.D:8.18
Months  since diagnosis Mean:  55.23 S.D: 60.45
Gender Male (n=8) 31% Female (n=18) 69% 
MS type B (n=2) 7.7% 
SP (n=3) 11.5% 
RR (n=7) 27% 
PP (n=14) 53.8% 
EDSS Mild 0-4 (n=2) 7.7% 
Moderate 4.5-6 (n=19) 73% 
Advanced 6.5+ (n=5) 19.3% 
Marital Status Single (n=11) 42.3% Married (n=15) 57.7% 
Employment Full time (n=15) 57.7% 
Unemployed (n=5) 19.2% 
Part time (n=5) 19.2% 
Student (n=1) 3.8% 
(Benign), PP (Primary Progressive, RR (Relapsing Remitting), SP (Secondary Progressive) 
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Participants’ age ranged between 23 and 51 years (Mean37.54, SD 8.18), and time since 
diagnosis ranged between 2 months and 15 years (Mean55.23, SD 60.45). Fourteen of 
those participants had MS of the primary progressive type; seven had relapsing remitting 
MS, three secondary progressive MS, and two benign MS. Nineteen participants scored 
4.5-6 on the EDSS, two scored 4 or below, and the remaining five scored 6.5 or above. 
Fifteen participants were married with dependent children, and eleven were single. 
Finally, the majority of participants were in full-time employment (n=15), 6 were part-
time employees, 2 unemployed and 1 was a student. 
It was also noted earlier that measures were taken twice before the trial (referred to as 
baseline 1 and baseline 2, B1 and B2), at week 12 (W12) at the end of the trial, and four 
weeks after the programme had been terminated (W16). Only four measures were applied 
at B1 (EDSS, MFIS, HADS, and Barthel Index). At B1, B2, W12, and W16, the same 
measures were repeated in addition to BBS, TUG, 10-metre walk, 6-min walk, 9-Peg-hole, 
as well as assessments for hand grip strength, knee, elbow and hip flexion and extension, 
and shoulder flexion and adduction. Rationale for performing B1 tests was given in 4.4. 
Measures at B1 and B2 were performed on all recruits (n=26). Only a few days before the 
training programme was due to be started, four participants withdrew out of the trial.  One 
had a relapse; another was diagnosed with renal and cardiovascular problems, and two 
due to work and family commitment. The remaining 22 participants selected the type of 
exercise of their choice and they underwent training.5 chose resistance exercise, and 17 
chose combined exercise. During the first two weeks of the training programme, four 
participants pulled out of the trial; one had to travel abroad to pursue his studies; one 
developed hernia and shoulder problems and was referred to hospital for treatment, one 
gave no explanation, and one mentioned family duties and time pressure as a reason. In 
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week three, one patient stopped attending training without giving a reason, and in week 
four another female participant thought she was not gaining much from training. Those 
who completed the training programme were 16 participants. W12 and W16 measures 
were administered on those participants Table 6.2 show subjects, assessment stages and 
exercise types. It is to be noted that 8 participants took part in the pre-training interview. 
One of those participants withdrew from the trial before it was started, another pulled out 
at weak 3, and the remaining 16 (4 males and 12 females) completed the programme. All 
participants in the post-training interview completed the trial. One participant took part in 
both interviews. The interview findings will be presented in Chapter 7 (also, see Chapter 
5). In the remainder of this chapter, analysis will be focused only on those who completed 
the trial. 
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Table 6.2. Subjects, method and exercise type 
Participant B1 B2 W12 W16 Inter1 Inter2 Type of 
Exercise 
 C1 X X X X X Combined 
C2 X X X X X Resistance 
C3 X X X X X Combined 
C6 X X X X X Combined 
C7 X X X X X Combined 
C10 X X X X Combined 
C11 X X X X X Combined 
C13 X X X X X Resistance 
C14 X X X X X X Combined 
C15 X X X X Combined 
C16 X X X X X Combined 
C18 X X X X  X Combined 
C19 X X X X Combined 
C20 X X X X Combined 
C23 X X X X X Combined 
C24 X X X X Combined 
P5(w1) X X Combined 
P8(w2) X X Resistance 
P12(w2) X X Resistance 
P17(w4) X X Combined 
P22(w3) X X X Combined 
P(26w2) X X Resistance 
WT4 X X X -- 
WT9 X X -- 
WT21 X X -- 
        C, completed trial, P, pulled out, W, withdrew. 
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6.3. The training intervention 
 Following basic functional assessment and consultation with each participant, the 
exercise type was determined according to his/her wishes, abilities and needs. Of the 16 
participants who completed the 12-week training programme, two chose resistance 
training and 14 opted for exercises of the combined type (i.e. resistance and endurance 
exercises). Initially, the plan was to provide 4 training sessions a week, each session 
lasting 45 minutes. However, given the fact that all participants had not exercised since 
diagnosis with the illness, it was decided that 3x30-minute sessions a week on alternate 
days would be sufficient for a start and that exercise intensity would be increased in due 
course.  . 
For participants who opted for combined training exercise, time was initially divided 
evenly between endurance training and resistance training and endurance training (15 
minutes each) separated by a 4-minute rest period. Endurance training consisted of 15 
minutes of treadmill walking, and resistance training consisted of   2 sets of 9 stretching 
and strengthening exercises, 15-20 repetitions. Those who opted for resistance training 
were asked to perform 3 sets 15-20 reps as a circuit (using the appropriate weights as 
indicated by the participant’s reports of exertion on those exercises marked with a W) on 
the Borg Scale. The exercises were: Upper extremities: Bicep Curl W, French Press W, 
Row (Theraband) Bench Press W, Shoulder front raise and lateral raise (reciprocal) W. 
Lower extremities:  Hamstring curl W, Calf raise W, Squat W and against the wall using 
a gym ball where required due to poor balance, Glute Bridge (Progressed to using weight 
over the low abdominal area), Dead bug, Alternating superman (Progressed to bird-dog 
exercise). Exercise days were alternated throughout the program in accordance with the 
date and not the last area exercised by the patient (i.e. if a patient attended for Upper 
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exercise and missed Lower exercise on the next scheduled day, they would return to 
Upper exercise if they returned on the next scheduled exercise day). Resistance was 
progressed using patient’s reports of exertion at a certain weight as indicated using the 
Borg RPE. Patients were instructed on how to stretch the muscles exercised on that day 
and performed their own exercises at the start and end of each resistance session. Aerobic 
exercises were performed in a semi-supervised manner with the patients instructed to 
maintain their exertion at a Borg level of 13-15 as long as no adverse symptoms were 
experienced. There was a minimum of one person and a maximum of six people 
exercising in the gym at any one time, with one-two supervisors for females. For males, 
there was a minimum of one person and a maximum of two exercising at one time with 
one supervisor. In week 7 onward, intensity was increased. For combined training, 
participants were given the choice between increasing the treadmill walking speed or to 
increase the walking time by 5 minutes. They were then required to perform 3 sets of 
stretching and strengthening exercises. For those who opted for only resistance training, 
sets were increased by 1 from 3 to 4. The participant’s heart rate and temperature were 
taken at the beginning and end of each training session and rate of exertion and speed 
were recorded using the RPE and CR10 scales. It is also to be noted that training was 
provided in air- conditioned environment. (Appendix 14 shows the results of all measures 
and tests administered on each participant as well as his/her demographic details. It also 
shows the participant’s daily monitoring record). 
6.4. Early measures 
It was stated above that four measures (EDSS, MFIS, HADS and BI) were applied at 
baseline 1 to determine whether or not any changes have taken place during the month of 
fasting (see Chapter 5).When the results of those tests were compared to those of B2, they 
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showed no significant changes between baseline 1 and baseline 2 (p-value 70.05) in the 
scores of MFIS, HADS, B1 and EDSS (Table 6.3). One possible explanation for this 
result is that participants' behaviour and daily routine might not have changed much 
during Ramadan. This is because Islam gives the ill the right to carry on with their lives 
as usual and not observe the month of fasting if they wish. This being said, we now turn 
to the results for those who completed the trial (n=16). 
    Table 6.3. Early measurements 
N Mean Std. 
Deviation Z 
Asymp. 
Sig. 
(2-tailed) 
MFIS-bl1  26 45.08 19.179 
-.496-b .620 
MFIS-bl2 26 43.31 16.984 
HADS-bl1 26 19.12 16.234 
-1.342-b .180 
HADS-bl2 26 19.23 16.187 
Barthel-bl1 26 18.00 2.191 
-1.342-b .180 
Barthel-bl2 26 17.54 2.929 
EDSS-bl1 26 5.73 .874 
.000b 1.000 
EDSS-bl2 26 5.73 .874 
6.5. Results 
Demographic information 
As seen in Table 6.4, four males and twelve females completed the training programme. 
With the exception of two participants who were over 50 years old and another four who 
were in their early 40s, all other participants were 40 years or younger. Three participants 
had been diagnosed with  the disease for less than one year before the trial, seven between 
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2-5 years, four between 5-10 years, and only 2 over 10 years. Two participants had
benign MS, five relapsing remitting MS, and another 5 primary progressive MS. Three 
individuals scored 4 or below on the EDSS, twelve scored 4.5-6, and only one scored 6.5. 
Nine participants were married and seven were single. Four were in part-time 
employment, nine full-time employment, two unemployed, and one a student. 
          Table 6.4. Demographic characteristics of participants 
Participant 
Age 
(years) 
Gender 
(M/F) 
MS 
duration 
(months) 
MS 
type 
Disability 
(EDSS) 
Marital 
status 
Employ-
ment 
C1 40 F 7 B 5 M FT 
C2 36 F 15 PP 5.5 S FT 
C3 23 F 2 RR 4 S St 
C6 27 F 16 PP 5.5 S FT 
C7 40 M 4 B 3.5 M FT 
 C10 30 F 52 RR 5 S FT 
C11 41 M 30 PP 5 M FT 
C13 30 F 99 RR 6.5 S FT 
C14 26 M 66 RR 6 S PT 
C15 27 F 38 PP 5 S FT 
C16 32 F 26 RR 6 M PT 
C18 45 F 44 PP 6 M U 
C19 41 F 88 PP 5.5 M PT 
C20 52 F 176 PP 5 M FT 
C23 54 M 258 PP 6 M U 
C24 44 F 98 PP 5 M PT 
B(benign),  C (completed training programme), D (dropped out),  , F (female), M (male), FT (full-
time),   Ma (married), N (no), NT (no training),  PT (part-time), PP (primary progressive), RR 
(relapsing  remitting), S (single),  SP (secondary progressive), St (student), U(unemployed),W (week), Y 
(yes). 
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Statistical analysis (Table 6.5) shows that significant beneficial effects on fatigue were 
obtained as a result of training at the end of the programme in week 12 (p-value < 0.05 
and mean value going down from 38.00 at baseline 2 to 29.94 at week 12). 
 There were  no significant differences between the MFIS follow-up scores at week 16 
and the end of the training programme scores at week 12 (p-value > 0.05). This indicates 
that the fatigue benefits gained as a result of training were still maintained over the four 
week period that followed the trial. With reference to anxiety and depression, there were 
no significant differences between HADS-B2 and HADS-12w (p-value > 0.05). The same 
can be said about HADS-12 and HADS-16w. There were also no significant differences 
between the B1 scores at baseline 2 and week 12, or between week 12 and week 16 scores 
(p-value > 0.05). The EDSS scores remained unchanged throughout the entire period. 
Table 6.5. Results of MFIS, HADS, EDSS and BI measurements (n=16) 
Var Measurement Mean±Std 
Deviation 
z Asymp. Sig (2-
tailed) 
MFIS Bl2 
12w 
38.00±15.297 
29.94±13.791 
-2.200-d .028 
12w 
16W 28.88±14.301 
-.701-d .483 
HADS bl2 
12W 
14.63±8.007 
13.94±5.483 
-.126-c .900 
12w 
16W 12.94±6.486 
-1.162-d .245 
EDSS bl2 
12W 
5.38±.719 
5.38±.719 
.000b 1.000 
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12w 
16W 5.38±.719 
.000b 1.000 
Barthel bl2 
12W 
18.56±1.788 
19.31±1.778 
-1.706-d .088 
12w 
16W 19.47±1.060 -.816-d .414 
Table 6.6 shows significant differences between TUG tests carried out at week 12 and 
baseline 2 (p-value < 0.05) but no significant differences between the follow-up and the 
end of training test (p-value > 0.05). This indicates improvement in mobility and static 
and dynamic balance asa result of training. These gains were carried over four weeks 
after training. Results similar to these were obtained when the BBS tests were applied. 
Significant improvements were also recorded as a result of training in short walk duration 
speed (the 10 meter walk) and exercise tolerance (6-minute walk). These benefits were 
still maintained when the 10-meter walk and the 6-minute walk tests were performed four 
weeks after the training programme had been terminated. No significant differences were 
recorded in the 9-Hole-Peg test in both hands neither between week 12and and baseline 2, 
nor between week 16 and week 12 (p-value > 0.05). 
Table 6.6. Results of TUG, 10-m Walk, 6-min Walk, BBS and 9-hole peg. 
Var Measurement Mean±Std 
Deviation 
z Asymp. Sig (2-
tailed) 
TUG 
bl2 
12W 
8.00±2.280 
6.81±1.109 
-2.549-c .011 
12w 
16W 7.13±1.455 
-1.508-d .132 
150 
10m 
bl2 
12W 
4.13±.806 
3.56±.629 
-2.714-c .007 
12w 
16W 3.63±.719 
-.378-d .705 
6m bl2 
12W 
387.56±73.117 
426.06±68.418 
-3.259-c .001 
12w 
16W 
411.69±81.302 -1.837-d .066 
BBS bl2 
12W 
51.50±4.290 
53.00±3.864 
-2.135-c .033 
12w 
16W 53.63±3.686 -.593-c b .553 
Nhpt R bl2 
12W 
17.00±4.274 
16.19±3.902 
-1.691-c .091 
12w 
16W 15.00±4.274 
-.839-c .402 
Nhpt L bl2 
12W 
20.75±7.767 
19.25±5.916 
-.860-c .390 
12w 
16W 17.75±5.360 
-1.020-c .308 
As seen in Table 6.7, there were no significant differences between all hand grip tests for 
both hands over the entire period under investigation. By contrast, gains were made as a 
result of training in right and left shoulder flexion and adduction (with significant 
differences being recorded between week 12 and baseline 2 tests, p-value < 0.05). All 
these gains were still felt four weeks after training with only right shoulder flexion being 
the exception. 
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Table 6.7.Results of hand-grip, shoulder flexion and shoulder adduction tests. 
Var Measurement Mean±Std 
Deviation 
z Asymp. Sig (2-
tailed) 
Max_grip R 
bl2 
12W 
18.63±5.795 
20.56±7.694 
-1.545-c .122 
12w 
16W 21.25±7.514 
-.884-c .377 
Max_grip L 
bl2 
12W 
18.63±7.848 
19.69±8.920 
-1.512-c .130 
12w 
16W 20.69±8.072 
-.985-c .324 
Max_shld flx R bl2 
12W 
62.19±6.210 
65.13±4.965 
-2.540-c .011 
12w 
16W 67.06±5.555 
-2.369-c .018 
Max_shld flx L bl2 
12W 
61.63±7.915 
66.69±6.954 
-3.191-c .001 
12w 
16W 67.94±6.846 -1.055-c .291 
Max_shld add R bl2 
12W 
61.06±4.404 
65.50±5.099 
-3.245-c .001 
12w 
16W 65.94±4.597 
-.288-c .774 
Max_shld add L bl2 
12W 
61.44±5.549 
66.06±4.864 
-3.429-c .001 
12w 
16W 65.69±5.400 
-.314-d .754 
152 
Table 6.8 shows results of elbow flexion and extension tests. These are as follows: There 
were significant differences between all elbow flexion and extension tests performed at 
week 12 and all elbow flexion and extension tests conducted at baseline 2 (p-value < 
0.05). There were no significant differences between R elbow flexion-16w and R elbow 
flexion-12w. There were significant differences between L elbow flexion-16w and L 
elbow flexion-12w. There were no significant differences between L elbow extension-
16w and L elbow extension-12w. 
Table 6.8. Results of elbow flexion and elbow extension tests 
Var Measurement Mean±Std 
Deviation 
z Asymp. Sig (2-
tailed) 
Max_elbflxR 
bl2 
12W 
63.50±7.385 
67.44±7.891 
-3.142-c .002 
12w 
16W 68.75±6.414 
-1.297-c .195 
Max_elbflxL 
bl2 
12W 
63.38±8.016 
67.50±8.230 
-2.802-c .005 
12w 
16W 68.75±10.829 
-2.107-c .035 
Max_elb ext R bl2 
12W 
62.81±5.319 
65.38±5.175 
-2.273-c .023 
12w 
16W 66.50±6.099 
-1.515-c .130 
Max_elb ext L bl2 
12W 
62.94±6.465 
67.94±9.609 
-2.358-c .018 
12w 
16W 66.75±5.106 -.444-c .657 
153 
Results of knee and hip flexion and extension (Tables 6.9a and 6.9b) were as follows: 
There were significant differences between all right and left knee and hip flexion and 
extension tests performed at week 12 and those performed at baseline 2 (p-value > 0.05 
between all tests). This indicates that there was a positive effect of training on knee and 
hip flexion and extension. This positive effect was still felt four weeks after the training 
programme in left knee extension and right and left hip flexion and extension.  
Table 6.9a.  Results of knee flexion and extension 
Var Measurement Mean±Std 
Deviation 
z Asymp. Sig (2-
tailed) 
Max_kf 
R 
bl2 
12W 
64.38±5.328 
68.88±5.290 
-2.702-c .007 
12w 
16W 71.38±6.469 
-2.494-c .013 
Max_kf 
L 
bl2 
12W 
64.00±5.046 
67.88±5.560 
-2.642-c .008 
12w 
16W 71.00±7.211 
-2.259-c
.024 
Max_kext R bl2 
12W 
64.25±6.476 
74.88±10.776 
-3.417-b .001 
12w 
16W 80.13±7.588 
-1.892-b .058 
Max_kext  L bl2 
12W 
63.13±5.608 
73.50±9.805 
-3.301-b .001 
12W 
16W 78.31±8.187 -1.822-b .069 
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Table 6.9b.  Results of hip flexion and extension 
Var Measurement Mean±Std 
Deviation 
z Asymp. Sig (2-
tailed) 
Max_hipflx R bl2 
12W 
63.75±5.285 
68.56±5.573 
-3.168-c .002 
12W 
16W 68.19±4.875 
-.429-d .668 
Max_hipflx L bl2 
12W 
63.81±5.394 
68.31±5.677 
-2.929-c .003 
12W 
16W 68.81±5.845 
-.892-c .372 
Max_hipext R 
bl2 
12W 
60.88±5.632 
65.75±5.615 
-3.413-c .001 
12w 
16W 68.00±4.226 
-1.775-c .076 
Max_hipext L 
bl2 
12W 
60.81±5.718 
65.38±4.897 
-2.826-c .005 
12w 
16W 67.53±3.871 
-1.291-c .197 
6.6. Summary 
Study results can be summed up in the following points: 
1. There were no significant differences between the four measures (MFIS, HADS, B1
and EDSS) taken at baseline 1 and baseline 2. 
2. The 12-week combined and resistance training programme resulted in significant
reductions in fatigue levels. This positive effect was still maintained 4 weeks after the 
training programme had been terminated. 
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3. There were significant improvements as a result of the training programme in: fine
mobility and static and dynamic balance (TUG); short duration walking speed (10m test); 
exercise tolerance (6-minute walk); balance and fear of fall (BBS). Follow up tests at 
week 16 show that all those gains were still maintained.  
4. As a result of the training programme, significant improvements were also made in left
and right shoulder flexion and adduction, and left and right elbow, knee and hip flexion 
and extension. Four weeks after the training programme had been terminated, 
improvements were still felt in: left shoulder flexion and left and right shoulder adduction, 
right elbow flexion and left and right elbow extension, left knee extension, and left and 
right hip flexion and extension. 
5. There was no significant effect of training on anxiety and depression (HADS); personal
basic functional activities (B1); fine motor coordination and finger dexterity (9-HolePeg) 
and hand grip (JAMAR). 
6. It is also to be noted that training in an air conditioned environment resulted in no
change in body temperature, that there was increase in heart rate within each session in 
many participants, which is an indicator of increased fitness, and also an increase in 
weight lifted and/or a reduction in effort. 
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Chapter 7:  Interview findings 
7.1. Introduction 
In Chapter 3, argument has been made in favour of employing both quantitative and 
qualitative analysis to better our understanding of fatigue. In realisation of this principle, 
two sets of semi-structured interviews have been employed for the purpose of the present 
study. The former aims to establish what MS fatigue is, the course it takes during the day, 
how it is alleviated or aggravated, and the impact it has on the patient’s mood and 
behaviour. The latter is aimed at identifying the outcomes of the training programme from 
the viewpoint of the participants, their motive for attending training, and the factor that 
hinder or facilitate participation in physical training activities. The first interview was 
conducted before the training experiment, and the second was administered soon after the 
trial had been terminated. Rationale for both interviews was provided in Chapter 5, and 
the interview procedure and qualitative data analysis were also described. In this chapter, 
the findings of the interviews are presented. 
7.2. The pre-training interview 
7.2.1. Interview schedule 
Questions raised during the first interview polarised around the nature of MS fatigue (see 
Appendix 16). On the whole, the main issues under consideration were: 
1. The difference between fatigue experienced before diagnosis with MS and fatigue
after diagnosis. 
2. How fatigue progresses during the day.
3. Factors that make fatigue better or worse.
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4. The impact of fatigue on the patient’s mood, behaviour and daily living activities.
7.2.2. Participants 
All participants recruited for the purpose of the trial were invited to take part in the 
interview, but only 8 (3 males and 5 females) accepted the invitation. One of those 
participants withdrew out of the trial before it was started, another pulled out of the trial 
in week 3, and six completed the training programme. As seen in Table 7.1, the mean age 
for participants is 37.25, SD: 10.10. Months since diagnosis, Mean78.5, SD:90.73. Four 
interviewees had primary progressive MS, three relapsing remitting MS and 1 benign MS. 
Only one participant scored 6.5 on EDSS, and the rest had a score of 6 or below. Five 
were single, three married, four in full-time employment, two partly employed, and two 
unemployed. 
Table 7.1. Pre-training interview sample demographics 
Age in years Interview 1 (n=8) Mean: 37.25 S.D:10..10
Months since 
diagnosis 
Interview 1 (n=8) Mean: 78.5 S.D:90.73
Gender Interview 1 Male (n=3) 37.5% Female (n=5) 62.5% 
MS type Interview 1 B (n=1) 12.5% 
SP (n=0) 0% 
RR (n=3) 37.5% 
PP (n=4) 50% 
EDSS Interview 1 Mild 0-4 (n=1) 12.5% 
Moderate 4.5-6 (n=5) 62.5% 
Advanced 6.5+ (n=2) 25% 
Marital Status Interview 1 Single (n=5) 62.5% Married (n=3) 37.5% 
Employment Interview 1 FT (n=5) 62.5% 
Un (n=2) 25% 
PT (n=1) 12.5% 
St (n=0) 0.0% 
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7.2.3. Interview findings 
Themes arising from the interview are considered under the headings: the nature of MS 
fatigue causes of fatigue, alleviating fatigue, and its psychosocial impact on the patient. 
7.2.3.1 The nature of fatigue 
All participants reported experiencing fatigue on a daily basis, though at varying levels of 
severity. Time of onset of the symptom during the day, its features and the way it 
develops also appears to vary from one participant to the other. In general, although 
fatigue appears to be related to the quality and amount of sleep as well as the time (during 
the day) of physical or mental activities and their demands, this is not always the case. On 
the issue of sleep, all participants stated that their night sleep is usually disrupted for one 
or more than one of three main reasons: pain, fatigue and nightmares. One participant said 
she hardly has any sleep at night because of what she described as "dark thoughts". In her 
words: 
Those thoughts come to me when I am left alone at night. I do also feel sorry for myself 
and often cry. When my parents wake up in the morning, they ask me if I had been 
crying but I deny it. 
In fact, as will be seen in our discussion, sorrow and grief have become part of the 
participants' daily lives, particularly females. Three other participants said they often 
wake up for no obvious reason. For the majority of the participants, uninterrupted sleep is 
a rarity. One participant said she "would be lucky" if she had two or three nights of good 
and uninterrupted sleep per month, 4 said "one or two nights a week", 2 said "almost 
every other night", and one said he sleeps well "almost all days of the week, 5 or 6 nights". 
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When asked how they felt in the morning after a "good" night sleep, two said they 
"usually do not feel tired", four said they "sometimes feel tired, sometimes not", and two 
stated that they "always feel tired" when they wake up in the morning, regardless of the 
quality and amount of might sleep. When the participants' night sleep is disrupted, which 
is often the case; all participants said they felt fatigued in the morning. According to one 
male participant, morning fatigue was "not unusual" because he used to "experience it 
long before he had been diagnosed with the illness". However, the majority of 
participants agreed that morning fatigue was mild and mainly physical and that normal 
daily activities were tolerated. Seven participants stated that fatigue starts building up 
gradually and steadily as the day progresses and reaches climax during the early hours of 
the afternoon. This is regardless whether or not they were fatigued in the morning. Only 
one male participant said that his fatigue levels remained "almost constant" throughout 
the day and that he "occasionally" experiences "hours of discomfort and unusual 
tiredness". 
In general, participants appeared to agree that there is a point in time when fatigue 
becomes "annoying" or "intolerable" according to one participant. This type of fatigue 
sometimes occurs during or after strenuous physical or mental activities, sometimes it is 
provoked by the slightest activity, and at other times it happens even in the absence of 
any form of activity. It can also take place any time of the day. On the whole, this type of 
fatigue has both physical and cognitive features, the former being more dominant. No 
participant mentioned cognitive fatigue in isolation from physical fatigue. 
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As to the physical aspects of fatigue, whereas some features appear to be common, others 
are not. Beginning with common features, all participants described in detail what they 
called "total loss of strength" or "total loss of energy" and "weakness". The following 
quotes are an illustration of what they reported. 
One participant said: 
I just feel that my muscles have lost strength altogether. They become dead, just like a 
piece of material. Even when I am feeling thirsty, I hesitate before trying to handle a 
glass of water because I know I would drop it or put in the wrong place. I become a 
sort of weak, clumsy and coward altogether. 
Elaborating on weakness, another participant said: 
Not only that my hands become weak. I also feel that my legs cannot support me. 
Unless I sit down, I know that they will give way and that I will collapse. 
Another participant noted that even when she manages to move, the best she can hope for 
is to "drag her feet". According to her, "even this type of activity requires a lot of thinking 
and planning". 
As to the uncommon features of excessive physical fatigue experienced by the 
interviewees, one participant mentioned "slurred speech", and another mentioned 
"tremor". Four mentioned "total loss of balance" and a similar number mentioned 
“excessive yawning". Another uncommon feature is "sweating" mentioned by only two 
participants. In this respect, it is worth alluding to the case of one male patient who 
participated in the exercise programme but did not take part in the interview about fatigue. 
That patient denied that he had MS and insisted that he was wrongly diagnosed with the 
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illness. When asked why he attended training, he said he only wanted to prove his point to 
others and to himself. 
With reference to cognitive impairment, this was a clear feature of fatigue. On the whole, 
this is manifested in the participants' inability to carry on with activities that require 
concentration or intensive mental effort. For example, the majority mentioned that they 
find it difficult to read or grasp the meaning of written texts. In the words of one 
participant: 
I read the same sentence slowly and more than once. Yet, I seem to forget what it is 
about. I feel my attention and memory are not normal. 
In this connection, all female participants said they found it difficult to concentrate and be 
focused even when they try to prepare a simple meal. As for the males, they do not have 
problems with cooking because they never do it and rarely enter the kitchen (a hallmark 
of Arab culture). However, they reported having problems with concentration when 
filling in forms, playing computer games or sending and receiving mobile phone texts. 
7.2.3.2 Causes of fatigue 
When the interviewees were asked what they thought the causes of fatigue were and how 
it was aggravated, they all agreed on two major factors: physical and/or mental activity, 
stress and heat. More precisely, they noted that fatigue would be easily provoked when 
both strenuous physical and mental activities are present but that it is induced more by 
physical than by the mental effort. With this in mind, they all find an urgent need to take 
regular breaks when they are engaged in any activity. Otherwise, there is the possibility of 
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fatigue increasing or having a relapse. According to female participants, they feel safer at 
home because they can take short breaks when they are doing the cleaning, or the cooking. 
However, for reasons to be discussed later (see post-interview), most women in full 
employment find it difficult to have any breaks at work. With reference to heat, this 
appears to be more of a problem for males than for females. This is possibly because 
unlike women, who are either at home or work, males spend longer time outdoors. On 
their part, although female participants did mention heat as a factor that can aggravate 
fatigue, they noted that humidity is more disturbing. Three participants mentioned 
"disrupted night sleep" as a source of fatigue, and another four (all females) thought that 
"depression" can easily induce the symptom. 
7.2.3.3 Alleviating fatigue 
All participants agreed that the best strategy to alleviate fatigue is to rest and/or have 
some sleep. What is interesting to note here is that the "sleep strategy" appears to be more 
effective during the day than at night. In the words of one female participant: 
When I am fatigued at night, the symptom is not relieved no matter how long I try to 
rest or sleep. On the other hand, when I am fatigued during the day, rest or sleep 
abolish fatigue, often in a manner of minutes. 
Other participants agreed with this comment, though the amount of time they said they 
needed for rest and sleep varied. Three said they did not actually need to sleep and that all 
they needed was "to sink in the chair" and stay inactive until fatigue disappears. When 
asked how long it usually takes fatigue to vanish, one said "about 15 minutes" and the 
other two mentioned "one to two hours, possibly more, depending on the level of fatigue". 
The other four said they needed a "couple of hours" of sleep. Again, when asked about 
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the type of "inactivity" they required, they all answered that they stop both mental and 
physical activities. All also noted that in order for the rest/sleep strategy to work, the 
environment must be peaceful and quiet. One male participant has this to say: 
I just want to be left alone and in peace. I do not want to hear or talk to any soul. Not 
even to myself. Then, the moment fatigue starts to retreat, I hear my   wife shouting: 
"Are you okay? Is there anything you need?" God! How good that woman is at 
inducing fatigue. The problem is even worse when the children are around and not in 
school. 
 
When that participant was asked if his wife and children knew about his illness, he simply 
answered: "Why should they?". In fact, as noted earlier in this discussion, the majority of 
Kuwaiti (and Arab) MS patients usually regard their illness as a personal secret they 
should not reveal.  
 
When participants felt that heat or humidity might precipitate fatigue, they said they 
usually turned on the air conditioning system. Three said that taking a shower would help. 
To evade fatigue, some patients took what they called "precautionary measures" or "pre-
emptive technique". This strategy is employed when they plan to go out for an event, and 
it requires them to have some sleep (even if they did not need it) before going out. One 
female participant also thought that mental and physical activity at work can prevent 
fatigue. When this same participant was reminded of what she had said earlier in the 
interview about the need to have regular breaks at work, her answer was. 
I mean reasonable activity. The activity that makes you feel cheerful, good and lively. It 
all depends on your mood and the people around you, of course. Sometimes I even 
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think that I need breaks because I feel bored and troubled by the work environment, I 
mean work colleagues. 
 
7.2.3.4. Impact of fatigue 
When participants were asked what impact fatigue had on their lives, some went to 
describe in detail the effects of the symptom and their MS experience as a whole. As they 
spoke, they showed clear signs of sorrow, pain, grief, frustration and even anger. The 
comments they made did clearly indicate that the impact of fatigue and MS was for them 
an issue of great importance and concern. One interviewee commented with bitterness: 
“we are often directly or indirectly reminded that we are ill but are never asked about the 
impact of the illness on our lives or told what we can do about it”. Another interviewee 
said with a sad smile on his face: “It is good to talk and take it off one’s chest!”. However, 
from the accounts given by those participants, it is evident that MS in general and fatigue 
in particular can lead to behavioural changes with profound physical, social and 
psychological consequences. 
Four interviewees noted that although mild fatigue, “which is almost always present”, can 
affect their physical and mental performance, it remains bearable and they can still cope 
with it. However, the main concern for those patients is that they do not know exactly 
how or when excessive fatigue or relapses are evoked or what the consequences will be. 
One participant noted:  
When I am at work, I try to take things easy lest fatigue or other symptoms associated 
with it become visible and colleagues know about my illness. But no matter how hard I 
try, I sometimes feel it coming and begin to feel more tired. In a sudden, I lose interest 
in what I am doing and stop working. Sometimes, I stay at my desk feeling sorry for 
 
 
 
 
 165 
myself and thinking about my colleagues who think that I am lazy and irresponsible, 
and at other times, I try to find excuses to run away home. 
 
Remarks similar to those above were made by another participant who added that she 
sometimes pushes herself to “get things done”. In her words, “by the end of the work day, 
I find myself exhausted and shaking and feel an urgent need to rush back home to go to 
bed”. That same participant added that despite her worries, she would “do the impossible 
to keep (her) job”.  It is worth noting that that participant is an expatriate who is not 
protected by Kuwaiti labour laws that apply only to locals. Another interviewee said she 
felt guilty because her mother gave up her job to look after her.  A male participant said 
he opted for a part time job because he could not cope with the type of work he was doing. 
Two participants noted that they had been feeling stressed since the days they were 
waiting for diagnosis. One even angrily noted that, “had the diagnosis process been 
speeded up, (his) condition wouldn’t have deteriorated”. Four respondents also pointed to 
“occasional clashes and tension” in their families due to behavioural changes dictated by 
the illness. They further noted that their condition forced them to abandon plans for a 
better future (e.g. better employment, education) and resulted in social withdrawal, 
disruption to daily living activities and changes in established relations. Two of those 
participants said they were not happy because they “lack independence” and added that 
their “sense of self-esteem was not as it used to or should be”. One participant was 
reluctant to talk about any negative effect of fatigue or of the illness, possibly because she 
thought others might feel sad or sorry for them, or possibly because they were more 
determined and optimistic. According to another interviewee, he hated to think about the 
illness and was used to pushing himself to remain physically and mentally active. In his 
words: “which is better, succeed sometimes or fail all the time?  
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7.2.3.5. Two unusual cases 
Two participants in the trial were a male (Y) and a female (Z). Although Y and Z did not 
take part in the pre-training interview, they still have an interesting story that is related to 
MS in general and fatigue in particular. It is worth noting that Y was aged 41 years, with 
primary progressive MS and an EDSS score of 5. Z was 45 years old, with primary 
progressive MS, and EDSS score of 6.     
 
During the fourth week of the training programme, a male participant (Y) and a female 
participant (Z) decided to take a few days off training to travel to Iraq in order to take part 
in the annual march between the two holy cities of Najaf and Karbala. The pilgrimage is 
performed in commemoration of the highly revered saint and martyr, Imam Hussein, who 
with his entire family were brutally murdered at the hands of Yazid, the dissident and 
Umayyad caliph at the end of the 7th century A.D. The rituals of the pilgrimage dictate 
that the faithful take the 50 mile journey from Najaf to Karbala on foot, stopping only for 
sleep and rest whilst chanting, swaying and praying all the way. Although Y and Z were 
advised by their doctor not to travel, they still insisted on performing what they described 
as their "holy duty". One week later, they were back to attend the training programme and 
tell their story. Both participants gave a similar account of their foot trip. Here is only a 
brief account of their journey and its impact on fatigue.  
 
Y and Z stated that they made the 50-mile foot journey in just over two days and a half, 
without walking aids. They said they used to sleep at night and stop for about 20 minutes 
for rest and/or food at the end of every hour. In total, each of them walked for 25 hours, at 
the rate of two miles an hour. Both said that they were taking disease modifying drugs but 
 
 
 
 
 167 
no medication for fatigue. They also said they were aware that the long march might 
trigger a relapse but that they were determined "no matter what", to reach their goal. In 
fact, they gave the impression that they hoped for a relapse. In the words of Z, "the harder 
it is, the more rewarding it becomes". They also noted they slept well during the journey 
and did not experience the "usual" sleep disturbances. Neither of them seemed to have 
experienced any MS symptoms during the trip except for the very "occasional and usual 
dizziness and stumbles". Although both mentioned they felt physically exhausted at one 
stage, they still insisted that they did not experience mental fatigue and that their ability to 
concentrate was not affected. In terms of weather, the spell of rain and relatively warm 
days (25°c) did not seem to have affected them. Both said they had been performing the 
pilgrimage long before they had fallen ill and continued to do so every year after they had 
been diagnosed with the disease.  
 
It is to be noted that the end of training measures showed a significant decrease in fatigue 
(by over 60%) in both Y and Z. This level was still maintained 4 weeks after the trial 
when follow-up measures were applied. Compared to other participants, they also 
displayed lower levels of anxiety and depression. (Transcript for a short interview with 
participant Y is seen in Appendix 15). 
 
7.3. The post-training interview 
7.3.1. Interview schedule 
The post-training semi-structured interview was focused on the participants’ attitude 
towards training (see Appendix 16). Main issues considered during the interview were: 
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1. The positive/negative outcomes of the training programme. 
2. Motives for attending the trial? 
3. Participants’ thoughts about programme leaders and other participants.  
4. Suggestions to improve future training programmes. 
 
7.3.2. Participants  
Participants in the post-training interview were 2 males and 4 females. Age, Mean 
34.5(SD: 8.78). Months since diagnosis, Mean, 29.17 (SD: 23.74). Two participants had 
primary progressive MS, three relapsing remitting MS, and 1 benign MS. Mobility 
disability was mild in 1 and moderate in 5. Three were married and three single, one was 
a student, one unemployed, two in full-time employment, and two partially employed 
(Table 7.2). 
 
Table 7.2. Interviews 2 (n=6): Sample demographics 
Age in years Interview 2 (n=6) Mean: 34.5 S.D: 8.78 
Months since 
diagnosis 
Interview 2 (n=6) Mean:29.17 S.D:23.74 
Gender Interview 2 Male (n=2) 33% Female (n=4) 67% 
MS type Interview 2 B (n=1) 16.6% 
SP (n=0) 0% 
RR (n=3) 50% 
PP (n=2) 33.4% 
EDSS Interview 2 Mild 0-4 (n=1) 16.6% 
Moderate 4.5-6 (n=5) 83.4% 
Advanced 6+ (n=0) 0.0% 
Marital Status Interview 2 Single (n=3) 50% Married (n=3) 50% 
Employment Interview 2 FT (n=2) 33.3% 
Un (n=1) 16.6% 
PT (n=2) 33.3% 
St (n=1) 16.6% 
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7.3.3. Interview findings 
The interview polarised around two main questions: the positive and negative outcomes 
of the training programme as seen by those participants, and their motive behind 
attending training. Given the fact that physical exercise, as a health promoting activity, is 
somewhat alien to Kuwaiti Arab culture, it was seen appropriate to begin the interview 
with a question that would enable the researcher to establish what the participants’ 
perceptions of exercise were and whether or not those perceptions had changed as a result 
of training. The question was: when you first arrived for training, what did you think 
about exercise and what exactly did you aim to achieve?  
 
7.3.3.1. Motive for training 
In answer to the question above, one female participant stated that she reluctantly agreed 
to take part in the training programme only to please her father. In her words: 
My father told me that I had nothing to lose by trying, and it was agreed that I 
would quit training the moment I felt it was going to trigger fatigue or a relapse. 
 
Another female participant stated that although she initially had "strong feelings and 
doubts about training", she still decided to "give it a try" only because she felt she would 
be “in safe hands”. When she was asked to elaborate, she had this to say: 
A friend invited me to her fitness club last year. Although I was no match for the 
training ladies, I still enjoyed exercising. At one point, an old lady challenged me 
to copy her moves. I failed, of course. They all had a good laugh and I pretended 
to join them. But deep inside, I felt depressed and hurt. That same day, I had a 
relapse.  
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At this point in her story, the interviewee was asked if her friend knew about her illness. 
She gave two deep sighs, one before and the other after her "NO" answer. She then asked 
a question and, herself, gave the answer: 
You know why I had a relapse that day? Maybe because I was fatigued, but I do 
know that I was fatigued because I was stressed.  
  
A third female participant admitted that she was not initially interested in training per se 
and that she mainly wanted to meet people with MS to "exchange views and see what 
they do". When she was asked why she was not interested in exercising, her answer was 
that she never trained when she was healthy and was not expected to train and take risks 
when she was ill. 
 
The fourth participant, a male, said he was aware of the benefits of training and that he 
was encouraged to join because trainers were "professionals who know about MS" and 
his abilities and needs.  
 
The fifth and sixth participants are Y and Z of the 85 kilometre walk (described above 
and in Appendix 15). These are highly motivated, determined and optimistic individuals 
as evidenced by their extraordinary pilgrimage story. Unlike other participants, they are 
open about their illness and not ashamed of it. When Y and Z were asked why they joined 
the programme and what they aimed to achieve, the former said he wanted to do 
“something enjoyable”, and the latter said she would rather be with others doing 
something useful that staying at home thinking about her illness. 
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The stories of the six interviewees and the attitudes they brought with them to the first 
training session have been narrated in some detail for one main purpose: to enable us to 
better understand and interpret the results obtained through questionnaires and functional 
measures. This point will be qualified in our final discussion where it is argued that our 
understanding of fatigue will remain incomplete unless the psychosocial impact of the 
symptom is appreciated rather than being underestimated..  
 
7.3.3.2. Training outcomes  
The most obvious and positive outcome of the training programme was that all 
participants completed the training course. This is despite the fact that interviewees some 
participant  arrived for the first training session with doubts about their abilities and 
negative, or at best neutral, perceptions of physical training. Factors that contributed to 
positive changes in those interviewees’ perception of exercise pertain to the physical,   
psychological and social outcomes of training.  
 
On the physical side, all six interviewees pointed to significant improvements in fatigue, 
endurance, mobility and flexibility. One interviewee boastingly stated:  
At the end of the training programme, I was able to help my mother prepare meals 
and make my father cups and cups of tea. He often tells me that I am spoiling him. 
 
Another interviewee jokingly said that she was “able to climb the tallest tree ". Similar 
comments were made by participant another female participant who noted that training 
made her stronger and energetic to the extent that she was no longer dependent on her 
crutches. Two participants said they witnessed an increased range of motion tn their arms 
and legs, and one said he was, at the end of training, used to walking to work and back 
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home and enjoy it. Participant Y commented that excessive rest or sleep can generate 
fatigue. This, according to him, explains why he tries to be busy and physically and 
mentally active. Similarly, Z said she preferred to keep busy and that rest makes her feel 
tired. 
 
The psychological outcomes of the training programme are possibly as important as the 
physical. In fact, there is good reason to argue that the latter would have been difficult to 
achieve without the former. The story of one female participant is quite telling:    
During the early days of training, I used to feel pains and really tense. This is because 
I was daunted by fears of having a relapse. But with encouragement, I was able to 
overcome my fears. Courage was what I needed. I now have it. 
 
One interviewee said he regained self- confidence as a result of training. Another   noted 
that she was more confident of herself, had no doubts about her abilities and was 
beginning to enjoy life. Two participants said they felt improvements in their mood, 
mental and physical abilities and relations with other people. Y said he felt more cheerful, 
lively and hopeful. Z said she was enjoying social life with her relatives and friends and 
having more time to help her children with their school work. 
 
No interviewee reported any negative outcomes of training, and all praised trainers for 
their dedication, encouragement and professionalism. However, two female interviewees 
thought that better results would have been achieved if all members of the training team 
were locals or expatriate Arabs due to cultural differences and communication problems 
with non-Arabic speaking trainers. Five of the six participants were of the view that the 
training programme should have lasted for a longer period of time. They further noted 
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that training for MS patients should be an ongoing process and provided free of charge. In 
this respect, it is worth mentioning a statement made by one interviewee who thought that 
the majority of those who participated in training shared with him the same view: 
Like many others, when I first agreed to join the training programme, I did have the 
feeling that exercises might help, but I was not sure. So, I decided to give it a try and 
see how it goes.  The first few sessions went well with no excessive fatigue or a relapse. 
Together with encouragement, that gave me a push. Day by day, fears, anxiety and 
stress began to retreat, and I began to feel more and more confident and physically and 
mentally stronger. Had I been free from anxiety and fear when the programme started, 
I am positive I would have gained more benefits from training.  
 
7.4. Summary 
Participants in the pre-training interview gave a vivid description of the nature and impact 
of MS fatigue. It is usually felt on a daily basis, comes easily and suddenly, is present and 
often mild in the morning even after good sleep, and it starts building up during the day to 
reach its peak n the afternoon. Physical fatigue is usually accompanied by mental fatigue, 
and both are thought to be aggravated by strenuous physical or mental activities, stress, 
humidity and heat. In some cases, patients feel fatigued for no obvious reason. Cold 
showers and short naps are often seen as an effective strategy in alleviating the symptom.  
As a result of fatigue, physical, mental and social activities are restricted, social relations 
and performance at work are negatively affected, patients are often depressed, and they 
experience a sense of sadness, frustration and low self-esteem. 
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Participants in the post-training interview clearly indicated that they were not fully aware 
of the benefits of exercise when they first joined the training programme. Some were 
even fearful of exercising and doubtful about its results. In the main, participants 
(particularly females) initially found in the programme an opportunity to “socialise”, 
break solitude, and explore new possibilities to improve their condition and mood. 
However, they reported a slow but gradual change in those perceptions during training, 
and gains in terms of improved fatigue, mobility, mood and quality of life. In their view, 
had they approached training with a positive attitude, they would have gained even more 
benefits. Commenting on the training programme, there has been the view that 
participants, especially females, would have felt more comfortable with Arabic speaking 
trainers. Some were also of the view that the training programme should have lasted for a 
longer period of time.  
In the following chapter, the interview findings, among others, are put in the context of 
the research objectives outlined in the opening sections of this paper.  
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Chapter 8: Conclusions 
8.1. Introduction 
In the opening chapter, it was noted that the objective of the present study is to explore 
the potential of physical activity in alleviating MS fatigue. The body of research in this 
area of knowledge is vast and still growing. If we manage to learn lessons from that 
research, we can possibly contribute to it by approaching it from a different perspective. 
With this in mind, the present writer conducted a comprehensive literature review activity 
(Chapters 2 and 3) that enabled him to identify areas in research where progress can be 
made.  The conclusion has been that if we are to establish the real effect of exercise and  
explore its potential, we: a) need to view MS fatigue is a multidimensional symptom, b) 
in order for this symptom to be properly assessed, both quantitative and qualitative date 
are needed, c) any training programme should be tailored to meet the abilities and needs 
of the participants, d) participants’ attitude towards training should be gauged, and e) they 
should be also fatigued and with no previous training experience. These guidelines 
informed the present research from design to execution.  The end result has been that: this 
study has achieved its objectives. In this final chapter, we will be reflecting on the present 
study and its findings.    
  
8.2. Overall outcomes 
When talking about the results of the present research project, the pilot study on patients’ 
perceptions of exercise (Chapter 4) would be a good starting point. Although that study 
was not designed to serve any comparative purposes (see 4.1 and 4.8), it still revealed 
some important information that should not escape our attention. 
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Individual differences are to be expected in a given group of MS patients, even when 
those patients belong to the same ethnic or racial group. In fact, this is not new knowledge, 
and it is not uncommon that writers allude to such differences. However, when we 
segregate and compare the two sex groups in a given sample (say Kuwaiti males and 
females in the pilot study), an interesting pattern emerges. Whereas only a few 
similarities exist between the two sex groups in that sample, huge differences still remain, 
and they extend to age, disease duration, relapse rates and causal factors, disability levels, 
MS type, the majority of MS symptoms, the impact of those symptoms on the patient, the 
kind of support individuals seek or receive,  and attitude towards physical exercise. 
 
Differences and similarities also exist between the British male and female groups. 
However, it is very often the case that they do not follow the pattern we witnessed in the 
Kuwaiti sample. For example, unlike Kuwaiti participants, hardly any differences can be 
seen between British male and female groups in terms of age, attitude towards exercise or 
the type of advice and service they receive. Some symptoms are also common in equal or 
almost equal proportions of the two British groups.  At the same time, marked differences 
in terms of relapse frequency and disease severity and symptoms and their impact are still 
seen between the same two groups of the sample. 
 
In a nutshell, clinical, demographic and attitudinal differences between the opposite sexes 
are present in both the Kuwaiti and the British samples, though such differences are more 
prominent in the former sample. But what about differences and similarities between the 
same sex groups across the two samples?   
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The pilot study shows that huge differences exist between the two British and Kuwaiti 
male groups. In fact, those differences are far too many, and the reader is referred to 
Tables 4.1-4.16 for details. For example, compares to their Kuwait counterparts, British 
males are much older, have been with the illness for a longer period of time, their MS 
condition is more advanced and severe, are more likely to have more than one relapse per 
year, have a more positive attitude towards physical activity, are less sensitive to fatigue, 
infection, depression and heat. In terms of MS symptoms and their impact levels, rates 
vary (often considerably) between the two groups, and whereas a number of symptoms    
are totally absent in Kuwaiti males, they are very or somewhat common in British males. 
As is the case in the male groups, huge differences also exist between the two female 
groups, and both exhibit different perceptions and concerns.    
 
To sum up, differences between the same sex groups in the two samples of the pilot study 
are far too many, and it would in fact be difficult to talk about real similarities. In itself, 
this shows how difficult it is to contemplate a unified, valid and universal set of MS 
gender specific characteristics or rules. In other words, what applies to (say) British 
females, does not necessarily apply to all other female groups. Although it is true that the 
type of the disease as well environmental conditions may be in part responsible for those 
differences, there is good reason to suggest that culture appears to shape some important 
symptoms of the disease and determine the course they take. At least in our study, 
stressors imposed by the rigid cultural norms are reported not only to trigger other 
symptoms, but also, to alter the patients’ quality of life and determine how they think and 
behave. This statement will be qualified in the next section. Nevertheless, this finding 
leads  to the question as to the possible role culture can play in shaping MS symptoms,   
how strong  that role be, and whether it strong enough to influence the course of the 
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disease. By bringing this question to the attention of interested researchers, it can be 
claimed that this study has contributed to MS research. 
 
Back to the results of the 12-week combined and resistance training programme, these 
showed significant improvements in fatigue (MFIS); fine mobility and static and dynamic 
balance (TUG); short duration walking speed (10m walk); exercise tolerance (6-minute 
walk); balance and fear of falls (BBS); shoulder flexion and adduction (Nicholas MMT); 
and elbow, knee and hip flexion and extension (Nicholas MMT). All these improvements 
were still maintained four weeks after the training programme had been terminated. On 
the other hand, there was no significant effect of training on anxiety and depression 
(HADS); personal basic functional activities (B1); fine motor coordination and finger 
dexterity (9-HolePeg) and hand grip (JAMAR). During the training programme, no 
changes in body temperatures were detected because training was provided in an air-
conditioned environment, no exacerbations or adverse effects as a result of training were 
reported, and there was noticeable increase in heart rate within each session in the 
majority of the participants. Adherence rate to training was very good, particularly among 
female patients. 
 
Information obtained from Kuwaiti patients through the pilot study and the interviews 
shows that: a) their physical and social activities are extremely restricted, b) they are 
totally dependent on pharmacological treatment and their neurologist to manage their 
condition, c) they are not aware of the benefits of exercise as a health promoting therapy, 
and d) their mood is adversely affected as a result of the disease, lacking support and 
social pressures. During the interviews, participants clearly noted that when they first 
joined the training programme, they felt tense, were fearful of physical exertion and 
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doubtful of any positive results of exercising. In the main, the motive of those patients 
(especially females) to join the programme was initially to meet fellow patients, socialise 
and break solitude, listen to professionals who are interested in their condition, and 
explore other avenues that might help them manage the disease and regain control. 
According to them, when they realised that no risks were involved in training, and in light 
of encouragement they received from programme organisers and fellow participants, their 
attitude towards exercise began to slowly and gradually change, and they began to feel 
more and more the benefits of training. More than one participant commented that had 
they initially approached the training programme with a more positive attitude, they 
would have started gaining benefits from day one and their gains would have increased. 
In itself, this comment indicates that fatigue is probably more related to the mood of the 
participant rather than to physical activity. To better understand the study results, we need 
to know more about the participants and put their training experience in a wider context. 
 
8.3. Reflections 
The comment made by the interviewees who noted that they had been living with anxiety 
since the days they were waiting to be diagnosed is quite telling. Indeed, given the fact 
that diagnosis is a complex process that may take a long period of time can, itself, lead to 
uncertainty and provoke anxiety. Moreover, when news of the chronic disease is 
communicated to patients, the majority are not expected to take it lightly. At least, not 
when they are told that the illness is incurable, unpredictable and can be disabling. Rather, 
the uncertainty about the course the illness will take and about the future will, no doubt, 
generate anxiety and fear. Added to this, as we have seen in Tables 4.2 and 4.3, the 
majority of Kuwaiti patients were diagnosed with MS in early adulthood when they are 
making important decisions about their future, such as starting a family or pursuing a 
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particular career. As a result of their condition, it is not surprising that many of those 
patients begin to reconsider their priorities and plans, question the value of life, and 
develop a feeling of personal loss. 
 
It can be argued that the stress and depression generated by the unpredictable, incurable 
and disabling MS are a universal rule. However, at least as far as Kuwaiti (and Arab) MS 
patients are concerned; it does appear that stressors need to be quantified in broader terms. 
For, as we have seen in the interviews, the majority of Kuwaiti patients choose to keep 
the news of their illness as a secret known only to them and their parents and partners. In 
two cases, even the parents did not know about the illness of their daughter and a wife 
was not told about the illness of her husband. There is also the case of the two female 
cousins, close friends and neighbours who were forced to unveil their secret to one 
another only because they joined the training programme. This is because in Arab 
tradition, disability is seen as a curse and a source of misery and shame. In that part of the 
world, the disabled know that not many people would be happy or willing to identify with 
them or take them as partners, and pity is the best thing they can hope for. Unmarried MS 
patients (particularly females) know that they may never be able to start a family, and 
those who are married know that they and other members of their families will be leading 
a miserable life.  
 
Revelations made by some patients during the interviews reflect a sense of guilt because 
they find themselves dependent on their families for help. There is also a sense of sorrow 
and sadness because they had to opt for a part-time job or contemplating abandoning 
work altogether because they were overweighed by job demands. A sense of sadness was 
also evident in the statements of those who noted that they were unable to disclose their 
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feelings to members of their families, close friends and work   colleagues. Interviewees 
also spoke in some detail about the double life they are forced to lead in that they need to 
pretend that they are fit and well, especially in public places and at work. They also noted 
they were fearful of physical exertion lest relapses, fatigue and other symptoms are 
triggered and, as a result, the secret of their illness is revealed and they lose face. Indeed, 
given the limitations imposed on those patients by their illness and the mounting social 
and psychological pressure, it would be surprising if they did not feel frustrated, 
vulnerable, alienated, defeated and depressed 
  
To add to the problems of Kuwaiti MS patients, except for the help they receive from 
their neurologist (Tables 4.8 and 4.13), not much is expected from the outside world. At 
the same time, all the neurologist can do is to prescribe drugs that hardly help them to 
manage their condition and advise them to try to be mobile and active. Yet, as we have 
seen in the discussion above, those patients remain fearful of exercising and are not aware 
of its benefits. In fact, as seen in Tables 4.9, 4.10 and 4.11, exercise as a health promoting 
activity is almost alien to Arab culture, and even healthy individuals are not used to 
physical training activities, let alone people with a disabling disease. Even if it happens 
that some of those patients are willing to exercise, it is likely that they will be discouraged 
by other members of the family lest fatigue or other symptoms are provoked. Added to 
this, professional trainers and rehabilitation institutions are a rarity, and their services are 
mainly directed to individuals with non-chronic conditions or disabilities. 
 
Despite the account given above, the possibility that some participants were aware of the 
advantages of physical activity and approached the training programme with a positive 
attitude is not to be discounted. Participants Y and Z, who performed the 50 mile walk 
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(7.2.3.5 and Appendix 15) provide a good example. However, it is evident that those two 
individuals represent an exceptional case in that they are highly motivated, optimistic, and 
strongly identify with their faith. As regards other participants, this does not appear to be 
the case. This problem is better understood when we put it into its cultural context. 
 
According to Arab tradition, respected men do not usually talk about their problem, at 
least not when those problems are related to a humiliating, chronic and disabling disease.  
Even when those males are offered help, it is likely that they will reject it and deny a need 
for it. This is unless they are extremely desperate for help and, at the same time, are 
certain that it is provided in secret and at the hands of people they closely know and trust. 
This explains why only a few males (relative to females) were persuaded to take part in 
the trial. In that patriarchal culture, the two sexes are strictly segregated, and at least as far 
as social life and leisure time is concerned, males have a relatively wide range of options. 
On the other hand, in order for females to be labelled virtuous, they must remain confined 
to their homes and serve other members of the nuclear family. Hence, when MS female 
patients are invited to take part in a training programme, they would be more willing than 
male patients to accept the invitation for at least one good reason. Needless to mention the 
immense social pressure as well as the pressure of MS on those patients, it is likely that 
they treat that programme as a rare event that would provide them with the opportunity to 
break away from the boring routine and stress at home, meet fellow female patients, and 
talk about their problems to those who appear to be willing to help and interested in their 
condition. In fact, this was their main objective of joining the training programme, and 
they did not hesitate to state it during the interviews. Their secondary objective was to 
explore whether exercise can actually help them manage their condition. Although they 
were not sure about this latter objective, they thought they would not lose much if they 
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gave the training experience a try especially that it would be provided by professional 
trainers who understood their condition, abilities and needs. Again, this objective was 
explicitly stated during the interviews. Nevertheless, reflecting on their training 
experience, those same interviewees noted that they achieved more than they hoped for: 
improved fatigue and mobility and developing a positive attitude towards training. More 
than that, they made new friends and formed  a “Multiple Sclerosis Group”. However, 
according to the participants, themselves, the gains they made occurred slowly and 
gradually, and they took place only after patients had quelled their fears of physical 
activity and the anxiety and uncertainty those fears had always generated. 
With the above stated, it can be safely argued that with encouragement and support, 
negative attitude towards training can be reversed, and patients, even those with no 
previous training experience, can benefit in terms of reduced fatigue, mobility, increased 
independence and quality of life. In fact, it is felt that participants in the present study 
could have reaped more benefits. However, this would have been possible if those 
patients had approached the training programme with a more positive attitude, not the 
negative mood and stress and depression on the scale just described.  
In closing, there is no argument that the social and psychological pressures on Kuwaiti 
MS patients and their families as a result of the disease are staggering. At the same time, 
it is felt that they do not receive the support they deserve and need. It is about time 
Kuwaiti policy makers, health professionals and other service providers developed 
training and support programmes that can be facilitated through counselling and 
education.      
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8.4. Study limitations 
Although the present study advocated the inclusion of MS adult patients regardless of 
their age or level of disability in training, it has not been possible to recruit relatively old 
patients or those with advanced disabilities. Hence, effect of training on those groups of 
patients remains unknown, and it needs to be investigated. It is also to be noted that some 
trainers were foreign expatriates with cultural and linguistic backgrounds different to 
those of the trainees. However, this has been necessary because of severe shortages in 
qualified Arabic speaking trainers, particularly females. To go about this problems, 
arrangements were made for participants to meet and interact with the (Arabic speaking) 
programme organisers before and after every training session. Furthermore, although it is 
true that that carers and family members of MS patients can be an important source of 
information, it has not been possible to include them in the interviews due to cultural 
sensitivities. It is also to be  noted that by not having a control group, we may have over 
estimated treatment effect. The mains reason for this is the variety of bias (e.g. regression 
to the mean, time course of changes) that were not controlled for. 
8.5. Suggestions for further research 
Until a cure to MS fatigue is found, there remains a need to continue exploring the 
potential of exercise therapy in alleviating this symptom, and hence minimise or slow 
down deconditioning, empower patients and help them lead a fulfilling life. Hence, it is 
felt that more needs to be known about patients’ attitude towards exercise and thus 
encourage them to participate in health promoting activities. It is also felt that the impact 
of stress and depression on fatigue requires further investigation. In particular, special 
attention should be paid to stressors which are shaped and determined by culture. To 
better understand the effect of stressors and establish their sources and how they can be 
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alleviated, it is suggested that both qualitative and quantitative data collection methods 
are employed. In this respect, in order to overcome the limitations of the present study, it 
is suggested that Kuwaiti (and Arab) researchers consider a sequence of qualitastive 
studies followed by a randomised control trial to more comprehensively understand the 
effects of exercise on MS and the steps that are to be taken to implement this research in 
practice.   
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Kurtzke Expanded Disability Status Scale (EDSS) 
❏ 0.0 - Normal neurological exam (all grade 0 in all Functional System (FS) scores*).
❏ 1.0 - No disability, minimal signs in one FS* (i.e., grade 1).
❏ 1.5 - No disability, minimal signs in more than one FS* (more than 1 FS grade 1).
❏ 2.0 - Minimal disability in one FS (one FS grade 2, others 0 or 1).
❏ 2.5 - Minimal disability in two FS (two FS grade 2, others 0 or 1).
❏ 3.0 - Moderate disability in one FS (one FS grade 3, others 0 or 1) or mild disability in three or
four FS (three or four FS grade 2, others 0 or 1) though fully ambulatory. 
❏ 3.5 - Fully ambulatory but with moderate disability in one FS (one grade 3) and one or two FS
grade 2; or two FS grade 3 (others 0 or 1) or five grade 2 (others 0 or 1). 
❏ 4.0 - Fully ambulatory without aid, self-sufficient, up and about some 12 hours a day despite
relatively severe disability consisting of one FS grade 4 (others 0 or 1), or combination of 
lesser grades exceeding limits of previous steps; able to walk without aid or rest some 500 
meters.  
❏ 4.5 - Fully ambulatory without aid, up and about much of the day, able to work a full day, may
otherwise have some limitation of full activity or require minimal assistance; characterized 
by relatively severe disability usually consisting of one FS grade 4 (others or 1) or 
combinations of lesser grades exceeding limits of previous steps; able to walk without aid 
or rest some 300 meters.  
❏ 5.0 - Ambulatory without aid or rest for about 200 meters; disability severe enough to impair
full daily activities (e.g., to work a full day without special provisions); (Usual FS 
equivalents are one grade 5 alone, others 0 or 1; or combinations of lesser grades usually 
exceeding specifications for step 4.0).  
❏ 5.5 - Ambulatory without aid for about 100 meters; disability severe enough to preclude full
daily activities; (Usual FS equivalents are one grade 5 alone, others 0 or 1; or combination 
of lesser grades usually exceeding those for step 4.0). 
❏ 6.0 - Intermittent or unilateral constant assistance (cane, crutch, brace) required to walk about
100 meters with or without resting; (Usual FS equivalents are combinations with more than 
two FS grade 3+). 
Appendix 1
❏ 6.5 - Constant bilateral assistance (canes, crutches, braces) required to walk about 20 meters
without resting; (Usual FS equivalents are combinations with more than two FS grade 
3+). 
❏ 7.0 - Unable to walk beyond approximately 5 meters even with aid, essentially restricted to
wheelchair; wheels self in standard wheelchair and transfers alone; up and about in 
wheelchair some 12 hours a day; (Usual FS equivalents are combinations with more than 
one FS grade 4+; very rarely pyramidal grade 5 alone). 
❏ 7.5 - Unable to take more than a few steps; restricted to wheelchair; may need aid in transfer;
wheels self but cannot carry on in standard wheelchair a full day; May require motorized 
wheelchair; (Usual FS equivalents are combinations with more than one FS grade 4+). 
❏ 8.0 - Essentially restricted to bed or chair or perambulated in wheelchair, but may be out of
bed itself much of the day; retains many self-care functions; generally has effective use of 
arms; (Usual FS equivalents are combinations, generally grade 4+ in several systems). 
❏ 8.5 - Essentially restricted to bed much of day; has some effective use of arm(s); retains some
self-care functions; (Usual FS equivalents are combinations, generally 4+ in several 
systems). 
❏ 9.0 - Helpless bed patient; can communicate and eat; (Usual FS equivalents are
combinations, mostly grade 4+). 
❏ 9.5 - Totally helpless bed patient; unable to communicate effectively or eat/swallow; (Usual FS
equivalents are combinations, almost all grade 4+). 
❏ 10.0 - Death due to MS.
*Excludes cerebral function grade 1.
Note 1: EDSS steps 1.0 to 4.5 refer to patients who are fully ambulatory and the precise step 
number is defined by the Functional System score(s).  EDSS steps 5.0 to 9.5 are defined by 
the impairment to ambulation and usual equivalents in Functional Systems scores are 
provided.   
Note 2: EDSS should not change by 1.0 step unless there is a change in the same direction of at 
least one step in at least one FS. 
Sources: Kurtzke JF.  Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). 
Neurology. 1983 Nov;33(11):1444-52. 
  Haber A, LaRocca NG. eds.  Minimal Record of Disability for multiple sclerosis.  New York: National Multiple 
Sclerosis Society; 1985. 
Modified Fatigue Impact Scale (MFIS) 
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above study. 
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Confirmation of ethical opinion 
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Ethical review of research sites 
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management permission being obtained from the NHS/HSC R&D office prior to the start of 
the study (see "Conditions of the favourable opinion" below). 
Conditions of the favourable opinion 
The favourable opinion is subject to the following conditions being met prior to the start of 
the study. 
Management permission or approval must be obtained from each host organisation prior to 
the start of the study at the site concerned. 
Management permission ("R&D approval'J should be sought from all NHS organisations 
involved in the study in accordance with NHS research governance arrangements. 
A Research Ethics Committee established by the Health Research Authority 
??????????
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(
(
Title:(A(pilot(study(to(investigate(the(preferences(of(Multiple(Sclerosis(patients(towards(
exercise(for(reducing(fatigue.(
(
My(name( is(Ali(Ashour,( and( I( am(a(PhD( research( student(at( the( Institute( for( Science(&(Technology( in(
Medicine,( Keele(University.(My( research(project( is( supervised(by(Professors(Clive(Hawkins( and(Anand(
Pandyan.(My(PhD(research(is(focused(on(the(impact(of(exercise(on(multiple(sclerosis((MS)(patients(and(its(
ability(to(help(them(cope(with(fatigue.(It(is(possible(that(exercise(may(be(beneficial(in(patients(with(MS(
and( details( related( to( research( carried( out( on( the( effects( of( exercise( can( be( found( at( the( following(
websites:(
Website( Link( Tel. Helpline 
MS#Trust## http://www.mstrust.org.uk/( 0800032(3839(
*Free(Phone(
Information((
Webpage(related(to(
Exercises((
http://www.mstrust.org.uk/information/exercises/(
Webpage(related(to(
Fatigue(
http://www.mstrust.org.uk/atoz/fatigue.jsp(
MS#Society## http://www.mssociety.org.uk/( 02084380700(
Webpage(related(to(
Exercises(
http://www.mssociety.org.uk/what[is[ms/treatments[and[
therapies/exercise(
Webpage(related(to(
Fatigue(
http://www.mssociety.org.uk/ms[events/ms[life/workshops[and[talks(
My(study(is(specifically(looking(at(the(whether(exercise(reduces(fatigue(or(the(feelings(of(fatigue.(In(order(
to(design(an(appropriate(exercise(protocol(for(the(clinical(trial(I(need(some(additional(information.(I(am(
interested(in(establishing(whether(patients(are(already(participating(in(any(form(of(physical(activity((or(
exercise)(and(also(whether(patients(would(consider(participating( in(a(clinical( trial( involving(exercise.( If(
patients(are( interested( in(participating( in(a(clinical( trial( involving(exercise(then( I(would(also( like(to(get(
some(information(related(to(their(exercise(preference.(This(short(questionnaire(will(help(me(collect(this(
information( in( a( structured(way.( I( do(hope( that( you( can( spare( ten( to( fifteen(minutes(of( your( time( to(
complete(the(enclosed(questionnaire(and((a)(return(this(in(the(clinic(or((b)(send(it(back(to(me(in(the(self(
addressed(and(stamped(envelope(provided.((If(you(are(unable(to(fill(this(questionnaire(in(by(yourself(you(
may(ask(someone(else(to(complete(this(on(your(behalf.(
(
(
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Although(the(information(you(provide(can(be(useful(to(my(research(there(is(no(direct(benefit(to(you.(You(
are(under(no(obligation(to(fill(and(return(this(questionnaire(and(your(quality(of(care(will(not(be(affected(
in(any(way(if(you(do(not(complete(this(questionnaire.(Also,(note(you(are(not(being(asked(to(sign(a(separate(
consent(form(as(returning(a(completed(questionnaire(is(considered(equivalent(to(giving(valid(consent(in(
this(particular(instance.((
If(you(wish(to(complain,(or(have(any(concerns(about(any(aspect(of(the(way(you(have(been(approached(or(
treated( during( the( course( of( this( study( you( can( speak( to(my( supervisors( (address( at( the( end( of( this(
document),( and( if( you( are( not( satisfied(with( this( response( you( can( send( a( formal( complaint( to(Ms(N(
Leighton((address(at(the(end(of(this(document)(
If(you(still(have(any(questions(or(need(help(to(fill(in(the(survey,(please(contact(me(on((address(at(the(end(
of( this(document)( ( (Monday(to(Friday,(9(p.m.(to(5(a.m.).(Your(support( for( this( research( is(very(greatly(
appreciated.(
I(do(thank(for(your(time(and(help.(
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!
"ﻠﺻﺗﻟ'!()*ﻣ!,ﻠﺿﻔ)!ﺎﻣ!ﺔﻓ*ﻌﻣﻟ!ﺔ)ﺣﺳﻣ!,ﺳ'*5!:7'8ﻧﻌﻟ'!)!55ﻌﺗﻣﻟ'MS(!*ﻟ'!>ﺎﻧ)*ﻣﺗﻟ'!8ﺣﻧﺔ)ﺿﺎ) !
Title:'A'pilot'study'to'investigate'the'preferences'of'Multiple'
Sclerosis'patients'towards'exercise'for'reducing'fatigue.'
!
Date!of!birth:!........................................................................... ﺎﺗ...................:5ﻼ)ﻣﻟ'!ﺦ)*.... !
Gender:!!!!!!!!!!!!!!!!!!!!!!!!!Female/!ﻰﺛﻧ'!!!!!!!!!!!!!!!! !!! !!!!!!!!!!!!!!!!Male/! :Uﻧﺟﻟ'!!!!!!!!!!!!!!!!!!!!!W*ﻛ! !
Date!of!MS!diagnosis:........................................................................:(*ﻣﻟ'![)ﺧﺷﺗ!ﺦ)*ﺎﺗ!
!
^)ﻛ!ـ`!ﺔ)ﺣﺻﻟ'!aﺗﻟﺎﺣ!b5ﺣ!c5ﻣ!`ﺻ8!aﻧﻛﻣ)؟ !
1.! How!would!you!describe!the!severity!of!your!condition?!
!!
!! Advanced/! !!ﺔﻣ5ﻘﺗﻣ!ﺔﻠﺣ*ﻣ ! !!!!!!!!!!!!!!!!!!!! Moderate/!ﺔoﺳ8ﺗﻣ!!!!!!!!!!!!!!!!!!!!!!!!!Mild !!/ﺔﻟ5ﺗﻌﻣ8!ﺔﻔ)ﻔﺧ
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! !
!
p'!ﻲrﺎﻣ!ـﻷ!ﻊﺿ8!aﻧﻛﻣ)!}!؟ﺔ)ﺿ*ﻣﻟ'!aﺗﻟﺎﺣﻟ!ﺔﺟ)ﺗﻧ!ﺎvﻧﻣ!ﻲﻧﺎﻌﺗ!ﻲﺗﻟ'!('*ﻋx!b*ﺎﺷ"ﺢﺻ"!{!ﺎﺑﺳﺎﻧﻣ!}'*ﺗ!ﺎﻣ!~ﺎﻣﺣﻟ.{aﺗﻟﺎ !
2.! What!are! the!symptoms!that!you!experience!as!a!result!of! the! illness?!(You!
may!tick!(/)!more!than!one!box!if!that!is!applicable).!
!!!!!!!!!!!!!!!!!!Üﺎﻌﺗ*x!!!!!!!!!!!!!!!!!!!!!!!!!!!!
Tremor!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
! ﺔ)ﺳﺣﻟ'!b*5ﻘﻣﻟ'!7'5ﻘﻓ!
Loss!of!sensation!
!
!
â)ﻛ*ﺗﻟ'!ﻰﻠﻋ!b*ﻘﻣﻟ'!~5ﻋ!
Inability!to!concentrate!
! ~ﻟﻷ'(
Pain!
!
!!!
!!
!!
'ﻹ"ﺎﺋﺗﻛ !
Depression!
! x7â'8ﺗﻟ'!ﻲﻓ!éﻼﺗﺧ !
Balance!problem!!
!!
ﺔ)ﺳﻔﻧﻟ'!o8ﻐﺿﻟ'!
Stress!
!
! >ﺎﺟﻧﺷﺗ!
Spasticity!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
!!
ﻹ'ëﺎr* !
Fatigue!
! ﻲﻠﺿﻋ!5ﺷ!
Muscle!spasms!
!
!
( ( (((
((
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!!
ëoﻧﻟ'!ﻲﻓ!éﻛﺎﺷﻣ!
Speech!difficulties!
! ,ﻧﺎﺛﻣﻟ'!ﻲﻓ!éﻛﺎﺷﻣ!
Bladder!problems!
!
ﻹ'!ﻲﻓ!>ﺎﺑ8ﻌﺻíﻼﺗﺑ !
Swallowing!difficulties!
! ءﺎﻌﻣﻷ'!ﻲﻓ!éﻛﺎﺷﻣ!
Bowel!problems!!!
!
!
x!ﺔ)ﺟ'85â*ﻟ'!î8ﺿ8!~5ﻋ8ﺎ)ï !
Double!or!blurred!vision!
!
! `ﻌﺿ!
Weakness!
!
!!!
!!!
!!
7ﺎﺧ85ﻟﺎﺑ!*8ﻌﺷ!
Dizziness!
! 5)5ﺷﻟ'!é8ﻣﺧﻟ'!
Lethargy!
!
!!
!!
Other(s)................................................................................ c*ﺧ'!ءﺎ)ﺷ'!!...........................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................!
!.!!! .........................................................!!
!
òﻣﻟ'!>ﻻﺎﺣﻟ'!7ﻣ!ö{!ـW!b*8ﻛ*)ﺛ)!!}ﻼﻋ'a5ﻧﻋ!؟ëﻠﻘﻟ' !!
3.!What!of!the!above!mentioned!symptoms!that!worries/worry!you!mostt?!
Other(s)................................................................................!...........................!c*ﺧ'!ءﺎ)ﺷ'
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................!
!!!. .........................................................!!
!
٤ـ!!8{!~ﻋ5ﻟ'!ëﻠﺗﺗ!ér!ùﺔ)ﺿ*ﻣﻟ'!aﺗﻟﺎﺣﻟ!ﺔﺟ)ﺗﻧ؟ﺔ)ﺣﺻﻟ'!8'!ﺔ)ﻋﺎﻣﺗﺟﻷ'!ﺔ)ﺎﻋ*ﻟ'!>ﺎvﺟ!7ﻣ!ûﻼﻌﻟ' !
4.!Do!you!receive!any!support!or!treatment!for!your!MS!condition!from!social!care!or!
health!professionals?!
!!!!!!!!No!/ﻻ!!!!!!!!!!!!!!!!!!!Yes! ~ﻌﻧ!/ !!!!!!!!!!!!!!!!!(!!
!
!
!
( ( 'W'!ﻛﺎﻧ>!'ﻻﺟﺎﺑﺔ!"ﻻ"!'Wr"!ﻟﻠﺳï'é!*ﻗ~!٦ !!!!!!!!!!!!!!!!!!!!!!!
If!the!answer!is!“No”,!please!go!to!Question!(6)(
Version(1.1(23/02/2012(
٥!ـxW!>ﻧﺎﻛ!'x!ﻊﺿ8!aﻧﻛﻣ)}!؟~ﻋ5ﻟ'!aﻟ!~5ﻘ)!ﺔ)ﻟﺎﺗﻟ'!>ﺎvﺟﻟ'!7ﻣ!7ﻣﻓ!ùëﺑﺎﺳﻟ'!é'ïﺳﻟ'!ﻰﻠﻋ!"~ﻌﻧ""!aﺗﺑﺎﺟx"!b*ﺎﺷ!~ﺎﻣ'!"ﺢﺻ
'!*ﺎ)ﺧ!7ﻣ!*ﺛﻛ'W{ﺎﺑﺳﺎﻧﻣ!7ﺎﻛ!' !
5.! If! the! answer! to! Question! 4! is! “Yes”,! who! of! the! following! specialists!
provide/provides!care?!(You!may!tick!more!than!one!box!if!applicable):!
!!!!!!!!!
Other(s)................................................................................!...........................!c*ﺧ'!ءﺎ)ﺷ'
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................!
!.!..................................................................................................................................!!
!
٦؟ﺔ)ﺣﺻﻟ'!ﺔﺳﺎﻛﺗﻧﻹ'!,ﺟ'8ﺗ!"ﻠﻏﻷ'!ﻰﻠﻋ!ﻰﺗﻣ!ـ !
6.!How!often!do!you!have!a!relapse?!!
Other(s)................................................................................!...........................!c*ﺧ'!ءﺎ)ﺷ'
.......................................................................................................................................!
!!!. .........................................................!
!
´ـﺑ!ﺎv)ﻓ!>ﻌﻗ8!b*ﻣ!*ﺧ¨!>ﻧﺎﻛ!ﻰﺗﻣﺈ؟ﺔ)ﺣﺻ!ﺔﺳﺎﻛﺗﻧ !
7.!When!was!the!last!time!you!had!a!relapse?!
Other(s)................................................................................!...........................!c*ﺧ'!ءﺎ)ﺷ'
.......................................................................................................................................!
!!!. .........................................................!
!!ﺔ)ﺑﺻﻋ!('*ﻣ'!ﻲﺋﺎﺻﺧ{!
Neurologist!
!
!
ﻲﻧvﻣ!ﻲﺋﺎﺻﺧ{!
Occupational!therapist!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
! ﻲﺿﺎ)*!"*5ﻣ!
Gym instructor
!
ﻐﺗ!*)ﺑﺧWﺔ) !!
Dietician!
! 78)ﻋ!ﻲﺋﺎﺻﺧ{!
Optician!
!ﻲﻌ)ﺑoﻟ'!ûﻼﻌﻟ'!
Physiotherapist!!
!
ﻲﺳﻔﻧ!")ﺑo!
Psychologist!
! *ﺎﺷﺗﺳﻣ!
Counsellor!
!!`∞8ﻣﺔ)ﻋﺎﻣﺗﺟﻷ'!ﺔﻣ5ﺧﻟ' !
Social!worker!
!
[ﺎﺧﻟ'!")ﺑo!!
GP!
! ﻲﺣﺻﻟ'!âﻛ*ﻣﻟ'!ﺔﺿ*ﻣﻣ!
practice!nurse!
!
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±!ﻲrﺎﻣ!ùa){*!ﻲﻓ!ـﻹ'!"ﺎﺑﺳ{؟ﺔﺳﺎﻛﺗﻧ !
8.!In!your!opinion,!what!causes!the!relapse?!!
!
!
!
!
!
!
!
!
!
Other(s)................................................................................!...........................!c*ﺧ'!ءﺎ)ﺷ'
.......................................................................................................................................
.......................................................................................................................................!
!!!. .........................................................!
!
≥ﻣ!í8ﻧ!ö{!>ﺳ*ﺎﻣ!7{8!ëﺑﺳ!ér!ـ؟ﺔ)ﺿ*ﻣﻟ'!aﺗﻟﺎﺣ![)ﺧﺷﺗ!éﺑﻗ!ﺔ)5ﺳﺟﻟ'!ﺔoﺷﻧﻷ'!8{!ﺔﺿﺎ)*ﻟ'!7 !
9.!Did!you!do!exercise!or!any!form!of!physical!activity!(…)!before!being!diagnosed!
with!MS?!
!!!!!!!!No!!/ﻻ!!!!!!!!! !!!!!!!!!!!!!!!! !!Yes !!!!!~ﻌﻧ!!/ !!!!!!!!!!!!!
}xW!ﻰﺟ*)!ù~ﻌﻧﺑ!ﺔﺑﺎﺟﻷ'!>ﻧﺎﻛ!'!ﻊﺿ8"ﺢﺻ"!ﺔﻣﻼﻋ!{ﺔ)ﺿ*ﻣﻟ'!aﺗﻟﺎﺣ![)ﺧﺷﺗ!éﺑﻗ!ﺔ)5ﺳﺟﻟ'!ﺔoﺷﻧﻷ'!aﻠﺗﻟ !
!(If!your!answer!is!“yes”!you!may!tick!more!than!one!box!if!applicable)!
`*ﻋ{!ﻻ!
I!do!not!know!
!
ﻹ'ëﺎr* !
Fatigue!
!
ﻟﻹ'8!c85ﻌﻟ'>ﺎﺑﺎvﺗ !
Infection!
!
x~ﺳﺟﻟ'!b*'*ﺣ!íﺎﻔﺗ* !
Increased!body!temperature!
!
ﺎﺟ8)!
Yoga!
! [ﻗ*ﻟ'!
Dancing!
!
!
ﻲﺷﻣﻟ'!
Walking!
!
ëﻠoﻟ'!ء'8vﻟ'!ﻲﻓ!ﺔoﺷﻧ{!
Outdoor!activities!!
! ﺔ)ﻟﺎﺗﻘﻟ'!"ﺎﻌﻟﻷ'!
Martial!Arts!
! !{ﻲﺷﻣﻟ'!âﺎvﺟ}!ﺔ)ﺋ'8vﻟ'!"ﺎﻌﻟﻷ'!
Aerobic!exercise!
!
ءﺎﻣﻟ'!ﻲﻓ!")*5ﺗﻟ'!
Aquatic!exercise!
! ﺔ)5ﺳﺟﻟ'!ﺔ)8ﻘﺗﻟ'!>ﺎﺑ)*5ﺗ!
Strengthening!exercise!
! ﺔﻟﺎoﻹ'!>ﺎﺑ)*5ﺗ!
Stretching!exercise!!
!
( (
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^∑ـ!!b*8ﺷﻣ!ﻰﻘﻠﺗﺗ!ér{ﺿﺎ)*ﻟ'!7ﺄﺷﺑ!,)ﺟ8ﺗ!8ﺔ؟ !
10.!!Do!you!get!any!advice!on!exercise?!
!!!!!!!!!!!!!!!!!!!!!!!!No/!ﻻ!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!Yes/! !!!!~ﻌﻧ !
x}W؟{b*8ﺷﻣﻟ'!~5ﻘﺗ!ﻲﺗﻟ'!ﺔvﺟﻟ'!aﻠﺗ!7ﻣﻓ!ù~ﻌﻧﺑ!!ﺔﺑﺎﺟﻷ'!>ﻧﺎﻛ!' !
(If!your!answer!is!“Yes”!who!gives!you!that!advice)?!
!!!
Other(s)................................................................................!...........................!c*ﺧ'!ءﺎ)ﺷ'
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.!....................................................................................................................................!!
!
^^؟*ﺿﺎﺣﻟ'!>ﻗ8ﻟ'!ﻲﻓ!ﻲﺿﺎ)*!")*5ﺗ!8{!ﺔoﺷﻧ{!ö{!U*ﺎﻣﺗ!ér!ـ !
11.!Do!you!currently!take!exercise!or!engage!in!any!form!of!physical!activity?!If!!!!
Yes!(please!go!to!Question!12)!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! ﻟ'!ءﺎﺟ*ﻟ'}!~ﻌﻧW!~ﻗ*!é'ïﺳﻠﻟ!"ﺎr^p{ !!!!!!!!!!!!!!!!!!!!
!!!No!(please!go!to!Question!13 ﻻ!!ﻟ'!ءﺎﺟ*ﻟ'}W!~ﻗ*!é'ïﺳﻠﻟ!"ﺎr^ò!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!{
!!!!!!!!!!!!!!!!!!!!!!!
!
!
!!ﺔ)ﺑﺻﻋ!('*ﻣ'!ﻲﺋﺎﺻﺧ{!
Neurologist!
!
!
ﻲﻧvﻣ!ﻲﺋﺎﺻﺧ{!
Occupational!therapist!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
! ﻲﺿﺎ)*!"*5ﻣ!
Gym instructor
!
ﻐﺗ!*)ﺑﺧWﺔ) !!
Dietician!
! 78)ﻋ!ﻲﺋﺎﺻﺧ{!
Optician!
!ﻲﻌ)ﺑoﻟ'!ûﻼﻌﻟ'!
Physiotherapist!!
!
ﻲﺳﻔﻧ!")ﺑo!
Psychologist!
! *ﺎﺷﺗﺳﻣ!
Counsellor!
!ﺔ)ﻋﺎﻣﺗﺟﻷ'!ﺔﻣ5ﺧﻟ'!`∞8ﻣ!
Social!worker!
!
[ﺎﺧﻟ'!")ﺑo!!
GP!
! ﻲﺣﺻﻟ'!âﻛ*ﻣﻟ'!ﺔﺿ*ﻣﻣ!
practice!nurse!
!
( (
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^px!ـW!~ﻗ*!é'ïﺳﻟ'!ﻰﻠﻋ!ﺔﺑﺎﺟﻹ'!>ﻧﺎﻛ!'^^!""!~ﻌﻧ!ﺔ)ﻋ8ﻧ!5)5ﺣﺗ!ﻰﺟ*)!ù!"ﻟ'!")*5ﺗﻟ'!8{!oﺎﺷﻧﻟ'W!ﻊﻣ!,ﺑ!~8ﻘﺗ!öWﻟ'!*ﻛ!b5ﻣ
.")*5ﺗﻟ'!ﻲﻓ!ﺎv)ﺿﻘﺗ!ﻲﺗﻟ'!!!!!!!!!!!!!!!!!!!!
12.!If!your!answer!to!Question!11!is!!“Yes”,!please!tick!the!type!of!exercise!you!
currently!do!and!state!the!length!of!time!you!to!spend!in!training?!
ﺑ)*5ﺗ!ﺔﺳﻠﺟ!éﻛ!b5ﻣﺔ) !
Time!per!
Session!
8ﺑﺳ{!")*5ﺗﻟ'!>ﺎﺳﻠﺟ!55ﻋﺎ)ﻋ !
Number!of!session!
per!Week!
ﻲﺿﺎ)*ﻟ'!oﺎﺷﻧﻟ'!í8ﻧ!
Type!of!exercise!!
! ! r!7ﻣﺿﺗﺗ!ù!c*ﺧ{!*8ﻣ{!7)ﺑ!:{a)ﺑ8*)ﻷ'}!ﺔ)ﺋ'8vﻟ'!ﺔoﺷﻧﻷ'Wﺔoﺷﻧﻷ'!}!'!ﻰﻠﻋ!~'5ﺧﺗﺳ
ﻰﻠﻋ!ﻲﺷﻣﻟ'8!ﺔ)ﺋ'8vﻟ'!>ﺎﺟ'*5ﻟ'!!bâvﺟﻷ'ﻠﻘﻟ'!o)ﺷﻧﺗ!`5vﺗﺳﺗ!ﻲr8!ﺔﻛ*ﺣﺗﻣﻟ'!"
.7)ﺗﺋ*ﻟ'8!
Aerobic!exercises:!Among!others,!these!include!cycling!
and!treadmill!training!and!they!work!the!heart!and!lungs.!
! ! ﺛﻷ'!a)*ﺣﺗ8!ﻊﻓ*!7ﻣﺿﺗﺗ8!>ﻼﺿﻌﻟ'!ﺔ)8ﻘﺗ!ﺎvﻧﻣ!`5vﻟ'!:ﺔ)8ﻘﺗﻟ'!7)*ﺎﻣﺗ!5ﺷ8!éﺎﻘ
.ﺔ)oﺎoﻣﻟ'!éﺗﻛﻟ'!
Strengthening!exercises:!These!are!aimed!at!
strengthening!muscles,!and!they!involve!lifting!and!moving!
weights!or!pulling!against!an!exercise!elastic!band.!
! ! r!:55ﻣﺗﻟ'!7)*ﺎﻣﺗW!}!!.ﺔﻧ8*ﻣﻟ'!7ﻣ!ﺎﻋ8ﻧ!éﺻﺎﻔﻣﻟ'8!>ﻼﺿﻌﻟ'!"ﺳﻛﺗ!!7)*ﺎﻣﺗﻟ' !
Stretching!exercises:!These!can!be!helpful! in!maintaining!
supple!muscles!and!flexible!joints.!
! ! .~ﺳﺟﻟ'!`'*o{!7)ﺑ!ء'5ﻷ'!ë)ﺳﻧﺗ8!7â'8ﺗﻟ'!∞ﻔﺣﻟ!`5vﺗ!:ﺔ)ﻛ*ﺣ!7)*ﺎﻣﺗ!
Posture!exercises:!These!can!help!in!maintaining!balance!
through! keeping! different! parts! of! the! body! properly!
aligned.!
! ! .,ﻗ8ﻓ!8{!ءﺎﻣﻟ'!ﻲﻓ!c5ïﺗ8!:ﺔ)ﺋﺎﻣ!7)*ﺎﻣﺗ!
Aquatic!exercises:!These!take!place!in!or!upon!water.!
! ! ﻣ!:c*ﺧ{!7)*ﺎﻣﺗﻟ'!"ﺎﻌﻟﻷ'8!ëﻠoﻟ'!ء'8vﻟ'!ﺔoﺷﻧ{8!ﻲﺷﻣﻟ'8![ﻗ*ﻟ'8!ﺎﺟ8)ﻟ'!éﺛ.ﺔ)ﻟﺎﺗﻘ! !
Other! (e.g.! yoga,! dance,! walking,! outdoor! activities,!
dancing,!martial!arts).!
!
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13.!Why!do!you!not!exercise?!!
Other(s).........................................................................................................!ﺎr5)5ﺣﺗ!ﻰﺟ*)
.............................................................................................................................!..........
.......................................................................................................................................
.......................................................................................................................................
.!..................................................................................................................................!!
!
^٤a)5ﻟ!ér!ـ!؟ﺔ)ﺿﺎ)*!ﺔoﺷﻧ{!7ﻣﺿﺗﺗ!ﺔﺑ*ﺟﺗ!ﻲﻓ!ﺔﻣrﺎﺳﻣﻠﻟ!5'5ﻌﺗﺳx !
14!Would!you!be!prepared!to!take!part!in!a!trial!that!involves!exercise?!
!Yes!(please!go!to!Question!15)!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! ءﺎﺟ*ﻟ'}!~ﻌﻧ!ﻟ'W!~ﻗ*!é'ïﺳﻠﻟ!"ﺎr^٥{ !!!!!!!!!!!!!!!!!!!!
!!!No!(please!state!why!if!you!are!able!to) }!ﻻ!ﺑ!~ﺎ)ﻘﻟ'!7ﻋ!aﻌﻧﻣﺗ!ﻲﺗﻟ'!"ﺎﺑﺳﻷ'!5)5ﺣﺗ!ﻰﺟ*)Waﻟ!!!!!!!!!{
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
Other(s).........................................................................................................!ﺎr5)5ﺣﺗ!ﻰﺟ*)
.............................................................................................................................!..........
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
......................................................................................................................................!
.!...................................................................................................................................!!
!
^٥؟ﺔﺑ*ﺟﺗﻟ'!aﻠﺗ!ﻲﻓ!ﺎvﺑ!~ﺎ)ﻘﻟ'!58ﺗ!ﻲﺗﻟ'!ﺔoﺷﻧﻷ'!ﺔ)ﻋ8ﻧ!ﻲrﺎﻣ!ـ !
15.!What!exercise!would!you!like!to!see!(take)!in!this!clinical!trial?!List!the!exercise?!
!
Other(s).................................................... ......................... ............................!ﺎr5)5ﺣﺗ!ﻰﺟ*)
.............................................................................................................................!..........
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.!….................................................................................................................................!!
!
!
!
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16º!If!you!take!part!in!research!will!you!be!happy!to!be!treated!by!a!male!
researcher?!
!!!!!!!
!!
!
!
^´ﻟ'!>ﻧﺎﻛ!'W{!ـﻘ)!7'!ﻰﻠﻋ!7)ﻘﻓ'8ﺗ!ér:~ﻌﻧﺑ!ﺔﻘﻓ'8ﻣ'!78Ωﺣﺎﺑﻟ!!>ﺎﺳﺎ)ﻘﻟﺎﺑ!~ﺎ)ﻘﻟﺎﺑ!ﺔﺳ'*5ﻟﺎﺑ!ﺔﺻﺎﺧﻟ'؟ !
17ºIf!you!take!part!in!research!will!you!be!happy!for!a!male!researcher!to!take!
measurements!need!for!the!research!project?!
!
!
!
!
!
!
!
!
!
ﻼ)âﺟ!'*ﻛﺷ!
Thank!You!
!/ﻻNo ! ! !/~ﻌﻧYes ! !
!/ﻻNo ! ! !/~ﻌﻧYes ! !
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Institute(for(Science(&(Technology(in(Medicine(and(Department(of(Neurology(Keele(University(And(the(University(Hospital(Of(North(Staffordshire(((Title:(A(pilot(study(to(investigate(the(preferences(of(Multiple(Sclerosis(patients(towards(exercise(for(reducing(fatigue.((My(name( is(Ali(Ashour,(and(I(am(a(PhD(research(student(at( the( Institute( for(Science(&(Technology( in( Medicine,( Keele( University.( My( research( project( is( supervised( by(Professors( Clive( Hawkins( and( Anand( Pandyan.( My( PhD( research( is( focused( on( the(impact(of(exercise(on(multiple(sclerosis((MS)(patients(and(its(ability(to(help(them(cope(with(fatigue.(It(is(possible(that(exercise(may(be(beneficial(in(patients(with(MS(and(details(related(to(research(carried(out(on( the(effects(of(exercise(can(be( found(at( the( following(websites:(Website( Link( Tel. Helpline 
MS#Trust## http://www.mstrust.org.uk/( 0800032(3839(*Free(Phone(Information((Webpage(related(to(Exercises(( http://www.mstrust.org.uk/information/exercises/(Webpage(related(to(Fatigue( http://www.mstrust.org.uk/atoz/fatigue.jsp(
MS#Society## http://www.mssociety.org.uk/( 02084380700(Webpage(related(to(Exercises( http://www.mssociety.org.uk/what]is]ms/treatments]and]therapies/exercise(Webpage(related(to(Fatigue( http://www.mssociety.org.uk/ms]events/ms]life/workshops]and]talks(My(study(is(specifically(looking(at(the(whether(exercise(reduces(fatigue(or(the(feelings(of(fatigue.( In(order( to(design(an(appropriate(exercise(protocol( for( the(clinical( trial( I(need(some( additional( information.( I( am( interested( in( establishing( whether( patients( are(already( participating( in( any( form( of( physical( activity( (or( exercise)( and( also( whether(patients(would(consider(participating(in(a(clinical(trial(involving(exercise.(If(patients(are(interested(in(participating(in(a(clinical(trial( involving(exercise(then(I(would(also( like(to(get(some(information(related(to(their(exercise(preference.(This(short(questionnaire(will(help(me(collect(this(information(in(a(structured(way.(I(do(hope(that(you(can(spare(ten(to(fifteen(minutes(of(your(time(to(complete(the(enclosed(questionnaire(and((a)(return(this(in( the( clinic( or( (b)( send( it( back( to( me( in( the( self( addressed( and( stamped( envelope(provided.( ( If( you( are( unable( to( fill( this( questionnaire( in( by( yourself( you( may( ask(someone(else(to(complete(this(on(your(behalf.(Although( the( information(you(provide( can(be(useful( to(my( research( there( is( no(direct(benefit(to(you.(You(are(under(no(obligation(to(fill(and(return(this(questionnaire(and(your(quality(of(care(will(not(be(affected(in(any(way(if(you(do(not(complete(this(questionnaire.(
(
(
(???????????
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Also,( note( you( are( not( being( asked( to( sign( a( separate( consent( form( as( returning( a(completed( questionnaire( is( considered( equivalent( to( giving( valid( consent( in( this(particular(instance.((If( you(wish( to( complain,( or( have( any( concerns( about( any( aspect( of( the(way( you( have(been( approached( or( treated( during( the( course( of( this( study( you( can( speak( to( my(supervisors((address(at(the(end(of(this(document),(and(if(you(are(not(satisfied(with(this(response(you(can(send(a(formal(complaint(to(Ms(N(Leighton((address(at(the(end(of(this(document)(If( you( still( have(any(questions(or(need(help( to( fill( in( the( survey,(please( contact(me(on((address(at(the(end(of(this(document)(((Monday(to(Friday,(9(p.m.(to(5(a.m.).(Your(support(for(this(research(is(very(greatly(appreciated.(I(do(thank(for(your(time(and(help.(
Contact#details#of#researcher:#
ALI##ASHOUR(PhD(Researcher((School(of(Health(and(Rehabilitation(0.02(Mackay(Building(Keele(University(a.ashour@istm.keele.ac.uk(Tel:(01782734417(Mob.:(07543433348((
Contact#details#of#supervisors:#
Clive#Hawkins(Professor(of(Clinical(Neurology(Guy(Hilton(Research(Centre(Thornburrow(Drive,(Hartshill(Stoke]on]Trent(c.p.hawkins@pmed.keele.ac.uk(Tel:((0)1782(555008((
Anand#Pandyan(Professor(of(Rehabilitation(Technology(for(Health(School(of(Health(and(Rehabilitation(0.01(Mackay(Building(Keele(University(a.d.pandyan@shar.keele.ac.uk(Tel:(01782(734252((
Nicola#Leighton#Research(Governance(Officer(Research(&(Enterprise(Services(Dorothy(Hodgkin(Building(Keele(University(ST5(5BG(n.leighton@uso.keele.ac.uk(Tel.(:(01782(733306(Fax(:(01782(733740((
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GUIDELINES!FOR!CONDUCTING!APPROVED!
RESEARCH!PROJECTS!
____________________________________________________________________________________!
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E t h i c a l ! R e v i e w ! C o m m i t t e e / R e s e a r c h ! A f f a i r s ! ! ! !
!
Research!Protocol!No.! !RA!!2013(010!
!
Principal!Investigators/CoD
Investigators!
!Dr.!Aziz!Al!Feeli!and!Mr.!Ali!Ashour!
Study!Title! An!investigation!into!the!effects!of!a!customized!patient!selected!exercise!intervention!on!fatigue!in!patients!with!MS.!!1! The!Investigators!are!required!to!abide!by!the!laws!of!the!State!of!Kuwait,!rules!and!regulations!of!the!Ministry!of!Health!and!Policies!and!Guidelines!of!the!Dasman!Diabetes!Institute.!!2! The! study! should! be! conducted! in! accordance! with! the! International! Conference! on!Harmonization!(ICH)!guidelines!for!Good!Clinical!Practice!(GCP),!ethical!principles!of!Belmont!Report!and!Declaration!of!Helsinki.!3! Only! the! Ethical! Review! Committee! (ERC)! approved! version! of! the! Consent! Form! (copy!attached)!should!be!used!for!the!enrollment!of!research!participants.!The!Consent!document!should!be!adequately!completed,!signed,!and!dated.!A!copy!of!the!signed!Consent!should!be!given! to! the! participant! and! the! original! should! be! retained! in! the! research! records! of! the!Principal!Investigator.!4! The!rights!and!welfare!of!research!participants!should!be!protected!at!all!times.!5! Research!data!should!be!secured!so!that!only!authorized!users!have!access!to!the!study!records!and!databases.! Personally! identifiable! information! and! data! should! only! be! collected!when!necessary;!secondary!disclosure!of!personally!identifiable!data!is!not!permitted.!6! It!is!the!Principal!Investigator’s!responsibility!to!ensure!the!compliance!of!investigating!team!to!applicable!regulations,!policies!and!guidelines.!7! The!Principal!Investigators!also!need!to!notify!as!soon!as!possible,!the!ERC!in!the!case!of:!i.! Their!departure!from!the!Institute.!ii.! Any!amendments!to!the!study!protocol.!iii.! Termination!of!the!study!for!whatever!reason.!iv.! Any!serious!and/!or!unexpected!adverse!events!(SUAE)!that!research!participants!may!experience,!using!the!Adverse!Events!Reporting!Form.!v.! Any!other!information!that!may!affect!the!benefit!to!risk!ratio!of!the!proposed!study.!!
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TO: 
FROM: 
CC: 
SUBJECT: 
Dr. Aziz Al Feeli 
Principal Investigator 
� 
Ms. Rashmi Shiju 
Research Compliance Officer 
Ethical Review Committee 
Dr. Abdulla Bennakhi 
Chairman 
Ethical Review Committee 
DDI Protocol No: RA-2013-010 
INTERNAL MEMORANDUM 
DATE: 
REF: 
27 May2013 
RA/069/2013 
Protocol Title: An investigation into the effects of a customized patient selected 
exercise intervention on fatigue in patients with MS. 
This is in reference to your reply, dated 22 May 2013, to the concerns of the Ethical Review 
Committee (ERC) on the above referenced proposal. 
The reply was reviewed on 27 May 2013 through expedited review process. It is my pleasure to 
inform you that the reply was accepted and the revised informed consent form and revised research 
proposal have been approved; attached please find copy of the approved consent form and necessary 
guidelines for conducting this study. 
The study investigators are required to submit a Progress Report by 26 May 2014. The approval of 
this study will automatically be suspended on the stated date, pending the submission and 
acceptance of a Progress Report. 
Wish you success in your research undertakings. 
Encl: As stated 
CC: Dr. Kazem Behbehani, Director General 
Mr. Michael Ferbuyt, CEO 
Research Affairs/Ethical Review Committee 
P.O Box 1180, Dasman 15462, Kuwaiti Tel:+ 965 22242999 (Ext 2303), FAX: +965 22492406
Website: www dasmaninstitute.org 
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INFORMED WRITTEN CONSENT FOR 
PARTICIPATION IN RESEARCH 
PART-A 
Research Participants' Information Sheet 
THE STUDY TITLE: 
An investigation into the effects of a 
customised patient selected exercise 
intervention on fatigue in patients with MS 
PURPOSE OF THE STUDY: 
You are being asked to voluntarily 
participate in a research study undertaken 
by PhD researcher (Mr Ali Ashour). The 
main purpose of this study is to investigate 
the impact of a 12-week exercise­
trainingprogramme on fatigue in MS 
patients. 
t-------- - -
STUDY DESCRIPTION: 
Once you have given us consent for study 
participation we will do the following.Dr AI­
Roughani will also check if you are safe to 
participate in the exercise study. 
1. We will take a series of measurements to
check your status. We will then repeat
these measurements a week later to
confirm that your condition is stable.
2. We will then ask you to identify the
exercises you are interested in and over
the next week customize the level of the
exercise to your ability.
3. We will then supervise you carrying out
the exercise for a further period of 11-
weeks. During this time we will monitor
your heart rare and body temperature.
4. At this point we will repeat all the
measurements to check if the exercise
has been of use to you.
5. We will then ask you to return in four
weeks time for a final measurement. This
Participant's Record No: 
'Y..r.":! '-:?�I �I � �)-�....14 t.,l:.:ill al.i yl.b.; 
.J�� .)\_;! � ol.1fo.l!I �y 
Y.:J'"'u u,o �I t...l .1.l!I o� J,..c. u,o ',!""\.,}J\ u�I
� y,,.:ill � t�l , 'I' -&.i....l �4:u.l:ill �l..i Y. 
. .)�\ �.,lll �I �.JA
�lll 1.:J:U.l:ill �,J,i .;lpl � �j ���-'I'
.a;,d .�.1, �,.;� c!:-4 � .,.11.1s:.1 � 
� e.J+.wll , , o.lAl u4,i...;.l:il4 t"l:!il4 �j � I"� ,. 
� �' i.;I>" "+.;.IJ yll)I u� �ljl lf.lja 
-�.JJ.I 
LS�I Oji ul....al:!i)I li.4 l"jil... �...;.l:ill 4.:1� � • t 
• �u.>,&ll �\.i LS.,_. u-- �
s:-1�\.:i l"jil.... �u.>,&ll s:-�I u,e �t....l t � .o 
<>, �...;.l:ill �li <>, u..,i.Jl) LS�' Oji ut....l:!i)I 
• J.a...,h)I LS.,_.
�-is_to check if you have been able to carry·��---------------� 
FORTHE RESEARCH AFFAIRS OFFICIAL USE ONLY 
This Consent Document is approved by the Ethical Review Committee of "DASMAN DIABETES INS1 T
�
lt is only valid for use if the 
validity dates are indicated and initialed by an authorized official. 
�• Eth' I R le C , \...-�- 1ca . ev w omm1tteeSTUDY NO: R A 2 0 1 3 0 1 0 � � 
From 27/ os / 2013 To: 26 / os /2014 Dasman Diabetes Institute 
(DD I MM/VY) Authorized Official's Initials 
(ORA002I 01 April 2009 Page 1 
??????????? ?






Timed Up and Go (TUG) Test 
Name:___________________________  MR: ______________________ Date:________ 
1. Equipment: arm chair, tape measure, tape, stop watch.
2. Begin the test with the subject sitting correctly (hips all of the way to the back of the seat) in a chair
with arm rests. The chair should be stable and positioned such that it will not move when the
subject moves from sit to stand. The subject is allowed to use the arm rests during the sit – stand
and stand – sit movements.
3. Place a piece of tape or other marker on the floor 3 meters away from the chair so that  it  is  easily
seen  by the subject.
4. Instructions: “On the word GO you will stand up, walk to the line on the floor, turn  around  and  walk
back to the chair and sit down.  Walk at your regular pace.
5. Start timing on the word “GO” and stop timing when the subject is seated again correctly in the
chair with their back resting on the back of the chair.
6. The subject wears their regular footwear, may use any gait aid that they normally use during
ambulation, but may not be assisted by another person. There is no time limit.  They may stop and
rest  (but not sit down) if they need to.
7. Normal healthy elderly usually complete the task in ten seconds or less. Very frail or weak elderly
with  poor mobility may take 2 minutes or more.
8. The subject should be given a practice trial that is not timed before testing.
9. Results correlate with gait speed, balance, functional level, the ability to go out, and can follow
change  over time.
Normative Reference Values by Age 
1
Age Group Time in Seconds (95% Confidence Interval) 
60 – 69 years 8.1 (7.1 – 9.0) 
70 – 79 years 9.2 (8.2 – 10.2) 
80 – 99 years 11.3 (10.0 – 12.7) 
Cut-off Values Predictive of Falls by 
Group Time in Seconds 
Community Dwelling Frail Older Adults 
  2 
> 14 associated with high fall risk
Post-op hip fracture patients at time of 
discharge3 
> 24 predictive of falls within 6 months after hip
fracture
Frail older adults > 30  predictive of requiring assistive device for
ambulation and being dependent in ADLs
Date Time Date Time Date Time Date Time 
????????????
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BERG BALANCE SCALE 
1. Purpose
The Berg’s utility includes grading different patients’ balance abilities, monitor functional balance over time
and to evaluate patients’ responses to treatment.
2. Content
The Berg is a test of 14 items; it is performance based and has a scale of 0-4 for each item (higher score
for independent performance) with a maximum score of 56.
The Berg is considered the gold standard assessment of balance with good intra-rater reliability and inter-
rater reliability and good internal validity.
3. Assessment
1. Sitting to standing
INSTRUCTIONS: Please stand up.  Try not to use your hands for support
4 able to stand without using hands and stabilize independently 
3 able to stand independently using hands 
2 able to stand using hands after several tries 
1 needs minimal aid to stand or to stabilize  
       0 needs moderate or maximal assist to stand 
2. Standing unsupported
INSTRUCTIONS:  Please stand for two minutes without holding
4 able to stand safely for 2 minutes 
3 able to stand for 2 minutes with supervision 
2 able to stand for 30 seconds unsupported 
1 needs several tries to stand for 30 seconds unsupported 
0 unable to stand for 30 seconds unassisted 
3. Sitting with back unsupported but feet supported on floor or on a stool
INSTRUCTIONS:  Please sit with arms folded for 2 minutes
4 able to sit safely and securely for 2 minutes 
3 able to sit for 2 minutes under supervision 
2 able to sit for 30 seconds 
1 able to sit for 10 seconds 
0 unable to sit without support for 10 seconds 
4. Standing to sitting
INSTRUCTIONS:  Please sit down
4 sits safely with minimal use of hands 
3 controls descent by using hands 
2 use back of legs against chair to control descent 
1 sits independently but has uncontrolled descent 
0 needs assistance to sit 
5. Transfers
INSTRUCTIONS: Arrange chair(s) for a pivot transfer.  Ask subject to transfer one way toward a
seat with armrests and one way toward a seat without armrests.  You may use two chairs, (one
with and one without armrests), or a bed and a chair.
4 able to transfer safely with minor use of hands 
3 able to transfer safely definite need of hands 
2 able to transfer with verbal cueing and/or supervision 
1 needs one person to assist 
0 needs two people to assist or supervise to be safe 
6. Standing unsupported with eyes closed
INSTRUCTIONS: Please close your eyes and stand still for 10 seconds
???????????? ?
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 4 able to stand 10 seconds safely 
 3 able to stand 10 seconds with supervision 
 2 able to stand 3 seconds 
1 unable to keep eyes closed 3 seconds but stays steady      
0 needs help to keep from falling 
 
7. Standing unsupported with feet together 
INSTRUCTIONS:  Place your feet together and stand without holding 
 
4 able to place feet independently and stand for 1 minute safely 
3 able to place feet together and stand for 1 minute with supervision 
 2 able to place feet together independently to hold for 30 seconds 
 1 need help to attain position but able to stand 15 seconds feet together 
0 needs help to attain position and unable to hold for 15 seconds 
 
8. Reaching forward with outstretched arm while standing 
INSTRUCTIONS:  Lift arm to 90º.  Stretch out your fingers and reach forward as far as you can.  
(Examiner places a ruler at end of fingertips when arm is at 90º.  Fingers should not touch the 
ruler while reaching forward).  The recorded measure is the distance forward that the finger 
reaches while the subject is in the most forward lean position.  (When possible, ask subject to 
use both arms when reaching to avoid rotation of the trunk.) 
 
4 can reach forward confidentially >25 cm (10 inches) 
 3 can reach forward >12.5 cm safely (5 inches) 
 2 can reach forward >5cm safely (2 inches) 
 1 reaches forward but needs supervision 
0 loses balance while trying/requires external support 
 
9. Pick up object from the floor from a standing position 
INSTRUCTIONS:  Pick up the shoe/slipper, which is placed in front of your feet. 
 
4 able to pick up slipper safely and easily 
 3 able to pick up slipper but needs supervision 
2 unable to pick up, reaches 2-5cm (1-2 inches) from slipper, keeps balance 
1 unable to pick up and needs supervision while trying 
       0 unable to try/needs assist to keep from losing balance or falling 
 
10. Turning to look behind over left and right shoulders while standing 
INSTRUCTIONS: Turn to look directly behind you over toward left shoulder.  Repeat to the right.  
Examiner may pick an object to look at directly behind the subject to encourage a better twist 
turn. 
 
4 looks behind from both sides and weight shifts well 
 3 looks behind one side only, turn to other side demonstrates less weight shift 
2 turns sideways only but maintains balance 
 1 needs supervision when turning 
0 needs assist to keep from losing balance or falling 
 
10. Turn 360 degrees 
INSTRUCTIONS:  Turn completely around in a full circle.  Pause.  Then turn a full circle in the 
other direction. 
 
4 able to turn 360 degrees safely in 4 seconds or less 
3 able to turn 360 degrees safely one side only in 4 seconds or less 
 2 able to turn 360 degrees safely but slowly 
 1 needs close supervision or verbal cueing 
0 needs assistance while turning 
 
  12.    Placing alternate foot on step or stool while standing unsupported 
INSTRUCTIONS: Place each foot alternately on the step/stool.  Continue until each foot has 
touched the step/stool four times. 
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4 able to stand independently and safely and complete 8 steps in 20 seconds 
 3 able to stand independently and complete 8 steps >20 seconds 
 2 able to complete 4 steps without aid with supervision 
 1 able to complete >2 steps needs minimal assist 
0 needs assistance to keep from falling/unable to try 
 
  13.    Standing unsupported one foot in front 
INSTRUCTIONS:  (DEMONSTRATE TO SUBJECT) 
Place one foot directly in front of the other.  If you feel that you cannot place your foot directly in 
front, try to step far enough ahead that the heel of your forward foot is ahead of the toes of the 
other foot.  (To score 3 points, the length of the step should exceed the length of the other foot 
and the width of the stance should approximate the subject’s normal stride width) 
 
4 able to place foot tandem independently and hold 30 seconds 
 3 able to place foot ahead of other independently and hold 30 seconds 
2 able to take small step independently and hold 30 seconds 
1 needs help to step but can hold 15 seconds 
       0 loses balance while stepping or standing 
 
   14.   Standing on one leg 
INSTRUCTIONS: Stand on one leg as long as you can without holding. 
 
4 able to lift leg independently and hold >10 seconds 
 3 able to lift leg independently and hold 5 – 10 seconds 
2 able to lift leg independently and hold ≥ 3 seconds 
1 tries to lift leg, unable to hold 3 seconds but remains standing independently 
       0 unable to try or needs assist to prevent fall 
 
TOTAL SCORE        (Maximum = 56) 
 
 
Interpretation of Berg Scores 
Please take note that these values are based on the Berg score alone and the patient mobilising without 
the assistance of a walking device. They do not take into account other falls risk factors 
 
• A score of 45 or less indicates a greater risk of falls 
• In the range of 56-54 each 1 point drop was associated with a 3-4% increase in falls risk 
• In the range of 54-46 each point drop was associated with a 6-8% falls risk 
• Below 36 falls risk is close to 100% 
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The Barthel Index 
!ﺛ#ﺎﺑ &ﺎ'ﻘﻣ 
Bowels  
 ءﺎﻌﻣﻷ& 
0 = incontinent (or needs to be given enemata) 
(ﺔﻣ#ﻼﻟ& '&(ﻸﻟ *ﺎ,ﺗﺣﻻ& 0&) #&1ﺑﻟ& *&1ﺧ4 ﺔ,ﻠﻣﻋ ﻲﻓ 9ﻛﺣﺗﻟ& ﻰﻠﻋ '1(ﻘﻣﻟ& 9(ﻋ 
1 = occasional accident (once/week) 
(!"ﺑﺳﻷﺎﺑ '(ﻣ) ﺎ*ﺿ(ﻋ -.ﺣﺗ 
2 = continent 
 ﻰﻠﻋ $%ﺎﻗ!ﻔﻧﻟ% &ﺑﺿ  
Patient's Score: 
Bladder  
ﺔﻧﺎﺛﻣﻟ' 
0 = incontinent, or catheterized and unable to manage 
ﻰﻠﻋ $%&ﻘﻣﻟ* +&ﻋ ﺔ"ﻟ$ﺑﻟ& 'ﻟﺎﺳﻣﻟ& '"ﻠﺳﺗﻟ ﺔﺟﺎﺣﺑ $/ 0$ﺑﻟﺎﺑ 1ﻛﺣﺗﻟ&  
1 = occasional accident (max. once per 24 hours) 
 !ﻛﻟ $%&ﻟﺎﺑ )*ﻣ ﻰﺻﻗ/ 0ﺣﻛ) ﺎ&ﺿ*ﻋ 40ﺣﺗ!٤ (ﺔﻋﺎﺳ  
2 = continent (for over 7 days) 
!ﻛﺣﺗﻟ& ﻰﻠﻋ *+ﺎﻗ 
Patient's Score: 
???????????? ?
Grooming  
(!ﻔﻧﻟﺎﺑ ءﺎﻧﺗﻋﻻ+) ,-ﻧ.ﺗﻟ+ 
0 = needs help with personal care 
!ﻔﻧﻟﺎﺑ ءﺎﻧﺗﻋﻹﺎﺑ ﺔﺟﺎﺣﻟ. 
 1 = independent face/hair/teeth/shaving (implements provided) 
 ءﺎﻧﺗﻋﻹﺎﺑ ﺔ)ﻟﻼﻘﺗﺳﻹ.(!"#$ﻷ" &ﻓ#ﺗ )ﺎﺣ ﻲﻓ) ﺔﻗﻼﺣﻟ"# 1ﺎﻧﺳﻷ"# &ﻌﺷﻟﺎﺑ  
Patient's Score: 
 
Toilet use 
!ﺎ#ﻣﻟ& '()* +&*ﺧﺗﺳ/ 
0 = dependent 
!"#ﺧﻵ& ﻰﻠﻋ *ﺎﻣﺗﻋﻹ& 
 1 = needs some help, but can do something alone  
ءﺎ#ﺷﻷ& 'ﻌﺑﻟ +ﺎ#ﻘﻟﺎﺑ ﻊ#.ﺗﺳ# 1ﻧﻛﻟ4 56ﻋﺎﺳﻣ ﻰﻟ: ;ﺎﺗﺣ# 
2 = independent (on and off, dressing, wiping) 
(!ﺑﻠﻟ%& 'ﻲﺗ%*ﻟ% +,ﺳﻐﻟﺎﺑ) ﺔ,ﻟﻼﻘﺗﺳﻹ% 
Patient's Score: 
 
Feeding 
!ﺎﻌ$ﻟ& '(ﺎﻧﺗ 
0 = unable  
!"ﺎﻗ !%ﻏ 
1 = needs help cutting, spreading butter, etc. 
 ﻊ"#ﻘﺗﻟ' ﻲﻓ *+ﻋﺎﺳﻣﻟ 0ﺎﺗﺣ2 
2 = independent (food provided within reach) 
 ﻲﻓ ﺔ$ﻟﻼﻘﺗﺳﻹ+!ﺳﻔﻧﺑ &ﺎﻌ)ﻟ+ ,-ﺎﻧﺗ  
Patient's Score: 
Transfer  
!ﺎﻘﺗﻧﻹ' 
0 = unable – no sitting balance  
!"#$ﺗﻟ# 'ﺗﺧﻣ ـ 'ﺎﻘﺗﻧﻹ# ﻰﻠﻋ 23ﺎﻗ 25ﻏ 
1 = major help (one or two people, physical), can sit 
!ﻠﺟ$ ﻰﺗﺣ (ﺛﻛ+ ,+ -ﺧﺷ 0ﻣ ﺔ$ﺳﺎﺳ+ 56ﻋﺎﺳﻣﻟ 9ﺎﺗﺣ$ 
2 = minor help (verbal or physical)  
(!ﻌﻔﻟ% &% 'ﻼﻛﻟﺎﺑ ء%&ﺳ) ./&/ﺣﻣ ./ﻋﺎﺳﻣ 
3 = independent 
!ﺳﻔﻧﺑ &ﺎﻘﺗﻧﻹﺎﺑ +ﺎ,ﻘﻟ. !ﻧﻛﻣ,1 &ﻘﺗﺳﻣ 
Patient's Score: 
 
Mobility  
ﺔﻛ#ﺣﻟ& 
0 = immobile  
ﺔﻛ#ﺣﻟ& ﻰﻠﻋ #*ﺎﻗ #-ﻏ 
1 = wheelchair independent, including corners, etc. 
!"ﺣﺗﻣﻟ' ﻲﺳ"ﻛﻟ' ﻰﻠﻋ .ﻣﺗﻌ0 ﻻ 
2 = walks with help of one person (verbal or physical)  
!ﺧ# $ﺧﺷ ﻊﻣ ﺔ)*ﺳﺟ -. ﺔ)/ﻔﻟ 2*ﻋﺎﺳﻣﺑ ﻲﺷﻣ) 
3 = independent (but may use any aid, e.g., stick) 
ﺦﻟ#$ ﺎﺻﻌﻟﺎﻛ )*ﻋﺎﺳﻣ .#$*# /*ﺧﺗﺳ2 ﺎﻣﺑ4 5ﻛﻟ$ ﺔﻛ4ﺣﻟ# ﻰﻠﻋ 4*ﻘ2 
Patient's Score: 
 
 
 
 
Dressing 
!ﺑﻼﻣﻟ& ء&(ﺗ*+ / !ﺑﻠﻟ& 
 0 = dependent  
!"#ﺧﻵ& ﻰﻠﻋ *ﻣﺗﻌ" 
1 = needs help, but can do about half unaided  
!"ﻋﺎﺳﻣ '(" ﺔﻣ*ﻣﻟ, -ﻔﻧﺑ 1ﺎ2ﻘﻟ, 'ﻛﻣ2 'ﻛﻟ( !"ﻋﺎﺳﻣ 5ﺎﺗﺣ2 
2 = independent (including buttons, zips, laces, etc.) 
(ﺦﻟ#$ %ﺑﻠﻟﺎﺑ) )ﺎ*ﻘﻟ# ﻰﻠﻋ ./ﺎﻗ$ 1ﻘﺗﺳﻣ 
Patient's Score: 
 
Stairs 
!ﻟﻼﺳﻟ% 
 0 = unable  
!ﻟ# ﻰﻠﻋ '(ﺎﻗ '+ﻏ 
1 = needs help (verbal, physical, carrying aid)  
(ﺔﻛ#ﺣﺗﻣ 'ﻟﻼﺳ '+,ﺧﺗﺳ. +/0ﻌﻟ+ ,2 ,ﻣ 03 ﻲ5ﻔﻠﻟ+ ﻊ2ﺟﺷﺗﻟﺎﻛ) <,ﻋﺎﺳﻣ ﻰﻟ. ?ﺎﺗﺣ2 
2 = independent up and down 
!"#ﻔﻣﺑ '(ﺑ)ﻟ+ (+ "(ﻌﺻﻟ+ .ﻧﺎﻛﻣﺈﺑ 
Patient's Score: 
 
Bathing 
!ﺎﻣﺣﺗﺳﻹ( 
 0 = dependent  
!"#ﺧﻵ& ﻰﻠﻋ *ﻣﺗﻌ" 
1 = independent (or in shower) 
!ﺳﻔﻧ ﻰﻠﻋ (ﻣﺗﻌ, 
Patient's Score:                                                       Total Score: 
Hospital Anxiety and Depression Scale (HADS) 
Patients are asked to choose one response from the four given for each 
interview.   They should give an immediate response and be dissuaded 
from thinking too long about their answers.  The questions relating to 
anxiety are marked "A", and to depression "D".  The score for each answer 
is given in the right column.  Instruct the patient to answer how it currently 
describes their feelings. 
A I feel tense or 'wound up':  
  Most of the time 3
  A lot of the time 2
  From time to time, occasionally 1
  Not at all 0
D I still enjoy the things I used to enjoy:  
  Definitely as much 0
  Not quite so much 1
  Only a little 2
  Hardly at all 3
A
I get a sort of frightened 
feeling as if something awful 
is about to happen:
 
  Very definitely and quite badly 3
  Yes, but not too badly 2
  A little, but it doesn't worry me 1
  Not at all 0
???????????? ?
  
D I can laugh and see the funny side of things:  
  As much as I always could 0
  Not quite so much now 1
  Definitely not so much now 2
  Not at all 3
  
A Worrying thoughts go through my mind:  
  A great deal of the time 3
  A lot of the time 2
  From time to time, but not too often 1
  Only occasionally 0
  
D I feel cheerful:  
  Not at all 3
  Not often 2
  Sometimes 1
  Most of the time 0
  
A I can sit at ease and feel relaxed:  
  Definitely 0
  Usually 1
  Not Often 2
  Not at all 3
  
D I feel as if I am slowed down:  
  Nearly all the time 3
  Very often 2
  Sometimes 1
  Not at all 0
  
A
I get a sort of frightened 
feeling like 'butterflies' in 
the stomach:
 
  Not at all 0
  Occasionally 1
  Quite Often 2
  Very Often 3
  
D I have lost interest in my appearance:  
  Definitely 3
  I don't take as much care as I should 2
  I may not take quite as much care 1
  I take just as much care as ever 0
  
A I feel restless as I have to be on the move:  
  Very much indeed 3
  Quite a lot 2
  Not very much 1
  Not at all 0
  
D I look forward with enjoyment to things:  
  As much as I ever did 0
  Rather less than I used to 1
  Definitely less than I used to 2
  Hardly at all 3
  
A I get sudden feelings of panic:  
  Very often indeed 3
  Quite often 2
  Not very often 1
  Not at all 0
  
D I can enjoy a good book or radio or TV program:  
  Often 0
  Sometimes 1
  Not often 2
  Very seldom 3
  
 
Scoring (add the As = 
Anxiety.  Add the Ds = 
Depression).  The norms 
 
below will give you an idea of 
the level of Anxiety and 
Depression.
  0-7 = Normal  
  8-10 = Borderline abnormal  
  11-21 = Abnormal  
     
 
Reference: 
Zigmond and Snaith (1983) 
  
  
  
  
  
  
  
  
 
Exercise(Monitoring(Form(
MS(Exercise(Study(
!
Patient!code:!!
!
Exercise!Prescription!and!progression!notes:!
Age!=!! ! ! ! Resting!HR!=!!
Temperature=!
!! !
??????????????
Patient'code:''
'
Week' Weight'
of'
subject'
Total'
intensity'
Heart'Rate' Temperature' RPE' CR10' Notes'
Week'no.' Date' Pre' Post' Pre' Post'
W1' D1D' ' ' ' ' ' ' ' ' '
'
D2D' ' ' ' ' ' ' ' ' '
'
D3D' ' ' ' ' ' ' ' ' '
'
W2' D1D' ' ' ' ' ' ' ' ' '
'
D2D' ' ' ' ' ' ' ' ' '
'
D3D' ' ' ' ' ' ' ' ' '
'
W3' D1D' ' ' ' ' ' ' ' ' '
'
D2D' ' ' ' ' ' ' ' ' '
'
D3D' ' ' ' ' ' ' ' ' '
'
'
W4' D1D' ' ' ' ' ' ' ' ' '
'
D2D' ' ' ' ' ' ' ' ' '
'
D3D' ' ' ' ' ' ' ' ' '
'
W5' D1D' ' ' ' ' ' ' ' ' '
'
D2D' ' ' ' ' ' ' ' ' '
'
D3D' ' ' ' ' ' ' ' ' '
'
W6' D1D' ' ' ' ' ' ' ' ' '
'
D2D' ' ' ' ' ' ' ' ' '
'
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W10' D1D' ' ' ' ' ' ' ' ' '
'
D2D' ' ' ' ' ' ' ' ' '
'
D3D' ' ' ' ' ' ' ' ' '
'
W11' D1D' ' ' ' ' ' ' ' ' '
'
D2D' ' ' ' ' ' ' ' ' '
'
D3D' ' ' ' ' ' ' ' ' '
'
'
W12' D1D' ' ' ' ' ' ' ' ' '
'
'
D2D' ' ' ' ' ' ' ' ' '
'
D3D' ' ' ' ' ' ' ' ' '
'
'
'
Subject(code Date(of(contacting Date(of(
consenting
Date(of(MS(
diagnosis
Date(of(
starting(study
Type(of(MS(((
0Benign;(1(
Primary(
progressive;(
2(Relapsing(
&(Remitting;(
3Secondary(
Progressive)
patient(
status
(1(drop,2(
only(
assess,3(
all)
Exercise(
type(
Exercise(
type
(0(no(
exercise,1(
resistance(
,(2(
endurance
,(3(Mixed)
Gender((0(
female;(1(
male)
Age
1 6/20/13 6/20/13 JanM13 10/21/13 0 3 3 0 40
2 6/20/13 6/20/13 AprM12 10/21/13 1 3 1 0 36
3 7/4/13 7/4/13 MayM13 10/21/13 2 3 3 0 23
4 6/23/13 6/23/13 SepM12 10/21/13 1 2 0 0 36
5 6/20/13 6/20/13 NovM10 10/21/13 1 2 0 1 33
6 6/17/13 6/17/13 MarM12 10/21/13 1 3 3 0 27
7 7/1/13 7/1/13 MarM13 10/21/13 0 3 3 1 40
8 6/17/13 6/17/13 NovM97 10/21/13 2 1 0 0 40
9 7/1/13 7/17/13 JunM12 10/21/13 3 2 0 0 36
10 7/1/13 7/1/13 MarM01 10/21/13 2 3 3 0 30
11 6/27/13 6/27/13 JanM11 10/21/13 ! 3 3 1 41
12 6/13/13 6/13/13 OctM12 drop 1 1 0 1 30
13 6/13/13 6/13/13 AprM05 10/21/13 " 3 3 0 30
14 6/13/13 6/13/13 JanM08 10/21/13 2 3 3 1 26
15 7/4/13 7/4/13 MayM10 10/21/13 ! 3 3 0 27
16 6/27/13 6/27/13 MayM11 10/21/13 2 3 3 0 32
17 7/1/13 7/1/13 SepM12 10/21/13 ! 3 3 0 38
18 6/27/13 7/27/13 NovM09 10/21/13 1 3 3 0 45
19 7/1/13 7/1/13 MarM06 10/21/13 1 3 3 0 41
20 7/1/13 7/1/13 SepM98 10/21/13 1 3 3 0 52
21 7/1/13 7/1/13 JunM06 drop 1 2 0 1 35
?????????????
22 7/1/13 7/1/13 MayM98 drop 2 1 0 0 40
23 7/1/13 7/17/13 FebM92 10/21/13 1 3 3 1 54
24 6/20/13 6/20/13 MayM05 10/21/13 1 3 3 0 44
25 6/25/13 6/25/13 MayM05 drop 3 1 0 1 35
26 6/25/13 6/25/13 JanM10 drop 2 1 0 0 35
Nationality(
(1(kuwati,(2(
other)
height weightMbl1 weightMbl2 weightM
12w
weightM
16w
MFISMbl1 MFISMbl2 MFISM12w MFISM16w HADSMbl1 HADSMbl2 HADSM
W12
1 160 68 67 60.2 61.4 26 26 36 23 5 5 9
1 162 59.5 60 63.9 65.2 45 46 43 42 22 22 22
1 151 55 55 54 53.9 36 36 26 36 13 13 10
1 168 72 71 79.1 77.6 78 36 69 84 69 69 26
1 183 79 75 78 79 45 36 31 33 3 3 10
1 154 49 47 49.4 49.1 58 46 65 64 15 15 21
1 180 109 105 108.9 109.7 7 6 14 12 1 2 9
1 163 67 61 67 67 67 67
1 154 35 35 42.2 39.2 73 73 75 59 21 22 22
1 154 35 35 37 36.3 29 29 17 8 12 12 7
1 180 119 115 118.3 118.3 45 45 28 18 11 11 11
1 170 78 75 9 24 10 10
1 173 64 63 64 63.7 31 31 15 22 17 17 19
1 181 79 78 79.9 78.2 51 51 29 29 15 15 11
1 170 104 103 103.4 100.1 70 70 33 31 34 34 12
2 154 56 55 56.3 57.3 42 43 31 31 20 20 18
1 162 61 59 58.8 59.2 74 74 20 71 29 29 68
1 155 45 65 56.3 ٦$.% 18 18 16 14 8 8 9
1 158 80 79 81.8 80 52 52 40 39 22 22 19
1 169 71 66 73 70.1 28 29 25 29 18 17 20
1 179 90 91 91.8 89.2 51 51 8 24 18 18 16
1 55 55 17 17
1 182 95 92 93.6 90.6 32 32 16 19 4 4 7
1 154 70 71 71 71.5 48 48 45 45 16 17 19
1 70 85 45 45 16 17
1 60 65 57 57 14 14
HADSM
W16
EDSSMbl1 EDSSMbl2 EDSS=12w EDSSM16w barthelM
bl1
barthelM
bl2
barthelM
12w
barthelM
16w
TUGMbl2 TUGM12w TUGM16w 10mM
bl2_S.S.V
7 5 5 5 5 20 20 20 8.5 7.9 7.98 6.5
21 5.5 5.5 5.5 5.5 17 17 20 20 9.8 7.8 9.1 4.8
18 4 4 4 4 20 20 20 20 6.5 5.59 5.5 5.5
35 6.5 6.5 6.5 6.5 19 19 20 20 9.7 7.4 8.68 6.9
10 5.5 5.5 5.5 5.5 19 19 18 20 7.1 5.98 7 5.5
21 5.5 5.5 5.5 5.5 18 18 20 20 5.8 6.33 5.95 4.3
4 3.5 3.5 3.5 3.5 15 15 20 20 5.6 4.88 5.45 10.1
5.5 5.5 13 13 14 %.
26 7 7 7 7 19 19 17 20 8.5 6.2 6.56 5.4
0 5 5 5 5 20 20 20 20 10.1 7.65 8.11 5.7
11 5 5 5 5 20 20 20 20 7.1 6.83 6.29 3.7
6 6 19 8 7.7 5
17 6.5 6.5 6.5 6.5 15 15 13 16 14.1 9.4 10.9 5.9
19 6 6 6 6 20 20 20 19 10.9 6.23 6.9 16.1
14 5 5 5 5 20 20 20 20 7.3 6.1 6.9 4
16 6 6 6 6 18 18 19 19 8.6 7.5 7.34 5.5
28 5 5 5 5 15 15 19 20 8.7 5.4 6.04 7.9
7 6 6 6 6 20 20 20 20 7.2 6.6 7.63 5.4
19 5.5 5.5 5.5 5.5 17 17 18 19 8 6 5.5 5.5
12 5 5 5 5 20 20 20 20 5.7 5.9 5.99 4
13 5.5 5.5 5.5 5.5 20 20 20 20 5.1 5.96 4.94 5.5
6 6 18 17 5.8 6.5
6 6 6 6 6 18 18 20 20 6.2 6.03 6.78 4.8
15 5 5 5 5 19 19 19 19 7.2 6.85 6.8 3.4
7.5 7.5 15 15 6.9 5.4
7 7 14 14 7.8 6.5
10mM
bl2_F.V
10mM
12w_S.S.V
10mM
12W_F.V
10mM
16w_S.S.V
10mM
16W_F.V
6mMbl2 6mM12w 6mM16 bbsMbl2 bbsM12w bbsM16w nhptRMbl2 nhptLMbl2
4.59 5.66 4 4.6 3.9 360 400 392 56 56 56 13.03 9.06
3.8 5.5 3.9 5.76 4.9 300 410 379 48 49 51 22.7 29.8
3.5 4.65 2.74 3 3 430 456 454 56 56 56 9.19 9.5
4.8 6 4 7.31 5.5 380 400 180 38 54 54 33.1 36.2
3.3 5.93 2.45 5.65 2.33 433 420 400 55 56 56 11.6 15.1
2.6 4.58 3.45 4.44 3.25 438 460 444 56 53 56 11.7 13.6
6.5 2.36 3.7 3.27 2.68 423 500 490 55 56 53 16.7 17.9
4.5 203 42 29 27
4.5 5.2 3.5 5.48 3.46 345 450 385 55 48 55 12.4 14.2
4.8 5.2 4.3 4.47 4.42 302 363 336 47 46 55 22.8 25.1
3.1 4.41 2.68 4.56 2.61 470 512 522 55 56 56 13.8 13.7
3.6 392 54 21.2 26.5
4.8 6.6 4.9 5.73 4.58 202 230 169 44 46 42 20.6 30.8
4.3 4.33 3.06 3.91 3.6 375 448 393 47 55 50 15.5 16.1
3.8 5 3.4 4.25 3.6 373 440 380 53 55 56 16.7 22
4.5 6.7 4.3 4.47 3.6 363 356 408 48 47 53 19.7 23.2
5.1 6.2 3.9 4.78 3.56 280 424 397 48 56 56 20.2 19.9
3.8 5.6 3.4 4.78 3.6 403 435 402 54 56 56 18 18.8
4.4 4.9 3.5 4 3.2 380 412 415 54 55 55 20 23.8
3.5 4.6 3.5 3.94 3.21 475 490 493 51 55 55 16.7 27.7
2.3 4.66 2.28 4.98 2.01 446 508 554 56 56 56 12.4 17.1
3.4 395 56 18.8 21.4
3.4 3.68 2.97 4.01 2.86 452 435 448 45 51 52 21.1 34.9
4.1 4.03 3.33 4.07 3.35 455 470 462 55 56 56 11 13.6
3.5 364 38 24.6 45.2
5 490 53 18.4 22.1
nhptRM
12w
nhptLM12w nhptRM
16w
nhptLM16w gripbl2R_1 gripbl2R_2 gripbl2R_3 max_gripb
l2R
gripbl2L_1 gripbl2L_2 gripbl2L_3 max_gripb
lL2
grip12W_
R_1
12.45 13.68 12.56 12.55 12 12 10 12 9 12 12 12 10
21 23.7 22.33 24.34 11 11 10 11 11 11 10 11 11
9.68 9.59 9.32 11.07 14 14 14 14 16 15 15 16 16
21.9 23.9 24.36 26.53 12 12 10 12 9 12 12 12 12
14.37 14.05 14 13.89 28 32 29 32 24 26 28 28 38
21 24.7 13.65 13.95 21 19 18 21 14 14 16 16 15
11.88 13.88 13.1 12.95 30 28 26 30 36 30 30 36 34
14 10 12 14 12 12 10 12
13.16 16.52 13.31 17.03 16 16 16 16 16 14 14 16 13
23.1 24.5 22.24 23.46 16 18 14 18 12 12 12 12 14
13.08 13 14.59 15.6 29 30 30 30 36 32 36 36 31
26 20 20 26 20 20 14 20
18.9 28 21.5 30.01 20 18 20 20 18 22 26 26 22
16.95 16.95 15.14 16.77 14 16 18 18 14 13 11 14 31
15.3 16.5 16.91 16.96 16 13 20 20 22 20 18 22 18
19.3 22.3 10.36 12.48 14 12 18 18 12 14 13 14 16
18.5 19 10.81 12.99 7 10 11 11 5 4 12 12 14
18.3 19.9 16.65 20.5 17 17 18 18 18 19 17 19 17
17.7 25.4 16.88 23.1 18 10 14 18 5 10 14 14 14
15.9 28.5 9.85 19.73 14 15 16 16 14 13 16 16 13
14.03 14.5 11.27 13.52 18 35 26 35 32 32 31 35 38
19 19 20 20 20 20 20 20
12.76 12.56 13.02 19.34 20 24 24 24 12 20 16 20 22
11.56 15.03 10.66 12.35 10 9 10 10 14 8 9 14 16
22 23 24 24 24 21 25 25
15 15 16 16 13 12 13 13
grip12w_R
_2
grip12W_
R_3
max_grip1
2W_R
grip12W_L
_1
grip12W_L
_2
grip12W_L
_3
max_grip1
2W_L
grip16W_
R_1
grip16w_R
_2
grip16W_
R_3
max_grip1
6W_R
grip16W_L
_1
grip16W_L
_2
14 11 14 13 13 13 13 16 13 13 16 14 13
11 11 11 12 11 9 12 13 10 12 13 11 10
16 15 16 16 14 14 16 16 14 12 16 15 14
18 14 18 14 12 12 14 8 8 6 8 15 14
38 31 38 26 24 23 26 33 38 38 38 26 26
12 14 15 13 12 12 13 19 14 14 19 16 11
31 19 34 44 44 39 44 37 34 31 37 40 38
12 12 13 11 11 11 11 16 16 17 17 16 15
14 13 14 12 11 10 12 14 15 15 15 15 10
33 31 33 36 29 33 36 37 35 35 37 36 36
23 24 24 25 25 25 25 23 20 21 23 26 26
32 27 32 19 19 17 19 23 26 22 26 17 15
23 13 23 19 18 22 22 20 17 14 20 20 22
16 15 16 13 12 13 13 18 20 17 20 20 18
16 14 16 14 13 14 14 11 13 14 14 14 12
19 19 19 18 18 18 18 24 22 22 24 26 26
14 16 16 13 14 16 16 14 17 15 17 15 15
16 16 16 14 16 17 17 18 17 18 18 20 18
38 36 38 40 32 30 40 42 44 38 44 45 41
30 28 30 22 20 20 22 26 27 27 27 22 20
13 11 16 15 17 13 17 10 10 12 12 13 9
grip16W_L
_3
max_grip1
6W_L
max_kfRM
bl2
max_kfLM
bl2
max_kfRM
12w
max_kfLM
12w
max_kfRM
16w
max_kfLM
16w
max_kext
RMbl2
max_kextLM
bl2
max_kext
RM12w
max_kextLM
12w
max_kext
RM16w
10 14 66.7 63.8 61.9 60.5 68.5 68.1 65.3 62.1 77.3 78.7 70.9
10 11 67.1 66.1 66.6 64.5 66 64.8 68.6 67.5 66.5 68.4 74.9
14 15 65.6 68.8 72.1 71.5 73.6 70.1 62.9 64 73.8 75.4 80.1
13 15 54.4 54.3 62.2 63.1 60.9 57.5 55.6 54.5 62.3 64 60.5
25 26 70.2 70.9 72 81.7 73.6 81 69.6 67.4 84.2 77.8 82.2
10 16 64.4 62.2 66.6 65.7 64.6 64.3 66.3 65.9 72.8 67.6 76
36 40 73.7 71.8 76.9 76.8 82.5 86.6 77.5 73.6 91.1 89.7 95.1
57.3 56.5 56.8 56.1
14 16 61.4 62 64.9 64.2 67 68.9 65.1 65.1 64.2 63.9 69.7
12 15 55 56.5 66.7 64.2 70 67.1 52.8 55.1 64.7 66.5 68.6
35 36 72.4 73.9 72.8 69.2 81.9 80.5 75.4 74.4 94.6 88 89.2
57.3 61.4 58.5 60.2
25 26 57.7 57.5 64 64 66.3 66.9 58.4 57.6 62.9 60.4 82.9
19 19 70.1 67.8 77.1 74.2 74.5 71.6 65.2 60 93.9 89.3 79.2
19 22 60.7 60.8 67.8 67.8 75.4 73.2 61.3 59.7 68.8 69.8 79.7
16 20 58.4 58.7 64.3 62.5 64.8 63.8 54.9 55 68 65.6 82.2
14 24 59.2 59.6 64.7 63.2 69.2 64.1 59 57.9 68.1 64.9 74.4
24 26 64.1 63.1 67.5 66.1 69.4 68.3 62.1 61.1 68.7 68.7 82.4
16 16 57.5 59.2 67.7 60.1 69.2 64.1 59.9 60 64.9 63 68.6
16 20 65.7 62.2 67.3 69.8 68.5 72.9 64.7 65.9 66 66.5 84.2
41 45 66.8 67.8 75.6 80.7 89.9 88.6 69.1 70.1 89.9 84.9 90.2
59.8 58.7 68 69.5
18 22 64 64.6 78.9 72.9 84.3 85.1 65.5 63.2 83 85.3 92.4
10 13 65.9 66.4 62 77.3 65.1 68.7 66.7 64.1 80.5 74 76.4
67.8 76.8 69 66.2
69.8 69.2 60.5 59.9
max_kextLM
16w
max_hipfl
xMRMbl2
max_hipfl
xMLMbl2
max_hipfl
xMRM12w
max_hipfl
x.LM12w
max_hipfl
xMR_16w
max_hipfl
xML_16w
max_hipex
tMRMbl2
max_hipex
tMLMbl2
max_hipex
tMRM12w
max_hipex
t.LM12w
max_hipex
tMR_16w
max_hipex
tML_16w
67.5 67.6 64.7 65.9 62.2 64.8 63.1 57.3 57.9 62.5 59.8 62.2 61.7
69.6 56.2 66.2 62.3 64.4 59.9 64.8 60.5 60.9 60.3 59.4 61.2 70.8
74.9 68.6 70.1 74.5 76.7 70.6 73 61.1 59 67 68 65.6 64.4
56.9 54.9 54.5 36 63.3 56.9 61.3 54.1 54 60.8 60.6 59 61.7
77.5 73.9 75.3 78 81.7 69 70.2 75.2 72.6 83.4 85.6 81.7 85.6
70 67.4 66.7 68.2 66.8 71 67.7 68.6 68.2 70.7 66 69.7 66
87.4 73.5 74.2 78.7 77.8 75.3 77.4 74.3 74.1 79.7 76.8 79.6 71.2
55.8 55.1 55.2 53.1
67.8 60.9 59.3 66.7 65.7 61.2 62.8 57.6 59.8 67.5 66 67.2 68.5
74.5 55.7 55.1 65 64.6 66.8 65.7 54.3 54.3 60.8 61.9 67 64.1
85.7 71.8 71.5 79.2 79.9 79.3 84.7 70.1 72.2 70.8 69.7 71.3 71.9
59.9 60.6 55.8 56.2
85.3 58.4 58.6 64 64 66 65.2 57.2 54.6 66.2 66.2 67.4 65.3
89.5 63.8 55.7 76 70 68.9 63.1 58.5 59.8 66.2 70.7 68.7 63.1
76.7 61.7 61.4 67.8 65.8 69.2 69.4 56.1 56.8 62.8 61.4 68.1 66.1
83.7 59.7 58.7 65 62.9 62.3 66.5 58.6 59.8 63.9 62.8 68.4 67.2
75.7 58.2 57.4 64.9 62.1 65 63.2 57.4 57.2 62.7 61.4 64.3 65.5
78.9 64.7 63.9 63.7 65 62.6 62 59.6 60.7 61.8 61.9 67.6 69.7
64.5 59.8 59.8 64.9 65.8 69.5 69.4 57.2 57 61.5 62.5
82.9 64.5 64.8 69.1 69.8 65.5 70.5 61 61.4 62 61.9 67.6 68.4
88.3 76.8 71.9 75.7 80.1 80 83.5 75.7 77.9 78.6 75.4 83.1 86.5
63.4 61.7 61.8 62.7
89.2 61.7 62.6 70 71.9 71.9 71.3 64 59.3 74.5 70.3 66.7 67.7
72.5 62.8 64.7 63.1 64.3 65.7 69.3 57.1 56.6 60.9 66.6 67.6 76.4
64.3 60.7 64.4 63.1
57.2 57.3 60.1 56.8
max_shldfl
xMRMbl2
max_shldfl
xMLMbl2
max_shldfl
xMRM12w
max_shldfl
x_LM12w
max_shldfl
xMR_16w
max_shldfl
xML_16w
max_shlda
bdMRMbl2
max_shlda
bdMLMbl2
max_shlda
bdMRM12w
max_shlda
bd_LM12w
max_shlda
bdMR_16w
max_shlda
bdML_16w
max_elbflxM
RMbl2
61.2 62.9 63.7 64.7 71.8 73.2 61.7 61.8 61.3 65.4 68.8 70.3 58.9
61.5 61.9 62.1 62 62.5 53.3 62.2 60.9 62.2 60.8 57.9 57.2 63.6
59.2 60.7 63.2 67.7 64.1 64.6 58.7 58 65.8 64.3 63.5 65 64.7
54.3 53.7 62.6 60.8 59.5 57 56.2 53.3 61.6 61.8 59.5 57 52.3
74.9 73.9 73.6 77.7 72.6 73.4 72.8 72.7 74.7 73.1 69 72.5 84.4
61.9 61.5 61.3 62.5 65.1 62.2 62 60.9 62.3 62 59.7 61.4 62.7
78.3 81 74.8 85.9 76.7 79.2 72.1 69.7 79.7 75 77.3 77.6 82
56.4 55.1 56.2 55 52.6
59.2 58.8 60.3 63 62.7 62.4 59.8 60.1 63 64.3 61.7 62.2 62
54.4 54.4 61.1 61.5 62.4 63.2 54.5 54.4 60.9 64.1 63.3 63 52.6
69.8 74.6 71.1 74.9 72.6 80.2 67.1 75.6 72.4 79.1 69 72.5 76.6
56.9 55.7 58 58.7 56
57.3 55.4 63.6 65.4 62.9 65.8 55.9 55.6 67.5 66.6 65.6 63 57.3
71 63.2 67.5 67.6 71.8 73.2 65.3 65.1 66.8 68.1 68.8 70.3 67
57.3 57.7 60.9 60.5 66.1 64.9 56.9 57.4 63.8 64.2 63 64.8 59.4
56.7 46 62.9 62.9 66 63.5 58.8 56.8 62.3 62.3 66.3 62.7 58.8
55.6 56.7 58.8 56.5 59.5 62.9 56.9 57.4 62.4 60.7 60.9 60.5 58.8
60.8 60 63.1 61.9 62.3 67 59.2 60.6 63.4 63.6 63.1 63.1 63.3
58.3 57.5 60 61.3 62.3 67 58.3 57.4 61.1 61.8 63.1 63.1 58.1
60.5 62.2 62.7 64.5 66.8 70.2 60.8 62.3 64.8 65.1 67.8 62.3 60.1
73.4 76.7 77.1 80.7 85.4 81.9 71.8 76.5 79.1 82.5 78.3 79.7 77.4
61.9 61.6 69.9 61.6 63.4
63.9 64.4 76.5 75.6 77.7 74.9 62.9 64 70.1 69.1 71.1 72.8 61.7
63.5 61.8 67.1 67.9 62.5 64.7 60.8 62.3 64.2 65.9 66.5 62.8 67.8
65.5 63.7 64 64.6 62.9
56.9 56.1 60 59.1 56.5
max_elbflxM
LMbl2
max_elbflxM
RM12w
max_elbflx
_LM12w
max_elbflxM
R_16w
max_elbflxM
L_16w
max_elbex
tMRMbl2
max_elbex
tMLMbl2
max_elbex
tMRM12w
max_elbex
t_LM12w
max_elbex
tMR_16w
max_elbex
tML_16w
61.5 65 65.7 72.2 70.8 60.8 61.6 65.6 63.9 68.6 67
64 61.8 62.1 61.5 62.6 61.9 64 62.4 63.6 59.5 60.6
61.8 67.2 65.1 61.4 67.6 66.3 67.3 64.9 63.8 63.3 64.3
53.6 59.6 61.6 62 64.5 53.5 53.8 60.1 62 58.3 61.8
80.6 73.1 82.1 72.2 70.8 69.5 66.9 73.1 76.9 72.9 75.6
61.3 67 60.6 66.7 63.1 63.3 64.5 60.7 60.9 61.3 62.3
82.8 82.4 80.5 79.7 84.4 73.1 72.3 69.2 75.7 74.7 75.1
58.4 53.5 55.2
62.9 60.4 36.6 72.2 70.8 60.1 60.9 62.2 61.9 68.6 67
53.2 59.2 61.8 63.1 67.8 54.5 53.4 62.1 60.3 61 60.2
80.4 80.5 83.5 80 84 74.3 78.7 78.3 78.6 82.9 77.6
53.4 56.3 55.9
56.7 63.2 64.9 66.7 68 55.8 53.5 61.7 62.7 61.4 66.7
63.9 69 71.3 72.2 70.8 64.7 61.9 74.7 72.3 68.6 67
59.8 61.3 63 70 66.7 60.3 60.6 65 63.4 66 67.2
57.6 62.3 61.3 64.8 36.8 58.9 59.6 61.3 65.1 64 65.7
57.7 62.4 61.2 61.2 63.5 58.4 58.8 61.9 61.4 63 60
60.4 65.3 59.9 67.2 68.9 64.2 64.1 62.3 60.8 64.4 66.5
58.8 62 61.4 61.2 63.5 59.8 60.1 62 61 63 60
58.1 62.7 64.4 68.7 70.6 58.6 57.8 61.2 64.7 66.4 67.4
78.1 82.3 91 87.6 87.3 72.8 78.8 84.5 80.2 84.4 79.6
61.7 61.7 62.7
62.6 85.1 84.2 78.9 81.8 64 59.3 70.5 72.3 71.8 73.4
69.7 67.1 70.7 64.8 69.6 65.2 67.7 64.6 96.7 67 67.5
64.2 66.8 65.8
54.8 59.7 58.7
p daycode day mass*(kg) Hrtarget Rest*HR Mid*HR End*HR maxHR
1 w1d1 1 62.6 122 64 71 71
1 w1d2 3 122 76 71 71
1 w1d3 5 122 75 76 76
1 w2d1 8 62.5 122 64 71 71
1 w2d2 10 122 67 71 71
1 w2d3 12 122 69 76 76
1 w3d1 15 122 0
1 w3d2 17 61.8 122 61 68 68
1 w3d3 19 122 69 75 75
1 w4d1 22 122 64 64 64
1 w4d2 24 59 122 71 73 73
1 w4d3 26 122 68 65 65
1 w5d1 29 60 122 68 76 76
1 w5d2 31 122 78 81 81
1 w5d3 33 122 75 76 76
1 w6d1 36 60.5 122 75 76 76
1 w6d2 38 122 64 73 73
1 w6d3 40 122 71 73 73
1 w7d1 43 122 0
1 w7d2 45 61 122 65 68 68
1 w7d3 47 122 0
1 w8d1 50 ٦"." 122 65 64 76 76
1 w8d2 52 122 65 72 76 76
1 w8d3 54 122 68 75 78 78
1 w9d1 57 61.2 122 68 83 83 83
1 w9d2 59 122 73 75 91 91
1 w9d3 61 122 76 83 81 83
1 w10d1 64 122 0 0 0 0
1 w10d2 66 62.5 122 68 98 91 98
?????????????
1 w10d3 68 122 76 96 89 96
1 w11d1 71 122 75 81 73 81
1 w11d2 73 122 67 75 76 76
1 w11d3 75 122 75 89 101 101
1 w12d1 78 61.9 122 75 98 89 98
1 w12d2 80 122 80 83 85 85
1 w12d3 82 122 0
2 w1d1 1 65 140 78 95 95
2 w1d2 3 140 86 104 104
2 w1d3 5 140 76 89 89
2 w2d1 8 63 140 83 95 95
2 w2d2 10 140 83 100 100
2 w2d3 12 140 79 96 96
2 w3d1 15 64.4 140 75 95 95
2 w3d2 17 140 82 95 95
2 w3d3 19 140 82 100 100
2 w4d1 22 64.7 140 84 95 95
2 w4d2 24 140 85 110 110
2 w4d3 26 140 78 95 95
2 w5d1 29 65.2 140 75 95 95
2 w5d2 31 140 75 95 95
2 w5d3 33 140 75 95 95
2 w6d1 36 64.7 140 73 78 78
2 w6d2 38 140 91 95 95
2 w6d3 40 140 75 95 95
2 w7d1 43 64.1 140 87 90 90
2 w7d2 45 140 96 90 90
2 w7d3 47 140 87 92 92
2 w8d1 50 64.7 140 86 82 82
2 w8d2 52 140 88 83 83
2 w8d3 54 140 81 92 92
2 w9d1 57 64.7 140 88 99 99
2 w9d2 59 140 87 99 99
2 w9d3 61 140 84 94 94
2 w10d1 64 64.9 140 84 90 90
2 w10d2 66 140 82 87 87
2 w10d3 68 140 76 90 90
2 w11d1 71 64.9 140 80 78 78
2 w11d2 73 140 85 84 84
2 w11d3 75 140 89 90 90
2 w12d1 78 0
2 w12d2 80 0
2 w12d3 82 0
3 w1d1 1 55 136 81 95 95
3 w1d2 3 136 79 99 99
3 w1d3 5 136 81 101 101
3 w2d1 8 55.8 136 81 101 101
3 w2d2 10 136 85 102 102
3 w2d3 12 136 85 99 99
3 w3d1 15 55.6 136 75 95 95
3 w3d2 17 136 83 99 99
3 w3d3 19 136 87 100 100
3 w4d1 22 55 136 75 95 95
3 w4d2 24 136 75 99 99
3 w4d3 26 136 72 98 98
3 w5d1 29 55 136 75 105 105
3 w5d2 31 136 79 95 95
3 w5d3 33 136 80 97 97
3 w6d1 36 54.4 136 74 115 115
3 w6d2 38 136 75 85 85
3 w6d3 40 136 69 100 100
3 w7d1 43 53.6 136 77 111 101 111
3 w7d2 45 136 77 127 95 127
3 w7d3 47 136 75 125 98 125
3 w8d1 50 53.6 136 77 126 116 126
3 w8d2 52 136 70 111 99 111
3 w8d3 54 136 73 100 123 123
3 w9d1 57 54.1 136 88 97 95 97
3 w9d2 59 136 88 98 127 127
3 w9d3 61 136 90 93 111 111
3 w10d1 64 54.2 136 85 100 117 117
3 w10d2 66 136 87 127 109 127
3 w10d3 68 136 96 110 110 110
3 w11d1 71 0
3 w11d2 73 0
3 w11d3 75 0
3 w12d1 78 0
3 w12d2 80 0
3 w12d3 82 0
4 w1d1 1 0
4 w1d2 3 0
4 w1d3 5 0
4 w2d1 8 0
4 w2d2 10 0
4 w2d3 12 0
4 w3d1 15 0
4 w3d2 17 0
4 w3d3 19 0
4 w4d1 22 0
4 w4d2 24 0
4 w4d3 26 0
4 w5d1 29 0
4 w5d2 31 0
4 w5d3 33 0
4 w6d1 36 0
4 w6d2 38 0
4 w6d3 40 0
4 w7d1 43 0
4 w7d2 45 0
4 w7d3 47 0
4 w8d1 50 0
4 w8d2 52 0
4 w8d3 54 0
4 w9d1 57 0
4 w9d2 59 0
4 w9d3 61 0
4 w10d1 64 0
4 w10d2 66 0
4 w10d3 68 0
4 w11d1 71 0
4 w11d2 73 0
4 w11d3 75 0
4 w12d1 78 0
4 w12d2 80 0
4 w12d3 82 0
5 w1d1 1 0
5 w1d2 3 0
5 w1d3 5 0
5 w2d1 8 0
5 w2d2 10 0
5 w2d3 12 0
5 w3d1 15 0
5 w3d2 17 0
5 w3d3 19 0
5 w4d1 22 0
5 w4d2 24 0
5 w4d3 26 0
5 w5d1 29 0
5 w5d2 31 0
5 w5d3 33 0
5 w6d1 36 0
5 w6d2 38 0
5 w6d3 40 0
5 w7d1 43 0
5 w7d2 45 0
5 w7d3 47 0
5 w8d1 50 0
5 w8d2 52 0
5 w8d3 54 0
5 w9d1 57 0
5 w9d2 59 0
5 w9d3 61 0
5 w10d1 64 0
5 w10d2 66 0
5 w10d3 68 0
5 w11d1 71 0
5 w11d2 73 0
5 w11d3 75 0
5 w12d1 78 0
5 w12d2 80 0
5 w12d3 82 0
6 w1d1 1 49 135 76 90 90
6 w1d2 3 135 77 85 85
6 w1d3 5 135 70 128 128
6 w2d1 8 48.5 135 78 91 91
6 w2d2 10 135 80 96 96
6 w2d3 12 135 84 90 90
6 w3d1 15 49 135 84 111 111
6 w3d2 17 135 75 96 96
6 w3d3 19 135 75 94 94
6 w4d1 22 48 135 75 82 82
6 w4d2 24 135 83 94 94
6 w4d3 26 135 77 99 99
6 w5d1 29 48.7 135 75 80 80
6 w5d2 31 135 78 93 93
6 w5d3 33 135 75 81 81
6 w6d1 36 48.7 135 76 96 96
6 w6d2 38 135 78 85 85
6 w6d3 40 135 85 110 110
6 w7d1 43 48 135 85 100 100
6 w7d2 45 135 84 109 96 109
6 w7d3 47 135 81 100 81 100
6 w8d1 50 48 135 88 100 118 118
6 w8d2 52 135 84 100 101 101
6 w8d3 54 135 90 110 110 110
6 w9d1 57 48.1 135 80 110 100 110
6 w9d2 59 135 75 118 120 120
6 w9d3 61 135 87 128 120 128
6 w10d1 64 0
6 w10d2 66 0
6 w10d3 68 0
6 w11d1 71 0
6 w11d2 73 0
6 w11d3 75 0
6 w12d1 78 0
6 w12d2 80 0
6 w12d3 82 0
7 w1d1 1 115 151 75 122 122
7 w1d2 3 151 95 125 125
7 w1d3 5 151 75 129 129
7 w2d1 8 115 151 75 120 120
7 w2d2 10 151 79 112 112
7 w2d3 12 151 78 138 138
7 w3d1 15 114 151 75 135 135
7 w3d2 17 151 85 126 126
7 w3d3 19 151 86 111 111
7 w4d1 22 113.5 151 85 114 114
7 w4d2 24 151 83 118 118
7 w4d3 26 151 85 120 120
7 w5d1 29 112.4 151 85 110 110
7 w5d2 31 151 75 121 121
7 w5d3 33 151 76 122 122
7 w6d1 36 110.3 151 85 121 121
7 w6d2 38 151 75 120 120
7 w6d3 40 151 79 116 116
7 w7d1 43 110.8 151 80 129 129
7 w7d2 45 151 85 127 127
7 w7d3 47 151 90 115 115 115
7 w8d1 50 110 151 118 97 113 113
7 w8d2 52 151 92 109 113 113
7 w8d3 54 151 97 98 122 122
7 w9d1 57 109 151 91 142 108 142
7 w9d2 59 151 75 118 125 125
7 w9d3 61 151 105 115 135 135
7 w10d1 64 110 151 97 100 112 112
7 w10d2 66 151 100 129 118 129
7 w10d3 68 "٥" 120 120 141 141
7 w11d1 71 110.3 151 86 119 120 120
7 w11d2 73 0
7 w11d3 75 0
7 w12d1 78 0
7 w12d2 80 0
7 w12d3 82 0
8 w1d1 1 0
8 w1d2 3 0
8 w1d3 5 0
8 w2d1 8 0
8 w2d2 10 0
8 w2d3 12 0
8 w3d1 15 0
8 w3d2 17 0
8 w3d3 19 0
8 w4d1 22 0
8 w4d2 24 0
8 w4d3 26 0
8 w5d1 29 0
8 w5d2 31 0
8 w5d3 33 0
8 w6d1 36 0
8 w6d2 38 0
8 w6d3 40 0
8 w7d1 43 0
8 w7d2 45 0
8 w7d3 47 0
8 w8d1 50 0
8 w8d2 52 0
8 w8d3 54 0
8 w9d1 57 0
8 w9d2 59 0
8 w9d3 61 0
8 w10d1 64 0
8 w10d2 66 0
8 w10d3 68 0
8 w11d1 71 0
8 w11d2 73 0
8 w11d3 75 0
8 w12d1 78 0
8 w12d2 80 0
8 w12d3 82 0
9 w1d1 1 0
9 w1d2 3 0
9 w1d3 5 0
9 w2d1 8 0
9 w2d2 10 0
9 w2d3 12 0
9 w3d1 15 0
9 w3d2 17 0
9 w3d3 19 0
9 w4d1 22 0
9 w4d2 24 0
9 w4d3 26 0
9 w5d1 29 0
9 w5d2 31 0
9 w5d3 33 0
9 w6d1 36 0
9 w6d2 38 0
9 w6d3 40 0
9 w7d1 43 0
9 w7d2 45 0
9 w7d3 47 0
9 w8d1 50 0
9 w8d2 52 0
9 w8d3 54 0
9 w9d1 57 0
9 w9d2 59 0
9 w9d3 61 0
9 w10d1 64 0
9 w10d2 66 0
9 w10d3 68 0
9 w11d1 71 0
9 w11d2 73 0
9 w11d3 75 0
9 w12d1 78 0
9 w12d2 80 0
9 w12d3 82 0
10 w1d1 1 35 152 113 113 113
10 w1d2 3 152 85 99 99
10 w1d3 5 152 99 112 112
10 w2d1 8 36.9 152 73 108 108
10 w2d2 10 152 75 107 107
10 w2d3 12 152 75 91 91
10 w3d1 15 35.6 152 80 97 97
10 w3d2 17 152 73 112 112
10 w3d3 19 152 75 85 85
10 w4d1 22 35.6 152 73 89 89
10 w4d2 24 152 75 92 92
10 w4d3 26 152 90 86 86
10 w5d1 29 35.7 152 75 105 105
10 w5d2 31 152 75 99 99
10 w5d3 33 152 75 86 86
10 w6d1 36 35.8 152 85 105 105
10 w6d2 38 152 75 99 99
10 w6d3 40 152 75 86 86
10 w7d1 43 35.6 152 95 86 89 89
10 w7d2 45 152 92 87 97 97
10 w7d3 47 152 93 89 115 115
10 w8d1 50 36.5 152 87 90 99 99
10 w8d2 52 152 93 93 96 96
10 w8d3 54 152 85 90 86 90
10 w9d1 57 37.5 152 74 90 115 115
10 w9d2 59 152 93 100 100 100
10 w9d3 61 152 89 92 95 95
10 w10d1 64 37.6 152 85 83 92 92
10 w10d2 66 152 97 86 97 97
10 w10d3 68 0
10 w11d1 71 0
10 w11d2 73 0
10 w11d3 75 0
10 w12d1 78 0
10 w12d2 80 0
10 w12d3 82 0
11 w1d1 1 119 128 76 95 95
11 w1d2 3 128 75 115 115
11 w1d3 5 128 73 113 113
11 w2d1 8 119 128 76 114 114
11 w2d2 10 128 78 100 100
11 w2d3 12 128 75 114 114
11 w3d1 15 118 128 75 109 109
11 w3d2 17 128 75 110 110
11 w3d3 19 128 82 112 112
11 w4d1 22 119 128 85 126 126
11 w4d2 24 128 74 104 104
11 w4d3 26 128 85 108 108
11 w5d1 29 119 128 89 116 116
11 w5d2 31 128 87 115 115
11 w5d3 33 128 89 109 109
11 w6d1 36 119.4 128 95 120 120
11 w6d2 38 128 98 116 116
11 w6d3 40 128 87 100 100
11 w7d1 43 118.6 128 90 111 111
11 w7d2 45 128 81 120 120
11 w7d3 47 128 86 108 108
11 w8d1 50 118.9 128 83 105 105
11 w8d2 52 128 84 120 115 120
11 w8d3 54 118 128 81 112 122 122
11 w9d1 57 128 80 99 100 100
11 w9d2 59 128 92 118 120 120
11 w9d3 61 128 87 120 119 120
11 w10d1 64 0
11 w10d2 66 0
11 w10d3 68 0
11 w11d1 71 0
11 w11d2 73 0
11 w11d3 75 0
11 w12d1 78 0
11 w12d2 80 0
11 w12d3 82 0
12 w1d1 1 0
12 w1d2 3 0
12 w1d3 5 0
12 w2d1 8 0
12 w2d2 10 0
12 w2d3 12 0
12 w3d1 15 0
12 w3d2 17 0
12 w3d3 19 0
12 w4d1 22 0
12 w4d2 24 0
12 w4d3 26 0
12 w5d1 29 0
12 w5d2 31 0
12 w5d3 33 0
12 w6d1 36 0
12 w6d2 38 0
12 w6d3 40 0
12 w7d1 43 0
12 w7d2 45 0
12 w7d3 47 0
12 w8d1 50 0
12 w8d2 52 0
12 w8d3 54 0
12 w9d1 57 0
12 w9d2 59 0
12 w9d3 61 0
12 w10d1 64 0
12 w10d2 66 0
12 w10d3 68 0
12 w11d1 71 0
12 w11d2 73 0
12 w11d3 75 0
12 w12d1 78 0
12 w12d2 80 0
12 w12d3 82 0
13 w1d1 1 63 139 80 95 95
13 w1d2 3 139 75 97 97
13 w1d3 5 139 75 98 98
13 w2d1 8 63.8 139 77 89 89
13 w2d2 10 139 76 100 100
13 w2d3 12 139 80 87 87
13 w3d1 15 64.6 139 83 1034 1034
13 w3d2 17 139 79 86 86
13 w3d3 19 139 75 99 99
13 w4d1 22 63.8 139 79 104 104
13 w4d2 24 139 72 99 99
13 w4d3 26 139 76 92 92
13 w5d1 29 64.5 139 87 95 95
13 w5d2 31 139 77 88 88
13 w5d3 33 139 89 91 91
13 w6d1 36 64.5 139 65 101 101
13 w6d2 38 139 75 104 104
13 w6d3 40 139 68 98 98
13 w7d1 43 63.4 139 76 88 88
13 w7d2 45 139 76 80 80
13 w7d3 47 139 80 85 85
13 w8d1 50 63.4 139 76 102 102
13 w8d2 52 139 82 99 99
13 w8d3 54 139 89 122 122
13 w9d1 57 62.8 139 94 105 105
13 w9d2 59 139 85 107 107
13 w9d3 61 139 99 115 115
13 w10d1 64 64.3 139 67 90 90
13 w10d2 66 139 86 99 99
13 w10d3 68 139 76 109 109
13 w11d1 71 64.1 139 80 96 96
13 w11d2 73 139 56 111 111
13 w11d3 75 139 71 99 99
13 w12d1 78 64 139 83 90 90
13 w12d2 80 0
13 w12d3 82 0
14 w1d1 1 79 132 69 73 73
14 w1d2 3 132 69 77 77
14 w1d3 5 132 78 80 80
14 w2d1 8 79.2 132 66 100 100
14 w2d2 10 132 67 95 95
14 w2d3 12 132 92 95 95
14 w3d1 15 79.5 132 72 91 91
14 w3d2 17 132 70 84 84
14 w3d3 19 132 72 104 104
14 w4d1 22 80.1 132 75 95 95
14 w4d2 24 132 64 108 108
14 w4d3 26 132 72 99 99
14 w5d1 29 78.8 132 69 108 108
14 w5d2 31 132 69 99 99
14 w5d3 33 132 70 99 99
14 w6d1 36 79.7 132 65 99 99
14 w6d2 38 132 79 102 102
14 w6d3 40 132 73 83 83
14 w7d1 43 79.9 132 66 80 80
14 w7d2 45 132 75 92 92
14 w7d3 47 132 80 93 93
14 w8d1 50 78.9 132 66 96 96
14 w8d2 52 132 79 121 92 121
14 w8d3 54 132 67 96 88 96
14 w9d1 57 79.9 132 67 96 100 100
14 w9d2 59 132 69 81 99 99
14 w9d3 61 132 66 88 107 107
14 w10d1 64 78.5 132 80 90 115 115
14 w10d2 66 132 77 90 115 115
14 w10d3 68 132 106 115 106 115
14 w11d1 71 78.8 132 74 95 98 98
14 w11d2 73 0
14 w11d3 75 0
14 w12d1 78 0
14 w12d2 80 0
14 w12d3 82 0
15 w1d1 1 106 140 87 100 100
15 w1d2 3 140 81 95 95
15 w1d3 5 140 83 95 95
15 w2d1 8 105 140 75 95 95
15 w2d2 10 140 86 87 87
15 w2d3 12 140 84 104 104
15 w3d1 15 105.9 140 85 95 95
15 w3d2 17 140 86 95 95
15 w3d3 19 140 83 99 99
15 w4d1 22 107.2 140 85 105 105
15 w4d2 24 140 79 95 95
15 w4d3 26 140 75 105 105
15 w5d1 29 106.7 140 94 99 99
15 w5d2 31 140 75 109 109
15 w5d3 33 140 85 90 90
15 w6d1 36 106.2 140 82 95 95
15 w6d2 38 140 79 105 105
15 w6d3 40 140 80 107 107
15 w7d1 43 106.2 140 75 100 100
15 w7d2 45 140 76 90 104 104
15 w7d3 47 140 86 98 96 98
15 w8d1 50 140 78 91 94 94
15 w8d2 52 105.7 140 77 93 80 93
15 w8d3 54 140 74 96 120 120
15 w9d1 57 104.7 140 78 96 98 98
15 w9d2 59 140 77 111 104 111
15 w9d3 61 140 82 96 91 96
15 w10d1 64 0
15 w10d2 66 0
15 w10d3 68 0
15 w11d1 71 0
15 w11d2 73 0
15 w11d3 75 0
15 w12d1 78 0
15 w12d2 80 0
15 w12d3 82 0
16 w1d1 1 55 127 65 85 85
16 w1d2 3 127 65 90 90
16 w1d3 5 127 75 95 95
16 w2d1 8 57.2 127 77 90 90
16 w2d2 10 127 68 95 95
16 w2d3 12 127 75 100 100
16 w3d1 15 57.5 127 64 85 85
16 w3d2 17 127 73 95 95
16 w3d3 19 127 79 100 100
16 w4d1 22 57.1 127 71 95 95
16 w4d2 24 127 72 90 90
16 w4d3 26 127 71 77 77
16 w5d1 29 56.6 127 79 95 95
16 w5d2 31 127 63 64 64
16 w5d3 33 127 72 100 100
16 w6d1 36 57.7 127 67 73 73
16 w6d2 38 127 74 95 95
16 w6d3 40 127 71 75 79 79
16 w7d1 43 57 127 73 99 99 99
16 w7d2 45 127 75 81 84 84
16 w7d3 47 127 72 80 99 99
16 w8d1 50 57.1 127 82 85 95 95
16 w8d2 52 127 68 85 95 95
16 w8d3 54 0
16 w9d1 57 0
16 w9d2 59 0
16 w9d3 61 0
16 w10d1 64 0
16 w10d2 66 0
16 w10d3 68 0
16 w11d1 71 0
16 w11d2 73 0
16 w11d3 75 0
16 w12d1 78 0
16 w12d2 80 0
16 w12d3 82 0
17 w1d1 1 0
17 w1d2 3 0
17 w1d3 5 0
17 w2d1 8 0
17 w2d2 10 0
17 w2d3 12 0
17 w3d1 15 0
17 w3d2 17 0
17 w3d3 19 0
17 w4d1 22 0
17 w4d2 24 0
17 w4d3 26 0
17 w5d1 29 0
17 w5d2 31 0
17 w5d3 33 0
17 w6d1 36 0
17 w6d2 38 0
17 w6d3 40 0
17 w7d1 43 0
17 w7d2 45 0
17 w7d3 47 0
17 w8d1 50 0
17 w8d2 52 0
17 w8d3 54 0
17 w9d1 57 0
17 w9d2 59 0
17 w9d3 61 0
17 w10d1 64 0
17 w10d2 66 0
17 w10d3 68 0
17 w11d1 71 0
17 w11d2 73 0
17 w11d3 75 0
17 w12d1 78 0
17 w12d2 80 0
17 w12d3 82 0
18 w1d1 1 65 122 69 90 90
18 w1d2 3 122 73 100 100
18 w1d3 5 122 65 90 90
18 w2d1 8 65 122 67 95 95
18 w2d2 10 122 70 100 100
18 w2d3 12 122 64 93 93
18 w3d1 15 64 122 67 91 91
18 w3d2 17 122 60 99 99
18 w3d3 19 122 67 95 95
18 w4d1 22 64 122 65 90 90
18 w4d2 24 122 75 93 93
18 w4d3 26 122 72 90 90
18 w5d1 29 64.4 122 68 90 90
18 w5d2 31 122 71 93 93
18 w5d3 33 122 71 90 90
18 w6d1 36 65.1 122 73 89 89
18 w6d2 38 122 70 86 86
18 w6d3 40 122 78 97 98 98
18 w7d1 43 64.2 122 78 99 79 99
18 w7d2 45 122 78 90 90 90
18 w7d3 47 122 73 94 90 94
18 w8d1 50 64.6 122 73 91 92 92
18 w8d2 52 122 56 89 84 89
18 w8d3 54 0
18 w9d1 57 0
18 w9d2 59 0
18 w9d3 61 0
18 w10d1 64 0
18 w10d2 66 0
18 w10d3 68 0
18 w11d1 71 0
18 w11d2 73 0
18 w11d3 75 0
18 w12d1 78 0
18 w12d2 80 0
18 w12d3 82 0
19 w1d1 1 80 122 65 80 80
19 w1d2 3 122 66 99 99
19 w1d3 5 122 78 80 80
19 w2d1 8 82 122 76 75 75
19 w2d2 10 122 69 75 75
19 w2d3 12 122 67 64 64
19 w3d1 15 81.5 122 69 97 97
19 w3d2 17 122 69 90 90
19 w3d3 19 122 70 97 97
19 w4d1 22 81.9 122 61 80 80
19 w4d2 24 122 79 90 90
19 w4d3 26 122 64 99 99
19 w5d1 29 81.9 122 69 72 72
19 w5d2 31 0
19 w5d3 33 0
19 w6d1 36 0
19 w6d2 38 0
19 w6d3 40 0
19 w7d1 43 0
19 w7d2 45 0
19 w7d3 47 0
19 w8d1 50 0
19 w8d2 52 0
19 w8d3 54 0
19 w9d1 57 0
19 w9d2 59 0
19 w9d3 61 0
19 w10d1 64 0
19 w10d2 66 0
19 w10d3 68 0
19 w11d1 71 0
19 w11d2 73 0
19 w11d3 75 0
19 w12d1 78 0
19 w12d2 80 0
19 w12d3 82 0
20 w1d1 1 73 126 75 100 100
20 w1d2 3 126 88 95 95
20 w1d3 5 126 83 100 100
20 w2d1 8 73 126 75 100 100
20 w2d2 10 126 86 103 103
20 w2d3 12 126 78 92 92
20 w3d1 15 73.3 126 81 105 105
20 w3d2 17 126 75 101 101
20 w3d3 19 126 77 100 100
20 w4d1 22 73.5 126 75 105 105
20 w4d2 24 126 75 105 105
20 w4d3 26 126 73 100 100
20 w5d1 29 74.6 126 80 105 105
20 w5d2 31 126 80 103 103
20 w5d3 33 126 75 109 109
20 w6d1 36 73.3 126 81 105 105
20 w6d2 38 126 78 103 103
20 w6d3 40 126 81 109 109
20 w7d1 43 73.8 126 80 109 109
20 w7d2 45 126 77 109 109
20 w7d3 47 126 77 95 95
20 w8d1 50 73.3 126 75 93 85 93
20 w8d2 52 126 81 104 97 104
20 w8d3 54 126 93 106 92 106
20 w9d1 57 73.2 126 82 124 98 124
20 w9d2 59 126 82 111 98 111
20 w9d3 61 126 86 118 92 118
20 w10d1 64 73.1 126 75 115 115 115
20 w10d2 66 126 81 107 116 116
20 w10d3 68 126 75 105 99 105
20 w11d1 71 73.8 126 83 110 101 110
20 w11d2 73 126 85 112 112 112
20 w11d3 75 0
20 w12d1 78 0
20 w12d2 80 0
20 w12d3 82 0
21 w1d1 1 0
21 w1d2 3 0
21 w1d3 5 0
21 w2d1 8 0
21 w2d2 10 0
21 w2d3 12 0
21 w3d1 15 0
21 w3d2 17 0
21 w3d3 19 0
21 w4d1 22 0
21 w4d2 24 0
21 w4d3 26 0
21 w5d1 29 0
21 w5d2 31 0
21 w5d3 33 0
21 w6d1 36 0
21 w6d2 38 0
21 w6d3 40 0
21 w7d1 43 0
21 w7d2 45 0
21 w7d3 47 0
21 w8d1 50 0
21 w8d2 52 0
21 w8d3 54 0
21 w9d1 57 0
21 w9d2 59 0
21 w9d3 61 0
21 w10d1 64 0
21 w10d2 66 0
21 w10d3 68 0
21 w11d1 71 0
21 w11d2 73 0
21 w11d3 75 0
21 w12d1 78 0
21 w12d2 80 0
21 w12d3 82 0
22 w1d1 1 0
22 w1d2 3 0
22 w1d3 5 0
22 w2d1 8 0
22 w2d2 10 0
22 w2d3 12 0
22 w3d1 15 0
22 w3d2 17 0
22 w3d3 19 0
22 w4d1 22 0
22 w4d2 24 0
22 w4d3 26 0
22 w5d1 29 0
22 w5d2 31 0
22 w5d3 33 0
22 w6d1 36 0
22 w6d2 38 0
22 w6d3 40 0
22 w7d1 43 0
22 w7d2 45 0
22 w7d3 47 0
22 w8d1 50 0
22 w8d2 52 0
22 w8d3 54 0
22 w9d1 57 0
22 w9d2 59 0
22 w9d3 61 0
22 w10d1 64 0
22 w10d2 66 0
22 w10d3 68 0
22 w11d1 71 0
22 w11d2 73 0
22 w11d3 75 0
22 w12d1 78 0
22 w12d2 80 0
22 w12d3 82 0
23 w1d1 1 92 122 75 95 95
23 w1d2 3 122 77 96 96
23 w1d3 5 122 74 96 96
23 w2d1 8 93.6 122 86 100 100
23 w2d2 10 122 77 91 91
23 w2d3 12 122 83 100 100
23 w3d1 15 93 122 88 105 105
23 w3d2 17 122 80 100 100
23 w3d3 19 122 72 100 100
23 w4d1 22 93 122 79 99 99
23 w4d2 24 122 79 91 91
23 w4d3 26 122 80 95 95
23 w5d1 29 93 122 77 95 97 97
23 w5d2 31 122 80 88 95 95
23 w5d3 33 122 86 99 105 105
23 w6d1 36 94 122 80 88 96 96
23 w6d2 38 122 73 90 99 99
23 w6d3 40 122 79 86 101 101
23 w7d1 43 94 122 74 89 99 99
23 w7d2 45 122 79 95 94 95
23 w7d3 47 122 80 93 93 93
23 w8d1 50 94.2 122 72 93 93 93
23 w8d2 52 122 74 96 96 96
23 w8d3 54 122 73 95 90 95
23 w9d1 57 0
23 w9d2 59 0
23 w9d3 61 0
23 w10d1 64 0
23 w10d2 66 0
23 w10d3 68 0
23 w11d1 71 0
23 w11d2 73 0
23 w11d3 75 0
23 w12d1 78 0
23 w12d2 80 0
23 w12d3 82 0
24 w1d1 1 75 131 85 95 95
24 w1d2 3 131 75 95 95
24 w1d3 5 131 75 95 95
24 w2d1 8 74 131 84 95 95
24 w2d2 10 131 85 100 100
24 w2d3 12 131 84 90 90
24 w3d1 15 74.5 131 87 95 95
24 w3d2 17 131 83 100 100
24 w3d3 19 131 73 120 120
24 w4d1 22 74.9 131 82 125 125
24 w4d2 24 131 75 100 100
24 w4d3 26 131 87 100 100
24 w5d1 29 73.3 131 82 121 121
24 w5d2 31 131 84 122 122
24 w5d3 33 131 74 100 100
24 w6d1 36 70.9 131 76 95 95
24 w6d2 38 131 75 100 100
24 w6d3 40 131 75 80 79 80
24 w7d1 43 70.8 131 90 99 90 99
24 w7d2 45 131 82 98 90 98
24 w7d3 47 131 76 87 83 87
24 w8d1 50 71.6 131 83 85 90 90
24 w8d2 52 131 83 85 90 90
24 w8d3 54 131 80 88 95 95
24 w9d1 57 70.9 131 80 96 99 99
24 w9d2 59 131 86 85 90 90
24 w9d3 61 131 81 97 97 97
24 w10d1 64 71 131 78 99 89 99
24 w10d2 66 131 84 103 95 103
24 w10d3 68 131 82 87 94 94
24 w11d1 71 0
24 w11d2 73 0
24 w11d3 75 0
24 w12d1 78 0
24 w12d2 80 0
24 w12d3 82 0
25 w1d1 1 0
25 w1d2 3 0
25 w1d3 5 0
25 w2d1 8 0
25 w2d2 10 0
25 w2d3 12 0
25 w3d1 15 0
25 w3d2 17 0
25 w3d3 19 0
25 w4d1 22 0
25 w4d2 24 0
25 w4d3 26 0
25 w5d1 29 0
25 w5d2 31 0
25 w5d3 33 0
25 w6d1 36 0
25 w6d2 38 0
25 w6d3 40 0
25 w7d1 43 0
25 w7d2 45 0
25 w7d3 47 0
25 w8d1 50 0
25 w8d2 52 0
25 w8d3 54 0
25 w9d1 57 0
25 w9d2 59 0
25 w9d3 61 0
25 w10d1 64 0
25 w10d2 66 0
25 w10d3 68 0
25 w11d1 71 0
25 w11d2 73 0
25 w11d3 75 0
25 w12d1 78 0
25 w12d2 80 0
25 w12d3 82 0
26 w1d1 1 0
26 w1d2 3 0
26 w1d3 5 0
26 w2d1 8 0
26 w2d2 10 0
26 w2d3 12 0
26 w3d1 15 0
26 w3d2 17 0
26 w3d3 19 0
26 w4d1 22 0
26 w4d2 24 0
26 w4d3 26 0
26 w5d1 29 0
26 w5d2 31 0
26 w5d3 33 0
26 w6d1 36 0
26 w6d2 38 0
26 w6d3 40 0
26 w7d1 43 0
26 w7d2 45 0
26 w7d3 47 0
26 w8d1 50 0
26 w8d2 52 0
26 w8d3 54 0
26 w9d1 57 0
26 w9d2 59 0
26 w9d3 61 0
26 w10d1 64 0
26 w10d2 66 0
26 w10d3 68 0
26 w11d1 71 0
26 w11d2 73 0
26 w11d3 75 0
26 w12d1 78 0
26 w12d2 80 0
26 w12d3 82 0
0
HR% TempPre TempPost TempChange cardio*Speed Time weights Resistance*dur.** RPE CR10
58 37 37 0 15 4 15 13 13
58 36.1 36.4 K0.3 2.3 15 2 15 13 13
62 36.9 37.1 K0.2 3 15 3 15 13 13
58 37.1 36.4 0.7 2.4 15 2 15 15 14
58 37.2 37.1 0.1 2.2 15 4 15 13 14
62 36.9 36.9 0 2.7 15 1 15 15 17
0 0
56 36.4 36.6 K0.2 2 15 2 15 14 15
61 37.1 36.4 0.7 3 15 1 15 13 15
52 36.2 36.2 0 3 15 1 15 13 15
60 36.3 36.2 0.1 3 15 1 15 13 15
53 36.7 36 0.7 3 15 1 15 13 15
62 36.2 36.4 K0.2 3.3 15 1 15 13 17
66 36.5 36.2 0.3 3.5 15 2 15 11 15
62 36.7 36.5 0.2 3.5 15 1 15 13 15
62 36.6 36.2 0.4 3.7 15 2 15 13 17
60 36.6 36.2 0.4 3.7 15 2 15 15 17
60 36.6 36.2 0.4 3.8 15 2 15 13 18
0 0
56 36.6 36.2 0.4 3 15 1 15 15 15
0 0
62 36.5 36.9 K0.4 4 15 2 15 11 13
62 36.5 36.5 0 3 15 1.36 15 11 17
64 0
68 36.5 35.9 0.6 4.5 15 2 15 11 17
75 0
68 35.9 35.9 0 5 15 2 15 13 17
0 0
80 35.9 36.6 K0.7 5 15 2 15 13 15
79 36.5 36.9 K0.4 5 15 2 15 13 15
66 36.9 36.4 0.5 5 15 2 15 13 16
62 37 36.4 0.6 5 15 2.5 15 12 15
83 36.4 36.5 K0.1 5.5 15 1.25 15 11 16
80 36.5 36 0.5 5 15 2 15 11 15
70 36.6 36 0.6 5 15 2 15 11 15
0 0
68 37 36 1 0.5 30 14
74 37 36 1 0.5 30 14
64 37 36 1 2 30 16
68 37 37 0 1 30 13
71 37 36 1 1 30 14
69 37 37 0 2 30 12
68 36 36 0 2 30 13
68 37 36 1 1 30 13
71 36 36 0 1 30 13
68 36 36 0 1 30 12
79 36 36 0 1 30 13
68 36 36 0 1 30 13
68 36 36 0 1 30 12
68 36 36 0 1 30 13
68 36 36 0 2 30 12
56 37 36 1 1 30 12
68 37 36 1 1 30 12
68 37 36 1 1 30 12
64 36 36 0 1 30 13
64 36.7 36.5 0.2 2 30 13
66 36.6 36.5 0.1 0.5 30 12
59 36.5 36.2 0.3 3 30 13
59 36.6 36.5 0.1 1 30 12
66 37.1 37.9 K0.8 2 30 12
71 36.9 36.9 0 1.5 30 12
71 36.8 37 K0.2 2 30 12
67 37.3 36.9 0.4 1.5 30 12
64 37.2 36.9 0.3 2 30 12
62 37.1 37 0.1 1.3 30 12
64 37 36.4 0.6 2 30 12
56 36.7 36.5 0.2 3 30 12
60 36.9 36.7 0.2 3 30 12
64 36.9 36.3 0.6 2 30 10
#DIV/0! 0
#DIV/0! 0
#DIV/0! 0
70 36 36 0 0.7 15 1 15 13 13
73 37 37 0 2.9 15 1 15 13 13
74 37 37 0 7.5 15 2 15 11 14
74 37 37 0 2.9 10 2 15 12 15
75 37 36 1 3.4 15 2 15 12 15
73 36 36 0 5 15 1 15 12 14
70 37 36 1 5 15 2 15 14 13
73 37 37 0 9 15 1 15 12 12
74 37 37 0 5 15 2 15 12 12
70 36 36 0 2 14 0.5 15 13 14
73 37 36 1 2.5 15 2 15 14 13
72 37 36 1 4 15 2 15 12 14
77 36 36 0 2.4 15 3 15 12 15
70 37 36 1 6 15 3 15 10 15
71 37 36 1 2 15 2 15 13 12
85 37 36 1 2.2 15 1 15 12 14
63 73 36 37 3 15 3 15 12 14
74 37 37 0 3.2 15 2 15 13 14
82 37 37 0 4 9 1 15 11 13
93 37 36 1 3.2 9 2 15 14 14
92 36.7 36.8 K0.1 6.3 15 1 15 12 12
93 36.7 36.5 0.2 3.9 15 2 15 14 14
82 36.8 36.6 0.2 3.6 15 1 15 13 12
90 37 36.5 0.5 4 15 1.6 15 13 13
71 37.2 37 0.2 5 15 2 15 13 12
93 36.9 36.5 0.4 3.3 15 3 15 11 12
82 37.1 36.8 0.3 3.3 15 2 15 11 12
86 36.9 36.7 0.2 3.5 15 2 15 12 13
93 36.8 36.7 0.1 3.8 15 2.5 15 12 12
81 3701 36.9 3664.1 3.8 15 3 15 12 13
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67 37 37 0 1 13 0.5 15 12 13
63 37 37 0 3.5 15 1 15 11 11
95 37 37 0 1 15 1 15 11 11
67 37 37 0 3.5 15 1 15 10 10
71 37 37 0 3.4 15 1 15 13 19
67 37 37 0 4.3 15 2.5 15 11 13
82 37 37 0 4.4 15 1 15 13 15
71 37 37 0 5 15 1 15 13 15
70 37 37 0 2.5 15 1 15 10 11
61 37 37 0 2 15 1 15 11 11
70 37 37 0 3.5 15 1 15 13 15
73 37 37 0 3.7 15 1 15 11 15
59 37 37 0 3.6 15 2 15 10 15
69 37 37 0 4 15 2 15 10 18
60 37 37 0 4 15 2 15 11 12
71 37 37 0 3.5 15 1 15 11 12
63 37 37 0 7 15 1 15 11 13
81 37 37 0 3.5 15 1 15 11 15
74 37 37 0 3.5 15 1 15 11 15
81 37.9 38.1 K0.2 4.5 15 3 15 14 15
74 37.7 37.5 0.2 4.3 15 1 15 12 15
87 37.2 37.2 0 4.1 15 3 15 10 15
75 37 37.3 K0.3 4.2 15 2 15 11 15
81 37 37.5 K0.5 4.5 15 3 15 12 12
81 37 37.2 K0.2 7.1 15 2 15 10 13
89 36.6 37.4 K0.8 4.5 15 3 15 14 10
95 37.5 37.3 0.2 5 15 2.5 15 11 12
#DIV/0! 0
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#DIV/0! 0
81 36 36 0 2.5 15 2 15 12 12
83 37 37 0 2.3 15 2 15 12 13
85 36 37 K1 3.5 15 2.5 15 11 12
79 36 37 K1 3.5 15 2.5 15 11 11
74 36 36 0 3 15 2.5 15 11 11
91 36 37 K1 3 15 2.5 15 11 12
89 36 36 0 4.1 15 2.5 15 11 11
83 36 36 0 4.1 15 2.5 15 11 10
74 36 36 0 2 15 2.5 15 11 12
75 36 36 0 4 15 2.5 15 10 11
78 36 36 0 4.5 15 2.5 15 10 11
79 37 37 0 5 15 2.5 15 11 11
73 36 36 0 5.3 15 5 15 12 13
80 36 36 0 5.5 15 5 15 12 12
81 37 36 1 5.2 15 2.5 15 13 12
80 36 36 0 5.2 15 5 15 12 12
79 36 36 0 5.6 15 5 15 12 11
77 36 36 0 5.3 15 5 15 12 12
85 36 36 0 5.3 15 2.5 15 12 12
84 36 36 0 5.5 15 5 15 12 13
76 36.2 36.4 K0.2 6.5 15 2.5 15 12 14
75 36.3 36.6 K0.3 5.5 15 5 15 12 14
75 36.8 36.6 0.2 5.5 15 5 15 11 12
81 36.7 36.5 0.2 5.4 15 5 15 11 11
94 36.7 36.6 0.1 6.2 15 6.2 15 11 11
83 36.7 36.7 0 5.5 15 5 15 11 11
89 36.7 36.2 0.5 6.6 15 5 15 11 11
74 36.6 36.6 0 6.3 15 5 15 11 11
85 36.6 36.8 K0.2 6.6 15 5 15 11 11
93 36.6 36.6 0 5.7 15 2.5 15 11 11
79 36.4 36.5 K0.1 6 15 5 15 11 10
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74 36 36 0 1.3 15 0.5 15 12 14
65 36 36 0 1 15 2.5 15 13 11
74 36 36 0 2.9 15 1 15 12 12
71 36 36 0 2.9 15 0.5 15 12 11
70 37 37 0 2 15 0.5 15 13 13
60 36 36 0 1.3 15 0.5 15 11 12
64 36 36 0 1.5 15 1 15 13 11
74 36 36 0 1.5 15 0.5 15 12 12
56 36 36 0 1.3 15 2 15 12 11
59 37 36 1 1.5 15 5 15 12 12
61 36 36 0 1.5 15 1 15 11 11
57 36 37 K1 1.5 15 0.5 15 12 13
69 36 36 0 1.5 15 0.5 15 11 11
65 36 36 0 1.6 15 1 15 11 11
57 37 36 1 1.7 15 1 15 12 12
69 36 36 0 1.6 15 1 15 11 12
65 36 36 0 1.8 15 1 15 13 11
57 36 36 0 1.9 15 0.5 15 13 12
59 36.8 36.9 K0.1 1.7 15 0.5 15 12 11
64 37 36.8 0.2 2.2 15 0.5 15 12 12
76 37.2 36.4 0.8 2.2 15 1 15 11 11
65 36.9 36.8 0.1 2.3 15 1.5 15 13 12
63 36.7 36.3 0.4 2.3 15 1.2 15 12 12
59 36.6 35.8 0.8 2.3 15 1 15 11 11
76 36.6 35.8 0.8 2.4 15 1.9 15 11 11
66 36.6 36 0.6 2.2 15 2.5 15 12 13
63 36.5 36.1 0.4 2.4 15 5 15 12 12
61 36.4 36 0.4 2.5 15 2 15 12 11
64 36.7 36.07 0.63 2.5 15 2 15 11 9
#DIV/0! 0
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#DIV/0! 0
#DIV/0! 0
74 36 36 0 4.3 15 2 15 11 11
90 36 36 0 4.3 15 2 15 11 15
88 36 36 0 4.3 15 3 15 11 11
89 36 36 0 5 15 3 15 11 12
78 36 36 0 5.5 15 3 15 11 12
89 36 36 0 5.5 15 5 15 12 12
85 36 36 0 5.5 15 5 15 11 11
86 36 37 K1 5.5 15 5 15 11 12
88 37 36 1 5.5 15 5 15 11 11
98 36 37 K1 5.5 15 5 15 11 11
81 36 36 0 5.5 15 5 15 11 12
84 36 37 K1 5.5 15 5 15 12 11
91 36 36 0 5.5 15 5 15 13 11
90 36 37 K1 5.5 15 2.5 15 12 12
85 36 36 0 5.5 15 5 15 12 12
94 36 36 0 5.5 15 2.5 15 12 11
91 36 36 0 5.5 15 5 15 12 12
78 36 36 0 5.5 15 5 15 11 11
87 36 36 0 5.5 15 5 15 11 11
94 36 36 0 5.5 15 2.5 15 11 11
84 36 36 0 5.5 15 5 15 10 10
82 36 36 0 5.5 15 5 15 10 11
94 36.1 36.7 K0.6 5.5 15 5 15 11 11
95 36.9 36.3 0.6 5.5 15 5 15 11 11
78 37 36.8 0.2 6 15 5 15 11 11
94 36.9 36.8 0.1 5.5 15 5 15 11 11
94 36.4 36.6 K0.2 5.6 15 5 15 11 11
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68 36 36 0 30 14
70 37 37 0 30 13
71 36 37 K1 1 30 13
64 37 37 0 1 30 11
72 36 37 K1 1 30 11
63 37 37 0 1 30 11
744 36 37 K1 1 30 11
62 36 37 K1 2 30 11
71 37 37 0 1 30 13
75 36 37 K1 1 30 11
71 37 37 0 0.5 30 12
66 36 37 K1 1 30 11
68 36 37 K1 1 30 13
63 36 37 K1 2 30 11
65 36 36 0 1 30 12
73 37 37 0 2 30 11
75 36 37 K1 1 30 15
71 37 37 0 2 30 11
63 36 37 K1 1 30 15
58 37 37 0 1 30 11
61 36 37 K1 2 30 13
73 36 37 K1 2.5 30 13
71 36.8 37 K0.2 1 30 11
88 37 37.2 K0.2 1 30 12
76 37.2 37.2 0 2 30 11
77 37.1 37 0.1 2 30 12
83 36.4 36.9 K0.5 2 30 11
65 37.2 36.9 0.3 2 30 13
71 37.6 37.4 0.2 2 30 11
78 37.7 37.6 0.1 2 30 13
69 37.5 37.4 0.1 2 30 11
80 37.5 37.5 0 2 30 12
71 37.3 37.2 0.1 2 30 11
65 37.6 37.6 0 4 30 13
#DIV/0! 0
#DIV/0! 0
55 35.8 35.9 K0.1 3.2 15 1 15 11 13
58 35.5 36.7 K1.2 5.3 15 1 15 11 13
61 36.5 36.1 0.4 3.5 15 1 15 13 13
76 36.5 36.8 K0.3 3.2 15 1 15 15 15
72 36.7 36.5 0.2 3.5 15 3 15 13 13
72 36.4 36.5 K0.1 3.1 15 1 15 13 13
69 36.5 36.8 K0.3 3.3 15 3 15 15 16
64 36.7 36.8 K0.1 3.1 15 3 15 16 17
79 36.6 37.3 K0.7 3.5 15 2 15 17 17
72 36.3 36 0.3 3.2 15 1.5 15 11 12
82 36.3 37 K0.7 3.1 15 2 15 14 14
75 36.1 36.9 K0.8 3.4 15 1 15 15 14
82 36 37 K1 3.3 15 1 15 15 15
75 36.1 36.7 K0.6 3.6 15 2.5 15 15 17
75 36.2 36.4 K0.2 3.5 15 2.5 15 15 15
75 36.3 36.7 K0.4 3.7 15 2.5 15 13 16
77 36.2 36.6 K0.4 3.7 15 2.5 15 15 16
63 35.5 36.8 K1.3 3.7 15 2.5 15 15 13
61 36 36.6 K0.6 3.5 15 2.5 15 13 12
70 36.2 36.8 K0.6 3.8 15 2 15 15 15
70 36 36.8 K0.8 3.4 15 2.5 15 15 17
73 35.9 36.2 K0.3 3.4 15 1.5 15 17 14
92 36 36.8 K0.8 3.4 15 2.5 15 15 15
73 36.2 36.6 K0.4 3.3 13 2.5 15 13 16
76 36 36.6 K0.6 3.2 15 2 15 15 16
75 36.1 36.3 K0.2 3.3 13 2.5 15 13 15
81 36.1 36.3 K0.2 3.3 15 2.5 15 13 15
87 36.2 36.8 K0.6 3.3 15 2.5 15 14 14
87 36.2 36.1 0.1 3.3 13 2.5 15 14 14
87 36.7 36.8 K0.1 3 15 5 15 14 14
74 36.3 36 0.3 3.3 15 2.5 15 14 14
#DIV/0! 0
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#DIV/0! 0
71 37 37 0 3 15 15 13 10
68 37 37 0 2.5 15 15 13 12
68 37 37 0 3.4 15 1 15 11 11
68 37 37 0 3.4 15 2.5 15 11 12
62 37 37 0 3 15 3.5 15 12 11
74 37 37 0 3.5 15 4 15 11 12
68 36 37 K1 4.5 15 3 15 11 12
68 37 37 0 4.5 15 1 15 13 13
71 37 37 0 4.5 15 3 15 13 12
75 37 37 0 4.5 15 3 15 13 13
68 37 37 0 4.5 15 3 15 13 11
75 37 37 0 4.5 15 3 15 13 13
71 37 36 1 4.5 15 3 15 15 13
78 37 37 0 4.5 15 3 15 13 15
64 37 37 0 4.8 15 3 15 13 11
68 37 37 0 5 15 3 15 13 15
75 37 37 0 5 15 3 15 16 15
76 37 37 0 5 15 3 15 15 12
71 37 37 0 5 15 4 15 13 11
74 37 36.8 0.2 5 15 2.5 15 13 15
70 37.4 37.4 0 4.5 15 3 15 12 12
67 37.4 37.2 0.2 5 15 3 15 12 13
66 37.3 37 0.3 6 15 3 15 11 9
86 37.3 36.5 0.8 3 15 3 15 9 11
70 37.9 36.9 1 3 15 3 15 11 15
79 36.9 36.8 0.1 5 15 3 15 11 9
69 36.9 36.8 0.1 5 15 4 15 11 9
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67 36 37 K1 2 15 0.5 15 15 16
71 37 36 1 3 15 1 13 13 11
75 37 37 0 2.2 15 0.5 13 13 11
71 37 37 0 2.2 15 0.5 13 11 11
75 37 36 1 2.2 15 0.5 13 13 11
79 37 37 0 2.2 15 2 16 13 15
67 36 36 0 2.2 15 2 15 13 15
75 36 36 0 2.2 15 0.5 13 13 13
79 36 37 K1 2.2 15 0.5 11 11 13
75 36 37 K1 2.2 15 1 12 12 13
71 37 37 0 2.2 15 0.5 13 13 12
61 36 37 K1 2.2 15 1 12 12 13
75 36 36 0 2.2 15 0.5 11 11 12
50 37 37 0 2.2 15 1 11 11 12
79 37 37 0 2.2 15 0.5 15 10 11
57 36 37 K1 5 15 1 15 11 12
75 36 36 0 2.2 15 1 15 11 11
62 36.7 36.9 K0.2 2.2 15 1 15 11 12
78 36.7 36.6 0.1 2.5 15 1 15 12 11
66 36.7 37.2 K0.5 2.2 15 1 15 13 11
78 37.1 37.1 0 2.4 15 0.5 15 11 11
75 37.1 37.4 K0.3 2.4 15 1.3 15 10 11
75 37 37.2 K0.2 2.4 15 1 15 10 12
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74 37 37 0 2 15 1 15 16 15
82 36 36 0 2.5 15 1.5 15 13 17
74 37 36 1 2.5 15 1.5 15 13 12
78 36 37 K1 3 15 1.5 15 11 20
82 36 37 K1 2.5 15 1 15 15 15
76 36 36 0 2.5 15 1.5 15 13 9
75 36 37 K1 2.8 15 2 15 14 13
81 36 36 0 3.5 15 2 15 20 16
78 36 36 0 3.5 15 2 15 11 10
74 36 36 0 3.5 15 2 15 10 15
76 36 37 K1 3.6 9 1 15 11 11
74 36 37 K1 3.7 15 2 15 10 11
74 37 36 1 3.5 15 2 15 13 10
76 37 37 0 3.7 15 1 15 11 12
74 36 36 0 3.7 15 2 15 10 8
73 36 36 0 3.5 15 2 15 8 8
70 37.3 37.5 K0.2 3.7 15 3 15 11 11
80 36.9 37 K0.1 3.7 15 1 15 12 12
81 36.6 36.6 0 3.5 15 2 15 12 12
74 36.9 37.1 K0.2 3.7 15 3 15 11 9
77 36.8 36.8 0 3.9 15 3 15 11 12
75 37.1 36.7 0.4 3.3 15 2 15 9 9
73 36.5 36.8 K0.3 3.4 15 3 15 9 8
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66 37 36 1 2 15 1 15 12 12
81 36 36 0 3 15 1 15 12 17
66 36 37 K1 1 15 2 15 15 19
61 36 36 0 2.4 15 1 15 13 13
61 36 36 0 2.5 15 1 15 14 13
52 36 36 0 2 15 0.5 15 15 17
80 36 36 0 1.8 15 1 15 12 13
74 36 36 0 2.3 15 1 15 15 17
80 36 37 K1 2.5 15 2 15 15 11
66 36 36 0 2.3 15 2 15 12 14
74 37 36 1 2.5 15 1 15 11 13
81 37 36 1 2.5 15 1 15 12 11
59 36.9 36.7 0.2 2.5 15 1 15 11 13
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79 36 37 K1 4.2 15 1 15 16 16
75 37 37 0 3 15 2 15 12 11
79 37 37 0 3 15 2 15 8 13
79 37 37 0 3.5 15 2 15 9 11
82 37 36 1 3.5 15 3 15 9 8
73 37 37 0 3.9 15 2.5 15 8 8
83 37 37 0 4.4 15 3 15 11 11
80 37 37 0 4 15 4 15 10 11
79 36 37 K1 4 15 4 15 8 9
83 37 37 0 4 15 1 15 11 12
83 37 37 0 4 15 2 15 13 13
79 36 37 K1 4 15 2 15 12 12
83 37 37 0 4.3 15 2 15 11 10
82 37 37 0 4.3 15 4 15 10 11
87 37 37 0 5 15 3 15 11 12
83 37 37 0 5 15 2 15 11 11
82 37 36 1 5.3 15 2 15 14 13
87 37 37 0 5.5 15 1 15 13 8
87 37 36 1 5.7 15 5 15 11 10
87 36 37 K1 5.7 15 2 15 11 8
75 36 36 0 5.5 15 3 15 10 10
74 37.1 36.9 0.2 4.5 15 2.5 15 11 11
83 36.9 37.2 K0.3 4.5 15 3 15 11 11
84 37.3 36.8 0.5 5 15 2 15 11 11
98 36.9 36.9 0 4.5 15 3 15 11 11
88 36.7 37.1 K0.4 4.5 15 3 15 12 10
94 37 37 0 5 15 3 15 13 11
91 36.9 37 K0.1 3 15 3 15 11 11
92 37.3 37.1 0.2 5 15 3 15 11 11
83 37.2 36.9 0.3 6 15 1.5 15 11 11
87 37.2 37.1 0.1 5 15 3 15 11 11
89 37.5 37.4 0.1 5 15 4 15 9 11
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79 36 35 1 3 15 2.5 15 13 13
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82 36 36 0 3.4 15 2.5 15 12 19
75 36 36 0 3.4 15 5 15 13 15
82 36 36 0 4 15 2.5 15 12 12
86 36 36 0 4.4 15 5 15 12 12
82 36 36 0 3.4 15 2.5 15 13 13
82 36 36 0 3.4 15 5 15 11 12
81 36 35 1 3.4 15 2.5 15 11 13
75 36 36 0 3.5 15 2.5 15 11 11
78 36 36 0 3.4 15 2.5 15 11 13
80 36.1 36.1 0 4 15 2.5 15 12 13
78 36.7 36.3 0.4 4 15 2.5 15 12 13
86 36.4 36.4 0 4 15 2.5 15 14 11
79 36.3 36.3 0 4 15 2.5 15 13 12
81 36.5 36.3 0.2 4 15 2.5 15 11 13
83 35.9 36.2 K0.3 4 15 2.5 15 12 13
81 36.4 36.4 0 4 15 2.5 15 13 11
78 36.5 36.2 0.3 4 15 2.5 15 13 12
76 36.6 36.2 0.4 4 15 2.5 15 11 12
76 36 36.3 K0.3 4 15 4 15 11 12
79 36.3 36.2 0.1 4 15 2.5 15 11 12
78 36.2 36.3 K0.1 4 15 5 15 12 11
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73 36 36 0 2.7 15 2 15 13 13
73 37 36 1 2.7 15 1 15 12 13
73 36 36 0 2.5 15 2.5 15 13 13
76 36 36 0 2.4 15 2.5 15 12 10
69 36 36 0 3.5 15 1 15 12 17
73 36 36 0 3 15 1 15 13 11
76 36 36 0 3.2 15 1 15 11 15
92 36 36 0 3.1 15 2 15 12 10
95 36 37 K1 3.4 15 2 15 13 13
76 36 36 0 3.4 15 2 15 13 13
76 36 36 0 3.4 15 1 15 11 11
92 36 36 0 3.7 15 2 15 13 12
93 36 36 0 3.4 15 1 15 11 11
76 36 36 0 3.5 15 1 15 11 13
73 36 36 0 3.4 15 1 15 9 11
76 36 36 0 3.7 15 0.5 15 9 13
61 35.8 35.5 0.3 3.8 15 1 15 11 12
76 36.3 36.1 0.2 4.1 15 3 15 10 10
75 36.2 36.4 K0.2 4 15 1 15 11 9
66 36.8 36.5 0.3 4.1 15 3 15 11 8
69 36.5 37 K0.5 4.1 15 1.5 15 8 9
69 36.4 36.5 K0.1 4.1 15 1.81 15 8 11
73 36.2 35.9 0.3 4.1 15 1 15 11 13
76 36 36.3 K0.3 5 15 1.8 15 11 11
69 36.6 36.4 0.2 4.1 15 1.8 15 11 11
74 36.3 35.9 0.4 4.1 15 2.5 15 11 12
76 36.5 36.5 0 4.2 15 1 15 8 9
79 36.6 36.3 0.3 4.4 15 1.8 15 8 8
72 36 36.4 K0.4 4.4 15 2 15 8 9
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Interview script: Participant Y (Literal translation of the participant’s account. 
R=Researcher) 
R: Could you describe your foot trip?  
Y: I started the journey with my family early Thursday morning. We walked all day 
stopping only for rest and food, say about 20 minutes after each hour of walking. We 
slept in the open air that night and marched the next day non-stop and arrived at our 
destination on Friday just after midnight. We did the 85 kilometer walk in exactly 55 
hours.  
R: Did you feel tired before the journey?  
Y: Not at all. I was actually feeling refreshed after a good night sleep.  
R: How tired did up you feel during and after the trip?  
Y: Beginning with day 1, tiredness started building up as the day progressed, but it was 
bearable possibly because we used to have some rest every hour. Strangely enough, 
although I used to feel in need of long rest in the afternoon, I carried on walking that day 
and had only the usual short breaks. After sunset, I was feeling really exhausted, and I 
immediately went to sleep.  
R: How was your sleep? How did you feel?  
Y: My sleep is usually disturbed. Not that night. I did feel some pain in my muscles, but I 
ignored it and slept for nearly 8 hours without interruption. Maybe because I was tired. 
When I woke up in the morning, I was still feeling tired but I knew I still had a long way 
to go, and I continued the journey. I was determined to get to my destination, no matter 
what. 
R: Did you not think that the exercise effort might trigger a relapse? Y: Not at all. Had it 
happened, I would have welcomed it. The harder the better, you know (smiling). By the 
way, we had a wheel-chair with us, but it was for my mother-in-law, and she refused to 
use it most of the way.  
R: What about the weather? Any effect?  
Y: It was not bad. Say about 25°c. We got a bit wet one night though. It was drizzly.  
R: Did you take any precautions?  
Y: No precautions whatsoever. Had any of us been blessed by death, others would have 
carried his dead body to Karbala to be buried there.  
R: Apart from tiredness, did you experience any other symptoms?  
Y: Not really. I did stumble twice or three times, but it was the usual thing. Like 
everybody else may, I also used to feel a bit dizzy at the end of the day. It is the sort of 
situation when you have no time to think about yourself. You see the old, the frail, people 
in wheel-chairs or with crutches or walking sticks. All are determined, marching and 
chanting. Then you say to yourself, thank God I am healthy and well. 
R: What about your ability to concentrate? For example when preparing your meals?  
Y: Food was provided free of charge all the way. I was focused only on one thing: to 
make it to the holy shrine in Karbala.  
R: You started talking about the first day of the journey. What about the second?  
Y: Just like the day before, although the distance was longer.  
R: Did you feel more tired than the day before?  
Y: Yes, in the beginning. But when I got to Karbala, you would be surprised if I told you 
that fatigue vanished altogether. It was a feeling I cannot describe. I slept for only three 
???????????? ?
hours or so. I was so excited and waiting impatiently for the dawn to break and start the 
celebrations. On Saturday, the day of Ashura, we spent all day praying and walking inside 
and around the shrine. Nearly eight hours non-stop and without food. I came to realise 
how tired I was only when everything was over. But I did promise Imam Hussein, peace 
be upon him, to go and see him again next year. I have been doing this for the past seven 
years, you know.  
R: How tired did you feel after the pilgrimage? Can you describe that?  
Y: I did actually feel very tired. But after some good rest and sleep, fatigue went back to 
its normal levels. As usual, I do sometimes feel tired during the day, especially in the 
afternoon. But that is bearable.  
R: Yours is an extraordinary story. Some will find it hard to believe.  
Y: It is up to the others to think or believe what they want. In my view, nothing stands in 
the way of true faith. I am not saying that only as a Muslim. A Hindu or a Christian would 
feel and tell you the same. 
 
 Interview guiding questions 
The pre-training interview was focused on the nature of MS fatigue, and the post-training 
interview was meant to gauge participants' attitude towards training. Both were semi-
structured interviews. What follows are only the guiding questions. 
Pre-training interview 
1. Can you describe the difference in fatigue between pre-diagnosis and post-diagnosis with
MS? 
2. Is MS fatigue permanent or transient?
3. How does fatigue progress during the day?
4. How would you describe the fatigue you experience in the morning/afternoon/at night?
5. In your view, what are the factors that alleviate fatigue?
6. What are the factors that reduce fatigue?
7. Can you describe the relationship between fatigue and anxiety (depression, pain, sleep
disorders)? 
8. What is the impact of fatigue on your daily living activities?
9. What is the impact of fatigue on your social activities (and work)?
10. How do you deal with fatigue?
Post training interview 
1. What was your view about exercise before the trail?
2. What motivated you to join the training programme?
3. What do you think about training after you had joined the programme?
4. What are the positive outcomes of the training programme?
5. What are its negative outcomes?
6. What do you think about the training programme in terms of its leaders (participants)?
7. What are your suggestions to improve future training programmes?
8. What are the factors that hinder the participation of MS patients in training?
????????????
RESISTANCE	  PROGRAM	  
1. Sit	  on	  the	  gym	  ball	  in	  a	  good	  posture.
2. Lift	  weights	  to	  your	  shoulders,	  alternating
sides.
3. Fully	  straighten	  your	  elbows	  between	  lifts.
4. Repeat	  10-­‐20	  times	  (as	  advised	  by	  your
supervisor)
1. Begin	  with	  your	  arms	  straight	  over	  your
head.
2. Slowly	  lower	  the	  weights	  over	  your	  head
by	  bending	  your	  elbows.	  Do	  not	  move	  your
elbows.
3. Straighten	  your	  elbows.
4. Repeat	  10-­‐20	  times	  (as	  advised	  by	  your
supervisor)
1. Sit	  on	  the	  gym	  ball	  in	  a	  good	  posture.
2. Keeping	  your	  back	  straight,	  pull	  the	  band
back,	  bringing	  your	  shoulder	  blades
together.
3. Slowly	  release	  the	  band	  back	  to	  the	  starting
position.
4. Repeat	  10-­‐20	  times	  (as	  advised	  by	  your
supervisor).	  Keep	  your	  shoulders	  down	  and
away	  from	  your	  ears.
1. Stand	  against	  the	  wall	  with	  your	  feet	  a	  little
out	  from	  it.
2. Slowly	  lower	  into	  a	  seated	  position.
3. Push	  back	  up	  into	  a	  standing	  position.	  Keep
your	  upper	  back	  against	  the	  wall	  at	  all	  times.
Keep	  your	  head	  up	  and	  gaze	  level.
4. Repeat	  10-­‐20	  times	  (as	  advised	  by	  your
supervisor)
?????????????
1. Stand	  at	  the	  wall,	  you	  may	  hold	  on	  to	  it	  for
balance.
2. Keeping	  your	  knees	  beside	  each	  other	  (not
touching)	  bend	  your	  knee,	  lifting	  your	  heel	  up	  as
far	  as	  you	  can.
3. Slowly	  lower.
4. Repeat	  10-­‐20	  times	  (as	  advised	  by	  your
supervisor)
1. Stand	  against	  the	  wall,	  holding	  hand	  weights.
2. Raise	  onto	  your	  toes,	  slowly	  lower	  all	  the	  way
down.
3. Repeat	  10-­‐20	  times	  (as	  advised	  by	  your
supervisor)
1. Lie	  on	  your	  back	  on	  the	  exercise	  mat	  with	  your
knees	  bent	  and	  feet	  slightly	  apart.
2. Squeeze	  your	  bottom,	  then	  raise	  your	  bottom	  off
the	  floor.
3. Keep	  the	  squeeze	  on	  your	  bottom	  as	  you	  slowly
lower	  all	  the	  way	  down.
4. Repeat	  10-­‐20	  times	  (as	  advised	  by	  your
supervisor)
Lie	  on	  your	  back	  on	  the	  exercise	  mat	  with	  your	  arms	  
and	  legs	  in	  the	  air	  as	  shown	  in	  the	  image.	  
1. Slowly	  lower	  opposite	  arm	  and	  leg	  to	  the	  floor
while	  breathing	  OUT	  (e.g.	  right	  arm-­‐left	  leg).
2. Raise	  back	  up	  into	  starting	  position.
3. Repeat	  with	  the	  opposite	  arm	  and	  leg.
4. Repeat	  10-­‐20	  times	  (as	  advised	  by	  your
supervisor)
1. Lie	  on	  your	  front	  with	  your	  forehead	  on	  a	  rolled-­‐
up	  towel.
2. Raise	  opposite	  arm	  and	  leg	  in	  the	  air	  as	  if	  you
are	  swimming	  as	  you	  breathe	  OUT.	  Slowly
lower.
3. Repeat	  10-­‐20	  times	  (as	  advised	  by	  your
supervisor)
Appendix 17.b 
